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Abstract 
Background  
Administering medication to patients with dysphagia (PWD) is a challenging 
process for patients and healthcare professionals (HCPs). This study aimed to 
improve those administrations by focusing on the development of the elements of a 
pharmacy service providing individualised guidance on the administration of 
medication to older PWD in care homes. The objectives were to: 
- assess the feasibility of a pharmacy service promoting guidance on the 
administration of medication to PWD, 
- identify and develop theory on the elements that affect the administration 
of medication to PWD in care homes, 
- identify outcomes for the modelling process previous to a large scale 
intervention. 
Methods 
A questionnaire was designed to evaluate the acceptability by HCPs of a pharmacy 
service for PWD in hospital wards. Qualitative interviewing was used in care 
homes to explore the perceptions of nurses on the administration of medication to 
PWD and nurse’s acceptability of a pharmacy service providing individualised 
medication administration guides (I-MAGs). Observational drug rounds were 
carried out in care homes to describe the quality, type and frequency of errors in 
the administration of medication to PWD. 
Results 
I-MAGs were well received on the hospital wards and nurses felt more confident 
and time efficient in their practice when the I-MAGs were present on the ward. 
Interviews identified the isolating environment of the care home, the importance of 
formulation choice, the lack of awareness of dysphagia and gaps in nurse’s 
pharmaceutical knowledge as barriers in the medicines management of PWD. 
Observational drug rounds revealed that medicine administration errors (MAEs) in 
care homes (excluding time errors) are three times more frequent in PWD than in 
those without. 
Conclusion 
Medicines management for PWD requires a multidisciplinary approach from 
several HCPs and consequently PWD could benefit from interventions that 
overcome the practice barriers between those HCPs.  
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1. Introduction  
The focus of this thesis is to explore the components involved in the development 
of a complex intervention in medicines management where a community 
pharmacist- led service provides individualised guidance on the administration of 
medication to patients with dysphagia (PWD) in care homes with nursing. This 
chapter describes why such an intervention is complex and reviews the literature 
that identifies the scope of the problems involved in the management of medication 
in older PWD. This chapter will also identify how those components of a complex 
intervention will be reflected in the research projects presented in this dissertation. 
1.1. Development and evaluation of complex interventions: MRC 
guidelines 
This section will outline the revised structure of complex interventions and some 
examples that illustrate the framework of the MRC for complex interventions.(1) 
In 2000, the Medical Research Council (MRC) defined complex interventions as 
those that include several components and its evaluation is difficult because of 
problems of developing, identifying, documenting, and reproducing the 
intervention.(2) Complex interventions included a phased approach to the 
development and evaluation of the interventions that was proposed to help 
researchers define clearly where they were in the research process and that was 
followed by an evaluation combining the use of qualitative and quantitative 
research methods. 
Post-publication several authors identified limitations in the framework and made 
the following recommendations: 
- greater attention to early phase piloting and development work,(3) 
- a less linear model of evaluation process,(4) integration of process and outcome 
evaluation,(5) 
- recognition that complex interventions may work best if they are tailored to 
local contexts rather than completely standardised,(6) 
- and greater use of the insights provided by the theory of complex adaptive 
systems.(7) 
These led to a review of the guidance in 2008 in which the MRC redefined 
complex interventions as those that contain several interacting components within 
the experimental and control interventions as well as: 
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- number and difficulty of behaviours required by those delivering or receiving 
the intervention, 
- number of groups or organisational levels targeted by the intervention, 
- number and variability of outcomes, 
- degree of flexibility or tailoring of the intervention permitted. 
The initial proposal by Campbell et al(2) for complex interventions considered the 
process of development and evaluation of such interventions as having several 
distinct phases that could be compared with the sequential phases of drug 
development. However, this structure was criticised(8) as it did not fit previous 
guidance on randomised controlled trials. The 2008 review of the guidance for 
complex interventions(1) provided a much more detailed but flexible structure on 
the ‘how to’ develop complex interventions. This structure will be described in this 
section. 
The design of a complex intervention should be a cycle containing four main 
phases as indicated in Figure 1. 
 
 
 
 
1.1.1. Theoretical development 
Before evaluating an intervention, it is essential to identify what is already known 
about similar interventions in order to avoid replication and to recognise the 
Feasibility and Piloting 
• Testing procedures 
• Estimating recruitment and 
retention  
• Determining sample size 
 
Development 
• Identifying the evidence base 
• Identifying or developing theory 
• Modelling process and outcomes 
 
Evaluation 
• Assessing effectiveness 
• Understanding change process 
• Assessing cost-effectiveness 
 
Implementation  
• Dissemination 
• Surveillance and monitoring 
• Long term follow-up 
 
Figure 1: Key elements of the development and evaluation process  (Craig et al. 2008, 
page 980)(1) 
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validity of some of the elements of the intervention. This phase should be 
composed by three steps: 
- identifying existing evidence: a thorough and high quality literature review 
about what methods have been used and the results obtained is essential at this 
stage. The MRC recommends that if there is no recent, high quality systematic 
review of the relevant evidence, one should be conducted and updated as the 
evaluation proceeds.(1) This evidence should help identifying an expectable 
effect, 
- identifying and developing theory: this step is the theoretical understanding of 
the intervention and should explore any theories available, the changes that are 
expected when implementing our intervention and the interaction between 
those changes,  
- modelling process and outcomes: s indicated in the MRC guides, modelling a 
complex intervention before a full scale evaluation can provide important 
information about the design of both the intervention and the evaluation. A 
series of studies may be required to progressively refine the design before 
embarking on a full scale evaluation. 
The processes mentioned above are illustrated in the next example. In 2005, 
Eldridge et al(9) developed a cost-effectiveness model of a complex intervention 
from pilot study data in order to inform the viability and design of a subsequent 
falls prevention trial. Two models were used to estimate the probability of falling 
over a 12-month period based on a probability tree and to assess the impact of the 
programme over time.  The results showed that the intervention would only reduce 
the proportion falling by 2.8% over a 12-month period making the intervention not 
cost-effective due to its inability to reach those at risk of falling. However, this 
study highlighted the importance of the model-building approach when designing 
complex trials and where a trial is not possible. 
1.1.2. Assessing feasibility 
This phase explores any challenges that need to be considered with regards to the 
acceptability, compliance, delivery of the intervention, recruitment and retention, 
and smaller than expected effect sizes that could have been predicted by thorough 
piloting. 
As an example, in 2009, Farquhar et al(10) carried out a feasibility study on a novel 
service for patients with persistent breathlessness. It was evaluated using the 
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Medical Research Council's framework for complex interventions. A single-
blinded fast-track pragmatic randomised controlled trial was conducted for patients 
with chronic obstructive pulmonary disease referred to the service. Patients were 
randomised to either receive the intervention immediately for an eight-week period, 
or receive the intervention after an eight-week period on a waiting list during 
which time they received standard care. Outcomes examined included: response 
rates to the trial; response rates to the individual questionnaires and items; 
comments relating to the trial functioning made during interviews with patients, 
carers, referrers and service providers; and researcher fieldwork notes.  
The fast-track trial methodology proved feasible and acceptable. Although two of 
the baseline/outcome measures proved unsuitable, this study added to the evidence 
that fast-track randomised controlled trials are feasible and acceptable in 
evaluations of palliative care interventions for patients with non-malignant 
conditions. Reasonable response rates and low attrition rates were achieved. 
Furthermore, with adequate preparation of the research and the randomisation 
teams, clinicians and respondents, and effective liaison with the clinicians, single-
blinding proved effective.(10) However, pilot study results should be interpreted 
cautiously when making assumptions about the numbers required when the 
evaluation is scaled up. Effects may be smaller or more variable and response rates 
lower when the intervention is rolled out across a wider range of settings and this 
study did not consider any adjustments to the waiting time due to the skewed 
recruitment suggested by other authors when participants are more positive about 
the intervention.(11, 12) 
1.1.3. Evaluation of the intervention 
There are many study designs to choose from and different designs suit different 
questions and circumstances.(1) Researchers should beware of blanket statements 
about what designs are suitable for what kind of intervention and choose on the 
basis of specific characteristics of the study, such as expected effect size and 
likelihood of selection or allocation bias.(2) Awareness of the whole range of 
experimental and non-experimental approaches should lead to more appropriate 
methodological choices. Three essential parts of the evaluation are the assessment 
of effectiveness, determining outcome measures and the understanding of 
processes.  
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Assessing effectiveness 
Randomisation should always be considered because it is the most robust method 
of preventing selection bias(1, 13) balancing both known and unknown prognostic 
factors, in the assignment of treatments. If a conventional parallel group 
randomised trial is not appropriate, other randomised designs should be considered. 
As indicated in the guidelines,(1) if an experimental approach is not feasible, 
because the intervention is irreversible, necessarily applies to the whole population, 
or because large scale implementation is already under way, a quasi-experimental 
or an observational design may be considered. 
Determining outcomes 
Researchers need to decide which outcomes are most important, which are 
secondary, and how they will deal with multiple outcomes in the analysis. A single 
primary outcome and a small number of secondary outcomes are the most 
straightforward for statistical analysis but may not represent the best use of the data 
or provide an adequate assessment of the success or otherwise of an intervention 
that has effects across a range of domains.  
The importance of identifying a variety of outcome measures is reflected in the 
following example. With the aim of estimating the extent to which a case-
management intervention for persons newly discharged into the community 
following an acute stroke effected a change in stroke outcome in comparison with 
usual care, Mayo & Scott(14) carried out an RCT in five acute care hospitals in 
Canada. The study targeted persons returning directly home within 28 days of an 
acute stroke who had one or more indicators of need for health-care supervision 
post-discharge: lives alone; mobility problem or need for post-discharge 
management for co-morbidity or social situation. For six weeks following 
discharge a nurse case manager delivered, depending on need, over 50 different 
nursing interventions, which targeted physical, emotional and psychological 
impairments, role participation restrictions and health perception. The primary 
outcome was the Physical Component Summary (PCS) instead of the Mental 
Component Summary (MCS) of the previously validated Measuring Outcomes 
Study 36 item Short-Form (SF-36).(15)  The results showed no statistically 
significant differences in average scores on the SF-36 PCS. The type of 
intervention described here did not have enough elements to impact on motor or 
physical function outcomes. This study failed to show an effect of a nurse case-
management intervention for people discharged home after acute stroke despite 
debriefing sessions indicating the potential for response. Clearly the intervention 
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was complex but the analysis, may not have reflected the true benefit of the 
intervention. 
Understanding processes 
Process evaluation explores the way in which the intervention under study is 
implemented, can provide valuable insight into why an intervention fails or has 
unexpected consequences. It is a method used to monitor and document 
programme implementation and can aid in understanding the relationship between 
specific programme elements and programme outcomes. The scope and 
implementation of process evaluation has grown in complexity as its importance 
and utility have become more widely recognised. Several practical frameworks and 
models are available to practitioners to guide the development of a comprehensive 
evaluation plan, including process-evaluation for collaborative community 
initiatives. However, frameworks for developing a comprehensive process-
evaluation plan for targeted programmes are less common. 
Saunders et al(16) presented a comprehensive and systematic approach for 
developing a process-evaluation plan to assess the implementation of a targeted 
health promotion intervention. They suggested elements for process-evaluation 
plans including fidelity, dose or data sources (delivered and received), reach, 
recruitment, and context and identified the questions and information required to 
complete the process (Table 1).   
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 Possible question  Information needed 
Fidelity  
 
1. To what extent was the intervention 
implemented consistently with the 
underlying theory and philosophy? 
1. What constitutes high-quality 
delivery for each component of the 
intervention? What specific behaviours 
of staff reflect the theory and 
philosophy? 
2. To what extent was training provided 
as planned (consistent with the 
underlying theory and/or philosophy)? 
2. What behaviours of trainers convey 
the underlying theory and philosophy? 
 
Dose 
delivered 
3. To what extent were all of the 
intended units or components of the 
intervention or programme provided to 
programme participants? 
3. How many units/components (and 
subcomponents as applicable) are in the 
intervention? 
 
4. To what extent were all materials 
(written and audio-visual) designed for 
use in the intervention used? 
4. What specific materials are supposed 
to be used and when should they be 
used? 
5. To what extent was all of the intended 
content covered? 
 
5. What specific content should be 
included and when should it be 
covered? What is the minimum and 
maximum time to spend on the content? 
6. To what extent were all of the 
intended methods, strategies, and/or 
activities used? 
6. What specific methods, strategies, 
and/or activities should be used in what 
sessions? 
Dose 
received 
7. To what extent were participants 
present at intervention activities engaged 
in the activities? 
7. What participant behaviours indicate 
being engaged? 
 
8. How did participants react to specific 
aspects of the intervention? 
 
8. With what specific aspects of the 
intervention (e.g., activities, materials, 
training, etc.) do we want to assess 
participant reaction or satisfaction? 
9. To what extent did participants engage 
in recommended follow-up behaviour? 
9. What are the expected follow-up 
behaviours: reading materials, engaging 
in recommended activities, or using 
resources? 
Reach 10. What proportion of the 
priority target audience participated in 
(attended) each programme session? 
How many participated in at least one 
half of possible sessions? 
10. What is the total number of people 
in the priority population? 
 
Recruitment 11. What planned and actual recruitment 
procedures were used to attract 
individuals, groups, and/or 
organisations? 
11. What mechanisms should be in 
place to document recruitment 
procedures? 
 
12. What were the barriers to recruiting 
individuals, groups, and organisations? 
12. How will we systematically identify 
and document barriers to participation? 
13. What planned and actual procedures 
were used to encourage continued 
involvement of individuals, groups, and 
organisations? 
13. How will we document efforts for 
encouraging continued involvement in 
intervention? 
 
14. What were the barriers to 
maintaining involvement of individuals, 
groups, and organisations? 
 
14. What mechanisms should be in 
place to identify and document barriers 
encountered in maintaining involvement 
of participants? 
Context 15. What factors in the organisation, 
community, social/political context, or 
other situational issues could potentially 
affect either intervention implementation 
or the intervention outcome? 
 
15. What approaches will be used to 
identify and systematically assess 
organisational, community, 
social/political, and other contextual 
factors that could affect the 
intervention? Once identified, how will 
these be monitored? 
Extracted from Saunders  et al. 2005(16) 
Table 1: Sample process evaluation questions for fidelity, dose delivered, dose 
received, reach, recruitment, and context 
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These articles also divided systematic process evaluation in six different steps: 
1. description of the programme: the previously planned programme is described 
fully, including its purpose, underlying theory, objectives, strategies, and the 
expected impacts and outcomes of the intervention, 
2. description of a complete and acceptable programme delivery: this includes 
specific strategies, activities, media products, and staff behaviours. The goal of 
this step is to state what would be entailed in complete and acceptable delivery 
of the programme,(16) 
3. develop potential list of questions: the initial wish list of possible process-
evaluation questions based on the programme (without full consideration of 
resources) needed is drafted, 
4. determine methods: the team begins to consider the methods that will be used 
to answer each question in the wish list of process-evaluation questions, 
5. consider programme resources, context and characteristics: the team considers 
the resources needed to answer the potential process-evaluation questions listed 
in step 3 using the methods proposed in step 4,(16) 
6. finalise the process-evaluation plan: the final process-evaluation plan emerges 
from the iterative team-planning process described in steps 3 to 5. 
In conclusion, the reviewers of the MRC guidelines for complex interventions 
acknowledged that many issues surrounding evaluation of complex interventions 
are still debated, that methods will continue to develop and that practical 
applications will be found for some of the newer theories. However, the revised 
guidance is aimed to help researchers, funders, and other decision makers to make 
appropriate methodological and practical choices. The key message for policy 
makers is the need to consider evaluation requirements in the planning of new 
initiatives and, wherever possible, to allow for an experimental or a high quality 
non-experimental approach to the evaluation of initiatives when there is uncertainty 
about their effectiveness. 
As suggested by the MRC framework,(1) the literature review presented in the 
following chapter will introduce evidence supporting the management of medicines 
in dysphagia, starting from the normal swallowing function and moving onto the 
causes, consequences and challenges of dysphagia and other issues surrounding our 
research topic. Consecutive chapters will also be introduced outlining how the 
methodological approach contributed towards the design of our complex 
intervention.  
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2. Literature review 
The delivery of a medicines management intervention in dysphagia required the 
exploration of the issues around dysphagia (such as causes, consequences, 
identification, management, etc.) and how those are related to a pharmacy 
intervention. Hence this literature review has been divided into two main sections 
that will identify the aims and objectives of the research presented in this thesis. 
These sections are: 
- normal swallowing and dysphagia, 
- medication and dysphagia. 
2.1. Normal swallowing and dysphagia 
2.1.1. Physiology of swallowing 
The normal swallow allows an individual to manage a wide range of food and 
drink, of varying volumes, textures and consistencies.(17) Swallowing normally 
occurs as an orderly physiological process that transports ingested material and 
saliva from the mouth to the stomach.(18, 19) 
There are numerous views on the number of phases in the process of normal 
swallowing. Whilst Logemann(17) described this process as four different stages, 
other descriptions of the swallowing process like Leopold & Kagel (1997)(20) 
consider the inclusion of a fifth phase, opposite to others like Hendrix (1993)(21) 
that divides this process in three main phases. From the anatomical point of view, 
dysphagia can appear in three different areas (oral cavity, pharynx and oesophagus) 
(Figure 2) and therefore the classification of normal swallowing in three phases 
will be the one explained.  
The oral phase – preparation of the bolus 
The preparatory phase consists of taking material into the mouth and preparing it 
for a swallow. In the case of solid or semi-solid food, the food is chewed, mixed 
with saliva, and usually positioned on top of the anterior tongue in anticipation of a 
swallow. The lips, tongue and soft palate are involved in retaining and controlling 
food and drink within the oral cavity. During the oral phase of swallowing, the 
tongue elevates and rolls posteriorly in a peristaltic motion, making sequential 
contact with the hard and soft palate, and thereby propelling the bolus into the 
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pharynx.(22)At the end of the oral preparatory phase the bolus is propelled towards 
the pharynx with a backward motion of the tongue. 
Pharyngeal phase – airway protection 
As the pharynx provides a shared passage for swallowing and respiration the 
pharyngeal phase provides a mechanism to prevent material entering the airway.  
This phase is initiated by the backward movement of the tongue and immediate 
detection of the bolus within the pharynx.   
 
Figure 2: Midsagittal section of the head and neck (Wright 2011, page 6)(23) 
 
Timing and coordination are crucial. The main activities during the pharyngeal 
phase are the cessation of breathing and the closure of the airway. Closure is 
achieved by drawing together the vocal folds within the larynx. This is 
accompanied by the upward and forward movement of the larynx. The epiglottis 
closes over the larynx diverting the bolus towards the oesophagus. The upward 
movement of the larynx facilitates the opening of the upper oesophageal sphincter. 
The major mechanism preventing the entry of secretions of swallowed material 
into the larynx, the trachea and lungs (aspiration) is contraction of the intrinsic 
laryngeal muscles that approximate the arytenoids and epiglottis, close the false 
cords, and adduct the vocal cords.(17) At the same time the pharyngeal musculature 
exerts pressure on the bolus pushing it into the oesophagus. 
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Oesophageal phase 
The oesophageal phase describes the transport of the bolus through the oesophagus 
and consists of muscular contractions, in a series of peristaltic waves, which 
actively transport the bolus to the stomach with some help from gravity. The 
pharynx and proximal oesophagus are the only areas in the human body where 
striated muscle is not under voluntary neural control.(19) While it is important to 
recognise the normal swallowing process, we also need to explore what happens 
when this function is compromised. Therefore, the following section will focus on 
describing dysphagia.  
2.1.2. Definition of dysphagia 
Dysphagia is a symptom that refers to difficulty or discomfort in swallowing a wet 
or dry bolus during the progression from the mouth to the stomach.(24) From an 
anatomical standpoint, dysphagia may result from oropharyngeal or oesophageal 
dysfunction:(25) 
- oropharyngeal or high dysphagia: the difficulties in swallowing are due to 
problems with the mouth or throat,  
- oesophageal or low dysphagia: this is where the difficulties in swallowing are 
due to problems with the oesophagus.  
Dysphagia may involve impairment in any or all phases of the swallowing process. 
Impairment involving the oral phases of swallowing may result in difficulty 
retaining the bolus in the oral cavity or in chewing or moving the bolus toward the 
oropharynx. Impairment involving the pharyngeal phase may result in the bolus 
being retained in the oropharynx and overflow aspiration after swallowing. The 
bolus may also be diverted and lead to nasal regurgitation. Impaired function in the 
oesophageal phase can result in ineffective movement and retention of the bolus in 
the oesophagus.(26) 
2.1.3. Prevalence of dysphagia 
When estimating the prevalence of dysphagia, it is important to outline several 
components that describe the population explored. The prevalence of dysphagia 
varies in different age groups and settings and it may be related to the occurrence 
of other conditions that the patient may suffer from. For the purpose of our 
research topic, this section will explore the prevalence of dysphagia in an ageing 
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population, the conditions associated to it and the different rates found between 
institutionalised patients and those in their own homes. 
Dysphagia in an ageing population 
An increase in the percentage of older persons is one of the principal demographic 
characteristics of the population of developed countries. In Europe, more than 17% 
of the citizens are older than 65 years. In the last decade, this group has increased 
by 28% whereas the rest of the population has only grown by less than 1%.(27, 28) In 
a study carried out in Sweden in a sample of ninety-one 55-year-olds, dysphagia 
was reported in 13% of the patients with normal oesophageal function and 27% of 
the patients with oesophageal dysfunction revealing an overall incidence of 
dysphagia of 22%.(29) In the same country, another study with 600 participants (300 
men and 300 women) from  50 to 79 years old, identified signs of dysphagia in 35% 
of the population.(30) However, none of these studies identified significant 
differences between men and women. More recently, a study including 2,359 
patients discharged from an acute geriatric unit between 2002 and 2009, with a 
mean age of 85 years, identified dysphagia in 47% of the sample after bedside 
assessment.(31) Despite the variation of these figures, it is clear that dysphagia is a 
symptom that is more commonly found in older patients as reported by Murry & 
Carrau (2006)(32) who suggested that 70-90% of older people have some degree of 
swallowing dysfunction.  
Conditions associated to dysphagia 
The prevalence of oropharyngeal functional dysphagia is also dependant on other 
conditions suffered by the patients. A review by Kuhlmeier in 1994(33) in 889 
patients form the Maryland Health Services in US identified that the most common 
condition associated to dysphagia was ‘diseases of the circulatory system’ 
(primarily stroke) with almost 17% of the sample suffering from both dysphagia 
and stroke. The following most common primary diagnosis is ‘diseases of the 
respiratory system’ (primarily inflammation of lung tissue) with 13% of the 
sample.(33) Current reported prevalence of dysphagia in stroke varies from 37% to 
78% depending on the type of test used to determine the presence of dysphagia.(34) 
Recent studies in Europe identified that dysphagia aﬀects more than 30% of 
patients who have had a cerebrovascular accident, 52%–82% of patients with 
Parkinson’s disease and 84% of patients with Alzheimer’s disease.(25, 35)A study 
carried out in Southampton General Hospital, UK examined 53 patients with 
Parkinson’s disease with similar nutritional status. The authors reported that 
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dysphagia was present in 81% of the cases, but in the majority of them, this was 
mild.(36) 
Institutionalised patients and patients’ own homes 
Dysphagia in older people is also an important cause of morbidity and mortality. A 
study that examined the factors associated with loss of functional capacity to eat 
across 240 residents (average age of 82) in nursing homes, found that in nursing 
homes PWD had a higher six-month mortality rate than those without dysphagia.(37) 
Croghan et al (1994)(38) documented increased morbidity (due to recurrent 
pneumonia and repeated hospitalisations) and mortality in older patients with 
oropharyngeal dysphagia and associated aspiration in nursing homes. Due to the 
observational nature of these studies it is, however, difficult to determine whether 
the dysphagia caused the increased morbidity and mortality or whether it was an 
indicator of the patient's worsening condition. 
A study by Smithard et al(39) confirmed that swallowing problems following acute 
stroke are common, and dysphagia may persist, recur in some patients, or develop 
in others later in the history of their stroke.(39) In this study 61 (51%) out of 121 
consecutive patients admitted to hospital in the UK within 24 hours of the onset of 
their stroke were considered to have a compromised swallow. 
A study from Mount Sinai School of Medicine(40) found that hospitalised PWD 
averaged a 40% longer hospital stay than patients without the condition. They also 
had a generally poorer prognosis. The researchers evaluated more than 77 million 
hospital admissions during 2005-2006, of which 271,983 were associated with 
dysphagia; the median number of days in the hospital for PWD was 4.04, 
compared to 2.40 days for patients without dysphagia. Mortality increased 
significantly in PWD and heart disease, and those undergoing rehabilitation had a 
greater than 13-fold increased risk of mortality. Patients aged 75 and older were 
twice as likely to have dysphagia.(40) Although this study seems to be establishing 
dysphagia as cause of longer stay in hospital, the authors actually concluded that 
dysphagia may be present as a consequence of other debilitating diseases that 
ultimately lead to these morbidities as, in fact, PWD had more diagnoses overall at 
the time of discharge than patients without dysphagia. 
These studies and others like Steel et al (1997)(41) and Lin et al (2002)(42) could be 
indicating not only higher prevalence of dysphagia in institutionalised patients 
compared to those in their own homes but also higher rates of admissions in 
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hospitals with longer stays. A summary of prevalence of dysphagia comparing 
different facilities is highlighted in Table 2. 
 
Facility Mean age 
Prevalence of 
dysphagia 
Studies 
Own homes 87+ 15-16% 
Bloem, et al. (1990)(43), 
Chen, et al. (2009)(44) 
Long term care 
facilities 
77 51-68% 
Lin et al.(2002)(42), 
Rofes, et al. (2011)(28),  
Steele et al. (1997)(41) 
Hospital /acute 
geriatric unit 
79-85 47-51% 
Cabré et al. (2013)(31) 
Smithard et al. (1997)(39) 
Table 2: Prevalence of dysphagia in different facilities 
 
Older PWD also have lower quality of life. Problems with dysphagia adversely 
affect social and mental health and lead to considerable isolation and meal-related 
anxiety.(45) 
The social and psychological impact of dysphagia has been limited in reported 
large studies. A study carried out by Ekberg et al(46) in 2002 sought to determine 
the effects of dysphagia on the quality of life of patients and to explore the 
relationship between the psychological handicaps of the condition and the 
frequency of diagnosis and treatment. The sample consisted of 360 patients 
selected on the basis of known subjective dysphagia complaints, regardless of 
origin, in nursing homes and clinics in Germany, France, Spain and the United 
Kingdom. The study participants were given a short questionnaire that was 
specifically modified to elicit problems related to dysphagia rather than to the 
ageing process.(47) While 36% per cent of patients acknowledged receiving a 
confirmed diagnosis of dysphagia, only 32% acknowledged receiving professional 
treatment for it.(46) Although these results varied greatly between countries, the 
study highlighted that patients’ perceptions of treatment were usually referred to 
movement therapy with a SALT or surgery and excluded any pharmacological 
treatment. However, one of the main findings was the high psychosocial effect of 
dysphagia where the UK represented the highest rates of anxiety and reduced 
quality of life related to the disorder when compared to the participants of other 
countries. It needs to be considered that this study was limited by the fact that 
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participants identified themselves as dysphagic. Although a selection assessment 
was carried out, it was recognised by the study that the professionals involved in 
the assessment had different approaches and difficulties when identifying PWD. 
Conversely, the study provided results that highlighted the social and psychological 
impact of dysphagia in institutionalised patients. 
In summary, it is important to identify the prevalence of dysphagia in order to 
estimate the proportion of patients that could benefit from a pharmacy intervention. 
The identification of the prevalence of dysphagia could also benefit from 
describing the conditions associated with dysphagia, the age of the population with 
that disorder and the differences in prevalence between the different levels of care 
provided (primary, secondary and tertiary care). This will be further explored in 
chapters 3 and 5.   
2.1.4. Dysphagia and ageing 
This section explains the normal development of the swallowing process in relation 
to age.  
Developments in modern medicine have improved the diagnosis, prevention, and 
management of diseases. One visible result has been increased longevity and a 
greater number of older people. When considering the importance of nutrition on 
individuals of advanced age, it is essential to explore the physiological changes of 
swallowing affecting older people. 
It is hard to define the boundary between middle age and older people in current 
society. Recent reviews on what age can be considered old, middle age and young 
revealed with reasonable consistency that individuals between the age of 40 and 60 
are considered middle age while those over 60 are classified as old.(48) However, 
current literature has specified that there are age-related changes in the oral, 
pharyngeal and oesophageal functions and people over the age of 65 swallow 
slower that those under the age of 45.(49-52) 
Changes in the oral cavity 
While chewing itself does not change with age,(48) poor dentition and missing teeth 
cause problems of mastication.(53) Also, an increase in connective tissue in the 
tongue and a decrease in masticatory strength(54) result in smaller size of boluses 
and a longer oral phase duration in older individuals causing older people to prefer 
softer food.(49) A reduction in the amount of saliva output has also been associated 
with ageing.(55) 
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Changes in the pharynx 
Dysmotility of the pharyngeal muscles, epiglottic dysfunction, defective closure of 
the larynx, and cricopharyngeal dysfunction all occur with increased frequency 
with advancing age.(56) Pharyngeal webs are also more commonly seen with 
advancing age, especially in women above 75 years of age.(56) Neuronal 
degeneration, vascular compromise and tumour invasion are all common in the 
older population. These changes can interrupt the swallowing reflex at any point, 
causing abnormalities of deglutition.(57) 
As a consequence of these changes, it is often found that there is also an increased 
rate of second (bolus free) swallows in older individuals(48) employed as a second 
‘clearing swallow’ to cleanse the oral and pharyngeal cavities of residue, after their 
primary swallow of a spoonful of food or a mouthful of ﬂuid. 
Changes in the oesophagus 
Oesophageal transit and clearance are slower and less efficient in the ageing 
individual.(48) Delays in oesophageal emptying and dilatation of the oesophagus(58) 
are commonly seen in older people causing non-propulsive, repetitive contractions. 
These changes result in slower transit of the bolus, increased retention, and 
dilatation of the oesophagus.(53) 
In summary, it could be said that dysphagia is not a consequence but a symptom of 
ageing and when it appears caused by other diseases, it should be the cause that is 
treated rather than the swallowing problem. This section of the literature review is 
highlighting that further exploration of the awareness of dysphagia and the training 
required for the management of dysphagia is required. This will be explored in 
chapters 4 and 5. The perceptions of HCPs on the implementation of training will 
be covered in chapters and 3 and 4. 
2.1.5. Causes of dysphagia in older people 
This section explains the main reasons why dysphagia appears. 
2.1.5.1. Conditions associated with dysphagia 
In older people, central nervous system diseases such as stroke, parkinsonism, and 
dementia, as well as other factors,  including prescribed medication, local oral and 
oesophageal physiopathology are common causes of swallowing dysfunction. 
Swallowing disorders in older people are associated with increased mortality and 
morbidity due to the rates of aspiration, dehydration, pneumonia, malnutrition and 
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functional decline.(59) There have been numerous attempts to classify the causes of 
dysphagia. Hurwitz et al (1975)(60) and Paterson (1996)(45) established some of the 
causes of dysphagia based on a structural and functional classification of the 
problem (Table 3). 
 
 Structural problem Neuromuscular problem 
Oropharyngeal 
dysphagia 
Neoplasms 
Infection or abscess 
Postsurgical (e.g., laryngectomy) 
Zenker's diverticulum complication  
Vertebral osteophytes 
Cerebrovascular accident 
Amyotrophic lateral 
sclerosis  
Multiple sclerosis Brainstem 
neoplasm  
Bulbar poliomyelitis and 
post-polio syndrome 
Miscellaneous peripheral 
neuropathies 
Oculopharyngeal muscular 
dystrophy 
Polymyositis and 
dermatomyositis 
Myasthenia gravis 
Metabolic myopathy 
Idiopathic neuromuscular 
dysfunction 
Oesophageal 
dysphagia 
 
Peptic stricture 
Rings and webs 
Neoplasm (intrinsic or extrinsic) 
Vascular compression  
Diverticula 
Achalasia 
Diffuse oesophageal spasm 
and related disorders  
Motility disorders 
Table 3: Classification of causes of dysphagia from Paterson(45) and Hurwitz et al(60) 
 
A much more comprehensive classification of the causes of dysphagia was 
published in 2006 by Cichero and Murdoch. In this book(48), the author offered an 
anatomical classification of the conditions that caused, or were associated with, 
dysphagia (Table 4). However, due to the complexity of dysphagia and the wide 
range of conditions associated with it, there are overlaps between those disorders. 
Furthermore, it also explored medication as a cause of dysphagia.  
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Cause Conditions associated 
Stroke 
Cortical and subcortical strokes 
Brain stem strokes 
Neurological medicine 
Cranial nerve lesions 
Bulbar and pseudobulbar palsy 
Myasthenia gravis 
Guillain-barre syndrome 
Multiple sclerosis 
Burns 
Thermal smoke and fire burns 
Caustic burns 
Thermal food and fluid burns 
Palliative medicine 
Motor neurone disease 
Parkinson’s disease 
Progressive supranuclear palsy 
Alzheimer’s disease 
Infectious diseases 
Poliomyelitis (polio) and post-polio 
Human immunodeficiency virus and aids 
Gastroenterology 
Gastroesophageal reflux disease (GORD)(hiatus hernia, 
Barrett’s oesophagus and oesophageal adenocarcinoma) 
Laryngopharyngeal reﬂux (LPR) 
Mechanical oesophageal disorders 
Oesophageal motility disorders 
Trauma 
Head trauma 
Direct laryngeal trauma 
Respiratory medicine Chronic obstructive pulmonary disease (COPD) 
Surgery 
Head and neck surgery 
Oral surgery – general 
Radiation therapy and chemotherapy 
Cardiac surgery 
Anterior cervical spine surgery 
General medicine 
Chronic obstructive pulmonary disease (COPD) 
Sjogren’s syndrome 
Psychiatric medicine Phagophobia 
Tracheostomy  
         Extracted from pages 237-298, Cichero (2006)(48) 
Table 4: Causes and conditions associated with dysphagia  
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2.1.5.2. Medication-induced dysphagia 
It is not only medical conditions that can cause dysphagia but also its 
pharmacological treatment.  
Stoschus & Allescher (1993)(24) described how dysphagia can be the consequence 
of the intake of medication in three different ways:  
- as a normal drug side-effect (xerostomia, anticholinergic effects, etc.), 
- as a complication of the drug actions affecting the pressure of the oesophageal 
sphincters, 
- as medication-induced oesophagitis and injury. 
Dysphagia caused by drug-induced xerostomia 
Xerostomia is the medical term for the subjective symptom of dryness in the mouth 
and is a common side-effect of a large number of commonly used drugs. 
Dysphagia due to xerostomia can be caused by two general mechanisms. The 
dryness of the mouth can cause impaired oropharyngeal bolus transport, giving the 
patient the feeling of impaired swallowing and also a link between xerostomia and 
oesophagitis has been suggested due to the role of saliva in the deglutition.(61) 
Most of the time, xerostomia is a reversible drug-induced side-effect and is 
frequent, particularly in elderly people and psychiatric patients with numerous 
medicines prescribed on a long-term continuous basis. It remains a neglected 
clinical problem. Besides the well-known antimuscarinics, antihistaminics and 
imipraminic antidepressants, many drugs may induce xerostomia. As an example, 
neuroleptics are commonly used for control of aggressive or disruptive behaviour 
in older patients with dementia.(62) Low potency neuroleptics, such as 
chlorpromazine, are associated with a low incidence of extrapyramidal side-effects, 
but frequently cause sedation, orthostatic hypotension, and dry mouth whereas high 
potency agents, such as haloperidol, are more likely to cause extrapyramidal side-
effects, and less likely to cause anticholinergic effects.(35) 
Reduced lower oesophageal sphincter pressure 
The smooth and striated muscle function of the oesophagus can be influenced by a 
variety of drugs. Substances that affect muscle tone and activity can be either 
inhibitory or excitatory.(48) Both mechanisms can increase the incidence and 
severity of gastroesophageal reflux which can subsequently cause dysphagia. 
Drugs affecting the striated muscle portion of the oesophagus act mostly via the 
central nervous system; these substances include sedative and narcotic agents. A 
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direct effect on the striated muscle can be caused by muscle relaxants like the ones 
used in anaesthesia or intensive care units.(48)  
Antipsychotic or neuroleptics can cause dysphagia as a side-effect due to the 
extrapyramidal motor disturbances which can lead to an impaired function of the 
striated muscle of the oropharynx and the oesophagus(63, 64) which presents as 
disorder of peristalsis that disrupt the propulsion of swallowed materials to the 
stomach. 
Cancer therapeutic agents, mostly cytotoxic agents, can cause dysphagia through 
two different mechanisms: first, by predisposing patients to viral and fungal 
infections of the oesophagus (candida, herpes, cytomegalovirus, etc.) causing 
ulcers; and secondly by causing an oesophagitis in which no infectious agent can 
be identified.(24) 
A summary of drugs that have been identified to be the cause of dysphagia through 
different mechanisms is presented in Table 5.  
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Mechanism Drug classiﬁcation Drug 
Xerostomia Anticholinergics  Atropine, pirenzepin, 
Hyoscine 
Antiemetics  Ondansetron 
Antihypertensives  Clonidine, terazosin  
ACE inhibitors  Captopril 
Antiarrhythmic drugs Disopyramide, mexiletine, ipatropium 
bromide 
Diuretics 
Opiates  
Antipsychotics 
Antidepressants  
Muscle relaxants 
 
Reduced lower 
oesophageal 
sphincter pressure 
 Cholecystokinin, sekretin,  progesterone, 
glucagon,  neurotensin, vasoactive 
intestinal polypeptide,  dopamine, 
calcitonin gene related peptide,  
atropine,  hyoscine,  theophylline,  
nitrates, dopamin,  calcium antagonists  
Oesophageal injury Antibiotics Doxycycline, tetracycline, clindamycin, 
oxytetracycline, minocycline, 
phenoxymethylpenicillin, erythromycin, 
tinidazole  
NSAIDs and aspirin Aspirin, ibuprofen 
 Alprenolol, ascorbic acid,  codeine, 
doxycycline,  , ferrous sulphate or 
succinate, indomethacin, 
phenylbutazone, prednisolone, 
potassium chloride,  quinidine, 
theophylline 
Extrapyramidal 
effects 
Antipsychotics Haloperidol 
 Metoclopramide, prochlorperazine, 
risperidone 
Extracted from Stoschus & Allescher (24, 35, 65) Sokoloff (24, 35, 65)  and Gallagher (24, 35, 65) 
Table 5: Drugs that cause dysphagia (24, 35, 65) 
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Medication-induced oesophageal injury (MIOI) 
MIOI is usually caused by local irritation of the oesophageal mucosa by orally 
ingested drugs. The clinical presentation is characteristic in most patients with 
MIOI. There is usually a sudden onset of dysphagia (20%), accompanied by retro-
sternal chest pain within 4-12 hours after ingestion of the medication.(24, 66) When 
swallowing small round tablets, the transit of these tablets can be transiently held 
up at the upper oesophageal sphincter, the aortic arch, and distal oesophagus 
immediately proximal to the lower oesophageal sphincter.(24) In addition, 
swallowing decreases during sleep, diminishing the frequency of peristalsis as well 
as the ability of saliva to dilute medications present in the oesophagus and to 
neutralise acidic substances.(67-69) 
Acid-producing substances with a pH less than three, i.e. the antibiotics 
doxycycline, tetracycline and other acidic drugs can produce a moderate-to-severe 
injury of the mucosal layer.(70) 
In summary, the identification of medication used by PWD can help to identify 
conditions associated with dysphagia, as well as approaches when prescribing for 
these patients. The analysis of the drugs prescribed in PWD is reflected in chapters 
4 and 5 of this dissertation. 
2.1.6. Consequences of dysphagia 
This section explains the physiological and psychological changes that may appear 
as a consequence of dysphagia. 
There are numerous adverse consequences of dysphagia and these are generally 
underrated. They range from deterioration in the quality of life (QOL), dehydration, 
under nutrition, asphyxia, congestion, recurrent respiratory tract infections due to 
aspiration and death.(35, 71) Literature has indicated that dysphagia is partly 
responsible for mortality in acute stroke and it can also lead to complications which 
hamper functional recovery.(72) Other minor complications were highlighted in a 
study where 796 older participants replied to a questionnaire concerning dysphagia 
and other chest symptoms. Chest pain, heartburn, and regurgitation occurred 
significantly more frequently in subjects with dysphagia during the ingestion of 
food (p<0.01) making apparent that difficulty in swallowing in older people leads 
to physical problems that may reduce their quality of life.(73) Dysphagia is also a 
significant cause of morbidity of head-and-neck cancer treatment, and the severity 
of dysphagia is correlated with a compromised QOL, anxiety, and depression.(74) 
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Aspiration pneumonia is the major cause of morbidity and mortality among older 
people who are hospitalised or in nursing homes.(75) 
2.1.6.1. Aspiration and aspiration pneumonia 
Aspiration is defined as the misdirection of oropharyngeal or gastric contents into 
the larynx and lower respiratory tract. Aspiration pneumonia develops after the 
aspiration of colonised oropharyngeal contents. However, when the term aspiration 
pneumonia is used, it refers to the development of a pneumonia in the setting of 
patients with risk factors for increased oropharyngeal aspiration.(76) Approximately 
half of all healthy adults aspirate small amounts of oropharyngeal secretions during 
sleep.(77, 78) 
Clinical signs of aspiration include absent swallow, coughing when lying flat or 
sitting up quickly from a reclined position, choking, a hoarsened voice during or 
after eating or drinking, difficulty handling secretions or reflexive cough after 
water bolus.(79-83) However, other authors have found no significant relationship 
between an abnormal, reflexive cough and aspiration.(84, 85) While these signs can 
be detected at a bedside clinical swallow examination, videofluoroscopy techniques 
are still considered the gold standard when identifying aspiration.(26, 81, 86, 87)  
A study comparing clinical bedside examination with videofluoroscopy evidence 
of a swallowing disorder(88) identified dysphagia in 51% (95% confidence interval 
(CI) 42–60%) and 64% (95% CI 55–72%) of patients respectively, and aspiration 
in 49% (95% CI 40–58%) and 22% (95% CI 15–29%) of patients, respectively. 
However, the authors reported lower sensitivity and specificity in the clinical 
evidence compared to videofluoroscopy. This was also suggested by other authors 
as the reason for videofluoroscopy to remain the most accurate tool when 
evaluating aspiration.(81, 86, 87) 
It is estimated that aspiration occurs in approximately 40 to 50% of PWD and those 
who aspirate are at an increased risk of acquiring pneumonia.(89, 90) There is an 
increased relative risk of pneumonia in stroke PWD (3.17 vs. individuals without 
dysphagia)(91) and the development of pneumonia from seven times greater(92, 93) to 
11 (11.56)(94) in stroke patients who aspirate, as compared to those who do not. 
Despite the fact that dysphagia improves in most patients following a stroke, often 
dysphagia follows a fluctuating course, with 10 to 30% of patients continuing to 
have dysphagia with aspiration.(39, 95) In 2000, Nakagawa et al(96) evaluated the 
cough reflex and swallowing in 143 stroke patients that were followed-up for one 
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year. Forty-three patients had a normal cough reflex and swallow; pneumonia 
developed in none of these patients. However, pneumonia developed in 24 of the 
100 patients with abnormal cough reflex and swallow function. This study 
demonstrated that older post-stroke patients have a five-fold higher risk of 
developing pneumonia than older patients without.(96) 
The close link between dysphagia and aspiration and aspiration pneumonia 
indicates that changes in the signs of aspiration could be considered as a patient 
outcome when implementing interventions that affect the way that patients receive 
medication.  
2.1.6.2. Psychological factors of dysphagia 
An increasing number of studies have been carried out on the social importance of 
dysphagia and its consequences on the quality of life. Dysphagia is considered a 
disabling disorder for the individual from the functional point of view of 
swallowing, as well as the emotional-relational viewpoint.(97) Psychosocial 
problems in those with dysphagia were given as anxiety at meal times and the wish 
to eat alone.(73) It has a negative influence on the patient’s life, worsening it 
qualitatively from both a social and an emotional point of view. In a survey carried 
out on 73 patients, with more than 50% over 60 years old, PWD after surgery were 
found to be more fragile, lacked self-confidence, with limited social relationships 
and consequently, a tendency to isolation. Most patients, who had previously 
considered meal times an opportunity to meet others and as a social gathering, no 
longer believed them to be a pleasant aspect of their day on account of the 
difficulty in swallowing. As a result, food consistency had to be changed and 
strategies had to be invented in order to make the meal less embarrassing.(97) The 
social ‘handicap’ is also worse after operations.(47) Denial and concealment of 
dysphagia are also common and in a study carried out on a small group of 19 
patients it was found that dysphagia influenced a reduction in self-esteem, security, 
work capacity, exercise and leisure time.  
In a European study that included PWD in nursing homes from the United 
Kingdom,(46) 84% of patients felt that eating should be an enjoyable experience but 
only 45% actually found it so. Moreover, 41% of patients stated that they 
experienced anxiety or panic during mealtimes. Over one-third (36%) of patients 
reported that they avoided eating with others because of their dysphagia. In a 
largely older population that might accept dysphagia as an untreatable part of the 
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ageing process, this study may be indicating that clinicians need to be more aware 
of the adverse effects of dysphagia on self-esteem, socialisation, and enjoyment of 
life as it was before dysphagia appeared. For the purpose of the research on PWD, 
these humanistic outcomes also should be considered. 
This section of the literature review is highlighting the need of combining 
quantitative health outcomes such as aspiration, as well as other qualitative values 
such as the individual perceptions of the HCPs on the patient’s health. Further 
research on these outcomes is, therefore, presented in chapters 4 and 5. 
2.1.7. Screening and assessment of dysphagia 
This part of the literature review will focus on current methods for identifying 
dysphagia. 
Speech and language therapists (SALTs) are trained to assess and treat an 
individual’s ability to swallow. A SALT will advise on the consistency required, 
foods and drinks that are suitable, the best sitting position to make swallowing 
easier, and certain techniques to aid swallowing.  
Despite the range of procedures that can be used for swallowing screening, no 
specific guidelines for clinical dysphagia assessment have been published as there 
is currently insufficient evidence available to support their production.(98) Screening 
methods at bedside clinical examinations may include, but are not limited to, (a) 
water swallow tests, such as the Burke water swallow test(99) or the 3oz. (85mls) 
water swallow test;(100) (b) swallowing screening protocols including brief 
assessments of oral motor and sensory function as well as water swallow tests, such 
as the Toronto Bedside Swallowing Screening(101) or the Simple Standardised 
Bedside Swallowing Assessment;(102) or (c) clinical (bedside) swallow 
examinations like the one described by Curfman(103) in Table 6.   
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1. Assess for alertness and control of secretions. 
2. Determine patient’s ability to follow directions. 
3. Have the patient say ‘‘ah’’ or count to ten to evaluate vocal quality.  
4. Have the patient smile or pucker to note facial symmetry.  
5. Have the patient puff cheeks out to determine lip seal. 
6. Have the patient protrude tongue to determine deviation and tongue mobility.  
7. Have the patient swallow saliva to note if ability to swallow is immediate or delayed. 
 8. Observe oral hygiene. 
 9. Have patient cough to determine strength. 
Table 6: Steps for clinical bedside swallow evaluation extracted from Curfman 
(2005)(103) 
 
An alternative to bedside clinical examinations is videofluoroscopy. 
Videofluoroscopy of swallow is a modification of the standard barium swallow 
examination used in the management of oropharyngeal swallowing disorders. It is 
described in a number of sources as the ‘gold standard’ for the assessment of 
oropharyngeal dysphagia. (26, 81, 86, 87) 
In a study that examined 128 patients with acute first-ever stroke,(88) clinical 
bedside examination, based on the steps indicated in Table 6, was compared with 
videofluoroscopy. This study found clinical and videofluoroscopy evidence of a 
swallowing disorder in 51% (95% confidence interval (CI 42–60%) and 64% (95% 
CI 55–72%) of patients, respectively. This data was also explored in 2005 in a 
systematic review(94) that reported incidence of dysphagia was lowest using cursory 
screening techniques (37% to 45%), higher using clinical testing (51% to 55%)(82) 
and highest using instrumental testing (64% to 78%). However, the literature 
contained in this systematic review was limited to only post-stroke dysphagia 
omitting any other conditions such as Parkinson’s disease that are also associated 
to dysphagia. 
Although clinical bedside examination underestimates the frequency of swallowing 
abnormalities and overestimates the frequency of aspiration compared with 
videofluoroscopy, it may still offer valuable information for the diagnosis of 
swallowing impairment.  
As part of the assessment, a complete physical examination should also be 
performed and include neurologic and muscular evaluation with full assessment of 
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mental status, head and neck position, oral sensory and motor function, protective 
reflexes, respiratory and laryngeal voice function status, cerebellar function, and 
weight. Assessment of cognitive and mental status is necessary because 
dysfunction in either may alter swallowing and nutrition. For example, patients 
with Alzheimer's disease may chew too quickly or completely forget to swallow, in 
addition to not recognising food or remembering how to use utensils. Patients with 
anxiety, severe depression, panic disorders, psychosis, and schizophrenia may 
present with a globus sensation, decreased attention spans, or poor muscular 
control, increasing the risk of dysphagia.(26) 
The goal of early assessment and diagnosis is to formulate an intervention plan that 
provides for safe, adequate nutrition. The interdisciplinary team, including patient 
and family, identifies interventions focused on correcting or moderating effects of 
swallowing abnormalities. Interventions include placing the patient in a relaxed, 
well-supported, anatomically correct position with head and trunk leaning slightly 
forward.(26) 
The assessment of dysphagia may require different skills and training depending on 
the HCPs delivering it and further research is required in identifying the different 
approaches of HCPs to the assessment and its impact on their usual practice. 
Chapter 4 of this dissertation will investigate those perceptions in the care home 
environment while chapters 3 and 5 will evaluate training provided by a pharmacist 
and potential improvements to that training. 
2.1.8. Management of dysphagia in older people 
This section will outline the strategies involved in the management of dysphagia in 
older patients. 
The management of older PWD requires the coordinated expertise of a number of 
healthcare professionals, including the patients’ primary care general practitioner, 
respiratory physician, SALT, clinical dietician, occupational therapist, 
physiotherapist, nurse, oral hygienist, dentist, as well as the primary caregivers.(76) 
The aim of the management of dysphagia is to improve the safety, efficiency and 
effectiveness of the oropharyngeal swallow, to maintain adequate nutrition and 
hydration, and to improve oral hygiene.  
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2.1.8.1. Compensatory strategies 
The management of dysphagia may include techniques of compensatory strategies 
such as dietary modification, postural manoeuvres and postural adjustments 
therapy (exercises to strengthen swallowing musculature).(17, 104, 105) 
The consistency of the patient’s food should be individualised according to the 
findings from clinical testing. Dehydration in older people is one of the leading 
problems in nursing homes and long-term care facilities.(106) Caution should, 
therefore, be taken with regard to the modification of fluids, as adherence with 
thickened liquids is often reduced. Small sips of cold water in patients with good 
oral hygiene may bring relief to thirsty patients and may reduce the resultant 
dehydration.(107) 
Swallow manoeuvres place aspects of the pharyngeal swallow under voluntary 
control.(108) The findings from the clinical bed examination and videofluoroscopy 
will direct which strategies and exercises are most beneficial for a specific patient; 
however, environmental strategies are often key in managing the dysphagia of 
older people.(76) These changes, which may include modifying the feeding 
environment or altering the feeding schedule, frequently improve nutritional intake. 
This implies that the right education, training, and counselling of the patient and/or 
their caregiver plays an important role on the management of dysphagia. 
2.1.8.2. Enteral feeding tubes (EFT) and surgery 
An enteral feeding tube (EFT) is a medical device which bypasses the oesophagus 
and is used to provide nutrition to patients who cannot obtain nutrition by mouth, 
are unable to swallow safely, or need nutritional supplementation. Various EFTs 
are available for delivering medications and nutrients to the patient. The tubes are 
typically classified by site of insertion (e.g., nasal, oral, percutaneous) and location 
of the distal tip of the feeding tube (e.g., stomach, duodenum, jejunum).  Enteral 
tube feeding may be indicated in older patients with severe dysphagia and 
aspiration when improvement of swallowing is likely to occur.(76) However, tube 
feeding is not essential in patients who aspirate as, in fact, studies have found no 
data to suggest that tube feeding of patients with advanced dementia prevented 
aspiration pneumonia, prolonged survival, reduced the risk of pressure sores or 
infections or  improved function.(109, 110) While a study carried out in 143 dysphagic 
patients demonstrated that the incidence of pneumonia was significantly higher in 
stroke PWD who were fed orally compared to those who received tube feeding 
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(54.3% vs. 13.2%, p < 0.001) the study failed to recognise that the orally-fed 
patients had a higher functional status. Another study in the UK showed that 
intubation proved to be an effective method of relieving dysphagia in patients 
unsuitable for curative treatment; however, 44% of the patients involved in the 
study developed further dysphagia due to tube dysfunction, and 19 patients (37%) 
were readmitted for further procedures to restore swallowing.(111) 
The use of surgery and prosthetic devices is another more radical form of 
compensation for dysphagia. Together, these devices may be useful for the 
treatment of speech and swallowing disorders where the deﬁcit lies with the soft 
palate region.(112) 
2.1.8.3. Pharmacological management of dysphagia 
There is limited literature in the management of dysphagia with medication as 
general swallowing treatment programmes are associated with a reduced risk of 
pneumonia.(113) 
Swallowing reflex is known to be impaired in elderly patients with aspiration 
pneumonia(114) and therefore it is important to explore whether drugs that  improve 
the quality of the swallow may help to prevent aspiration pneumonia. In a study 
carried out in Japan, the use of ACE inhibitors was preferred when compared with 
other antihypertensive drugs. This study explored the incidence of pneumonia in 
127 stroke PWD treated with ACE inhibitors compared with 313 PWD treated with 
other antihypertensive agents. During a two-year follow-up period, pneumonia was 
diagnosed in 7% of patients receiving an ACE inhibitor (antihypertensive drug) 
compared to 18% in patients receiving other hypertensive agents (relative risk, 2.65; 
95% CI, 1.3 to 5.3; p = 0.007).(115) The authors of the study could not specify at the 
time the reasons for the improvement on the swallowing disorder and the rate of 
pneumonia. However a recent review(116) explained that patients taking ACE 
inhibitors often suffer from chronic cough associated with throat irritation. This 
coughing helps protect the respiratory tree from aspiration of pharyngeal contents 
and increases clearance of inhaled organisms.(116)  
A consecutive study, demonstrated a significantly lower rate of pneumonia in older 
people hypertensive patients randomised to an ACE inhibitor compared to an 
angiotensin-II receptor antagonist. Although this study was aiming to identify the 
best antihypertensive treatment for patients with high blood pressure and stroke, 
the authors provided evidence that patients with oropharyngeal dysphagia should 
Literature review 
 
Page 44 of 380 
 
be considered for treatment with an ACE inhibitor (even if normotensive) as the 
incidence of pneumonia in the ACE inhibitors-treated group was significantly 
lower (p = 0.013) than the one in the group treated with other antihypertensive 
drugs.(117) However, these studies did not reveal the types of formulation compared 
(liquid medication, tablets, etc.) nor identified any association with any funders 
who could bias the research.  
A UK study in four patients suggested that pharmacological agents such as 
nifedipine (calcium-channel blocker and antihypertensive drug) may have a role in 
the management of stroke-related dysphagia and merit further investigation.(118) 
However, the small sample size and the fact that the participants were post-stroke 
patients may limit the validity of the results as dysphagia can rapidly resolve post- 
stroke.(48) 
One study has reported improvement of dysphagia with the use of cisapride,(119) 
with three patients completely recovering their ability to swallow. This could be 
due to the biofeedback (psychotherapy used in conjunction with the drug) and 
further research was recommended as later studies have not been able to establish a 
therapeutic effect of cisapride on dysphagia.(120) The symptomatic improvement 
may possibly be due to increasing the number of peristaltic contractions and 
oesophageal emptying of solids.(121, 122) However, the product license for cisapride 
(used to treat gastric and digestive disorders in adults and children) was suspended 
by the Medicines Control Agency after five deaths in the United Kingdom and 125 
deaths worldwide that were thought to be associated with the drug.(123) 
It can be seen that evidence to support the use of medicines for the management of 
dysphagia is limited and treatment via this route is rare.  
Summarising, the management of dysphagia may require different strategies and 
techniques and these may involve several HCPs with different expertise. This 
interaction between professionals can be seen as a challenge to the management of 
dysphagia and, therefore, the perceptions of that interaction need to be explored. 
The perceptions of nurses on the role of the prescriber, pharmacist, nurse and 
SALT and on the interactions between them are explored in chapter 4 of this thesis.   
2.1.9. Dysphagia in acute and long-term care facilities 
This section outlines some of the problems related to dysphagia in older patients in 
hospitals and care homes. 
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It is recognised that hospitalisation of older patients may result in functional 
decline despite cure or repair of the condition for which they were admitted. 
Hospitalisation can result in complications unrelated to the problem that caused 
admission or to its specific treatment for reasons that are often avoidable.(124) 
The use of acute-care hospitals by older people is rising rapidly, particularly in the 
age group 75 and older.(125) Hospital admission and bed rest commonly involve 
enforced immobilisation, reduction of plasma volume, accelerated bone loss, 
increased closing volume, and sensory deprivation.(124) These factors could trigger 
an irreversible functional decline as a consequence of the vulnerability of the older 
population. 
It is also important to identify the different types of care provided in long-term care 
facilities as care homes for older people may provide personal care (residential) or 
nursing care. Residential care homes are registered to provide personal care and 
will offer support, ensuring that basic personal needs, such as meals, bathing, going 
to the toilet and medication, are taken care of. In some homes more able residents 
have greater independence and take care of many of their own needs. Some 
residents may need medical care and some care homes are registered to provide 
this. These are often referred to as nursing homes or care homes with nursing. In 
this type of facility, nurses are responsible for the care for all the patients assigned 
to them. Generally, the nurse is assigned a group of patients each day. For that 
group, the nurse must monitor vital signs, pass medications, change dressings, 
check the status of wounds, attend patient care-plan meetings, oversee carers, 
administer enemas and start intravenous (IV) medications and fluids. They may 
also counsel families and provide other personal hygiene care, depending on 
nursing assistant staffing levels. The number of patients varies according to the size 
of the facility and the type of shift. Generally, midnight shift nurses will be 
responsible for more patients as most of them sleep through the night and require 
little care. Some care homes with nursing also specialise in certain types of 
disability, for example, dementia and EFTs. 
Through inspections and creation of policies, the Care Quality Commission (CQC) 
is in charge of making sure that hospitals and care homes (as well as dental and GP 
surgeries, and all other care services) provide people with safe, effective, 
compassionate and high-quality care according to national standards in England.(126) 
However, only a small amount of research is conducted in care home settings in the 
UK. In the last few years, the Dementia and Neurodegenerative Diseases Research 
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Network (DeNDRoN) and Enabling Research in Care Homes (ENRICH)  have 
focused their efforts in providing information, tools, case studies and further 
resources for facilitating research in care homes and since 2012 a whole new 
network of care homes are ready to participate in research. 
2.1.9.1. Hospital 
Within healthcare institutions, it is estimated that 47% to 51% of older patients in 
hospitals have dysphagia during their stay and at the time of discharge. This is 
especially predominant after stroke.(31, 39, 127) The consequences of dysphagia on 
hospitalised patients with heart disease(110) and pneumonia(128) and its association 
with laryngopharyngeal abnormalities (particularly with intubation) have also been 
recognised.(129) Despite 15.2% of referrals of PWD to other departments being 
inaccurate (dysphagia is erroneously identified),(130) PWD are believed to benefit 
from a multidisciplinary dysphagia management programme that has the potential 
to enhance patient care while decreasing the cost of healthcare delivery for the 
hospital.(131) 
In Norfolk, UK, a retrospective database study, including 1,330 stroke patients 
(median age 78) indicated that PWD have worse outcome in terms of inpatient 
mortality and length of hospital stay, odds ratios 12.5 (95% CI=8.9–17.3) and 3.9 
(95% CI=3.3–4.6) respectively, than those without dysphagia. The presence of 
dysphagia appears to determine the likelihood of a poor outcome. However this 
study didn’t clarify whether this effect is related just to stroke severity or results 
from problems related directly to dysphagia.(132) 
In the US, the National Hospital Discharge Survey (NHDS), 2005-2006, was 
evaluated for presence of dysphagia and the most common co-morbid medical 
conditions. A total of 271,983 hospital admissions were identified as associated 
with dysphagia, which was most commonly associated with fluid or electrolyte 
disorder, oesophageal disease, stroke, aspiration pneumonia or congestive heart 
failure. The median number of hospitalisation days for all PWD was 4.04 
compared with 2.40 days for those patients without dysphagia. Mortality also 
increased substantially in PWD associated with rehabilitation, intervertebral disk 
disorders, and heart diseases.(40) 
These results indicate that dysphagia is related to hospital length of stay and is a 
poor prognostic indicator. Early recognition of dysphagia and intervention in the 
hospitalised patient is advised to reduce morbidity and length of hospital stay.(76) 
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2.1.9.2. Care homes 
When considering the high incidence of cerebrovascular and degenerative 
neurologic diseases in nursing home residents, it is not surprising that up to 75% of 
care home occupants are suffering from dysphagia,(82, 133-135) and that those 
residents with oropharyngeal dysphagia and aspiration have a 45% 12-month 
mortality.(38, 127) A variety of symptoms may indicate that a care home resident has 
a swallowing disorder. 
A retrospective study(136) in Valencia, Spain collected information from 254 PWD 
across 107 care homes with nursing. The study identified that only 54% of nursing 
homes had a specific diet for the management of dysphagia and 51% used 
nasogastric feeding. The most frequent complications in these patients were lung 
aspirations (75%), dehydration (39%), malnourishment (32%) and pneumonia 
(31%).(136) This data correlates with other studies that indicated that PWD in care 
homes are not positioned properly, they were fed inappropriate food and/or liquid 
consistencies, or were given large, unmanageable bites of food and forced to eat 
quickly.(82) It is also concerning that only 22% of these residents had been referred 
to a SALT or an occupational therapist for evaluation. 
Residents in long-term care facilities (LTCF), especially thos orally-fed with 
dysphagia, are prone to dehydration. Dehydration was found to be very common 
amongst orally-fed patients but surprisingly was also common in those patients 
fed via nasogastric tubes.(137) Dehydration in older people is one of the leading 
problems in nursing homes and long-term care facilities.(106) Caution should, 
therefore, be taken with regard to the modification of fluids, as adherence to 
treatments with thickened liquids is often reduced.(107) 
Additionally, the magnitude of problems identified has implications for both 
resource and staff-training requirements in long-term care facilities.(41) Clinicians 
who work in long-term care settings rely heavily on the clinical examination 
because instrumented examination procedures such as videofluoroscopy, 
endoscopy or manometry are difficult to obtain.(138) The research literature, 
however, does not support the use of clinical examination as a method of detecting 
aspiration or planning diet or management modalities. 
Summarising, dysphagia is a debilitating condition but it may be reflected 
differently in primary care when compared to secondary care. Further research 
should describe the differences observed in the development of dysphagia between 
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acute and long-term care facilities. These differences are explored in chapters and 3 
and 5 of this thesis.  
2.1.10. The role and interaction of healthcare professionals in dysphagia 
This section outlines a brief description of the role of HCPs involved in dysphagia 
and describes the models of interaction between them. 
A multidisciplinary approach to the assessment and management of dysphagia has 
been shown to be beneficial for the patients.(139, 140) The SALT will assist with 
making an accurate diagnosis and may recommend oral muscular exercises and 
specific swallowing techniques. Muscle exercises to strengthen weak facial 
muscles and improve coordination may be recommended. The dietician can advise 
on the nutritional content of food and drink and the texture and temperature of the 
diet, as well as provide advice on foods that will suit the individual’s ability to 
swallow and diets to help reduce the risk of aspiration.(141) The physiotherapist can 
advise on the optimum positioning of the patient for eating and drinking (the 
patient should remain in an upright position while eating and drinking). The nurse 
can ensure that the patient is in a relaxed environment at meal times and is well-
positioned(142) when administering food and medication. The prescriber has an 
important role in the diagnosis and treatment of swallowing disorders. However, it 
is currently expected that bedside clinical examinations to identify dysphagia are 
carried out by the SALT. While the role of the pharmacist is traditionally limited to 
the provision of medication, a complete description of this role is described broadly 
later on in this dissertation.  
If dysphagia is suspected, the healthcare provider should involve an 
interdisciplinary team for additional diagnostic evaluation. Most of the time, an 
interdisciplinary team includes the carer, nurse, speech pathologist, dietician, 
patient, and family.(75, 143) The interdisciplinary team, including patient and family, 
identifies interventions focused on compensating, moderating or correcting effects 
of swallowing abnormalities.(26) 
The literature has identified different models of interaction between the HCPs in 
their roles of identifying, assessing and managing dysphagia.(34) These are some 
examples:  
- model A: the SALT trains nursing staff to conduct swallowing screenings. 
Nursing staff perform swallowing screenings and refer patients with identified 
swallowing problems to a SALT for a comprehensive swallowing assessment. 
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Given nursing staff turnover, training may need to be offered on a regular basis. 
In one study reported in the literature, the SALT maintained a presence in the 
emergency department for several months with the purpose of conducting 
swallowing screenings and, at the same time, demonstrating screening 
procedures to nursing staff who ultimately assumed the responsibility of 
conducting swallowing screenings for future patients.(144) This model may 
allow for senior nursing staff to become sufficiently skilled to train future 
nursing staff in screening, 
- model B: the medical practitioner performs swallowing screening in the course 
of his or her regular medical evaluation. He or she requests further swallowing 
assessment by the SALT when he observes signs of swallowing difficulty. 
However, medical practitioner swallowing screening tends to be less structured 
than swallowing screening conducted by nursing staff,(145) 
- model C: model A or B followed by an automatic referral within a specific 
timeframe (often 24–48 hours) for swallowing assessment by SALT for all 
patients admitted with a specific diagnosis. This model may include an on-
going in-service training module for nurses during annual education days or 
staff inductions, as well as frequent in-services/presentations to medical 
residents and/or attending doctors, 
- model D: all patients are automatically referred to SALT for swallowing 
screening or assessment,  
- model E: nursing staff contact the SALT on an on-call basis to request 
screening for patients who have presented to accident and emergency with 
conditions that are recognised to pose a possible risk of dysphagia. 
Model A (in which nurses are trained to perform screening) has received the most 
attention in research studies probably due to the cost-efficiency of training nurses 
and extending their role in dysphagia. In Canada, Martino and colleagues designed 
an extensive training programme for nurses to perform screening procedures using 
a tool known as the TOR-BSST (Toronto Bedside Swallowing Screening Test).(101) 
The accuracy of screening results was studied in comparison to videofluoroscopy. 
The TOR-BSST offered an accurate method to identify stroke PWD in the acute 
and rehabilitation setting with confidence that patients with a negative screen will 
not have dysphagia.  
Cichero et al(146) in 2009, during the development of a dysphagia screening tool 
involving 38 nurses in a seven-week study where 442 patients were screened on 
two general medical wards, highlighted that improved quality of care and cost 
Literature review 
 
Page 50 of 380 
 
savings are likely when training nurses in the management of dysphagia. Also an 
audit carried out in Heartlands Hospital, Birmingham, identified how a systematic 
approach to train nurses reduced the time patients wait for dysphagia screening 
from 35 hours to less than one hour.(147) 
By enabling non-specialist staff to screen and manage the more persistent 
dysphagia cases, practitioners with higher dysphagia management competence can 
be used in a more consultative role for the more complex and long-term cases.(148) 
However, no national guidance on developing these programmes or on the roles, 
responsibilities and competencies of the respective professions was available until 
recent years, leading to considerable variation of practice across the UK. In 2006, 
the National Dysphagia Competence Steering Group  created the Inter Professional 
Dysphagia Framework(149) (IDF) with the aim of  informing strategies or 
developing the skills, knowledge and ability of SALTs, nurses and other healthcare 
professionals/non-registered staff, to contribute more effectively in the 
identification of people with, and in the management of, feeding/dysphagia.  
This nationally recognised framework refers to five levels of dysphagia 
practitioner:  
- awareness: they need an awareness of the presenting signs and symptoms of 
dysphagia and will need to be aware of the associated health risks. 
Professionals at this level will need to know how and to whom the observed 
difficulties should be highlighted, 
- assistant dysphagia practitioner: the assistant dysphagia practitioners can 
demonstrate basic skills that contribute to the care and treatment of individuals 
presenting with dysphagia. They will contribute to the implementation of 
dysphagia management plans prepared by others in the care team and report to 
foundation, specialist or consultant dysphagia practitioners. Assistant 
dysphagia practitioners may prepare oral intake for individuals and contribute 
to feeding and providing fluids, 
- foundation dysphagia practitioner: the foundation dysphagia practitioners can 
demonstrate acceptable performance undertaking a protocol-guided assessment 
of swallowing.  They will identify presenting signs and symptoms, and will 
undertake a protocol-guided assessment of dysphagia.  They will be working to 
pre-defined criteria, which may include the use of liquids, semi-solids and 
solids, as appropriate to the individual’s age and needs. They are able to initiate 
and implement the actions dictated by the protocol and disseminate this 
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information to the individual, the carer and the team. They demonstrate 
knowledge and understanding of relevant policies, procedures, and guidelines, 
- specialist dysphagia practitioner: the specialist dysphagia practitioners can 
demonstrate competent performance in the assessment and management of 
dysphagia, working autonomously with routine and non-complex cases. They 
will receive referrals from others in the care team, prioritise referrals in line 
with local risk assessment procedures, and conduct a comprehensive 
assessment of the feeding/swallowing function. In this comprehensive 
assessment they will utilise a range of assessment techniques based on current 
research/best practice and any relevant policies, procedures and guidelines. 
They will generate a working hypothesis, analyse the emerging information 
and they will provide advice and guidance to other care team members taking a 
holistic view of the individual.  They will provide rehabilitation programmes 
and suggest interventions to manage the ongoing problems with feeding or 
swallowing, 
- consultant dysphagia practitioner: the consultant dysphagia practitioners can 
demonstrate skilled activity with advanced theoretical knowledge and 
understanding, based on current research/best practice and any relevant 
policies, procedures and guidelines. They will be able to determine the 
underlying cause of complex dysphagia problems, develop and test hypotheses, 
identify and trial interventions to rehabilitate or compensate for the presenting 
difficulties, and devise extensive dysphagia management plans. They will 
undertake specialist interventions, and/or alternative examinations, particularly 
for those individuals who present with unusual, complicated or co-existing 
difficulties. They may identify that further assessments are needed and refer for 
specialist assessments, interpreting the results and modifying dysphagia 
management plans accordingly.  
Dysphagia still remains a shared field between professionals as a multidisciplinary 
approach is essential in its assessment and management. However, the roles of 
these HCPs are not always defined and it seems that the full responsibility of 
training and delivery of dysphagia services falls on the SALTs. With the role of the 
pharmacist in the management of dysphagia virtually non-existent in current 
literature, it is hard to identify the approaches towards other concerns in dysphagia 
such us the pharmaceutical care of PWD. Nurses still seem to be the focus of many 
studies on the implementation of assessment tools and training on dysphagia 
probably due to the cost-efficiency of nurse-led interventions.  
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In summary, numerous models can be identified to describe the interaction between 
HCPs. However, the impact of this interaction on the nurses’ practice and 
ultimately on the care received by PWD needs to be explored. A theoretical model 
could benefit the implementation of pharmacy interventions on the administration 
of medicines and hence chapter 4 will apply a theoretical model to the current 
practice as perceived by nurses in care homes.   
2.2. Medication and dysphagia 
This section describes the physical, legal and technical challenges associated with 
the provision of medication to PWD. 
2.2.1. Oral medication in older PWD 
The use of medications is common in older people and this population has the 
highest risk of medication-related problems. The increasing number of older people 
in the population is leading to a growth in the amount of treatments prescribed for 
chronic diseases. As these diseases require treatment with a greater number of 
medicines, the problems of polypharmacy are becoming more important. In 2000 a 
systematic review exploring 143 articles tried to determine the extent and nature of 
polypharmacy in older people and to identify the morbidity and mortality which 
may result from polypharmacy in general practice.(150) While the study defined 
polypharmacy as the use of two or more drugs, the quality of the studies failed to 
draw conclusions about the extent to which polypharmacy is associated with health 
problems. However, further efforts in recent years to reduce unnecessary 
polypharmacy in older adults and updates in the literature have found that 
polypharmacy continues to increase and is now a recognised risk factor for 
important morbidity and mortality.(151) 
Polypharmacy is associated with a number of harmful effects. The incidence of 
adverse drug reactions (injury caused by taking a medication)(ADRs) and drug 
interactions increases with advancing age,(152) partly due to changes in the 
pharmacokinetics and pharmacodynamics associated with ageing but also to the 
presence of multiple disease states and their consequent drug treatments. Drug 
adherence (the likelihood of patients taking their medication as expected) is known 
to decrease as the number of drugs prescribed increases.(152) Patients prescribed 
multiple medications are also more likely to be admitted to hospital, have a longer 
length of stay, an increased mortality rate and to be readmitted after discharge.(152-
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154) Polypharmacy may also be a predictor of nursing home placement, malnutrition, 
fractures and impaired mobility.(154) 
As previously discussed, dysphagia is more often found in older patients due to its 
relation with ageing and chronic conditions associated with advanced age such as 
dementia and Parkinson’s.  
A qualitative study carried out by Kelly et al(155) recruited 11 PWD over 60 years 
old. The study found in some of the participants that the adherence to medication in 
PWD was affected by the medicine’s importance (as perceived by the patient), the 
number of medicines, the complexity of the regimen, the degree of respect for the 
prescriber, the ability to remember to take medicines and the medicine’s 
formulation. Participants identified that the formulation can affect the ease with 
which patients are able to take their medications. They also generally preferred 
liquid medicines but found tablets more normal. This study also highlighted the 
lack of awareness of the availability of liquid medicines on the part of participants, 
resulting in some crushing their tablets and enduring the unpleasant taste and the 
concerns of PWD on how to take their medication. However, these results were 
limited by the self-selected nature of the interviewees, small sample size, the short 
length of the interviews and the similar demographic data of the participants and, 
therefore, they may not represent the experiences of the whole population.  
A survey carried out nation-wide in the US in 2003 revealed that over 40% of 
adults (over 18 years old) in the general community experience problems 
swallowing tablets and capsules.(156) Of 679 adults who reported difficulty 
swallowing solid dose forms in a centre for swallowing disorders, 26% were older 
patients. In this group, 14% disclosed that they had delayed taking a dose of their 
medication, and 8% had skipped a dose completely. These findings indicate that 
some adults who have difficulty swallowing these forms of oral medications do not 
comply with prescribed regimens. Poor adherence to oral medication regimens may 
be elevated in the patient with dysphagia.(157) For example, 15% of all residents in 
surveyed long-term care facilities reported difficulty swallowing tablets and 
capsules. Of this group, 5% regularly expectorated this medication, while 27% did 
not even attempt to swallow these medications.(158) PWD who fail to comply with 
prescribed medication dosing are likely to encounter further increases in morbidity 
and mortality. 
A survey carried out by Morris (2005),(159) which included 154 patients (most over 
75 years of age) and received an overall response rate of 94%, reported problems 
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swallowing medications. Interestingly, 80% of those patients said that they did not 
inform their doctor or pharmacist if they could not take their medication and only 
22% of patients said that their doctor or nurse asked them if they had problems 
swallowing before issuing a prescription. The survey was carried out based on a 
computer search that identified patients with one or more risk factors for dysphagia 
and receiving medications. The high recruitment rates may be due to the fact that 
the doctor and the research nurse approached the patients or carers in person or 
over the phone. Patient consent was taken on receipt of the completed 
questionnaire and no ethics committee approval was sought.  
Evidence suggests that healthcare providers need to be more pro-active in 
identifying dysphagia and not assume ability to easily swallow solid dosage forms 
and when it is identified, methods to effectively deliver oral medications need to be 
improved to minimise non-adherence.(157) If a patient fails to take their medication 
this not only represents a waste of the medicines themselves but increased future 
costs to the health system due to poorer health outcomes.(160) 
In summary, the awareness of dysphagia by HCPs and the adherence to treatment 
can be compromising the management of the condition. Therefore, the prescriber’s 
approaches to the management of dysphagia and the way that nurses administer 
medication need to be explored and described. The observations of drug rounds in 
care homes, as explained in chapter 5, provide an opportunity to identify these 
issues. 
2.2.2. Prescribing for PWD 
This section highlights some of the challenges faced by HCPs when prescribing 
medication for PWD. 
2.2.2.1. Appropriateness of prescribing to PWD 
Appropriate prescribing is a general phrase encompassing and compressing a range 
of values and behaviours to express in a simple term the quality of prescribing.(161) 
Many other words are used to describe prescribing quality, such as good, poor, 
appropriate or inappropriate, optimal or suboptimal, and error. Not only quality but 
also quantity can compromise the appropriateness of prescribing. Under-
prescribing refers to failure to prescribe drugs that are needed and over-prescribing 
refers to prescribing more drugs than are clinically needed.(161) 
Literature review 
 
Page 55 of 380 
 
Mis-prescribing, or inappropriate prescribing (IP), refers to incorrectly prescribing 
a drug that is needed(162, 163) and it can be described as the use of medicines where 
the risk of an adverse drug event outweighs the clinical benefit, particularly when 
safer or more effective alternatives are available.(164) For example, Cornish in 2005 
described two cases in which PWD had been administered solid formulations 
orally and through the EFT where alternative liquid formulations were available.(165) 
This caused respiratory depression and loss of efficacy of the drugs, respectively. 
Older people are particularly vulnerable to problems like inappropriate 
prescribing.(166) Parkinsonism and cerebrovascular disease commonly result in 
dysphagia requiring more creative prescribing methods to ensure that adequate 
serum-drug-concentrations are achieved.(167) As a consequence, PWD may be 
prescribed less medication than needed as highlighted in a recent study in the UK 
which reported that dysphagia is a factor to under-prescribe medication such as 
warfarin.(168) 
2.2.2.2. Prescribing and law 
The legal framework in the UK which regulates the provision of medicines is 
formed by the Medicines Act(169) and the Consumer Protection Act.(170) 
Additionally, patients have redress through negligent practice in the UK via civil 
law courts.(171) 
Consumer Protection Act 1987(170) 
This Act gives initial statutory protection for all products. The Consumer 
Protection Act 1987 also implements the Product Liability Directive issued by the 
European Union to protect consumers from harmful products, including medicines, 
and makes a producer liable for damage caused by a defective product. If harm is 
caused to a patient by an inherent defect in the medicinal product then liability 
would fall to the producer not the practitioner. This act is relevant to patients when 
medicines are supplied which are defective or if medicines are altered prior to 
administration and become defective. 
Medicines Act 1968(169) 
The Medicines Act 1968 (now superseded by Human Medicines Regulations 2012) 
is the principle statutory framework that regulates the licensing, supply and 
administration of medicines in the UK. The legislation is interesting as it starts by 
prohibiting all activities associated with medicines and then provides a long list of 
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exceptions to this rule. Within this, the Medicines Act places a duty on the 
Secretary of State for Health to identify those medicines which represent a danger 
to the patient if their use is not supervised by an appropriate practitioner (registered 
medical practitioners, registered dentists, vets, independent and supplementary 
prescribing nurses and pharmacists (Medicines Act 1968, s.58 (1)) and, therefore, 
they require a prescription before they can legally be supplied. Consequently, 
prescription-only medicines can only be administered by or in accordance with the 
directions of an appropriate practitioner and any amendments to the initial 
directions on a prescription must be referred back to the appropriate practitioner.(23) 
The legal classification of a medicine is determined when a marketing 
authorisation, previously known as a licence to supply, is obtained.(172) Whilst the 
Medicines Act allows independent prescribers to supply and administer medicines 
with and without licences, other healthcare professionals without prescribing rights 
may only legally supply medicines within the bounds of their marketing 
authorisation. 
However, it is frequently observed in practice how the instructions from the 
prescriber are sometimes ignored, i.e. a recent study involving the administration of 
1,045 doses to PWD reported that tablets were crushed or capsules opened for 25.5% 
(266/1,045) of solid oral doses and for 44% of these doses, the tablet crushing had 
not been authorised by the prescriber (117/266).(173) If a medicine was used in an 
unlicensed manner (dose, route or form were outside the licensed terms), it is, in 
effect, a transgression of the Medicines Act and a criminal offense. Furthermore, if 
the medicine is found to harm the patient then the Consumer Protection Act may be 
utilised to demonstrate further transgression of criminal law. 
To ensure that criminal legislation is adhered to it is necessary for healthcare 
professionals to adhere to the policy commonly referred to as the “5Rs” which 
involves: 
- right medicine is given to the, 
- right patient at the,  
- right time in the, 
- right form of the drug at the, 
- right dose. 
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In recent years, nine rights (the five rights plus right response, documentation, 
action and route) have been proposed in order to decrease the incidence of 
medication errors.(174) 
For criminal law to be successfully applied the case has to be demonstrated 'beyond 
all reasonable doubt' and consequently the burden of proof required is set at a high 
level. It is, therefore, difficult to demonstrate that the incorrect dose or drug was 
given and taken without serum blood levels to corroborate it or that the authorised 
act of crushing a tablet actually caused the adverse event seen. 
Two key principles of common law apply to the medicines: the person’s right to 
self-determination (respect must be given to the wishes of the patient)(175) and the 
practitioner’s duty to be careful when prescribing and administering medicines to 
those in their care.(23) 
Even though a general practitioner has the right to prescribe a medicine, the 
medicine can only be given to the person with their consent providing the patient 
has mental capacity (Mental Capacity Act 2005, section 4).(176)  
In cases when patients who actively refuse medication but who are judged not to 
have the capacity to understand the consequences of their refusal, the covert 
administration of medicines may be necessary or appropriate. Covert medication is 
the administration of any medical treatment in disguised form. This usually 
involves disguising medication by administering it in food and drink. As a result, 
the person is unknowingly taking medication. In the case of lack of capacity, and 
when there is no designated decision maker appointed under the Mental Capacity 
Act 2005, the decision to act in the best interests of a patient rests with the general 
practitioner. 
Off-label or off-licence prescribing are terms used to describe the use of licensed 
medicines in a dose, age group, or by a route not in the product specification 
outlined within the marketing authorisation.(23) When prescribing off-label, full 
accountability of any harm that the patient may suffer as a consequence of the off-
licence administration goes to the prescriber and administrator if they were aware 
of the potential for harm and in a position to intervene.(177) 
An unlicensed medication does not have a marketing authorisation. For example, a 
doctor may prescribe a medicine for an individual patient in a form that’s not 
readily available, to be made up as a special preparation by a specialist 
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pharmaceutical company. In some cases, the pharmacist may arrange to obtain an 
unlicensed medicine from a manufacturer who makes it especially, under a 
‘Specials’ manufacturing licence. PWD are often required to only take liquid 
medication or to have it administered through the enteral feeding tube. When liquid 
licensed medications are not available, the use of liquid unlicensed medications, or 
‘Specials’, may be a sensible alternative for the practitioners to prescribe. However, 
if a patient is harmed by an unlicensed medicine which has been appropriately 
authorised they or their relatives may actively sue the practitioners involved to 
obtain compensation.(23) 
Negligence 
A patient can make a claim under civil law for compensation if they are able to 
demonstrate on the ‘balance of probabilities’ that the practice they have 
experienced is negligent. To be successful in court they need to demonstrate that 
the practitioner had a duty of care(178) to them, the practice was below standards 
which would normally be expected from a competent practitioner and harm 
resulted from this. 
Duty of care extends to all aspects of the doctor/patient relationship including 
advice giving, diagnosis, treatment and prescribing practice.(178, 179) In the case 
where an older male patient with angina died after his granddaughter had been told 
to crush his slow-release verapamil tablet by a practice nurse, the family would 
probably be able to argue that the nurse had a duty of care and that the practice was 
below that of a competent practitioner; however, they may find it more difficult to 
demonstrate 'beyond all reasonable doubt' that the harm resulted from the tablet 
crushing. It may have been possible to demonstrate that this occurred on the 
'balance of probabilities', however.(180) 
In the study by Stubbs et al,(173) tablet crushing was avoidable by the correct use of 
more suitable preparations in 57.5% (153/266) of doses. Failing to consider these 
issues would render GPs liable to negligence if harm is caused or in trespass to the 
person for unlawful touching if it cannot be objectively demonstrated to be in the 
person’s best interests. 
Consequently when prescribing and administering medicines to patients it is 
always preferable to supply a medicine within its marketing authorisation as the 
responsibility for any subsequent harm which the patient was not already aware of 
at the point of receipt goes to the manufacturer. If a medicine is to be supplied 
outside of the marketing authorisation then this can only be authorised by 
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prescribers and the safety of the decision requires careful consideration. In such 
situations, it is preferable to record the decision and rationale as this then provides 
evidence of practice expected of a competent practitioner. If the patient refuses to 
receive the medicine then any decision to covertly administer the medicine must be 
carefully considered taking into account the patient’s ability to be involved in the 
decision, the wishes of relatives and what is in the patient’s best interests.(176) 
This section is highlighting that liability concerns and awareness of dysphagia are 
factors that may be affecting prescribing practices. Further research on the 
approaches to these concerns is presented and discussed in chapter 5 of this 
dissertation.  
2.2.3. Administering oral formulations 
This section outlines the different oral formulations of a drug and explores the 
issues surrounding their administration. 
Recent literature has highlighted the importance of the formulation of the 
medicines for PWD.(155, 181, 182) The different types of oral formulations may 
represent advantages and disadvantages for PWD and it is, therefore, relevant to 
explore these differences and how the literature has identified their acceptability 
within PWD. 
2.2.3.1. Tablets and capsules 
A tablet comprises of a mixture of active substances and excipients, usually in 
powder form, pressed or compacted into a solid dose.(183) The excipients can 
include diluents, binders or granulating agents, glidants (flow aids) and lubricants 
to ensure efficient compacting; disintegrants to promote tablet break-up in the 
digestive tract, sweeteners or flavours to enhance taste and pigments to make the 
tablets visually attractive. A polymer coating is often applied to make the tablet 
smoother and easier to swallow, to make it more resistant to the environment 
(enteric-coated formulations), or to enhance the tablet's appearance. About two-
thirds of all prescriptions are dispensed as solid dosage forms.(184) 
Capsules generally consist of a gelatine shell in two parts with the drug and a 
filling agent held inside. This is easier for manufacturers to put together and is very 
often, due to the torpedo shape, easier for patients to swallow.(23) 
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As the ingredients in each tablet or capsule are carefully chosen to not adversely 
affect the active drug and its absorption, it is never appropriate to crush two 
different tablets or open two capsules together in the same container.(23) The 
inactive ingredients from one could theoretically adversely affect the absorption of 
the active ingredients in another. 
In order to control the location in the digestive system where a drug is absorbed, an 
enteric coating is sometimes applied to tablets and capsules.(185) Most enteric 
coatings work by presenting a surface that is stable at the highly acidic pH found in 
the stomach, but breaks down rapidly at a less acidic environment present in the 
small intestine. Enteric coats are placed on tablets to protect the stomach lining 
from the drug, e.g. NSAIDs, to protect the drug from the acidic environment, e.g. 
proton pump inhibitors, or to release the drug where it is required to work, e.g. 
sulfasalazine in Crohn’s disease. Often the abbreviations such as ‘EC’ or ‘Gastro-
resistant’ are added beside the name of the drug to indicate the additional coating. 
Sometimes, capsules and tablets can be prescribed as modified-release formulation. 
This is a mechanism used in tablets or capsules to release a drug over time in order 
to be released at a controlled rate into the bloodstream.(185) These formulations are 
used to prevent peak serum concentrations which arise from immediate release 
tablets and can cause side-effects in certain medicines, e.g. theophylline, nifedipine 
and to improve adherence in medicines with short half-lives e.g. felodipine as the 
patient is required to take the medicine once a day rather than twice daily. The 
disadvantage of such medicines is that they frequently contain more than the 
recommended single dose found in an immediate-release formulation. 
Consequently, any tampering with these formulations increases the chance of side 
effects and toxicity and as the body metabolism increases to remove the drug more 
rapidly, it results in a period of time when the drug concentrations are too low to be 
effective.  
Between 15% and 30% of residents in care homes have difficulties in swallowing 
their medicines,(158) where medicines are most commonly prescribed as tablets and 
capsules due to cost, availability and convenience. With a professional 
responsibility to ensure that PWD receive their medicines, it has been found that 
nurses resort to inappropriate crushing of tablets, dispersing them in water or 
mixing them with foodstuffs(186) and many of them have not received recent 
training about enteral feeding in their own homes.(187) The practice of tablet 
crushing and dispersing prior to administration can be appropriate; however, in 
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some instances it may be dangerous and, if not authorised by a prescriber, 
illegal.(188) There is also the problem of a potentially altered response to the drug as 
changing the formulation through crushing the tablet or opening the capsule can 
affect its pharmacokinetics, therapeutic efficacy and side- effect profile(189) and 
result in significant harm. For example, crushing controlled-release formulations 
such as morphine sulphate tablets (MST), which are designed to release the drug 
slowly over 8-12 hours, can result in a rapid increase in blood concentration to 
potentially toxic levels. This can cause the patient to become drowsy and develop 
respiratory problems and patients do not receive the prolonged pain control 
expected from the formulation.(190) The clinical sensitisation of PWD and HCPs 
exposed to contact with the medication or allergy to certain drugs like antibiotics 
are other problems associated with crushing medication. Exposure to certain drugs 
also represents a risk of carcinogenesis (tumour formation) from anti-cancer 
medication.(189, 191) 
In the UK, the administration of medication via enteral feeding tubes was the most 
common reason to crush tablets and open capsules as reported in a study carried 
out in 30 hospital wards.(192) Also, 20.6% of a total of 1,177 participants in an 
American survey in an acute hospital unit reported routinely crushing and 
administering enteric-coated medications whilst 14.6% routinely crushed modified-
release medications.(193) Equally, in an Australian survey, 31 hospitals reported that 
medications were modified at the bedside and most of the tablets or capsules had 
standard-release characteristics. Eight hospitals crushed modified-release dosage 
forms and 11 hospitals crushed medications with a narrow therapeutic index. 
Multiple crushing was a common practice (84% of hospitals).(194) The practice seen 
in care homes derives from training within secondary care where similar problems 
are still being identified.(195) In 2002, Wright carried out a survey of 540 nurses 
attending conferences. The research found that 40% of the nurses that worked in 
UK care homes admitted to crushing medicines on every drug round; 29% every 
day and 12% every week.(188) Additionally, nurses reported regularly crushing 
medicines which were modified-release or had enteric coats and rendering 
medicines unlicensed prior to administration when licensed alternative 
formulations were available. There are a large number of surveys carried out 
internationally on this practice but the difficulty with such surveys is their construct 
validity, i.e. they are unlikely to provide an accurate estimate of true practice which 
could only be ascertained via covert observation. While there are a smaller number 
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of observational studies and these are not covert they are more likely to provide a 
more accurate reflection of current practice. 
In an observational study of medication administration on two long-stay wards for 
older mentally ill inpatients in the UK, the administration of 1,257 oral doses of 
medication at 36 medication rounds was observed. Tablets were crushed or 
capsules opened for 25.5% (266/1,045) of solid oral doses. For 4.5% (12/266) of 
doses, crushing was specifically contra-indicated by the manufacturer. In 57.5% 
(153/266) of doses, tablet crushing was avoidable by the correct use of more 
suitable preparations and caused contamination, spillage and hygiene problems.(173) 
An observational study of medicine administration errors in nursing homes in the 
Netherlands(196) identified a lower crushing rate of 16% (330 observations out of a 
total of 2,025).(196) Higher prevalence was reported in another observational study 
carried out in 10 different aged-care facilities in South Australia where tablets were 
crushed or capsules opened in 34% (n=1,207) of administrations.(197) Very recently, 
medicines administration to 160 patients across two aged-care facilities in Australia 
revealed that of the 75 medications crushed prior to administration, 24 (32%) were 
identified as not suitable for crushing.(198) The results of this study are in agreement 
with other reports in the literature of a high prevalence of solid dosage form 
modification in residential aged-care, recording an overall incidence rate of 18% of 
residents having their tablets crushed prior to administration.(173, 197, 199) Although 
some of these studies are carried out outside the UK, their practice and the 
structures of their health systems are based on UK models and may add important 
value to the research in PWD. To date, however, there are no UK based studies 
regarding observed practice in care homes. 
The practice of crushing tablets or opening capsules involves altering the 
formulation of a medication affecting the marketing authorisation granted to a 
pharmaceutical company. Therefore, if a tablet is crushed, a capsule opened, a 
medicine tampered with, or if a medication is given via an enteral tube, it is being 
administered outside the medicine’s product licence and the manufacturer ceases to 
be liable for any harm that occurs from taking the drug under the Consumer 
Protection Act 1987.(188, 200-204) There is also the problem of the clinical sensitisation 
of PWD and HCPs exposed to contact with the medication or allergy to certain 
drugs like antibiotics and the  risk of carcinogenesis.(189, 191) 
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When dysphagia is identified in a patient it is appropriate to first ascertain whether 
suitable alternative formulations are available before resorting to tampering with 
the medication which may render its administration unlicensed. 
2.2.3.2. Dispersible, orodispersible and buccal formulations 
Difficulties with and resistance to tablet taking are common and particularly 
prevalent in geriatric, paediatric, and psychiatric patients.(205) Dysphagia can 
exacerbate adherence problems and undermine treatment efficacy.(206) Difficulty in 
swallowing conventional tablets and capsules has emerged as an additional factor 
in medication non-adherence and has led to the development of alternative drug 
delivery strategies such as orodispersible tablets (ODT).(207) ODT is a drug dosage 
form designed to be dissolved on the tongue rather than swallowed whole. The 
ODT serves as an alternative dosage form for patients who experience difficulty in 
swallowing or where adherence is a known issue and, therefore, the provision of an 
easier dosage form ensures that the medication is taken. An additional reason to use 
ODTs is the convenience of a tablet that can be taken without water. Dispersible 
tablets are typically dispersed in water or another liquid before they are 
administered to the patient. This drug product is designed for patients experiencing 
difficulties in swallowing solid dosage forms like tablets or capsules. While this 
formulation counts on the advantage of obtaining an increased rate of absorption 
that can be desirable for example for pain relief, it is highly unlikely that the dose 
is evenly distributed when adding water to dispersible products. This creates 
problems when only part of the dispersed formulation is administered. 
Buccal tablets are those formulated to dissolve when held between the cheek and 
the gum, permitting direct absorption of the active ingredient through the oral 
mucosa. This route is used for anti-nausea drugs and nicotine replacement gums. 
Anti-nausea medicines are particularly suitable for buccal administration as the 
nausea itself can cause swallowed tablets to be vomited and, therefore, rendered 
ineffective.(208) 
ODTs offer some advantageous features over other conventional dosage forms 
(especially for patients of specific age groups and with disease conditions) such as 
the removal of the need to swallow a tablet or capsule, thereby reducing the effort 
and physiological stress associated with tablet swallowing. Thus, ODTs ease oral 
administration of medication in paediatric and geriatric populations where 
swallowing may be challenging.(209) ODTs also offer easily-measured dosing(210) 
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thus accuracy of dosage can be obtained.(206) The system gives rapid onset of action 
and increase in bioavailability compared to conventional tablets due to the 
dispersion in saliva and pregastric absorption. Pregastric absorption avoids first-
pass metabolism which can provide a great advantage in drugs that undergo hepatic 
metabolism.(211, 212) 
A survey of 1,576 Norwegian PWD concluded that in order to achieve good 
adherence and optimal pharmacotherapy, it is important for medical practitioners 
and pharmaceutical personnel to be aware of the general problems connected to 
swallowing tablets, to enable them to select the correctly formulated drug for their 
patients.(213) ODTs may alleviate the problem of swallowing tablets and they offer 
substantial advantages over ordinary tablets, are more convenient to administer, 
and enhance the potential for improved adherence in patients who experience 
difficulty in taking tablets. 
2.2.3.3. Liquid medicines and specials 
PWD are at risk of adverse drug events caused by the inappropriate modification of 
the dosage form through the crushing of a tablet or capsule that should not be 
crushed. In these cases, liquid medicines can be the most appropriate alternative to 
tablets or capsules for patients who can’t swallow solid dose formulations and 
other routes cannot be considered. A recent study that observed 266 
administrations estimated that liquid formulations could be a more suitable 
alternative in up to 57.5% of those observations.(173) Liquid medication is designed 
for PWD; however, they may not always be the best alternative. The switching of 
solid medications to a liquid form for patients who develop dysphagia can be 
considered potentially unsafe practice since the patient may have difficulty with 
both solids and liquids and should only be carried out after receiving specific 
SALT recommendations.(214) 
Liquid medicines are obtained in the form of solutions, syrups, suspensions and 
mixtures. These are complex formulations that contain not only the active 
ingredient but a liquid vehicle that provides long term stability, a suspending agent 
to ensure that the drug is evenly distributed throughout the formulation and often 
preservatives, flavourings and colourings to make the final mixture longer lasting 
and more palatable to the patient.(23) These characteristics not only make them 
easier to swallow than solids but also make them frequently possible to administer 
via an enteral feeding tube without the need for further manipulation.(215) 
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However, the advantage gained in the administration of liquid products is often lost 
because of the inaccuracy of the devices used to measure and administer them.(216) 
Such variations may be related to factors such as pouring the liquids from 
different-sized bottles, the colour of the liquids, and the adequacy of available light. 
Perhaps the most important factor in measurement is related to the care practiced 
by the person performing the measuring.(216) In a study involving 282 carers in 
American care homes, approximately one in 10 participants measured doses of 
liquid medication with a volume error greater than 10%, and these dose errors were 
more common with the etched dosing cup, the dosing spoon, and the printed dosing 
cup.(217) This coincides with another similar study by Sobhani et al(218) in 2008 that 
showed how droppers and dosing cups were the most commonly used devices in 
the home for measuring liquid medications. The carers and nurses were more likely 
to measure an acceptable dose with an oral syringe when compared with a dosing 
cup. However, a large proportion of study participants were unable to measure an 
accurate dose with either device.(218) Lawrence suggested a possible explanation to 
this fact after a study reviewing notes from SALTs that revealed that while 
recommendations for swallowing solid oral medications were often present, 
recommendations regarding the administration of liquid medications were absent in 
the patients’ notes and medication charts.(214) These challenges were faced when 
administering liquid medication could potentially be leading to treatment failure 
according to a survey carried out across 130 participants in primary care clinics in 
2000.(219) 
Additionally, while the cost of licensed liquid formulations is a significant issue for 
the NHS,(220) more recently, concerns have been raised regarding cost of unlicensed 
liquid medicines which nurses request for use in their residents in care homes to 
ease medicines administration and reduce reliance on tablet crushing and 
dispersing.(158) As an example, the analysis of specials prescribing in a primary care 
Trust in 2008 found the average cost to be £102, with prices reaching over 
£2,000.(221) 
This section highlights the need of exploring the formulation choices made by the 
prescriber when prescribing to PWD. Identifying ways of optimising the use of 
medication could be an essential part of a pharmacy intervention and, therefore, the 
cost of alternative formulations needs to be explored. This is described in chapters 
3 and 5 which aim to estimate the financial impact of suggested alternative 
formulations for PWD. 
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2.2.4. Challenges to the administration of medication 
The next section will describe the three main challenges faced in the administration 
of medication by nurses to PWD. 
As the various studies previously described in this chapter show, the administration 
of medication to PWD is a complex task that can be challenged by numerous 
elements. When focusing exclusively in the interaction between the patient and the 
nurse or carer at the time of the medicines administration, three main problems 
may challenge this process: 
- problems related to the person administering medication, 
- problems related to challenging administrations, 
- problems in the acceptability by the patient. 
This section will explore these problems through the perception of nurses on the 
administration of medication, the impact on whether medicines are taken as agreed 
or directed and the impact on the medication administration errors. 
2.2.4.1. Nurse views on administering medication 
Nurses administer medications every day as part of their practice. Consequently, 
many studies have explored nurses and the role they play in medication 
administration. The focus of these studies has often been limited to drug errors, 
rather than investigating a broader view of the medication administration process 
from the nurses’ point of view. 
Several qualitative studies have been identified to reflect some of the likely 
concerns and perceptions of factors affecting the quality in the administration of 
medications and altering medication dose forms prior to the administration to 
patients in their practice setting. These studies outlined categories that were re-
classified into broader themes that could provide us with an indication of the 
perceptions that nurses have on administering medication to PWD. Table 7 
summarises the themes reflected in these studies based on the categories identified. 
These themes highlight environmental factors, knowledge and skills and time 
constraints as the main concerns of the nurses. The time concerns coincide with the 
results of an observational study by Thomson et al(222) in 2009 where it was 
concluded that time requirements for the medication administration process are 
substantial in long-term care facilities, particularly when nurses are unfamiliar with 
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residents and in the presence of interruptions, potentially affecting the efficiency, 
quality, and safety of this process. 
Numerous concerns highlighted the importance of the interaction between 
healthcare professionals and between the nurses and the patients(199, 223-226) and how 
this communication can be affected by the limited information resources in 
facilities like care homes.(199) The lack of pharmaceutical knowledge was also 
highlighted by a survey carried out in 2006 with 34 nurse participants from six 
different intensive care units in the State of Qatar. The study identified how little 
was known by the nurses about the different codes used by drug companies in the 
modified release formulations and about the consequences of crushing these 
preparations.(227) 
 
Theme Categories 
Time Time constraints.(224, 225) 
Communication with HCPs The groups of professionals involved(223) 
Informal communication with other healthcare 
professionals(199) 
Multidisciplinary communication as a contextual barrier(224) 
Miscommunications with other Healthcare professionals(225) 
Interaction between nurse 
and patient 
Personal attributes of individual staff(223) 
Concerns about implementing appropriate procedures in 
individual facilities(199) 
Patient participation(224) 
Interventions for patient care(226) 
Nurse’s skills Client implications of the nursing education(223) 
Lack of knowledge(225) 
Difficulty of coordinating information and policies about 
altering medications(199) 
Impact of nurse’s practice 
on patient 
Client implications of the nursing practice(223) 
Administration of medication with risk (199) 
Monitoring medications(226) 
Provision of individualised care(224) 
Work Environment Information vacuum(199) 
Context of the procedures(223) 
Interruptions and distractions(225) 
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Table 7: Nurses' perceptions on the factors affecting the administration of medication 
 
No qualitative studies were identified through literature search that were specific to 
nurses’ views on dysphagic patients until 2009 in a study by Kelly et al.(228) Kelly 
carried out focus groups with a consultant in medicine for older people, a clinical 
nurse specialist in stroke management,  another in enteral nutrition, an endoscopy 
nurse,  hospital and a community pharmacist, a senior lecturer in pharmacy practice, 
a dietician, and a SALT. Six themes were identified: 
- the wide spectrum of dysphagia, 
- medicine formulation,  
- problems with data flow, 
- the primary function of swallowing is nutrition rather than taking medication, 
- cost of medicines, 
- therapeutic dilemmas. 
The fact that only some of the themes identified by Kelly et al(228) have been 
previously contemplated by the studies presented in Table 7 suggests that 
administering medication to PWD is a complex process. Although the results from 
this study by Kelly also include views from other HCPs, the multidisciplinary 
interaction was also an emerging theme as this study concluded that improvements 
in inter-professional communication are needed to improve medicine 
administration to dysphagic patients. 
2.2.4.2. Medication adherence 
Adherence has been defined as the “active, voluntary, and collaborative 
involvement of the patient in a mutually acceptable course of behaviour to produce 
a therapeutic result” (Delamater (2006) page 74).(229) Other authors have described 
it further, exploring how a patient's behaviour in terms of taking medication 
coincides with medical or health advice.(230, 231) These definitions imply that the 
patient has a choice and that both patients and providers mutually establish 
treatment goals and the medical regimen.(229) Medication adherence usually refers 
to whether patients take their medications as prescribed (e.g. twice daily), as well 
as whether they continue to take a prescribed medication.(232) 
When exploring adherence it is important to consider demographic, psychological, 
and social factors, as well as the healthcare provider, the medical system, the 
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disease, and the treatment related factors.(229) These factors can affect the adherence 
related to complex dosing or administration requirements, cost, and a lack of 
understanding of the importance of adherence.(233) 
Medication adherence is a complex phenomenon. As individuals assume greater 
responsibility for decisions about their healthcare, it is essential to support 
adherence behaviours that reflect a clinician-patient partnership. The term 
adherence is intended to be non-judgmental, a statement of fact rather than of 
blame of the prescriber, patient, or treatment(234) and it should not be confused with 
compliance. Compliance includes taking medication at the desired strength, in the 
proper dosage form, at the appropriate time of day and night, at the proper interval 
for the duration of the treatment, with proper regard to food and drink, and 
consideration of other concomitant medications (both prescribed and non-
prescribed) and herbal remedies.(235) However, the notion of compliance is an 
outdated concept and should be abandoned as a clinical goal in the medical 
management of patients as it has connotations of  dependence and blame and does 
not move the patient forward on a pathway of better clinical outcomes.(236) 
As the older population in the UK is increasing,(237) dysphagia is becoming a major 
problem in medicine adherence.(213, 238-240) Older people are more susceptible to the 
adverse effects of medicines and more prone to practical difficulties with medicine-
taking such as poor eyesight, trouble opening packaging or difficulty swallowing 
tablets.(241) In 2005, a survey of patients attending community pharmacies 
demonstrated that 68.7% of patients responded to experiencing difficulty with 
swallowing oral solid dose forms by not taking them.(239) In a study carried out in 
New Zealand on 316 people over 75 years old, low scores in adherence were 
related to difficulty swallowing solid dose forms in 14% of the cases.(242) (If a 
patient is prescribed a painkiller for an injury to be taken as one tablet four times a 
day for a week but takes only two tablets a day for five days, the adherence would 
be 36% (10/28)). 
As dysphagia may impair a patient’s ability to adhere to a prescribed regimen,(213, 
243) HCPs can play a significant role by monitoring patients, identifying potential 
barriers to adherence, and implementing appropriate intervention strategies. It is 
recognised that the  most frequently reported problem by patients with respect to 
swallowing is the large size of oral solid dosage forms.(23) If barriers to adherence 
with solid formulations cannot be overcome, the use of smaller size formulations(23) 
with equivalent efficacy and acceptable safety can be considered.(233) Other 
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alternatives are the replacement with liquid or orodispersible formulations. 
Difficulty in swallowing conventional tablets and capsules has led to the 
development of alternative drug delivery strategies such as ODTs.(207) Patients with 
physical swallowing issues have shown a strong preference for ODTs over 
conventional tablets. A crossover study of 36 adult PWD in the US aimed to 
evaluate differences in swallowing physiology and safety in PWD between 
conventional tablets and ODTs.(157) 76% expressed a preference for an ODT 
compared with a conventional tablet formulation and the authors concluded that the 
ODT medication delivery technology may provide benefit to adults with dysphagia 
in convenience, compliance, and accuracy of dosing. Despite the fact that this 
research was supported by a grant from a pharmaceutical company, there is clear 
advantage on the use of ODT formulations that may increase the adherence to 
treatment. 
2.2.4.3. Medication Administration Errors (MAEs) 
The term `medication error’ has been described as: “A mistake that happens in the 
stages of either prescribing, dispensing or during the administration of medication 
where a patient is injured, killed or potential harm could arise” (Wolf (1989) page 
8).(244) More recently, this term has been redefined as: “Any preventable event that 
may cause or lead to inappropriate medication use or patient harm while the 
medication is under the control of the healthcare professional or patient” (Jevon 
(2010) page 146).(245) 
With regards to the administration of medication, MAEs can be defined as: “A 
deviation from the prescriber’s order as written on the patient’s drug chart” (Allan 
(1990) page 555).(246) However, it must be noted that a drug prescription does not 
necessarily contain all the information required to administer a drug safely such as 
the viscosity required in the administration or the interaction with other drugs. 
The Department of Health states that any trained member of staff from health or 
social care can administer a medicine that has been prescribed by someone who is 
authorised to do so.(247) Although many different healthcare professionals are 
legally permitted to prescribe and dispense medicines, it is usually nurses and 
carers who administer the drug to a patient. As a consequence, the responsibility 
for avoiding potential medication errors is largely held by the nurses.(174) Allan and 
Baker’s definition also does not take into account the responsibility of nurses to use 
their professional judgement to ensure medicine administration is clinically 
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appropriate and safe,(248) i.e. nurses should not blindly give the medicines 
prescribed. 
Healthcare professionals are often involved in procedures and skills that affect 
patients, but the administration of medicines is a procedure that will be carried out 
on a day-to-day basis. Lengthy and repeated drug rounds open up a risk for 
potential administration errors almost to be made on a regular basis.(249) It has been 
highlighted in the literature that one of the reasons why adverse events are so 
common is that clinicians are human, and thus prone to error.(174, 249-252) In a study 
carried out by Wilson et al(250) in 1995 in Australia, the majority (81%) of adverse 
events associated with errors in the administration of medication were related to 
one or more human factors, such as lack of knowledge, care or attention. Of the 
errors that were considered highly preventable, less than 1% were not associated 
with human error.  
Medication errors are one of the main causes of morbidity and mortality of patients 
who are hospitalised(174) as they carry a high risk of adverse events. In the UK, as 
many as 10% of hospitalised patients may experience an adverse event, and some 
may experience multiple events.(253, 254) Studies from other countries suggest that up 
to 30% of patients will experience an adverse event, and these come at a very high 
cost.(255-257) This clearly shows the need to reduce medication errors so that patients 
receive safe and efficient care around the medication administered.(258, 259) Vincent 
et al (2001)(253) reported that patients experiencing an adverse event in hospitals in 
the UK remain in hospital for almost nine additional days, incurring an extra 
annual cost to the value of £290,268 to the Trusts concerned. While these costs are 
likely to be higher in the present time, in 1999, it was estimated that the total 
annual cost of preventable adverse events in North America was between 
£10billion and £17billion.(260) However, the most important cost of a medication 
error is the effect on the patient. Medication administration errors can cause 
patients to experience adverse events making them 4-7 times more likely to die 
than those who do not.(255) 
2.2.4.3.1. Types of errors 
The best way to understand how medication errors happen and how to prevent 
them is to consider their classification. The literature recognises that the 
classification of errors can be contextual, modal, or psychological.(261) Contextual 
classification deals with the specific time, place, medicine and people involved. 
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Modal classification examines the ways in which errors occur (e.g. by omission, 
repetition, or substitution). Psychological classification explains events (nature of 
the errors). While contextual classification of errors provides a description of the 
error within its context, it is hard to explore and classify all the categories 
described as they can be almost unlimited.  
On the contrary, current theories and definitions of psychological and modal 
classifications are broad but limited to certain categories. For that reason, this 
literature review will only explore the psychological and modal classification of 
errors without, however, underrating the importance of contextual categories and 
their power to contribute to a deeper classification of the type of errors identified. 
Classification of medication errors is important because the probabilities of errors 
of different classes are different, as are the potential remedies.(262) 
Psychological classification 
Classification based on psychological theory tends to be preferred(263) as it explains 
events rather than merely describing them. However, it concentrates only on 
human behaviours rather than systems-based sources of error. This classification 
has been discussed in detail  and supported by several authors.(262, 264) 
Psychologists consider an error to be a disorder of an intentional act, and they 
distinguish between errors in planning an act and errors in its execution.(265) If a 
prior intention to reach a specified goal leads to action, and the action leads to the 
goal, all is well. If the plan of action contains some flaw, that is a ‘mistake’. If a 
plan is a good one but is badly executed, that is a failure of skill.(262, 266) This theory 
highlights four types of medication error (numbered 1–4) as indicated in Figure 3. 
Mistakes can be divided into (i) knowledge-based errors and (ii) rule-based errors. 
Failures of skill can be divided into (iii) action-based errors ('slips', including 
technical errors) and (iv) memory-based errors (‘lapses’). 
Knowledge-based errors can be related to any type of knowledge, general, specific, 
or expert. It is general knowledge that penicillin can cause allergic reactions; 
knowing that your patient is allergic to penicillin is specific knowledge; knowing 
that co-fluampicil contains penicillin is expert knowledge. Ignorance of any of 
these facts could lead to a knowledge-based error.(265) Rule-based errors can further 
be categorised as (a) the misapplication of a good rule or the failure to apply a good 
rule; and (b) the application of a bad rule. 
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(Extracted from Ferner & Aronson (2006) page 1013)(262) 
Figure 3: The classification of medication errors based on a psychological approach(262) 
 
Norman, in 1981, defined action-based errors as ‘the performance of an action that 
was not what was intended,(267) e.g. a slip of the pen, when a doctor intends to write 
penicillin but writes penicillamine’. Technical errors form a subset of action-based 
errors. They have been defined as occurring when ‘an outcome fails to occur or the 
wrong outcome is produced because the execution of an action was imperfect’.(268) 
An example is the addition to an infusion bottle of the wrong amount of drug.(261) 
Memory-based errors occur when something is forgotten; for example, giving 
penicillin, knowing the patient to be allergic, but forgetting.(265) 
Modal classification 
Attempts are often made by researchers and committees to define or classify the 
type of medication errors. Many of those definitions are unsatisfactory and have 
been rejected because of the lack of transferability to other studies.(269) 
Nevertheless, those definitions may be useful in formulating new and better ones, 
since they may contain helpful ideas. This review aims to examine published 
definitions of the types of errors to produce a definition that incorporates what is 
relevant and omits what is not, adding relevant features that may have previously 
been missed.  
In 2002, Barker et al(270) carried out a study across 36 healthcare institutions in the 
US to identify the prevalence of medication errors in patients. This study classified 
and defined the types of errors found in the administration of drugs in eight 
different categories. These eight types of MAE were included in a systematic 
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review in 2006 by McBride-Henry & Foureur(271) but McBride-Henry & Foureur 
also included intra venous push rates in their classification. 
More recently, a similar study in hospitals in East Anglia, UK(272) combined a 
classification of errors from the American Society of Hospital Pharmacist(273) with 
categories reported by Dean.(274) This study by Kelly et al included types of MAEs 
that were not mentioned in McBride-Henry & Foureur(271) such as “wrong 
formulation” and “deteriorated medicine”. In the same way, McBride-Henry & 
Foureur(271) included “drug compatibility” and “allergy related error” that were not 
identified within Kelly’s categories. Wolf in 1989 defined MAEs as:  
“Mistakes associated with medicines and intravenous (IV) infusions that are made 
during the prescription, transcription, dispensing and administration phases of 
medicine distribution” (Wolf (1989) page 8).(244) 
As per Wolf’s definition, we need to include errors derived from inappropriate 
prescribing in our categories as these are also a contributing factor to the MAE. In 
conclusion, MAEs can be classified as 14 different types when combining the 
categories identified by the literature. These categories are outlined and defined in 
Table 8.  
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Error Type Definition 
Omission 
Patient fails to receive medication by the time of the next 
scheduled dose 
Unordered drug 
Administration of a dose that was not prescribed for the 
patient concerned 
Wrong drug Administration of a dose that was not the medicine prescribed 
Extra dose 
Administration of a prescribed additional dose of a prescribed 
medicine 
Wrong dose Incorrect quantity supplied 
Wrong formulation 
Administration of the correct dose in a formulation different 
to the recommended/prescribed 
Wrong dose preparation 
and administration 
Errors in preparation of a medicine prior to its administration 
Wrong route 
The administration of the correct drug by a route or site that 
was not prescribed 
Wrong time 
The Administration of a medication ± 60 minutes from its 
scheduled time 
Deteriorated medicine 
The physical or chemical integrity of the medicine has been 
compromised 
Drug Compatibility 
Administration of two drugs that should not be administeredin 
conjunction 
Allergy related error 
Administration of a drug that triggered an expected allergic 
reaction 
Inappropriate prescribing 
Administration of a drug as a result of an inappropriate drug 
or formulation prescribed 
Others 
Any medication error which does not fall into any of the 
above 
Summarised from Wolf (1989),(244) ASHP (1993),(273) Dean (1999),(274)  
Barker et al.(2002),(270) McBride-Henry and Foureur (2006),(271)  and Kelly et al. (2011).(272) 
Table 8: Modal classification of MAEs 
 
2.2.4.3.2. Reporting errors 
One of the limitations of retrospective studies is the use of self-reported errors as 
an outcome measure. Because the identification and reporting of medication 
administration errors (MAE) is not automated and is a voluntary process, it is 
important to understand potential barriers to MAE reporting. A range of factors 
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have been identified as contributing to medication administration errors in these 
settings and these include: staff being unable to find the patient or the medicine, 
inadequate protocols, staff knowledge and training, interruptions(222) and 
environmental factors.(275-277) Other individual factors like the fear of disciplinary 
action, poor communication at the change of shift,(278, 279) disagreement over error, 
reporting effort and administrative response(279) are contributing factors which 
decrease the amount of errors reported. The factors that contribute to the 
identification and reporting of MAEs need to be considered when designing studies 
that aim to explore or implement interventions where the MAE is used as an 
outcome measure. 
2.2.4.3.3. MAEs in secondary care 
The number of medicines administration errors in UK hospitals has been an 
increasing concern for the Department of Health for the last decade.(177) It was 
estimated in a UK study that approximately 4% of hospital inpatients experienced 
an adverse event resulting from a medication error related to prescribing, 
dispensing or administration.(280) In order to reduce the amount of serious errors 
related to the use of prescribed drugs, the Department of Health set up the National 
Patient Safety Agency (NPSA). This independent body ran a mandatory reporting 
system for logging all failures, mistakes, errors and near-misses across the health 
service. Since it was set up, there had been a significant year-on-year increase in 
reporting of medication incidents, the majority of which were 
administration/supply errors.(177) 
Numerous studies have been carried out to explore the prevalence of MAEs in 
secondary care. We carried out a literature review of studies that had identified 
MAE rates as an outcome measure. For the purpose of this dissertation, studies 
reporting MAEs of intravenous administration were discarded and only 
observational studies were included. However, the technique used for the 
observations, the professional background of the observer and the criteria for 
identifying errors were often different in the studies and, therefore, that data may 
not always be comparable. These studies are discussed in detail in this section and 
summarised in Table 9.   
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Study Setting Method 
Number 
of  
errors 
observed 
MAE 
rate* 
(95% CI) 
§ 
Including Time errors 
Barker et 
al.(1982)(281) 
10 Hospitals 
(US) 
Observation of  
nurse-led medicine 
administration 
rounds 
Not 
available 
11.0 Not available 
Bates et 
al.(1995) 
(282) 
Urban 
tertiary care 
hospital 
(US) 
Self-report by 
pharmacists, nurse 
review of all patient 
charts, and review 
of all medication 
sheets 
530  5.2% (4.7 
to 5.6%)  
No 
Ridge et 
al.(1995)(283)  
6 Hospital 
wards (UK) 
Direct observations 
of medicine rounds 
115 3.5% (2.9 
to 4.1%) 
Yes 
Dean & 
Barber, 
(2000)(284) 
2 Hospital 
Wards (UK) 
Direct observations 
of medicine rounds 
6,067 
 
4.2% (3.7 
to 4.7%) 
No 
Lisby et al. 
(2005)(285) 
Hospital 
(Denmark) 
Direct observations, 
unannounced 
control visits, and 
chart reviews 
1,065 41% (39.1 
to 42.9%) 
Yes 
Barker et al. 
(2002)(270) 
Hospital 
(US) 
Observation, by a 
research pharmacist 
605  18.8% 
(17.04 to 
20.2%) 
Yes 
Calabrese et 
al.(2001)(286) 
Intensive 
care units 
(US) 
Observational 
evaluation 
187  3.3% (2.8 
to 3.7%) 
No 
Tissot et al. 
(1999)(287) 
Medical 
intensive 
care unit 
(US) 
Prospective study 
using the 
observation 
technique 
132  6.6% (5.5 
to 7.7%) 
No 
Kelly et al. 
(2011)(272) 
Stroke and 
care-of-older 
people wards 
at four acute 
general 
hospitals 
(UK) 
Observation of 65 
nurse-led medicine 
administration 
rounds 
817  38.4% 
(36.3 to 
40.5%) 
Yes  
* There was considerable variability in the criteria used to identify error, so the results of different 
studies are not necessarily comparable.  
§ CI= confidence interval; where it is not quoted in the papers cited, it has been calculated using the 
equation 𝑃 − 1.96√𝑃(1−𝑃)
𝑁
 for the lower CI and 𝑃 + 1.96√𝑃(1−𝑃)
𝑁
 for the upper CI where P=𝑅
𝑁
 and R = 
number of errors and N = number of observations 
Table 9: Summary of studies of MAEs in secondary care 
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Time errors, where the medicine is over one hour earlier or later than prescribed,(272) 
are often the most common type of error identified and in many instances, this is 
not a problem for the patient. However, it can be a significant problem for those 
patients who require their medicines at specific times, for example, those on anti-
Parkinson drugs. For that reason, many studies (270, 272, 282-287)  tend to differentiate 
between MAE including time errors or excluding them. 
In 1982, Barker et al(281) compared the MAE rate between 10 hospitals and 58 
LTCFs using an observational method. Although the MAE rate was found to be 
higher in hospitals than in LTCFs, not enough accurate data was provided about 
these rates as the study was evaluating the reliability of the method. The authors 
concluded that, although the observation method was promising, further evaluation 
of the observer efficiency with the method was required in order to examine the 
relationship of medication errors with the process variables. 
Bates et al (1995)(282) tried to evaluate the frequency of medication errors using a 
multidisciplinary approach (self-report by pharmacists, nurse review of all patient 
charts, and review of all medication sheets) to classify these errors by type, and to 
determine how often medication errors are associated with adverse drug events 
(ADEs). Over the study period, 10,070 medication orders were written, and 530 
medications errors were reported (5.3 errors/100 orders), for a mean of 0.3 
medication errors per patient-day, or 1.4 per admission. Of the medication errors, 
53% involved at least one missing dose of a medication; 15% involved other dose 
errors, 8% frequency errors, and 5% route errors. During the same period, 25 
ADEs and 35 potential ADEs were found. Of the 25 ADEs, five (20%) were 
associated with medication errors; all were judged preventable. Thus, five of 530 
medication errors (0.9%) resulted in ADEs. This study highlighted the high 
prevalence of omission errors in hospital. However, it has to be considered that 
pharmacists and nurses may not necessarily identify errors equally and the MAEs 
may not have been accurately or routinely identified. 
A study by Ridge et al(283) in the UK carried out a covert observational survey on 
two general surgical, two medicine-for-older-people and two general medical 
wards at a district general hospital. The study was explained as a work sampling 
study, although the authors admit that they were uncomfortable using a covert 
methodology. Thirty-seven nurses were observed carrying out single-handed 
medicine rounds. The authors did not provide precise information about how many 
times each nurse was watched or how many of them refused to be observed but as 
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the researchers observed 74 medicine rounds, some of the nurses must have been 
watched at least twice. The observers were pharmacists from another Trust which 
has the advantage that the nurses did not know them and would probably be less 
affected by the observation. The researchers intervened discreetly before the nurse 
left the trolley if the nurse was about to make an error. In the case of omissions, the 
error was not indicated until after the nurse had signed the drug chart indicating all 
administrations had been completed. The authors identify three types of error that 
predominated: non-availability of the drug, omitting to give the drug when 
available and giving the wrong dose.  There was no explanation provided for the 
likely causes of the errors. The use of a covert technique often raises ethical issues 
and when compared to studies where direct open observations were carried out,  
this technique didn’t identify significantly different MAE rates. 
An observational method was used by Dean & Barber (2000)(284) to identify MAEs 
before and after introducing patients' own drugs (PODs) schemes on one surgical 
and one medical ward in a teaching hospital in the United Kingdom. A validated 
severity assessment method was also applied to the MAEs identified. Overall the 
MAE rate was 4.2% (257 MAEs / 6,067 opportunities for error). There was no 
significant difference in the overall MAE rate for the traditional system (4.3%) 
compared to the POD system (4.2%; P=0.99). There was also no difference in 
types of MAE or stage in which they originated. Higher rates of omission of drugs 
were reported and related to evening times possibly due to unavailability of ward 
stock medicines. A relationship was also found between error rate and nurse 
experience, with error rates decreasing with increasing nursing experience 
(P=0.004). 
Lisby et al(285) detected a total of 1,065 errors in 2,467 opportunities for errors 
(43%) in a randomly selected medical and surgical department at Aarhus 
University Hospital, Denmark. It was reported that 20–30% of all evaluated 
medication errors were assessed as potential adverse drug events. 166 
administration errors were observed, omission of drug/dose was the most common 
of the MAEs. Almost 50% of all errors in doses and prescriptions in the medication 
process were caused by missing actions. The authors concluded that the number of 
errors could be reduced by simple changes to existing procedures or by 
implementing automated technologies in the medication process. However, the 
study was conducted in one medical and one surgical ward in a single university 
hospital and therefore results cannot be appropriately extrapolated to other 
hospitals or cultures.  
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On a larger scale, Barker et al(270) in 2002 carried out  an observational study where 
medication errors were witnessed and verified by a research pharmacist over a 
stratified random sample of 36 sites in US (several facilities were randomly 
selected for each of three types of setting in each state: six accredited hospitals, six 
non-accredited hospitals and six skilled nursing facilities for a total of 36 sites).  
This study provided data from primarily non-teaching sites, complementing data 
from large teaching hospitals, and examined the association of accreditation with 
error rates. In the 36 institutions, 19% of the doses (605/3,216) were in error. The 
most frequent errors by category were wrong time (43%), omission (30%), wrong 
dose (17%), and unauthorised drug (4%). Seven per cent of the errors were judged 
potential adverse drug events and there was no significant difference between error 
rates in the three settings (P=0.82). Accreditation by the relevant regulatory 
commissions was not associated with significantly lower error rates. Despite the 
fact that the 36 institutions studied were selected at random (or via random 
replacement), another 26 institutions declined as they had concerns that they might 
have poor scores and wanted to improve their performance first. Thus, the error 
rates presented by this study are likely to be understated due to  the large 
proportion of facilities who declined to participate.  
In order to quantify the incidence and specify the types of medication 
administration errors, Calabrese et al(286) carried out an observational evaluation in 
five intensive care units (ICUs) in the United States. The participants were 851 
patients who were at least 18 years of age and admitted to surgical, medical or 
mixed ICUs during a three-month period. Of 5,744 observations in 851 patients, 
187 (3.3%) medication administration errors were detected. Twenty-one errors did 
not reach the patient and 159 reached the patient but did not result in harm, 
increased monitoring or intervention. This multicentre evaluation found fewer 
medication administration errors than the published literature to date, possibly due 
to the varying observational techniques. As an example of a similar study, Tissot et 
al(287) followed a parallel methodology to assess the type, frequency and potential 
clinical significance of medication-administration errors. This prospective study 
also used an observation technique in a medical intensive care unit (ICU) in a 
university hospital. 132 (6.6 % of 2,009 observed events) errors were detected. The 
study identified 41 dose errors, 24 wrong preparation technique, 19 
physicochemical incompatibility, 10 wrong administration technique and nine 
wrong time errors. No fatal errors were observed, but 26 of 132 errors were 
potentially life-threatening and 55 potentially significant. However, the author 
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concluded that these errors were due to deficiencies in the overall organisation of 
the hospital medication track, in patient follow-up and in staff training. 
In 2011, Kelly et al(272) observed 62 nurses administering oral medication to 625 
patients in one stroke and one care-of-older-people ward in each of four hospitals 
in East Anglia, UK. The wards were selected by staff working in each hospital with 
the aim of observing as many patients as possible with dysphagia. All the 
observations were carried out by one researcher using two standard proformas (one 
for oral administration and one for enteral) to ensure consistency of data collection. 
Nurses’ practice was compared with what had been prescribed and also compared 
with best practice guidelines. The observer intervened in incidents where there was 
potential for patient harm but these incidents were still recorded as errors. A total 
of 65 drug rounds involving 2,129 potential drug administrations were observed in 
625 patients. Of the 2,129 potential medicine administrations 817 doses (38·4%) 
were given incorrectly (95% CI=36·3–40·4). The most common error was either 
administration of the medicine over an hour early or more usually over an hour late. 
Excluding time errors there were 228 errors (10·7%; 95% CI=9·4–12·0). 283 
patients experienced at least one drug error (45·3%; 95% CI=41·4–49·3), which 
reduced to 126 (20·2%; 95% CI = 17·0–23·3) when time errors were excluded. 143 
different non-time related incidents of which 35 (25%) were purposively selected 
so as to ensure that all types of error were included as well as an equal number of 
errors involving dysphagic and non-dysphagic patients. Ten incidents (28·6%) 
were classified as minor (score < 3·0), 24 (68·6%) as moderate (score 3·0–7·0) and 
one (2·9%) as severe (score > 7·0). The overall mean harm score of the 35 
incidents was 4·1 (range 1·1–8·6, SD 1·8) on a scale of 0–10. The MAE rate and 
severity scores found in this study were higher, even when time errors are excluded, 
than similar previous studies. This has implications for MAE research as although 
it is important to reduce the MAE rate, it is more important for the patient and the 
health service to reduce the more severe errors to minimise patient harm.(272) 
This article published by Kelly et al(272) was one of two that described a parent 
study in which the MAE rate for PWD was explored and compared to the MAE 
rate of those without. Of the 625 patients, 214 (34.2%) had swallowing difficulties 
and they accounted for 679 (31.9%) potential drug administrations involving 150 
different formulations. A total of 170 patients without dysphagia and 133 PWD 
experienced at least one drug error. Thirty-six of the 50 patients with enteral tubes 
experienced at least one error. There were 313 MAEs in PWD and 504 MAEs in 
patients without (Table 9). After normalising, the frequency of MAEs (excluding 
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errors) for PWD was 21.1% (95% CI = 18.0 – 24.1%) compared with 5.9% (95% 
CI = 4.7 – 7.1%) for patients without dysphagia. There was a clear distinction in 
error-rates between PWD (but without tubes) and patients without dysphagia and a 
further clear distinction for PWD between those with and those without enteral 
tubes. MAEs were found to be higher in PWD, and this was largely due to drug 
formulation or preparation. Although this study is limited to the small sample size, 
it is the ﬁrst to concentrate on the MAE rate in relation to PWD and to identify the 
size of the problem in an acute hospital setting.(288) 
To date, Kelly’s was the only study that specifically considered dysphagia as part 
of the design. However, the study by Haw et al (2007)(240) in two older people long-
stay wards in an independent UK psychiatric hospital found a strong association 
between MAE rate and dysphagia (179/480, 37.3% vs. 190/943. 20.1%; P<0.0001). 
The researchers excluded the doses of medicines where tablets and capsules were 
tampered with and still found a strong association between PWD and MAE rate 
(110/377, 29.2% vs 117/780, 15%; P<0.0001). However, the sample size (n=32) 
was composed of only 13 PWD and the authors did not clarify how the results were 
calculated. Another study by Kelly et al(195) compared the administration of 
medication by two nurses to the same older patient with dysphagia in a hospital 
ward. Using root cause analysis, the administrations were compared and contrasted 
in order to gain an understanding of how nurses interpret and administer multiple 
medicines to a PWD. While the administrations of medicines by both nurses were 
not considered optimal, the authors concluded that the fundamental root cause of 
the problem was insufﬁciently skilled staff. Although the results of this analysis are 
limited by the fact that only two nurses were observed, this study is highly relevant 
to the research topic of this thesis as it not only identifies flaws in the practice of 
the nurses, but also highlights the lack of standardised practice observed in the 
hospital wards when administering medication to PWD. 
There is a large variation between the type of observations and observers in the 
studies presented. However, there seems to be concordance in the literature about 
the most likely types of errors, being time errors, omissions and dose errors the 
most frequently found. Although there are many studies exploring the MAE rates 
to patients in secondary care, no other studies have been found to relate MAE rates 
to PWD. The old age of patients with this condition and the complexity of the 
administration of oral medication in dysphagia are likely to show more MAEs in 
line with those found by Kelly.  
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2.2.4.3.4. MAEs in long-term care facilities  
Medication administration errors in care homes and other LTCFs are common 
despite regulations and national minimum standards introduced to protect residents’ 
safety. The governments in Wales and England have introduced minimum 
standards which must be met by care home providers but still, medicines 
management in care homes remains problematic. According to a recent report by 
the Care Quality Commission, 30% of care homes for older people in England are 
failing to meet the minimum standards required for the management of 
medicines.(289) However, the evidence for interventions to reduce medication 
administration errors in care homes is limited. In this section, we will examine 
some of the literature available. In parallel with the literature search carried out for 
MAEs in secondary care, most of the studies included are observational. Those 
where intravenous administration is examined were excluded. A summary of the 
studies reviewed is outlined in Table 10. 
Study Setting Method 
Number 
of  
errors 
observed 
MAE 
rate* 
(95% CI) 
§ 
Including 
Time 
errors 
Haw et al., 
(2007)(240) 
2 older people 
long-stay 
psychiatric 
units (UK) 
Direct observation, 
medication chart 
review and incident 
reports 
1,423 
 
25.9% 
(23.7 to 
28.2%) 
Yes 
Barker et 
al. 
(1982)(270) 
58 LTCFs 
(US) 
Observation of  
nurse-led medicine 
administration 
rounds 
Not 
available 12.2% 
Not 
available 
Pierson  et 
al. 
(2007)(290) 
Nursing 
Homes (US) 
Evaluation of 
recorded detailed 
information about 
medication errors 
631 Not applicable 
Not 
applicable 
Van den 
Bemt, et 
al. 
(2009)(196) 
Nursing 
Homes 
(Netherlands) 
Observation 
technique 2,025 
21.2% 
(19.4 to 
23.0%) 
Yes 
Alldred et 
al. 
(2009)(275) 
Residential 
homes and 
care 
homes(UK) 
patient interview, 
note review, 
observation of 
practice and 
examination of 
dispensed items 
116 8.4% (7.0 to 10.0%) No 
* There was considerable variability in the criteria used to identify error, so the results of 
different studies are not necessarily comparable. § CI= confidence interval; where it is not 
quoted in the papers cited, it has been calculated using the equation 𝑃 + 𝑜𝑜 − 1.96√𝑃(1−𝑃)
𝑁
 
where P=𝑅
𝑁
 and R = number of errors and N = number of observations 
Table 10: Summary of studies of MAEs in LTCFs 
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Haw et al(240) investigated the frequency and nature of medication administration 
errors by nurses on two older people long-stay wards in an independent UK 
psychiatric hospital.  Errors occurred in 25.9% drug administration opportunities 
(369/1,423) and the most common errors were: unauthorised tablet crushing or 
capsule opening (111/369, 30.1%), omission without a valid reason (100/369, 
27.1%) and failure to record administration (87/369, 23.6%).  One of most relevant 
findings of this study was that more errors were associated with PWD, even after 
crushed doses of medication were excluded from the analysis. Although this study 
was carried out in hospitals, it was included  as part of the LTCFs literature review 
as the patients studied were not atypical of those found in nursing homes and it 
may have applicability to the care home setting, particularly homes with older 
people mentally infirm (OMI) beds. However, it took place on two wards of an 
independent sector hospital, and thus the findings may not apply to National Health 
Service hospitals or community settings. 
Van den Bemt et al(196) used a disguised observation technique to measure  
administration errors at three nursing homes in the Netherlands, over a two-week 
period (Monday, Wednesday, Thursday, Friday only). 137 residents were included 
in the study. Medication was supplied to each home in a plastic bag filled with the 
tablets that needed to be administered to each patient, at each medicines round.  
Errors in picking the right medication from a central supply were therefore reduced. 
Errors were observed in 428/2,025 (21.2%) administrations and of these 312 errors 
related to wrong administration technique.  Incorrect crushing of tablets was 
identified as a common problem, with crushing occurring even with enteric coating 
or modified release formulations.  Another frequently occurring problem was the 
failure to supervise the intake of medication when instructions to do so had been 
given. Supervision was considered important for patients with dementia to ensure 
medication was actually taken and to prevent dementia patients from taking the 
wrong medication.  Incorrect time errors accounted for 18% (77/428) of 
administration errors and were defined as medication not given within 60 minutes 
of the prescribed time.  Patients that were prescribed antibiotics were significantly 
more likely to experience an administration error odds ratio (OR) 11.11 (95% CI, 
2.66-46.50), and it was postulated that this might be due to the short-term nature of 
antibiotics and staff being less familiar with the medication.  Errors were also more 
likely to occur between 7am-10am, OR 2.28 (95% CI, 1.50-3.47) and 10am-2pm, 
OR 1.96 (95% CI, 1.18-3.27) compared with later in the day. The authors did not 
measure workload but hypothesised that this increase could be linked to increased 
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staff workload in the mornings when residents needed help getting out of bed, 
getting dressed, having breakfast, etc. They also suggested that pharmacists could 
help reduce this workload by considering which medication could be administered 
in the afternoon or evening instead of in the morning.   
Alldred et al(275) observed administration of medication in 55 UK care homes.  Two 
drug rounds were observed for each of the 256 residents included in the study.  
Administration errors by opportunities for error were 8.4% (116/1380) [95%CI 7.0-
10.0] and 22% of residents were exposed to an administration error in one or other 
of the drug rounds. The mean harm score from administration error was 2.1 (range 
0.1- 5.8) on a scale of 0 to 10 where 0= no harm and 10=death.  Nearly half (49.1%) 
of the 116 administration errors observed were omissions and a further 21.6% 
errors were due to the wrong dose of medication being administered.  This study 
had a high recruitment rate (72% (79/108) of homes, 67% (269/399) of residents 
and 61% (54/89) of general practices) and the results were supported by a strong 
mixed methodology of qualitative and quantitative methods. The qualitative work 
was ethnographically informed and involved field notes, observation and semi-
structured interviews with the home staff, GP or pharmacist based on Reason and 
Vincent’s frameworks (263, 291) to help understand the causes of specific errors. The 
results identified: 
- patient factors included patients’ lack of awareness of their medicines, fears 
about medicines,  
- task factors included inability to find the medicine, failure to order the right 
quantity of “as required medicines”, 
- individual factors related to the staff included lack of knowledge about inhalers 
and the timing of medicines with respect to food, 
- team factors included the medication administration record chart, which should 
be the documentary line of communication among GP, home and pharmacist; 
these records were often inaccurate, 
- work environment factors included homes being hot, airless, having unpleasant 
smells, being poorly lit, noisy and short of space. There were often staffing 
problems in the morning round. The members of staff were frequently 
interrupted and did not have dedicated time to order medicines.  
Although the author considered the sample size as a limitation, the high 
recruitment rate, the transparency of the results and the methodology design made 
this study one of the most relevant studies in care home settings in the UK. Despite 
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the fact that the MAE rates in PWD was not explored as part of the design, this 
methodology and the results could help in identifying the factors to consider for 
future research on PWD. 
The results from a web-based error reporting system introduced into nursing homes 
in North Carolina, US, were reported by Pierson et al.(290) This study was an 
evaluation of recorded information, in contrast to the rest of the studies presented 
in this section of the literature review which used observational techniques. 
However, the results helped in identifying the type of MAEs and a likely 
estimation of the MAE rates that could be found in other observational studies. Of 
the 25 homes that volunteered to take part in the study, 23 successfully entered 
error reports into the system during the one-year study period. 631 error reports 
were made covering 2,731 discrete error instances when weighted by the number 
of times the errors were repeated before being addressed. The most common errors 
were: 
- dose omission (203, [32%]), 
- overdose (91, [14%]), 
- under dose (43,[7%]),  
- wrong patient (38, [6%]), 
- wrong product (38, [6%]), 
- wrong strength (38, [6%]). 
Most errors occurred during medication administration (296, [47%]) and, of the 
errors with the most serious patient impact, 67% (34) first occurred in the 
administering phase. Nearly half of all errors were attributed to basic human error 
(402, 48%). The author concluded that the web-based medication error reporting 
system had strong indications that it would be a valuable tool for preventing future 
errors. Although this study outlines the most common errors reported, the author 
did not contemplate the factors that stop errors from being reported and, therefore, 
the accuracy of the results is questionable. 
Studies investigating medicine administration errors in LTCFs consistently identify 
dose omission as a significant problem with wrong dose and incorrect 
administration errors also being a concern. Equally to the studies in secondary care 
it seems sensible to estimate that the MAE rate in future studies in LTCFs with 
PWD will show higher figures than those identified in general patients.   
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In summary, the practice of nurses may affect the care received by PWD. The 
factors which affect that practice need to be identified in order to design a 
pharmacy intervention that overcomes likely difficulties in the nurses’ practice. 
While the subjective views of the nurses are essential to identify barriers in the 
administration of medication - and therefore explored in chapter 4 - the observation 
of MAEs can provide an objective description of the practice of the nurses in care 
homes. It is important to also highlight how direct observations are rated as better 
practice over those covert techniques. The descriptions of the types of errors 
observed during drug rounds are presented in chapter 5 of this dissertation. 
 
2.2.5. Alternatives to medicine administration 
After exploring the challenges that are faced by nurses during the administration of 
medication to PWD, it seems sensible to explore the alternatives available to avoid 
some of the problems introduced in the previous section and the rationale for them. 
Tablets and capsules are often the preferred method by practitioners for the 
administration of drugs to patients due to the numerous advantages in cost, 
accuracy and drug stability of these formulations. When difficulties in the 
swallowing function appear, HCPs play an important role in identifying the ability 
of the patient when taking oral medication and also in identifying ways on how to 
overcome that problem. National guidelines are available which outline how to 
approach prescribing for PWD.(292) These guidelines identify several strategies. 
Alternative formulation 
When dysphagia is likely to be long-term or when treatment cannot be stopped 
suddenly at the onset of dysphagia, a liquid or a dispersible/orodispersible product 
could be considered providing that the patients can still swallow these formulations. 
Wright(23) in 2011 describes in his book what needs to be considered when 
changing to liquid or dispersible formulation (Table 11). 
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• Viscosity – patients may have problems controlling liquids when swallowing 
them and so the correct consistency needs to be prescribed, or a thickener such 
as Thick and Easy® or Nutalis® added to provide the correct consistency. NB:  
There are no tests undertaken to demonstrate how the addition of such 
thickeners may affect the bioavailability of a drug. 
• Consider if the patient can pour and measure the dose accurately. 
• Check dose equivalence – bioavailability can be greater with liquids. 
• Adjust dose frequency if necessary. 
• Evaluate efficacy and side-effects. 
• Recognise that some liquid medicines are unlicensed (Specials) (consult a 
pharmacist to identify what is obtainable). 
Table 11: Considerations when changing to liquid or dispersible formulations (Wright 
2011, page 14)(23) 
 
Alternative medication 
When products are not available in an alternative dosage form, another drug with 
similar pharmacological effects could be considered, e.g. sachets of Macrogol can 
replace the intake of senna tablets. 
Alternative route 
If the patient is unable to take medication by the oral route and a suitable 
preparation is not available, the prescriber may request the medication to be given 
by an alternative route, e.g. transdermal, rectal or parenteral,(293) e.g. transdermal 
glyceryl trinitrate patches could be used instead of modified release isosorbide 
trinitrate.(23, 215) Often, the availability of these medications for use via the 
transdermal route is limited. Also it needs to be considered that rectal 
administration may be undesirable or unpleasant for the patient, and parenteral 
routes are usually more expensive, inconvenient, painful and require trained staff to 
prepare and administer them.(294) 
Altering solid-dose formulations 
The majority of patients need their drugs and often there are not suitable alternative 
medicines or dosage forms. A frequent response to this is to crush tablets or open 
capsules and to mix the residue with food or to administer via the patient’s enteral 
tube.(173, 188, 192, 193, 287, 294, 295) Tablet crushing or capsule opening should only be 
recommended as a last resort and only carried out after discussion with a 
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pharmacist or local Medicines Information Centre.(23) Although limited, there are 
evidence-based reference sources available which provide recommendations for the 
administration of medicines for PWD and via enteral feed tubes.(215) If used 
appropriately, then reliance on potentially expensive unlicensed medicines can be 
minimised whilst still optimising patient care.(23) The reference sources are 
designed for use by pharmacists and rely on a good understanding of 
pharmaceutical formulations and availability of medicines. 
Medication discontinuation 
Occasionally it may be possible to stop the medication either temporarily if the 
dysphagia is believed to be transient or permanently if the risks of the medication 
outweigh the benefits. 
A pharmacy intervention for PWD needs to consider alternative strategies as the 
condition develops. It is, therefore, important to explore the factors that are 
relevant to the administration of medication from the point of view of the HCPs. 
The perceptions and feedback from nurses on the implementation of a pharmacy 
intervention are essential for a suitable development of the intervention. These 
feedback and perceptions are therefore explored in chapters and 3 and 4, 
respectively.  
 
2.2.6. Medicines management in dysphagia: the role of the pharmacist 
Medicines management could be defined as the practice that seeks to maximise 
health through the optimal use of medicines and it includes all aspects of medicine 
use from the prescribing of medicines through to the ways in which medicines are 
taken or not taken by patients.(296) Medicines management also involves the 
systematic provision of medicines therapy through a partnership of effort between 
patients and professionals to deliver best patient outcomes at minimal cost.(297, 298) 
The management of dysphagia is a complex process. Dysphagia can appear 
suddenly after stroke or it may emerge gradually as it happens with ageing or 
Parkinson’s disease. It is, therefore, important that HCPs are able to early identify, 
assess and when possible treat the condition. As previously mentioned, older 
patients are prone to polypharmacy specially those in care homes who are 
prescribed eight medicines on average.(299) Also in this setting, 50% of residents are 
believed to have some form of dysphagia(28) with anything between 15 and 30% of 
them reported as finding it difficult to take medicines.(188) 
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The likelihood of the presence of pharmacological treatments in older PWD 
requires the pharmacist to be involved in the medicines management of dysphagia, 
this including identification, assessment, treatment, communication with other 
professionals and further individualised interventions required by a patient. 
Identification of dysphagia 
Due to easy accessibility, pharmacists are the ﬁrst point of contact for patients in 
the healthcare system in countries like the UK, America or Australia.(300) This 
provides an ideal location for pharmacist to identify early signs of dysphagia from 
their patients.  
In 2005, a survey conducted by Strachan & Greener(239) aimed to determine 
whether community pharmacists could identify patients with difficulties in 
swallowing solid medicines in the community.  The survey involved 17 pharmacies 
from England and Northern Ireland which distributed a questionnaire to customers 
who were suspected (by the pharmacist) to experience difficulties swallowing solid 
medicines, based upon their clinical judgement and knowledge of the customer. 
The 792 returned questionnaires were completed by patients (85%) and carers 
(15%). From all the patients, 90% were aged between 60 and 89 years. The results 
showed that almost 60% (n=477) of respondents stated that they experienced 
difficulties in swallowing tablets or capsules. Furthermore, 68% (n=333) of those 
who answered that question needed to open a capsule or crush a tablet to swallow 
the medication. A similar proportion (69%; n=305) admitted to not taking a tablet 
or capsule because it proved hard to swallow. Thus, about two thirds of customers 
that pharmacists suspected might have problems, did have dysphagia. What was 
more revealing from this study was that 72% (n=218) of patients and carers 
reported that their doctor or nurse never asked if they have difficulties taking 
tablets or capsules before writing prescriptions. In the same year, a survey carried 
out by Morris(159) in a health centre found 80% of patients said that they did not 
inform their doctor or pharmacist if they could not take their medication. Only 22% 
of patients said that their doctor or nurse asked them if they had problems 
swallowing before issuing a prescription. 
These surveys suggest that enquiries about dysphagia are not made regularly 
enough and highlight how the community pharmacist is in an ideal position to 
identify PWD through medication review or consultation with the patient. 
Dysphagia is a well-established warning sign for some cancers and other 
gastrointestinal diseases(301) and such enquiries could be especially important in the 
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middle-aged and older people. As compared to younger subjects, people aged more 
than 55 years are 9.5 times more likely to develop gastrointestinal cancers than 
younger subjects.(239) 
Assessment of dysphagia 
Solid dose medication has become the mainstay of medical treatment for many 
reasons, including safety with dosing, convenience, and efficiency.  However, the 
task of swallowing a solid dose medicine is quite complex.  From infancy we are 
taught to chew food well. The gag reflex is designed to eject foodstuffs that are not 
adequately chewed as a safety mechanism for choking. Particles as small as 2mm 
will trigger a chewing reflex.(48) 
There are numerous screening and assessment tools available for dysphagia(101, 302-
304) of which the TOR-BSST is the most thoroughly evaluated,  based upon best 
available evidence. The measurement properties of the TOR-BSST have been 
established in a well-controlled study and it has a prepared education module. 
However, to date, none of the screening and assessment tools have contemplated 
the assessment of swallowing medication and in consequence, the role of the 
pharmacist has been excluded from the group of HCPs that these tools have 
targeted.  
Swallowing a solid dose medicine requires a deliberate learning to override both 
the need to chew and the response to gag. Some medications have the same length 
as a coin or a cashew nut. Both nuts and coins are recognised choking risks but 
little thought is given to the dimensions of some solid dose oral medicines. 
However, for people with dysphagia, risk of aspirating solid dose medications is 
very real.  They have lost the oral control and in some cases the sensation within 
their mouth to identify where the bolus is  
Pharmacists, from their knowledge of medications, have an important role in 
assessing the medication regimen of PWD for potential problems that might impact 
patient safety, adherence, and therapeutic outcome. An assessment may be 
requested by the patient’s primary care or other health provider (such as a speech 
and language pathologist). Ideally, an assessment should take place soon after the 
patient is diagnosed with dysphagia. For example, a patient who is hospitalised 
following a new stroke that resulted in dysphagia should have their medications 
reviewed so that any changes or instructions for proper medication use can be 
provided prior to discharge. Often the availability of the SALT outside of standard 
Literature review 
 
Page 92 of 380 
 
working hours or in aged-care facilities means that it is difficult to obtain a timely 
swallow evaluation.  However, the need for the medication is immediate.   
Advice to the prescriber 
Drugs are increasingly being marketed in an assortment of sophisticated 
formulations that are intended to improve the efficacy of the active ingredient.  
A study carried out by Lesar et al(305) identified that the most common error (in 70% 
of cases) in hospital wards was the failure to specify the extended-release 
formulation when it was intended (e.g., prescribing nifedipine 60mg orally once 
daily instead of nifedipine XL 60mg). Although these errors were identified and 
intercepted by pharmacists, they had the potential for serious consequences if the 
short-acting formulation had been given in the dose intended for the long-acting 
drug.(165) These results agree with those highlighted by Kelly et al(228) who also 
identified that prescribers are not always aware of the availability and cost of the 
prescribed formulations. 
Pharmacists are the only HCPs trained in formulation science and are aware of the 
formulations available. Therefore, they are the most suitable professionals to 
provide advice to the prescriber ion the best available formulation for PWD. Before 
prescribers recommend unlicensed medication, alternative routes of administration 
(buccal, intravenous, transdermal, rectal, intramuscular, subcutaneous or liquid 
medicines) could be recommended to the prescriber. When specials are prescribed 
for PWD, pharmacists have a responsibility to help ensure that prescribers are 
aware they are prescribing an unlicensed medicine.(306) Also, the pharmacist is 
advised to periodically reconfirm with the prescriber that the ongoing use of an 
unlicensed product is appropriate, having regard to any circumstance that might 
suggest that a licensed product may become more suitable. It is also recommended 
that any discussions between the prescriber and pharmacist in relation to the 
unlicensed nature of the product and its suitability should be documented. The 
urgency of the patient’s need for the medicine should also be noted and reasonable 
steps taken to ensure timely supply.(306) 
Guidance to the patient and provision of medication 
Pharmacists should become familiar with the causes of a higher risk for 
medication-induced oesophageal injury in older people and recognise those agents 
considered to raise the risk in this vulnerable population. Older people do not 
always drink enough water when they take medication.(307) If a patient in a 
recumbent position ingests a tablet or capsule with less than 15mL of water, the 
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medication's passage through the oesophagus is hampered(308) and, therefore, 
patients should be discouraged from taking medications at bedtime with small sips 
of water. 
Pharmacists sometimes suggest that patients can split capsules or crush tablets, 
which are dispersed in a small amount of water and drunk immediately. Wright 
(page 34)(158) suggests considering crushing of medication or opening of capsules 
only ‘in the rare instance of no alternative administration route or liquid 
formulation being available’. 
Several authors have highlighted that specific educational interventions could help 
patients.(217, 227, 239) Often, patients use the wrong technique when swallowing 
tablets.(156) Whilst most patients tip their head back to allow the tablet to drop 
towards the back of the mouth, this narrows the oesophagus and makes swallowing 
more difficult. A pharmacist can inform PWD in using better techniques such as 
dropping their head and looking down as this widens the oesophagus.(239) 
In other cases where other symptoms are involved, the pharmacist has the expertise 
to review the patient’s medication and identify underlying concerns. In a study of 
600 older Americans, 33% took at least one medication that could cause or 
exacerbate xerostomia.(309) Xerostomia can present as a cause or a consequence of 
the medication management of dysphagia. If patients report xerostomia and /or 
difficulties swallowing their medication, pharmacists could review the medication 
for drugs associated with dry mouth. According to Parsons et al,(310) medication 
review has the potential to address several of the issues identified that contribute to 
sub-optimal use of medicines but also can be used to promote appropriate 
polypharmacy and is also an opportunity to promote medication adherence. In 
addition, medication review can identify and resolve problematic medication issues 
for patients such as alternative medicine formulations, i.e. non-oral products, can 
also be recommended for PWD. 
Training and supporting other HCPs 
Multidisciplinary management of dysphagia ensures that the dysphagic patient 
receives careful, in-depth assessment and treatment/rehabilitation of their 
swallowing disorders, and its underlying aetiology.(311) Members of this team 
usually often include the SALT, gastroenterologist, radiologist, ENT doctor, 
neurologist, respiratory specialist, pharmacist, dietician, occupational therapist, 
physical therapist and nurse. 
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When considering that the nurses and carers are often in charge of the 
administration of medication to PWD, it is sensible to assume that this nursing 
team should receive enough support to develop their skills and knowledge in their 
role on the medicine management of dysphagia. However, available literature (270, 
272, 282-287) repeatedly highlights deficiencies in the practice of the nurses when 
administering medication possibly due to the lack of support from other 
professionals. 
While the awareness and the correct use of measuring devices remains a challenge 
for the nurses,(217-219) other more complex gaps in their knowledge can represent a 
bigger concern. the resulting availability of multiple products with similar names 
and a lack of carers’ understanding of the properties of the various preparations 
create a significant risk of adverse drug events.(165) For example, a study carried out 
in the state of Qatar(227) assessed the nurses' knowledge of the purpose of modified-
release (MR) preparations, codes used for such medication, the consequences of 
crushing these preparations, and their interactions with enteral feeds and feeding 
tubes. All the nurse participants (n=34) were recruited from six different intensive 
care units and invited to complete a questionnaire. The study revealed a complete 
lack of awareness on MR codes and poor knowledge on correct crushing of solid 
preparations, 35% to 90%, and interactions with the enteral feed or feeding tubes 
from (35% and 51%, respectively). This offered an opportunity for pharmacy staff 
to develop a two-day training programme that consisted of a presentation of the 
results of the questionnaire, leading to a statement of the objectives of the training. 
This was followed by a series of presentations that included an overview of 
incidents reported in the literature, formulation and absorption of drugs, technology 
of MR and other modified-release preparations, alternative routes and methods of 
drug administration, managing drug therapy in patients receiving enteral nutrition, 
drugs and the EFTs, and chronic use of phenytoin in patients with feeding tubes. 
Twelve (32%) nurses who completed the questionnaire at baseline took part in the 
training course and, therefore, completed the same questionnaire at the end of the 
training programme. Overall, the scores on the knowledge questions were 
increased by 40% for CR codes and to almost 90% for the other knowledge-related 
questions. This study highlights the need for support from the pharmacy team and 
its impact on the nurses’ practice.  
Other studies in care homes have also supported this data. In 2002, an exploratory 
study of issues concerning the nursing practice of altering medication dose forms 
prior to administration of medicines to residents in homes for older people was 
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carried in South Australia by Barnes et al.(199) The study used semi-structured 
interviews with 11 registered nurses working in a purposive sample of 10 
residential homes for older people. The results highlighted that nurses felt 
constrained to ensure that prescribed medication was administered to residents and 
they were concerned that they were working in an information vacuum, due to 
limited information resources and informal communication with other healthcare 
professionals such as speech pathologists, pharmacists and general practitioners. 
There was also concern about the difficulty of coordinating information and 
policies about altering medications and of implementing appropriate procedures in 
individual facilities. The authors concluded that clinical guidelines for the 
processes surrounding the alteration of medication dose forms and relevant 
pharmaceutical information are needed in all residential homes for older people as 
well as ongoing education for nurses in this area.(199) 
Several authors and organisations have issued guidelines and educational charts 
emphasisng the correct practice and providing plenty of rationale for doing so.(215, 
292, 312, 313) However, this information may not be readily available, and nurses may 
not be adequately trained in the selection of the correct formulation and how to 
prepare it for administration. Without updated knowledge on drug formulations and 
the possible consequences of cutting and crushing these formulations, patients can 
be exposed to serious unwanted effects or sub-therapeutic doses.(23) This is also in 
addition of other issues  commonly found in practice like incomplete drug 
administration charts, lack of records of pre-existing drug allergy, topical 
application and self-medication in care homes with nursing.(314) 
Following appropriate swallowing assessment training, members of the medical or 
allied health team could screen for swallow safety for solid and liquid dose 
medicines, ensuring that the patient’s medications continue uninterrupted, but 
provided in the safest form possible. With appropriate medication training, medical 
or allied health team members administering medication could also ensure that 
only medications that can be modified safely are modified. 
However, the results of the discussed studies contrast with a recent systematic 
review which found little research on the efficacy of nursing educational 
interventions in reducing medication administration errors.(315) Also, in a recent 
RCT, the use of dedicated medication nurses who had undergone brief review 
training in safe medication use did not result in a reduction in medication 
administration errors compared with the control group.(277, 316) 
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To overcome these educational challenges other authors have suggested the 
creation of lists of commonly used medications or drugs on the formulary that 
should not be crushed, with suggestions for alternative products, the inclusion of 
instructions on the medication administration record that can provide the nurse 
with guidance regarding appropriate administration of specific drugs (e.g. “mix 
liquid medication in pureed food”)(165) and the implementation of a dedicated 
service from a  specialised HCP to reduce the problems of medicine administration 
to PWD.(317) The literature could, therefore, be suggesting an opportunity for the 
pharmacist in developing training for other HCPs in the administration of 
medication to PWD as part of medicines management of dysphagia. 
In summary, this section is indicating that the management of dysphagia offers an 
opportunity for the involvement of the pharmacist.  Pharmacists could potentially 
identify and assess dysphagia as well as provide training and support for HCPs. 
The perceptions and experiences from other HCPs on this extended role need to be 
explored in order to identify its acceptability as part of an intervention for PWD. 
These factors are explored and discussed in chapters 3 and 4 of this dissertation. 
2.3. Summary 
Dysphagia is more commonly observed in older patients and is found to be more 
prevalent in institutionalised patients compared to those in their own homes. Whilst 
it is often related to the ageing process, it also appears as a consequence of 
structural and neuromuscular disorders(48) in conditions such a stroke which is one 
of the most commonly recognised causes of this condition. One of the main 
complications of dysphagia is the presence of respiratory conditions such as 
aspiration pneumonia which is known to be a major cause of morbidity and 
mortality and may result from patients receiving food, liquid and medicines of the 
wrong consistency, i.e. thin runny fluids may be more likely to be aspirated than 
thicker gloopy ones. Due to patients concerns regarding choking or aspiration, 
administration of medication becomes a complex challenge for HCPs involved in 
their care.  
The administration of medication to PWD requires more creative prescribing 
methods to ensure that patients receive their medication appropriately. Difficulties 
identifying suitable formulations may result sometimes in under-prescribing 
medication or choosing the wrong formulation for that patient. It is recognised that 
liquid formulations are, in the majority of cases, the best formulation for PWD as 
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they avoid the tampering of solid dose formulations and provide a safer 
administration for the patient and the administrator.(23) However, the cost of 
licensed and unlicensed liquid formulations is a significant issue for the prescriber 
and the NHS.  
Research within the hospital environment has demonstrated that due to the 
complexity of administering medicines to PWD they are three times more likely to 
be at risk of medication error. It has been found that environmental factors, 
knowledge and skills and the time constraints are the main concerns of the nurses 
when administering medication to patients. In order to ensure that PWD receive 
their medicines, nurses resort to inappropriate crushing of tablets, dispersing them 
in water or mixing them with foodstuffs and many of them have received limited 
relevant training.(188) 
Due to the high likelihood of errors and evidence that practice in hospital varies 
dependent on the practitioner, an intervention to improve medicines administration 
in this environment is warranted.  Individualised guides to medicine administration 
for each patient with dysphagia should increase and standardise the quality of 
practice in the secondary care setting. In line with MRC guidance for complex 
interventions(2) all new ideas require testing for feasibility before being piloted and 
tested definitively. 
If the intervention to improve medicines administration in dysphagia in the 
secondary care setting was found to be effective then the natural next location for 
implementation is within the care home. The differences in the settings with 
respect to inter-professional communication, constraints on prescribing and the less 
frequent medication changes warrant some understanding before any intervention 
is transferred across. 
The development of a theoretical model to describe medication administration 
processes in the care home setting would help to refine any hospital-based 
intervention to improve medicines administration for the care home setting. To test 
the validity of the theoretical model which would underpin the design of the final 
intervention and refine it further, observation of practice with respect to medicines 
administration in care homes is appropriate.  
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3. Implementing and evaluating a novel service in dysphagia 
in secondary care 
Problems of acceptability, compliance, delivery of the intervention, recruitment 
and retention, and smaller than expected effect sizes can challenge the evaluation 
of services,(318) which is why it is important to understand the context in which 
interventions take place. Also, researchers need to decide which outcomes are most 
important and represent the best use of the data or provide an adequate assessment 
of the intervention. Service evaluations can help in understanding processes when 
they explore the way in which the intervention under study is implemented. They 
can also provide valuable insight into why an intervention fails or has unexpected 
consequences, or why a successful intervention works and how it can be optimised. 
The following study adds components of feasibility and evaluation to the process 
of defining a complex intervention in medicines management (highlighted in 
Figure 4). 
 
 
 
 
 
  
Figure 4: Initial components of feasibility and evaluation  (Craig et al 2008, page 980)(1) 
Feasibility and piloting 
• Testing procedures 
• Estimating recruitment and 
retention  
• Determining sample size 
 
Development 
• Identifying the evidence base 
• Identifying or developing theory 
• Modelling process and outcomes 
 
Evaluation 
• Assessing effectiveness 
• Understanding change process 
• Assessing cost-effectiveness 
 
Implementation 
• Dissemination 
• Surveillance and monitoring 
• Long term follow-up 
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3.1. Introduction 
Before the commencement of the research described in this thesis, a pilot study had 
been designed by Jennifer Kelly (former PhD student and chief investigator), her 
supervisors at the university of East Anglia, healthcare professionals in the Norfolk 
and Norwich University hospital and lay members of Patient and Public 
Involvement in Research. Her pilot study aimed to determine the design of a 
randomised controlled trial in which a dedicated pharmacist trained in the 
management of dysphagia and enteral nutrition (via naso-gastric and percutaneous 
endoscopic gastrostomy tubes) promoted best practice in relation to medicine 
administration to PWD on care of older people and stroke wards through the use of 
Individualised Medication Administration Guides (I-MAGs) (Appendix 1)  which 
are described in this chapter. 
The study received ethical and governance approval from the appropriate Research 
and Ethics Committees and relevant Clinical Governance Committees 
(08/H0302/153). 
The addition of the pharmacist in charge of delivering the dysphagia service as part 
of the steering committee provided an opportunity for more in-depth research of 
the administration of medication to PWD. This opportunity developed into a PhD 
project reflected in this thesis.  
The dysphagia service pharmacist (DP) was responsible for: 
- training the nurses in the use I-MAGs in the intervention wards, 
- the development of software to help in the generation of I-MAGs, 
- the delivery of the service in the intervention wards, 
- obtaining consent from the patients to be approached by an independent 
researcher,  
- collecting the data from the patients recruited during the six months follow-up. 
The DP also performed a service evaluation aiming: 
- to better understand how to implement I-MAGs, 
- to identify the workload issues associated with the guides, 
- to describe the acceptability of I-MAGs, 
- to determine whether it would be feasible to recruit patients to a future trial 
based on the service, 
- to determine the quality of data collection, 
- to determine what outcomes, if any, may be appropriate for such a trial. 
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Figure 5 shows the structure and the timeframe of the study. 
 
Figure 5: Structure of the responsibilities of the DP in the pilot study 
 
3.2. Aim and objectives of this section 
This chapter aims to evaluate the feasibility of the I-MAG service and to explore 
the consent and recruitment rates obtained during the service. The data obtained 
will contribute to the development of our complex intervention for PWD. 
The main objectives of the service evaluation were: 
- to describe and define the elements of an I-MAG service, 
- to determine the acceptability by HCPs in the wards, the suitability of the 
training provided by the pharmacist to the nurses and the potential workload 
implications, 
- to estimate the proportion of patients for whom I-MAGs are suitable, 
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- to determine the recruitment of participants and the patient outcomes of the 
service, 
- to identify the potential costs that would need to be explored in future research, 
- to estimate the cost of prescribing alternative formulations that are more 
suitable for PWD, 
- to explore the acceptability of the I-MAGs service by the HCPs and their 
opinions on the provision of the guides (main focus of this chapter). 
3.3. Methods 
This section will explain the methods that composed: 
- the main pilot study, 
- the clinical  interventions made by the DP, 
- costing estimates of recommendations, 
- service evaluation. 
Although the main focus of this dissertation is the service evaluation, this will be 
explored last to follow the chronological sequence of the study. 
3.3.1. Development of the service and main pilot study 
The aim of the pilot study designed by Jennifer Kelly was to determine the design 
of a randomised controlled trial in which a dedicated pharmacist (DP) trained in the 
management of dysphagia and enteral nutrition via NG and PEG tubes promoted 
best practice in relation to medicine administration to PWD on care-of-the-elderly 
and stroke wards through the use of I-MAGs. In her original design, the primary 
objective was to estimate the effect of I-MAGs on nurses’ clinical practice using 
observations of MAE rates and nurse questionnaires to evaluate nurse-stated 
practice. The secondary objectives of Jennifer Kelly’s study were to estimate: 
a. whether randomisation for a full trial should occur at ward or hospital level, 
b. the most efficient method of patient recruitment, the likely ‘drop out’ rate, the 
best outcome measures, and the feasibility of a full cost-effectiveness analysis, 
c. the effect of the introduction of I-MAGs on patients’ health-related quality-of-
life, satisfaction with medicine information, post discharge adherence and 
hospitalisation. 
 
Jennifer Kelly’s dissertation addressed the primary outcome and the first secondary 
objective (a). It didn’t address objectives (b) and (c) as these objectives related to 
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recruitment of patients on discharge to a six month questionnaire based study to 
evaluate the usefulness of I-MAGs to patients themselves and those objectives (b 
and c) were explored in the dissertation presented in this document. Although the 
data formed part of this PhD thesis, Jennifer Kelly co-supervised this secondary 
part of the study. This section of this chapter will present the methods employed to 
prepare and develop the I-MAGs service and the components of the pilot study 
based on that service.  
3.3.1.1. Development of the service 
This section will explain how the service was prepared and developed. It is 
important to highlight that the I-MAG service was provided only in wards 
restricted by the main pilot study and, in order to enhance the clarity of this 
document, references to the sections relevant to the study are made as part of this 
section. 
3.3.1.1.1. I-MAG and software development 
I-MAGs were developed by the Steering Committee of the study. The guides 
consisted of individualised instructions on the administration of medication to be 
used by the nurses and the carers of PWD with or without enteral feeding tubes 
(EFTs). I-MAGs (Figure 6 and complete version of example in Appendix 1) 
contained: 
- patient details, 
- information regarding the diet texture as recommended by the SALT, 
- a list of the patient’s medication with frequency and instructions on the 
administration adapted to the patient’s needs, 
- contact details for the pharmacist generating the guides. 
The information provided in the I-MAGs was developed to be used in the hospital 
wards in conjunction with the standard medication charts and was based on the 
BAPEN Guidelines on administering drugs via enteral feeding tubes,(319) the 
algorithm for medication management of adults with dysphagia(320) and specific 
information about each drug extracted from current literature such as “Handbook 
of drug administration via enteral feeding tubes”(215) and “The NEWT Guidelines 
for administration of medication to patients with enteral feeding tubes or 
dysphagia”.(321) The guides were designed to provide clear guidance on which 
formulation should be used, how tablets and capsules should be modified (if 
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required) and how the medicine should be measured (in the case of liquids) or 
administered. 
 
Figure 6: Example of an I-MAG 
 
The I-MAG was introduced to assist nurses to give medications safely to PWD. It 
was envisaged that the nurse would refer to the I-MAG every time they 
administered medicines orally or via enteral tube to the patient. The I-MAG was 
intended to ensure consistency in medicines administration and, therefore, reduce 
errors.  
In order to ease the generation of I-MAGs in the hospital wards, the DP created a 
database of over 450 drugs with information based on current literature on how to 
administer those drugs to PWD with or without EFTs and possible alternatives that 
could improve the administration. The database was then incorporated into a 
Microsoft Access tool that allowed the addition of patient details and their 
medication and combined them with the information in the drug’s database. The 
tool also permitted the editing of the information about medicines by the DP in 
order to produce individualised guidance for the nurses, carers, and relatives of 
patients or PWD on how to administer the medication.  
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3.3.1.1.2. Dysphagia pharmacist training 
The main researcher and DP was a pharmacist with expertise in care for older 
people who received some training in the issues surrounding the administration of 
medication to PWD.  
The DP was trained to the level of Foundation Dysphagia Practitioner(149) of the 
Inter-Professional Dysphagia Framework between July and November of 2010. It 
was implicitly required that the DP: 
- demonstrated acceptable performance undertaking protocol-guided assessment 
of swallowing, 
- identified presenting signs and symptoms, and undertook a protocol-guided 
assessment of dysphagia, 
- initiated and implemented the actions dictated by the protocol and 
disseminated this information to the patient, the carer and the team. 
The training for the DP also consisted of different sessions with some of the 
healthcare professionals involved in the care of PWD. These sessions included:  
- shadowing a senior SALT during the assessment of PWD admitted to the 
wards, 
- informative session with a Nutrition Nurse Specialist followed by theatre 
observations of the insertion of EFTs to PWD, 
- communication partners: this course consists of training sessions for healthcare 
professionals within the NHS that aims to optimise the communication with 
patients with speech impediments secondary to another condition such as 
stroke, which is one the main conditions associated to dysphagia, 
- hospital training for a wider understanding of the wards’ management on the 
provision of medication and medicines reconciliation.   
3.3.1.1.3. Service introductory sessions 
The healthcare professionals in the participating wards (see section 3.3.1.2) were 
invited to attend introductory information sessions about the content and the 
rationale of the study. These sessions were part of the original study designed by J. 
Kelly. Flyers (Appendix 2) were placed during July 2010 in the common areas of 
the study participating wards and in the pharmacy, SALT and dietetics departments 
in order to obtain participation of different professionals involved in the care of 
PWD. The comments collected from these introductory sessions provided the main 
researcher with an opportunity to identify the training needs of the nurses in the 
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training sessions that were carried out prior to the implementation of I-MAGs. 
These sessions also offered an opportunity to liaise with other professionals 
involved in the care of PWD and to explore the views of the attendants with 
regards to the study design. The attendants were given a short feedback form 
(Appendix 3) to provide their optional evaluation feedback on the sessions and to 
suggest other areas of practice to be covered in the subsequent training sessions. 
Two introductory sessions per day (on 27th July and 3rd August) were held in order 
to facilitate attendance. Nineteen healthcare professionals attended the sessions 
(three pharmacists, eight SALTs, one dietician, one assistant practitioner and six 
staff nurses). 
3.3.1.1.4. Training sessions on the use of I-MAGs 
On 21st of September 2010 and 30th September 2010, one-hour training events were 
held on the two service (intervention) wards by the dysphagia pharmacist. The 
event was repeated four times each day to enable at least 85% of relevant staff to 
attend. Flyers (Appendix 4) were placed in the service wards and feedback forms 
(Appendixes 5) were collected from the attendants. The training sessions were 
aimed at the nurses but were open to all staff on the two intervention wards if they 
were involved with prescribing, dispensing and/or administering medicines. The 
feedback from the introductory sessions helped to identify the issues that the 
researcher needed to cover during these sessions. The content of the training was 
discussed with two sister nurses on the service wards one week before the events in 
order to confirm that the content would be suitable for the understanding of the 
nurses. The sessions served to introduce the I-MAG and rationalise and maximise 
its use, in relation to crushing tablets and opening capsules, using liquid 
formulations, and administering medicines through enteral tubes. Handouts of the 
material covered in the training session were made available to those staff 
attending and those unable to attend the sessions. These handouts included: 
- recent publications highlighting the issues in the administration of medication 
to PWD, 
- general guidance on the administration of medication to patients with 
dysphagia. This guidance contained information gathered by the DP related to 
the types of formulations and their uses and applications to PWD and/or EFTs, 
- printouts and descriptions of available devices for the correct administration of 
medicines, 
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- A copy of an I-MAG. 
A total of 19 staff nurses (60% of the employed nurses) and six healthcare 
assistants from the intervention wards attended one of the three sessions. 
3.3.1.1.5. Piloting the service 
The implementation of I-MAGs was tested in one of the intervention wards for six 
weeks (1st December 2010 until 9th January 2011) before the complete service 
delivery. The aim of this preliminary part of the study was to estimate the time, 
facilities and equipment required for a regular provision of I-MAGs and to prepare 
the environment for delivering the intervention. A diary was used to record any 
problems identified. Implementing a new service may encounter unexpected 
challenges especially as some components of the pilot study such as the software 
used to generate I-MAGs or the inclusion of DP in the wards had not yet been 
tested. 
3.3.1.1.6. Implementation of the service 
For 23 weeks (from 10th January until 17th June 2011) the DP generated an I-MAG 
for all the patients diagnosed with dysphagia by the SALT on the two service 
wards. 
The provision of I-MAGs allowed the DP to collect data regarding: 
- the number of PWD admitted to the intervention wards, 
- the number of patients suitable to receive I-MAGs, 
- the number of new and updated I-MAGs generated, 
- the number of drugs contained in the guides, 
- the estimated cost of the drugs prescribed, 
- the time involved in producing the guides, 
- the length of stay of patients with I-MAGs in the intervention wards. 
The number of PWD admitted to the intervention wards was identified from the 
daily referral report received by the SALT department, to which the DP was 
granted access by the head of the department for the purpose of the service. The 
number of those patients that were suitable for receiving I-MAGs was then 
identified by medication assessment (explained in Section 3.3.2.) and recorded in a 
Microsoft Excel database created by the DP for analysis. The number of new and 
updated I-MAGs generated, the number of drugs contained in the guides and the 
length of stay of patients with I-MAGs in the intervention wards were obtained 
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from the software used to generate the I-MAGs. The estimated cost of the drugs 
prescribed was obtained from Drug Tariff(322) as indicated in Section 3.3.3. 
Although the complete dataset was analysed to present the characteristics 
mentioned above, the time involved in producing the guides was extracted from the 
provision of I-MAGs to 10 patients selected randomly (the first patient of the day 
during 10 consecutive days) towards the end of the study. A sample of 10 was 
taken as the variation in time was limited and consequently a greater sample size 
would provide no greater precision. The time involved in producing the guides 
included not only the electronic data generation but also a review of the patient’s 
notes and availability of the medication prescribed in the medicines cabinet next to 
the patient’s bed.  
3.3.1.2. Main pilot study 
The pilot study was conducted on four wards at the Norfolk and Norwich 
University Hospital, a large teaching hospital with over 800 beds providing acute 
secondary and some tertiary hospital services to the population of central Norfolk 
including Norwich, much of South Norfolk, Breckland, North Norfolk and 
Broadland.  
Inclusion criteria for these wards were that they: 
- routinely care for adult medical patients, 
- routinely care for patients who have neurological conditions that can affect 
swallowing, e.g. strokes. 
 
Exclusion criteria for these wards were: 
- senior nurse unwilling for his / her staff to participate in the study, 
- expected closure of the ward during the study period, e.g. for decorating. 
 
The two control wards for the study were formed by two care-of-older people 
(COO) wards while the intervention wards were formed by a COO and a 
neurological-stroke unit. Further discussion about the choice of these wards can be 
found in the chief investigator’s dissertation.(323) The participating wards will be 
referred to as indicated in Table 12 for the rest of this dissertation. 
 
 
Implementing and evaluating a novel service in dysphagia in secondary care 
 
Page 108 of 380 
 
 Intervention Control 
Type of ward 
Neurological-
stroke unit 
Care-of-  older 
people 
Care-of- older 
people 
Care-of- older 
people 
Nomenclature I1 I2 C1 C2 
Table 12: Nomenclature of the wards 
 
During the preparation for the pilot study it was identified that the neurological-
stroke unit often transferred patients that require specialised care post-stroke to a 
recovery unit off-site that provided longer-term care. Unless otherwise specified, 
the recovery unit is considered an “extension” of the neurological-stroke unit 
during this thesis and, therefore, combined data from the two units will be referred 
to as data from the neurological-stroke unit. 
3.3.1.2.1. Patient recruitment 
It was estimated, based on previous work in the type of wards being used for this 
study, that approximately 15 patients would be recruited per ward per month,(324) 
making a total of 360 patients, 180 each on the intervention and control wards 
during the six months of recruitment. However, allowing for 33% not consenting or 
consenting and dropping out, we expected that data would be available from 240 
patients.  
For the 23 weeks (from 10th January until 17th June 2011) whilst the research was 
in progress, it was standard practice for all PWD on the two intervention wards to 
have I-MAGs prepared for them by the dysphagia pharmacist. Patients were 
recruited for the purposes of the study to provide feedback on the use of the I-
MAG and to provide data on its effectiveness. Figure 7 shows the recruitment flow 
after the implementation of I-MAGs and the collection of data for the patient 
outcomes. 
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In order to comply with good clinical practice, a clinician in the ward was to ask 
the patients if they were happy to be approached by a researcher to receive 
information about the study before any involvement by the research team. This was 
achieved and recorded using CTA forms (Appendix 6). SALTs, nurses, ward 
pharmacists and the DP were able to ask the patients or their carers for Consent To 
Approach (CTA) in the intervention wards but this role was exclusively done by 
the DP. The DP then annotated the outcome in order not to ask the same patient 
again. In the control wards, where the DP was not carrying out any intervention, 
only the clinicians in the wards were able to ask for CTA from the patients and 
when a negative answer was given, the clinicians in the control wards preferred not 
to release this information in order to protect the confidentiality of the patient, 
therefore, only data from the patients that provided CTA to the research team were 
recorded. 
Figure 7: Recruitment and data collection flow chart 
 
2 control wards 2 intervention wards 
DP carries out a one-hour training session on I-MAGs 
and how to use them  
For 6 months RA recruits and consents PWD. Prior to 
discharge RA helps PWD complete EQ-5D, patient 
satisfaction, Health service questionnaire and drug 
adherence questionnaires; (Jan–Jun 2011) 
DP devises individualised I-MAGs for all PWD on 
ward, teaches patients prior to discharge how to use I-
MAGs and sends copy + covering letter to each patient 
Data analysis  
6 weeks and 6 months post-discharge RA sends patients 
a QOL questionnaire, health service questionnaire 
satisfaction and adherence questionnaires 
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PWD were approached from all four intervention and control wards by the research 
assistant, who visited the wards daily. The research assistant liaised with the ward 
staff to ensure that patients or their relatives were willing to be approached by a 
researcher. The research assistant selected patients who meet the following criteria: 
Inclusion criteria: 
- current problems with swallowing as diagnosed by the SALTs, 
- problems taking medicines as identified by the nurses, e.g. patient chews 
tablets as unable to swallow whole. 
Exclusion criteria: 
- patient unwilling to give informed consent, 
- patient lacked mental capacity and their dysphagia is completely unrelated to 
the reason for their mental incapacity, as judged by the clinical team caring for 
the patient and personal consultee was unavailable, 
- the consultee advised that the person would not have wanted to take part in the 
project. 
The research assistant, when seeking patient consent, was guided by the clinical 
staff and used the Mental Capacity Act 2005(325) definition to identify whether the 
patient was lacking capacity and thus was unable to consent to taking part in the 
study, i.e. if they were unable: 
- to understand information relevant to the decision, 
- to retain that information, 
- to use or weigh that information, 
- to communicate a decision. 
If the patient was found to be lacking capacity, the research assistant discussed the 
criteria with the patient’s carer and explained why he did not believe the patient 
could consent to taking part in the research, and hence why he was asking for the 
carer to act as personal consultee. Personal consultees were offered a copy of the 
Department of Health’s booklet ‘Making decisions: A guide for family, friends and 
other unpaid carers’,(326) which includes a section on research to help clarify the 
situation for them. 
The research assistant gave each patient a copy of the patient invitation letter and 
the patient information sheet (Appendix 7). Where patients were unable to consent, 
but the personal consultee had indicated that, in their opinion, the potential 
participant would have wanted to take part in the project had they retained capacity, 
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the research assistant gave them a copy of the personal consultee invitation letter 
and information sheet (Appendix 8). The research assistant returned the next day to 
answer any questions the patient or personal consultee might have and obtain their 
written consent or assent (Appendix 9 and Appendix 10. 
Patients who had given written consent to be involved in the study, and identified 
as ready for discharge, received a pre-discharge information session from the DP to 
ensure that they could use the medicine administration guidelines at home and that 
these were easy to read and understand. This session was also used to address any 
concerns the PWD had regarding the administration of their medication. 
For all patients who were recruited to the study, the researcher included a copy of 
the I-MAG and a covering letter with the discharge information normally sent to 
the patient’s general practitioner. The patient was also given a copy of the I-MAG 
and a covering letter to give to his community pharmacist. In the cases where the 
patient was discharged to a care home, the DP also visited the home and the nurse 
in charge of the care of that patient to inform her/him about how to use the I-MAG, 
the purpose of it and the nature of the study. The discharge I-MAGs had the 
dysphagia pharmacist’s contact details at the bottom and the number and nature of 
queries made were recorded as part of data collection. 
3.3.1.2.2. Patient outcomes 
Secondary outcome measures were recorded at the time of recruitment to the trial, 
i.e. at discharge, at six weeks and again six months later. Patients who provided 
written consent were requested to complete the following: 
- health-related Quality of Life measure: the EQ-5D(327, 328) was be given to 
patients to identify its acceptability and validity, in terms of convergent 
validity, for the main study, 
- a patient satisfaction questionnaire about information and pharmaceutical care 
(SIMS),(329, 330) 
- a medicine adherence questionnaire – patient or carer (Morisky),(331) 
- a health services use questionnaire (Appendix 11). 
The EQ-5D and the SIMS are both validated tools. The medicine adherence 
questionnaire is based on questions developed by Morisky et al (1986) to measure 
compliance with antihypertensive medication. They have been demonstrated to 
show predictive validity (alpha reliability = 0.61)(331) and they have been used to 
assess adherence with medication for a variety of disease states, including asthma 
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and HIV. The questions are phrased in such a way that the answers demonstrating 
compliance require the patient to answer ‘no’, thus overcoming patient’s yes-
saying bias.(332) 
The research assistant explained these to the patients after gaining their written 
consent and assisted the patients, if necessary, to complete the forms prior to 
discharge. At the time of discharge the research assistant collected the 
questionnaires. 
Six weeks and six months after being recruited to the study and after discharge 
from hospital the research assistant posted the following evaluation forms for self-
completion by the patient: 
- health-related Quality of Life measure – the EQ-5D, 
- Morisky’s adherence questionnaire, 
- patient satisfaction with information and pharmaceutical care questionnaire 
(SIMS), 
- health services use questionnaire. 
Two weeks after posting, the research assistant followed-up with a telephone call 
to non-responders and those who needed help filling in the forms (as identified at 
the time of discharge by the research assistant). The research assistant also 
reviewed the hospital electronic data (PAS system) to identify the number of 
emergency hospital admissions each patient had had. 
 
3.3.2. Clinical interventions made by the DP 
Previous to the generation of the I-MAG, a medication assessment based on current 
guidance(333) was carried  out on the patients identified. This assessment consisted 
of: 
- reviewing the patient’s dysphagia treatment plan, specifically for food and 
fluid consistencies recommended for the patient, 
- reviewing the patient’s medication profile for medications that may be difficult 
to swallow, are potentially dangerous if crushed or chewed, or can cause harm 
to others if crushed or handled incorrectly (e.g., finasteride), 
- identifying dosage forms that should not be crushed include the following: 
• enteric-coated (EC), 
• extended-release (ER, XR), 
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• long-acting (LA, XL), 
• controlled-release/delivery (CR, CD), 
• sustained-release/action (SR, SA), 
- asking the patient or carer the following: 
• how they intend to administer each medication, 
• if any medication is difficult to swallow, or causes choking 
or gagging, have they been chewing or holding 
medications in the oral cavity, 
- being prepared to suggest alternative methods of administration, dosage forms, 
or therapeutic agents that are in a more suitable formulation if necessary or 
recommending a liquid dosage form may not always be appropriate as the 
liquid may be too thin or the suspension too thick. There is no data on the 
stability or bioavailability of liquid medications mixed with thickening agents, 
- communicating findings and recommendations in the medical record to the 
SALT and other allied healthcare professionals. 
The outcome of the assessment was reflected on the generation of individualised 
recommendations on I-MAGs and stored in a database as part of the I-MAG 
software (see screenshot of database in Appendix 12). The DP also recorded those 
cases where good prescribing practice was not achieved (i.e. unsuitable formulation 
choices made by the prescriber, recommendations not based on scientific evidence 
or prescriptions containing non-existent formulations) and those where the DP’s 
suggestions were disregarded. A printed red-paper form was used to record these 
events, which included date, nature of the event and, when possible, the outcome. 
I-MAGs were updated during the admission in response to feedback, medication 
changes, and changes in the patient’s condition. 
The researcher visited the wards daily to identify new patients that were suitable to 
receive I-MAGs and also to update the current I-MAGs placed in the wards. When 
new I-MAGs were generated, the DP liaised with the ward pharmacist to confirm 
compliance with internal policies of the hospital (formulary, etc.) and once agreed 
the I-MAG was printed and placed with the patient’s medicines chart. Subsequent 
ward rounds identified whether any changes were made by the prescriber to the 
patient’s medication and, when necessary, the I-MAG would be updated and 
confirmed again with the ward pharmacist.  
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At the time of discharge, the DP issued I-MAGs for the patients to take with them. 
Before leaving the hospital, the DP explained to these patients or their carers how 
to use the I-MAGs and confirmed that the guides were understandable and legible 
by the patient or the carer. The outcomes of these conversations were not formally 
recorded as the outcomes were not part of the original pilot study design. 
3.3.3. Costing estimates of recommendations 
The recommendations presented in the I-MAGs represented the safest option to the 
drugs prescribed taking into consideration availability of the drug in the hospital 
formulary and the likely increase on the cost of alternative drugs or formulations.   
The I-MAG software recorded all the recommendations made by the DP. These 
records helped to identify where safer alternatives for the patient were not 
recommended due to formulary restrictions. The likely cost of the safest 
alternatives not recommended was compared to the estimated cost of the available 
recommended formulations based on pricing obtained from Drug Tariff,(322) which 
reflected what would be paid to pharmacy contractors for NHS services provided 
for reimbursement (the cost of the drugs, appliances etc. supplied against an NHS 
prescription form). 
3.3.4. Evaluation study of stakeholders’ opinions 
A mixed methods evaluation was developed as a follow-up of that trial to assess 
the delivery of the guides. I-MAGs had not been provided before and their design 
may not be optimal. Opinions and experience on the relevance and acceptability of 
the I-MAGs from the HCPs involved in the delivery of the service were explored in 
this evaluation. Ethical review for the service evaluation was sought for this study 
and approval was granted by the Faculty of Health of the University of East Anglia 
on 22nd September, 2011. Due to the low risk of the research based on the 
evaluation character of the study, the school provided a fast-track pathway for 
ethical approval where full ethics committee review was not needed and an email 
confirmation of approval for the study as a service evaluation was received without 
further referential registration.  
The aim of this evaluation section was to explore the acceptability of the I-MAGs 
service by the HCPs and their opinions on the provision of the guides. 
The objectives of this evaluation were to: 
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- obtain opinions on the advantages and disadvantages of the guides and the 
suitability of the service provided by the pharmacist, 
- describe the acceptability of the I-MAGs service, 
- compare the views of the HCPs on the use of these guides compared with 
normal practice, 
- describe how I-MAGs could be improved, 
- identify what support could help the care staff to use these guides. 
In order to achieve the aim of this part of the study, a questionnaire was designed 
to be workable in practice, acceptable to participants and to effectively and 
efficiently gather valid and reliable data.(334) 
Various methods to maximise recruitment rates were used in the design of the 
questionnaire such us university sponsorship, use of stamped return envelopes, and 
including a statement that others had responded.(335) It was also recognised that a 
covering letter was likely to increase response when it includes the aim and 
sponsorship  of the survey and emphasises the importance of the response and how 
the results will be used.(336) 
The strength of using questionnaires for this purpose is that they are useable to 
collect unambiguous and easy to count answers, leading to quantitative data for 
analysis.(336) However, pre-coded choices may not be sufficiently comprehensive 
and not all answers may be easily accommodated and respondents may, therefore, 
be “forced” to choose inappropriate pre-coded answers that did not represent their 
views.(336) To compensate for this disadvantage of the questionnaires, there was a 
space for further comments at the end of every question and at the end of the 
questionnaire so the respondent could express any other opinions not fully 
represented by the pre-coded answers. 
The style of the closed questions consisted of a combination of Likert scale and 
dichotomous in order to get an opinion from the audience in limited words, assess 
how the participants felt towards a certain issue or to avoid ambivalent answers, 
respectively depending on the issue approached. 
Face validity checks were carried through peer review discussions of the 
questionnaire with the academic supervisors. However, in order to avoid the risk of 
sharing similar perspectives,(337) a preliminary version of the questionnaire was 
piloted with a hospital pharmacist which also served to explore the content validity 
of the questionnaire in relation to the extent to which the design could gather data 
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relevant to the topic. The questionnaire was piloted with the ward pharmacist from 
the intervention wards at the end of September 2011. This pharmacist didn’t 
identify any concerns when completing the questionnaire and highlighted that it 
took no more than 20 minutes to complete the open and closed questions. 
All participants received the same questionnaire (Appendix 13 and Appendix 14) 
but two additional questions relevant only to nurse practice were included in the 
nurses’ questionnaires to enhance content validity: one related to the nurse training 
sessions and the other referred to the practicality of the I-MAGs when nurses were 
following the recommendations on the guide.  
This service evaluation was carried out in one of the wards where almost all I-
MAGs (94.5%) were implemented. The participants were all nurses, pharmacists 
and SALTs who were practising in the ward during the term of delivery of the I-
MAGs. The chosen wards relied on the regular support from 20 members in the 
nursing team, three pharmacists and three SALTs during the delivery of this 
service.  
The questionnaire covered the six main aspects of the delivery of the service across 
26 questions. These aspects were: 
- preparation and training sessions before I-MAG introduction, 
- the presentation of I-MAGs, 
- the practicality of I-MAGs, 
- delivery of the service by the Dysphagia Pharmacist (DP), 
- content of the I-MAG, 
- personal opinions of participants. 
The DP that had been fully involved in the delivery of the I-MAGs approached in 
person the potential participants during September and beginning of October 2011, 
two months after the removal of the I-MAGs in the intervention ward. The 
participants were encouraged to take the questionnaire away for completion. All 
the questionnaires were pseudo-anonymised (anonymised within the group of HCP) 
and then presented to the staff members involved during the delivery of the service, 
with the cover letter explaining the purpose of the study with the questionnaire 
(Appendix 15)  and a pre-stamped envelope addressed to the DP. Due to the 
limited size of the group of participants, only their role in the ward was asked for 
as part of the demographic data in order to safeguard the confidentiality of the 
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responses. The participants were then coded with a letter that represented their role 
(S for SALT, P for pharmacist and N for nurse) followed by a randomised number. 
3.3.5. Data analysis 
The analysis of the data obtained was a combination of qualitative and quantitative 
elements gained from the delivery of the service, the recruitment and follow-up of 
the participants of the pilot study and from the stakeholders’ opinions (service 
evaluation).  
The data obtained from the delivery of service was used to identify the prevalence 
of dysphagia in the hospital wards. Additional data was collected about the number 
of patients receiving I-MAGs, time spent on the generation of the guides, number 
and formulation of the drugs included in them and the length of stay of the patients 
receiving I-MAGs with the aim of exploring elements of feasibility of the service. 
The analysis of optimising the administration of medication to PWD receiving I-
MAGs was carried out through an estimation of the percentage increase in the cost 
of providing suitable alternative formulations in order to estimate potential costs in 
a larger trial. 
The comments and answers to the open questions were analysed using a simple 
qualitative thematic analysis. Thematic analysis is one of the most commonly used 
methods of qualitative analysis and the task of the researcher was to identify a 
limited number of themes which adequately reflect their textual data. As with all 
qualitative analysis, it was vitally important that the researcher was extremely 
familiar with the data as the analysis was dynamic (prompting emerging themes) 
and insightful (inductive).(338) For this reason, the researcher carried out the data 
collection himself and then coded the data. On the basis of the codings, the 
researcher then identified themes which integrated substantial sets of these codings. 
The researcher tried to define each theme sufficiently so that it was clear to others 
exactly what the theme was. The recruitment rates were also identified and 
analysed. It was intended that the analyses of the follow-up questionnaires were 
carried out by fitting generalised linear models to the data, with the aim of 
estimating the sizes of any differences between the groups and their standard errors. 
Models fitted(339) would respect the structure of the data (before and after pairing 
for example), and baseline measures would have been included as covariates where 
appropriate. A sub-group analysis would have been performed when a patient 
representative had completed the questionnaire as they would provide a third-party 
estimate of Quality of Life. 
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3.4. Results 
In line with the structure followed in the presentation of the methods, the results 
are presented in four different sections: 
- the main pilot study (including service), 
- the clinical  interventions made by the DP, 
- costing estimates of recommendations, 
- service evaluation. 
3.4.1. Development of the service and main pilot study 
This section explains the results of the delivery of the service and explores the 
outcomes of the pilot study. 
3.4.1.1. Development of the Service 
3.4.1.1.1. Piloting the I-MAGs 
The implementation of I-MAGs was piloted for six weeks in one of the 
intervention COO wards and three patients received I-MAGs during this period. 
The delivery of the service during this period identified: 
- further required development of the software: the tool used to generate I-
MAGs had not been tested in the field before and it required additional features 
such us record keeping of enquiries and interventions made by HCPs, 
- the need for Standard Operation Procedures (SOPs): although all the HCPs 
involved in the care of PWD were invited to participate in the introductory 
sessions, the implementation of I-MAGs required written SOPs to help the 
delivery of the service, 
- technical support: the electronic collection of any patient’s details required 
certified devices capable of encrypting content and assure data protection. 
Several days were spent on setting up the technical support for the service. 
3.4.1.1.2. Implementation of I-MAGs 
During the provision of the service, 755 patients were admitted in the service wards 
(I1 and I2).  A total of 244 (32.3%) suffered from dysphagia of which 75 (9.9%) 
patients received I-MAGs. Table 13 compares the proportion of PWD that received 
I-MAGs within the different service wards. 
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 I1 I2 
Female (% from 
total) 
Admissions 479 276 Not available 
PWD (%) 203 (42.4%) 41 (14.9%) 108 (44.5%) 
Patient with I-
MAG (% from 
PWD) 
61 (30.0%) 8 (19.5%) 31 (41.3%) 
Table 13: Proportion of patients that received I-MAGs in the service wards 
 
The patients that received I-MAGs were female in 31 cases (41.3%). The Median 
(Quartiles) of the age of these patients was 81.6 (74.7, 87.1) in females and 80.1 
(72.7, 88.4) in males. 
 
The remaining 169 patients did not receive the administration guides due to: 
- patient had been discharged or transferred to other wards of the hospital 
before DP’s assessment of the patient (n=99), 
- limited access to the wards during Norovirus outbreak (n=18), 
- dysphagia was no longer present (n=19), 
- patient was on IV medication or palliative care (n=29), 
- patient deceased before DP’s visit (n=4). 
3.4.1.1.3. Number of medicines 
A total of 523 items were prescribed during the stay of the 75 patients that received 
the I-MAGs, with each patient receiving a mean (SD) of 6.9 (3.2) medicines during 
their stay. 
3.4.1.1.4. I-MAGs generated and number of recommendations 
When the medication was reviewed, the patient’s condition changed or the patient 
was discharged the I-MAGs were updated or removed, as appropriate. Almost half 
of the 75 patients received only one copy of their I-MAG while 51% received at 
least one further update/revision (Figure 8).  A total of 164 I-MAGs were issued 
containing a total of 1,002 different recommendations on how to administer the 
medicines showing a Median (Quartiles) of 6 (5, 8) per I-MAG. 
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Figure 8: I-MAGs received per patient 
3.4.1.1.5. Length of stay in the intervention wards 
PWD stayed in hospital 24 days (Median 24.5, Quartiles 9.7, 34.2) between 
admission and discharge. Differences in the length of stay were observed within 
our sample as indicated in Figure 9. The length of stay was increased to an average 
of 55 days if patients were transferred to the recovery unit from the neurological- 
stroke unit where the average length of stay was 31 days. 
 
Figure 9: PWD’s length of stay in the Stroke Unit (I2) 
 
3.4.1.1.6. Time to produce I-MAGs  
The mean (SD) time dedicated to issuing the I-MAGs from a randomly selected 
sample of 10 patients indicated that the DP required 30.4 (6.2) minutes per I-MAG 
plus an average of seven minutes on the initial assessment of the patient. This 
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Implementing and evaluating a novel service in dysphagia in secondary care 
 
Page 121 of 380 
 
assessment included review of the patient’s notes and availability of the medication 
prescribed in the medicines cabinet next to patient’s bed.  
3.4.1.2. Pilot study 
3.4.1.2.1. Recruitment of Patients 
During the 23 weeks of the intervention in the hospital wards, 755 patients were 
admitted the intervention wards and 621 were admitted in the control wards (Table 
14). In the intervention wards, a total of 244 PWD (32.3%) were referred to the 
SALTs after an early assessment by the nursing team. Figure 10 (page 122) shows 
a summary of the recruitment flow throughout the study. Data on the number of 
patients admitted to the wards was provided by the ward clerk; however, no further 
details such as gender, age or condition for the admission were made available.   
 
I1 I2 
 
C1 C2 
479 276  278 333 
Total: 755  Total: 621 
Table 14: Number of admissions to hospital during research period 
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Figure 10: Recruitment flow chart 
 
Wards randomisation 
Intervention wards Control wards 
Patients admitted n=755 Patients admitted n=621 
Patients with dysphagia n=244 
Patients that received I-MAGs n=75 
Patients recruited n=17 
Patients completing baseline data collection 
n=14 
Patients completing 6-weeks data collection 
n=10 
Patients completing 6-mMonths data 
collection n=8 
Mortality n=2 
Drop out n=1 
Patient did not receive I-MAG n=169 
Patients asked for consent/assent to approach 
(CTA) n=45 
Patients asked for consent to participate 
(+Assent) n=23 
Patients not asked for CTA n=30 
CTA denied n=6 
Consent/assent denied n=6 
Mortality n=1 
Drop out n=3 
Mortality n=2 
Patients asked for consent to participate 
(+Assent) n=10 
Consent/assent denied n=5 
Patients recruited n=5 
Patients completing baseline data collection 
n=5 
Patients completing 6-weeks data collection 
n=2 
Patients completing 6-mMonths data 
collection n=1 
Mortality n=3 
Drop out n=1 
Patients accepted CTA n=39 
Patients not asked for consent n=16 
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3.4.1.2.1.1. Consent to approach 
In the intervention wards, a total of 75 patients were eligible to take part in the 
study and 45 of them were asked for CTA. The remaining 30 patients were 
unexpectedly discharged before the estimated discharge date (EDD) (n=29) or the 
patient did not have capacity to respond to the question and no relatives were 
available (n=1) (Table 15). CTA was accepted by 10 patients in the control wards 
but no data about the number of patients that did not want to be approached by the 
RA were provided to the research team by the clinicians in the ward. 
 
 I1 I2 Total intervention 
CTA accepted 37 2 39 
CTA denied 6 0 6 
CTA not asked 25 5 30 
Table 15: Obtaining CTA from eligible patients 
 
3.4.1.2.1.2. Consent to participate 
From the 39 patients that consented to be approached by the RA in the intervention 
wards, 23 were interested in receiving more information about the study. 16 were 
not asked for consent to participate as, between getting CTA and the RA having the 
opportunity to approach the patient, they were discharged (n=14), transferred to 
another ward (n=1) or the patient did not have capacity to respond to the question 
and no relatives were available (n=1). The total of 23 patients in the intervention 
wards interested in receiving more information about the study were asked to 
participate and 17 patients were recruited for the study. 
All the patients that consented to be approached by the RA in the control wards 
were visited by the RA and offered the opportunity to participate. Consent was 
obtained from five of the 10 patients in the control wards (Table 16). 
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 I1 I2 Total intervention C1 C2 
Total 
Control 
Consent 
obtained 16 1 17 3 2 5 
Consent 
denied 6 0 6 0 5 5 
Consent 
not asked 15 1 16 0 0 0 
Table 16: Summary of consent obtained 
 
If found lacking capacity, a ‘consultee’ who was willing to be consulted about the 
person’s participation was identified. During the recruitment period the decision of 
taking part in the study was made by the consultee in 17 cases (51%). This 
proportion was higher in the intervention wards where in 15 cases (65.2%) the 
consultee made the decision compared to two cases (20.0%) in the control wards as 
seen in Table 17. 
 I1 I2 
Total 
intervention C1 C2 
Total 
Control 
Consent 
given by 
patient 
6 0 6 (26.1%) 3 2 5 (50.0%) 
Consent 
denied by 
patient 
2 0 2 (8.7%) 0 3 3 (30.0%) 
Assent 
given by 
NOK 
10 1 11 (47.8%) 0 0 0 
Assent 
denied by 
NOK 
4 0 4 (17.4%) 0 2 2 (20.0%) 
Table 17: Comparison of consent and assent rates 
 
After giving consent to be approached by the RA, 73.9%  and 50.0% of the patients 
in the intervention and control wards, respectively, were interested in taking part in 
the study and were, therefore, recruited.  Table 18 provides a summary of the 
recruitment rates in the control and intervention wards and a comparison of these 
rates when considering the total number of patients eligible for the study and also 
the total number of patients approached. 
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 Total intervention Total Control 
Total Eligible Patients 
(TEP) 75 Not known 
CTA obtained from TEP 39 (52.0%) Not known 
CTA obtained from 
approached patients 39 (86.7%) Not known 
Consent obtained from TEP 17 (22.6%) Not known 
Consent obtained from 
approached patients 17 (73.9%) 5 (50.0%) 
Table 18: Recruitment rates 
3.4.1.2.2. Patient outcomes 
As mentioned during the methodology of this study, the recruited patients were 
followed-up six weeks and six months after discharge and after completion of the 
baseline data collection. 
From the total  of 22 recruited patients across the intervention and control wards, 
nine patients (eight intervention and one control) completed the study. Eight 
patients passed away during the follow-up period and another five dropped out 
(Table 19). 
 
 I1 I2 Total intervention C1 C2 
Total 
Control Total 
Consent 
obtained 16 1 17 3 2 5 22 
Dropped 
out 3 1 4 (23.5%) 1 0 1 (20.0%) 5 (22.7%) 
Mortality 5 0 5 (29.4%) 2 1 3 (60.0%) 8 (36.3%) 
Table 19: Drop out and mortality rates 
 
Due to the small number of participants completing the questionnaires during the 
period of follow-up to measure secondary outcomes, no statistical analysis was 
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carried out. However, the questionnaires were returned fully completed in the 
majority of cases and they offered an opportunity to identify whether the patients 
were being discharged to care homes or to their own homes. 
It was expected that the differences between the conditions suffered by the patients 
would probably not allow the observation of any side-effects directly related to the 
implementation of the service. However, a clinical audit was carried out by the 
research and development coordinator at the same hospital. This audit reviewed the 
medical history of the patients receiving I-MAGs and of those recruited for the 
study. The report generated on 23rd May of 2012, didn’t identify any side- effects 
or negative outcomes as a consequence of the implementation of the service. 
 
3.4.2. Cost of medication prescribed 
During the provision of I-MAGs, 116 different medicines were prescribed to PWD 
receiving the guides in the intervention wards. These 116 medicines were 
recommended in the I-MAGs as a safe option within alternatives offered by the 
hospital’s formulary and restricted by price. Table 20 provides information about 
medicines and their formulations for the 20 most frequently prescribed. These 
medicines represent 66.3% of the oral medications prescribed for PWD. This table 
also shows the differences in cost between the formulations and the likely rates of 
increase of the cost when all the oral solid formulations are replaced by a safer 
liquid or dispersible alternative. 
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Drug Formulation used 
Times 
prescribed 
Cost per 
dose 
(dose) 
Liquid 
formulation 
or dispersible 
tablet 
available 
Cost of 
alternative 
formulation 
per dose 
Percentage 
increase of cost 
when using 
alternatives on all 
administrations* 
Paracetamol 
Efferves. 
tablet 
108 
11p 
(500mg) 
Paracetamol 
250mg/5ml 
suspension 
13p 18.2% 
Aspirin 
Dispersible 
tablet 
75 
3p 
(75mg) N/A 
N/A N/A 
Lansoprazole 
Capsules 17 
4.6p 
(15mg) 
Lansoprazole 
15mg 
Orodispersible 
tablets 
10.6p 
21.2% 
Orodispers. 
tablets 
38 
10.6p 
(15mg) N/A 
N/A 
Simvastatin Tablets 48 
4.2p 
(40mg) 
Simvastatin  
20mg/5ml 
suspension 
148p 3,423.8% 
Amlodipine Tablets 44 
3.5p 
(10mg) 
Special 
Amlodipine 
10mg/5ml 
solution 
452.3p 12,822.9% 
Digoxin 
Tablets 41 
3.8p 
(125mcg) 
Digoxin 
50mcg/ml 
elixir 
22.3p 
425.9% 
Elixir 1 22.3p N/A N/A 
Bisoprolol Tablets 39 
4.1p 
(5mg) 
Special 
Bisoprolol 
2.5mg/5ml 
solution 
441.7p 10,673.2% 
Thick And Easy 
Used as 
carrier for 
medication 
33 N/A N/A N/A N/A 
Senna Syrup 27 
5.38p 
(15mg) N/A 
N/A N/A 
Citalopram 
Tablets 25 
3.4p 
(20mg) 
Citalopram 
40mg/ml 
drops 
28.5p 
552.9% 
drops 1 
28.5p 
(20mg) N/A 
N/A 
Clopidogrel Tablets 25 
6.7p 
(75mg) 
Special 
Clopidogrel 
75mg/5ml 
solution 
270.6p 3,938.8% 
Levothyroxine 
Tablets 17 
9.9p 
(25mg) 
Levothyroxine 
50mg/5ml 
solution 
137p 
373.0% 
Suspension 3 137p N/A N/A 
Prednisolone 
Soluble 
Tablets 
16 
68.1p 
(5mg) N/A 
N/A 
23.3% 
Regular 
Tablets 
4 
3.7p 
(5mg) 
Prednisolone 
5mg Soluble 
tablets 
68.1p 
(5mg) 
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Table 20: 20 most common drugs prescribed on patients with I-MAGs 
 
Table 20 shows that the cost of the alternatives is usually much greater and the 
largest differences are seen when the alternative is an unlicensed ‘special’. Further 
analysis of this cost is reflected in Table 21 in which a general approximation of 
the cost of alternative formulations with and without the use of specials is shown. 
While the use of available liquid or dispersible formulations would be 2.4 times 
larger than the original cost, the use of special formulations in all the 
administrations where no other alternative is available would be almost ten times 
greater. 
  
Drug Formulation used 
Times 
prescribed 
Cost per 
dose 
(dose) 
Liquid 
formulation 
or dispersible 
tablet 
available 
Cost of 
alternative 
formulation 
per dose 
Percentage 
Increase of cost 
when using 
alternatives on all 
administrations* 
Metoclopramide Suspension 19 
95p 
(10mg) N/A 
N/A N/A 
Morphine 
Suspension 12 
8.25p 
(10mg) N/A 
N/A 
-3.6% 
Tablets 4 
9.48p 
(10mg) 
Morphine 
10mg/5ml oral 
solution 
8.2p 
Ramipril Capsules 15 
4p 
(2.5mg) 
Special 
Ramipril 
2.5mg/5ml 
solution 
266.7p 6,567.5% 
Thiamine Tablets 15 
4.8p 
(100mg) X 
N/A N/A 
Gabapentin Capsules 13 
2.5p 
(100mg) 
Gabapentin 
50mg/ml 
solution 
76.7p 2,968.0% 
Lisinopril Tablets 12 
3.5p 
(10mg) 
Special 
Lisinopril 
5mg/5ml 
solution 
416.5p 11,800.0% 
Perindopril Tablets 12 6.7p X N/A N/A 
Prices obtained from Drug Tariff 2013(322) 
(cost of alternative formulations +  cost of the ones without  alternative) − Cost of the current practiceCost of current practice x100 
*This figure  indicates the  percentage increase of the total amount of administrations = 
Implementing and evaluating a novel service in dysphagia in secondary care 
 
Page 129 of 380 
 
 Cost Increment 
Current administration 6,926.38p (£69.26) N/A 
Current administration when adding 
only available alternatives 
16,735.5p 
(£167.35) 141.62% 
Current administration when adding 
available alternatives and special 
formulations 
69,043.1p 
(£690.31) 896.69% 
Table 21: Comparison of cost increment (percentage increase) between alternative 
available formulations and special formulations 
 
3.4.3. Clinical interventions made by the DP 
A total of 1,002 different recommendations were reflected in the I-MAGs during 
the delivery of the service as indicated in section 3.4.1.1.4. (see example extracted 
from database in Appendix 12). 
 
During the period of the study, several cases were observed where the DP 
intervened in changes to the current medication prescribed before the 
administration was carried out. While the role of the DP was often limited by the 
hospital formulary to suggest correct ways of administering the medication 
prescribed, in certain instances further suggestions had to be highlighted to the 
prescriber or to other HCPs to safeguard patients’ wellbeing.  These suggestions 
were grounded on: 
- corrections of human errors or inadequate practice identified,  
- drugs that were not part of the hospital formulary,  
- lack of evidence based practice on the prescribing. 
While these interventions could be considered part of the normal practice of a ward 
pharmacist or a pharmacist trained on dysphagia, they have been selected as they 
may help in gaining more understanding about the context in which the nurses 
routinely practice. The cases presented are all related to challenges due to the 
formulation. 
Morphine sulphate MR case 
A patient received a prescription for Zomorph 5mg. Zomorph is a 12-hours 
modified-release formulation in capsules, where the lowest strength manufactured 
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is 10mg. As the dose prescribed was lower than the lowest strength formulation, 
the nurses administered MST continus 5mg tablets (also a 12-hours modified-
release formulation). This tablet was previously crushed as patient was 
recommended by the SALT team to have liquid medication. On observation, the 
DP stopped the administration and alerted the ward pharmacist who endorsed the 
prescription as “morphine sulphate/MST” with the intention of safeguarding the 
practice of the nurse. The DP highlighted the issue to the prescriber and the 
prescription was then changed to Zomorph 10mg capsules twice a day which can 
be dispersed in water and administered to the patient safely.  
 
Amisulpride case 
A patient was prescribed amisulpride 25mg tablets twice a day for negative 
symptoms of schizophrenia and was under the recommendations of the SALT team 
of only taking liquid medication. The lowest dose manufactured in tablet form is 
50mg. During observation, it was identified that the nurse had been halving the 
tablets and crushing them before dispersing them in water. These tablets are not 
licenced for crushing and there is no evidence of their efficacy when being crushed. 
The DP identified amisulpride liquid as an alternative and suggested it to the 
pharmacy department as a replacement. Despite not being part of the formulary, 
and after justifying its use, the liquid formulation replaced the original prescription 
of tablets. This intervention involved a total increase of £11 in the treatment of the 
patient across four months of treatment (£2.75 per month) but it made the 
administration of this medication safer than crushing tablets. 
Co-amoxiclav case 
Co-amoxiclav is an antibiotic that was often prescribed in the intervention wards. 
In three cases, this antibiotic was prescribed in tablet form for the administration 
via enteral feeding tubes. Although the suspension form is manufactured, it is very 
resistant to flushing and, therefore, the use of dispersible tablets is recommended 
for its use via enteral feeding tubes.(215) The DP highlighted these recommendations 
with evidence-based references and dispersible tablets replaced the regular tablets. 
Felodipine MR case 
Similar to the morphine case mentioned above, felodipine is a modified-release 
formulation that is not licensed for crushing. The prescription had been endorsed 
by the ward pharmacist with “crush” next to it as the patient was recommended 
only liquid medication. The DP suggested liquid alternatives of drugs with similar 
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effects. In the process of changing the prescription, the patient passed away as he 
was terminally ill. 
Lisinopril and digoxin cases 
Throughout the 23 weeks of the implementation of I-MAGs, it was observed that 
the patients that had been prescribed lisinopril (treatment of high blood pressure) 
and digoxin (treatment of atrial fibrillation) were administered these tablets 
sublingually when the patients had problems swallowing. The use of these 
medicines sublingually is not licensed and there is no evidence to support this way 
of administration. However, the prescribing team refused to change it or justify it 
as they considered that the effect of the medication was the same as that of the 
licensed administrations.   
3.4.4. Service evaluation 
3.4.4.1. Recruitment  
All of the pharmacists (n=3, 100%) and all of the SALTs (n=3, 100%) but only 13 
out of 20 (65%) members of the nursing team completed the questionnaire. 
Reasons for not completing included some of them having moved from their job on 
the ward, not being in charge of administration of medication or working on 
occasional night shifts and so could not be approached during the period for 
completion. 
3.4.4.2. Closed responses to the questionnaire 
Eighteen out of the 19 respondents affirmed that they would like this service to 
continue being provided with most adding substantial comments to the open 
questions. Due to the small size of the groups of SALTs and pharmacists, the 
answers to the closed questions presented are those from the nurses. However, 
Appendix 16 offers a summary of the answers from all the participants. 
Preparation and training sessions 
Six of the 13 participating nurses remembered attending the training sessions 
organised in September and October 2010. Figure 11 summarises the opinions of 
the respondents about the training sessions offered. 
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Figure 11: Nurses’ evaluation rates of the training sessions [%,(n)] 
 
Presentation of I-MAGs 
All participants said they had seen I-MAGs in the ward and agreed that the 
medication chart was the best place to locate the guide as it had been done during 
the delivery of the service.  Nine nurses stated that they would have preferred the I-
MAG in portrait layout compared to four who preferred the landscape format in 
which it was provided. Eleven of the respondents considered that the format and 
the font size of the I-MAGs were easy or very easy to read, while the rest were 
undecided. 
Practicality of I-MAGs 
The answers from the nurse participants identified very positive results to the 
incorporation of the I-MAGs in their practice on the ward as illustrated in Figure 
12. Additionally, eight out of the 13 nurses felt more confident in their practice 
when the I-MAGs were in place. The remaining five answered that they did not 
feel more confident because very often or every time they would have done the 
same as indicated in the guide. 
“The training session adequately 
informed me about the 
implementation of the I-MAGs on 
the ward" 
“The time allocated for the training 
sessions was appropriate” 
“I found the handout of the session 
helpful" 
33.33%(2) 
16.67%(1) 
33.33%(2) 
50.00%(3) 
66.67%(4) 
50.00%(3) 
16.67%(1) 
16.67%(1) 
16.67%(1) 
Strongly agree Agree Undecided Disagree Strongly disagree
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Figure 12: I-MAGs practicality evaluation [%,(n)] 
 
Delivery of the service by the dysphagia pharmacist (DP) 
A total of nine of all the nurse respondents considered that the availability of the 
DP was adequate, but this was in marked contrast to the four nurses who wanted 
more DP availability such as during evenings and weekends. 
Content 
While all the respondents confirmed that they found the instructions in the I-MAGs 
easy to understand, eight of the nurses accepted that without the guide, mostly or 
every time, they would have administered medication differently.  
In the final section of the questionnaire, 12 out of the 13 nurse participants 
concluded that they wanted the I-MAGs to carry on being implemented as a regular 
service. 
How often did you find an I-MAG
attached to the medication chart of
patients with dysphagia?
 How often did you see the
warning that was located in the
medication chart indicating how to
use of the I-MAG?
How often did you follow the
recommendations on the I-MAG?
“The use of the I-MAG increased 
the amount of time that I spent 
administering medication” 
 How often were the I-MAGs up-
to-date with the information in the
medication chart?
8%(1) 
31%(4) 
69%(8) 
38%(5) 
23%(3) 
69%(8) 
46%(6) 
23%(3) 
8%(1) 
62%(7) 
23%(3) 
23%(3) 
8%(1) 
31%(4) 
15%(2) 
23%(3) 
Every time Very often Sometimes Rarely  Never
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3.4.4.3. Open responses 
Seventeen out of the 19 respondents provided further comments where space was 
made available at the end of each section of the questionnaire. The qualitative 
analysis of all additional comments from respondents highlighted several themes 
related to the use of I-MAGs for administration for PWD. The most common 
themes were: 
- time, 
- safety, 
- usability, 
- presentation, 
- practicality, 
- training. 
 
Time  
I-MAGs had the potential of having an impact on the routines of the HCPs 
involved. Time was the most concerning issue for the participants. Most of the 
answers made a clear distinction between the time it takes to administer medication, 
the time pressure that nurses feel in their routines and the time needed by ward 
pharmacist to improve the recommendations on how to administer medication. The 
comments highlighted how the I-MAGs can increase the time of directly 
administering medications, but responses also noted that the guides reduce the time 
needed by the nurses in checking with the pharmacists on how to proceed with 
medicines administration when instructions have not been provided. One of the 
nurse participants mentioned: 
“Medication given more timely (no need of checking with pharmacy about 
crushing, etc. first.” (N23) 
Other professionals’ responses highlighted other types of issues. The time of the 
ward pharmacist adding elaborated endorsements to the medication chart is 
reduced as the presence of the DP avoids having to initiate enquiries to the 
medicines information centre or having to check literature on the administration of 
drugs. One of the pharmacists commented the following about this issue:  
“Presence of I-MAG avoided need for pharmacy endorsement and drug chart re-
administration of medication.”(P6) 
The time of the drug rounds is strongly related to other issues in the ward (staffing, 
paperwork, etc.) and some participants highlighted the need for more members of 
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staff in the ward. They considered that this would allow them to concentrate more 
on the I-MAGs especially when they are first implemented. Some of the nurse 
participants identified that the I-MAGs were taking some extra time to start with 
but once they got used to them the time spent on the drug round was actually 
reduced.  
"If we followed IMAGs, it took a lot of time to finish the meds round, but later it 
was easy." (N18) 
One of the issues more closely related to the time spent on the drug rounds is how 
the time is affecting their confidence. I-MAGs seem to be accepted as a very time-
efficient tool as the nurses receive precise instructions and that makes them feel 
confident about the time spent in the administration and the quality of care that 
they have provided. Not only medication is given more ‘timely’, but also the nurses 
feel more confident in their practice. Comments from these respondents also 
highlighted specific ways in which safety was prioritised and improved during the 
administration of medicines:  
“More confident in my practice, knowing right way of administering each drug.” 
(N27) 
Safety  
The respondents highlighted emphatically how the use of I-MAGs could improve 
the safety from two different perspectives: 
- safety of the patient when receiving the right formulation adequately as the 
participants consider that the I-MAGs are an improvement to the patient care: 
“Patients receive medication in the correct format/administered the correct 
way. Safer for patients and staff.” (S1), 
- safety of the nurses administering the medication as correctly administering 
medication may avoid harm to nurses from exposure to certain drugs such as 
steroids or cytotoxic drugs, but also legal liability concerns when manipulating 
incorrectly the original formulation of the drug. The safety of the healthcare 
professional had not been considered before, but these comments identify other 
concerns in the practice carried out in the wards: 
“Increases staff safety (e.g. avoid exposure to medication that should not be 
crushed).” (P7) 
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Usability 
Some comments added by the respondents pointed out wider potential uses of the 
I-MAGs to other patients without dysphagia, implementation of I-MAGs from time 
of admission, and its uses for carers or relatives of PWD at home. Some of the 
participants highlighted that the safety that the presence of  I-MAGs offered, 
should be expanded not only during the patient’s stay in the ward but also at the 
time of discharge to secure appropriate care of PWD. 
“Very useful to obtain provision of I-MAG to patients being discharged before, or 
having not recovered their swallow to assist them with medicines administration on 
discharge.” (P6)  
The I-MAGs were originally being considered by the researchers for use in the 
hospital environment. However, the respondents identified numerous further uses 
for the guides. For example: implementation at the time of admission linked to the 
information provided to the nurses when a patient commences their stay in hospital: 
“A chart in the department with all information of commonly used drugs in 
dysphagia patients will improve basic understanding and is useful in newly-
admitted patients as well as newly commencing medicines whilst waiting for I-
MAGs.” (N27) 
In primary care, the implementation of the guides could support relatives and 
carers in the administration of medication and also other nurses and professionals 
in care homes when the patients are discharged to these settings: 
”Use by the patients themselves or, e.g.: carers/family as appropriate either at 
home or if discharge to a rehab unit, residential/nursing home, etc.” (P6) 
 
Presentation 
Comments provided confirming that only minor changes in the format would be 
needed reiterated:  
“They are quite wordy. Maybe drug and dose in larger font.” (P8) 
Practicality 
Participants found I-MAGs to be a very convenient tool for their practice, as 
already confirmed it in the closed questions. I-MAGs were found to promote a 
safer and more time-efficient administration of medication. Some of the 
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participants also identified that the I-MAG could help highlighting areas of 
improvement in their practice:   
“Useful.  Made me realise of how I can improve.” (N16)  
Training 
The respondents considered that more detailed training would be needed before 
implementation of an I-MAG service to get a full understanding of the purpose of 
the guides. Although the training sessions were aiming for increasing the 
awareness of dysphagia, it is clearly needed to facilitate the access of resources to 
the nurses on the ward to help them increase their knowledge in the subject. The 
participants also reflected in their comments the positive approach towards learning 
and training: 
“More detail training sessions could improve understanding and effective use of 
the I-MAGs.” (N27) 
Other themes  
The open responses also identified other concerns of the participants such as 
individualised treatment of PWD, disadvantages of new services, clinical 
confidence and availability of the I-MAGs. One of the pharmacist participants 
described this novel service as: 
“Provision of individualised uniform information for nurses regarding medication 
administration.” (P6) 
Further comments showed that the participants received the service very positively 
and the general acceptability of the guides was exceptional: 
“I would like to see them continue and expand.” (N23) 
 
3.5. Discussion 
The main aim of this study was to explore the provision of I-MAGs by a 
specialised pharmacist to PWD and in liaison with other healthcare professionals as 
part of a pilot study. The discussion of the results will help us to understand how to 
enhance the design, delivery and evaluation of future research with similar 
interventions in older PWD. It is, therefore, important to consider that the main, but 
not only, focus of this discussion is on how to improve the implementation and 
evaluations of novel and complex interventions that may not necessarily show a 
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significant change in the health of patients but in the practice of the healthcare 
professionals involved in the care of those patients.   
3.5.1. Provision of the service 
Based on the results presented (Section 3.4.1.1.5), it could be estimated that a 
patient with dysphagia with average stay in hospital of 20 days would require 
around 105 minutes of the DP’s time in order to receive I-MAGs. On average, this 
would mean spending just over five minutes per day with each PWD admitted to 
hospital.  
It was also highlighted by the stakeholders that full time availability of the DP was 
required to deliver the service. It was important that the I-MAGs were generated at 
a particular time after the medicine reconciliation was carried out in order to apply 
any changes to the medication chart before any medication was dispensed. 
However, this process does not mean that the DP is required to constantly stay on 
the same ward but that he would need to be fully contactable to enable revision and 
update of I-MAGs when needed. The prevalence of dysphagia tends to be much 
higher in the stroke unit as dysphagia is a common condition post-stroke. The 
diversity of the wards and the patients admitted to them makes it hard to precisely 
estimate the scope of the workload for a potential DP, but based on the novel 
implementation of I-MAGs where the DP was able to manage two wards in half a 
working day, it seems sensible to admit that the regular provision of such a service 
could be managed by one single person assisting PWD from no less than four and 
no more than seven wards of the size and characteristics mentioned above. This, 
however, raises the question as to whether the additional costs are justified by the 
improvement in patients’ safety and whether the role of the DP could be 
incorporated into the care-for-older-person pharmacist role. 
3.5.2. Professional and personal views of the DP’s training and 
development 
The DP was an innovative role that combined the experience and knowledge of the 
pharmacist with specialised knowledge in the administration of medication to PWD 
and the issues surrounding dysphagia such as assessment, management and 
implementation of guidance.  
The IDF, however, only provides competences for the different levels and the 
required training for this innovative role could only be estimated. As DP and author 
of this thesis, I judged that the training received had fulfilled the requirements of 
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the framework appropriately based on confident assessments of the patients’ 
medication. Nevertheless, the experience and knowledge of other pharmacists may 
differ and the suitability of this training should be explored when applied to other 
environments and received by other individuals.  
It is important to highlight the essential role of the DP as the link between other 
professionals such as ward pharmacists, SALTs, nurses and prescribers. It was 
identified in the pilot study that the DP would liaise with all these professionals 
during the delivery of the service. However, this role became an essential part 
during the research period and it could set an example of good practice for the 
HCPs in the ward. The DP role could also offer an opportunity to use the unique 
expertise in formulation science and to extend the role of the pharmacist in the 
management of chronic conditions as it has been supported in literature by 
increasing the involvement in admission assessment,(340) optimisation of inpatient 
therapy, discharge education, implementation of self-management plans, enhanced 
medication liaison and post-discharge follow-up.(340-342) 
3.5.3. Training needs for nurses and carers 
The training provided was positively received within the majority of the 
respondents (page 131). However, the lack of general agreement about the 
competences required by nurses in the management of dysphagia makes the 
assessment of the training and the identification of measures of effectiveness a 
complicated task.  Previous publications by nurses (343-345) indicated the need of the 
nurses to acquire more knowledge of the physiology of swallowing disorders and 
in the management of dysphagia. 
It is, therefore, reasonable to consider that the training received helped some of the 
nurses to obtain a wider understanding of issues around administering medication 
and at least increased the awareness of issues surrounding medication in dysphagia. 
Measures and records of competency should be included in future training when 
similar services are permanently implemented in order to identify the effect of this 
training in the changes of practice and in order to be able to observe the changes in 
the patient’s health which solely derive from this training. 
3.5.4. Acceptability of the service by HCPs 
The results of this study indicated that the delivery of I-MAGS was generally well 
received by the nurses, pharmacists and SALTs as most of them stated that they 
would like to see the service continued. The one-hour training before the service 
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was implemented was well-received by the participants and the answers to the 
questionnaire suggested that only minor amendments to the presentation of the I-
MAGs were needed.  
The nurses’ perceptions on improvements in safety for the patients and for the 
nurses were some of the remarkable findings of the study. It is possible that the 
nurses were not aware of the risk of being exposed to certain medication like 
steroids or antibiotics and having the I-MAGs present in the ward was a reminder 
of what medications require special caution. 
Often time constraints are the main concerns in the practices of the nurses as 
highlighted in chapter 1. The implementation of I-MAGs was seen as a positive 
feature by the participants as the time spent reading the instructions was 
outweighed by reducing the time spent by the ward pharmacist endorsing general 
comments on the administration, as well as by reducing the need for the nurses to 
check with other HCPs on the correct ways of administering medication.  
Some of the participants recognised that the I-MAGs could not only be used in the 
hospital ward, but they could also help carers and nurses in LTCFs. As observed by 
personal experiences (nurses previously known by the DP from community work , 
conversation with nurses during drug rounds, comments from ward sisters, or 
comparisons made by the nurses during training sessions), nurses in the hospital 
wards often had worked before in community settings like care homes. Identifying 
the potential of I-MAGs in other LTCFs could be indicating that they are aware of 
the high prevalence of challenges in the administration of medication to PWD in 
care homes. It is also important to consider the positive perceptions of the nurses 
on their clinical confidence when the I-MAGS were in place. Although this study is 
limited to the opinions of a small group of participants, this finding could be 
indicating that the support offered by this intervention may have the potential of 
reducing the gaps in knowledge and skills identified in the literature in similar 
settings.(195, 288) 
The results discussed also offer an opportunity to incorporate outcomes that had 
not been identified before such as confidence and safety when implementing I-
MAGs as part of a larger trial. 
3.5.5. Participation of healthcare professionals 
The recruitment of HCPs for participating in research can sometimes be seen as a 
methodological challenge. However, the majority of the stakeholders (20 out of 26) 
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were recruited when completing the questionnaire that explored their opinions 
about the practicality and delivery of the service. It takes time to develop a 
collaborative relationship between researchers and ward staff but this relationship 
may be vital for the recruitment of participants.(346) A study carried out by Nuttank 
and colleagues(347) attempted to determine the potential contribution of a new 
healthcare practice model based on a specialist menopause pharmacist (SMP) role. 
Similar to the DP, the SMP also had the role of researcher and a questionnaire 
combining qualitative and quantitative methods was introduced to explore the 
acceptability of HCPs and patients of this innovative role. This pharmacist practice 
model was positively accepted both by patients and health professional colleagues. 
Although similar reactions to the study by Nuttank were observed in our 
questionnaire, it seems appropriate to mention that the questionnaire responses may 
be affected by a tendency of the respondents to answer questions in a manner that 
will be viewed favourably by the researcher as the individuals on the ward knew 
that the DP would be analysing the results and may want to please rather than 
being perfectly honest (i.e. social desirability bias).(348)  
3.5.6. Optimised prescribing 
During the study, it was noticed how most of the PWD receiving I-MAGs were 
prescribed medication as solid dosage formulations. While the majority of solid 
dosage formulations have an alternative treatment in the form of liquid preparation 
or dispersible tablet, prescribing tablets or capsules was usual recommended 
practice within the hospital in PWD as indicated previously in Table 20. 
Consequently, the nurses had no choice other than to crush, disperse or encourage 
the patient to take their tablet whole.   
Although there is no national guidance that recommends the exclusive use of 
liquids when prescribing to PWD, recent consensus in the administration of 
medication(292) to PWD agreed that when the oral route is appropriate and a liquid 
or dispersible product is available, these types of formulations should be prescribed. 
Liquid medication may not be, in some cases, the best alternative but it is a much 
safer option for PWD when the right consistency of the formulation is achieved.  
Based on the cases presented previously (page 129), it could be estimated that 
prescribers are not always aware of the appropriateness of the formulations 
recommended and the importance of evidence-based practice within a product 
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licence. The factors that lead prescribers to recommend oral solid medications may 
not always prioritise safety and, therefore, these factors should be explored. 
It is undeniable that enhancing the administration of medicines to PWD is a 
complex task and it may involve an increase in the cost. As it was indicated in 
Table 21, the use of liquid formulations as an alternative could significantly raise 
the cost of the medicines supply. However, this increase in the price may be 
outweighed by a reduction in health complications such as aspiration when 
administering solid dosage forms which is one of the main reasons for chest 
infections and pulmonary diseases in older people that could lead to hospital 
admissions. Although the link between the use of liquid formulations on PWD and 
the decrease of hospital admissions has not been researched, it would be sensible at 
the time of making decisions on the cost of treatment, to model the costs involved 
against the complications appearing as a result of sub-optimal formulation choices.  
3.5.7. Elements affecting the recruitment of patients 
The original design of the pilot study estimated that during the length of the 
intervention a total of 360 patients (180 in the intervention wards and 180 in the 
control wards) could be recruited after considering that in similar studies 33% of 
the patients may drop out for different reasons. Although these calculations 
represent a difference to the 22 patients recruited (17 in the intervention group and 
five in the control), we need to consider that 244 patients were eligible for 
receiving I-MAGs and were, therefore, potential candidates for recruitment. This 
section will discuss the barriers that affected the recruitment and will suggest how 
to enhance these rates in future research. 
The first barrier found in the intervention group was the prompt transfer of patients 
to other wards. The identification of eligible patients required the correct diagnosis 
of dysphagia after a written referral to the SALT team by clinicians in the ward 
after the admission into hospital. Between the time that the patient was admitted 
and the first chance for the DP to identify the referral to the SALT team, 58% of 
the 244 PWD admitted in the intervention wards had already been transferred to 
other wards excluded from the study. Another 11% no longer had the condition and 
a further 19% had deceased or were administered medication intravenously under 
palliative care pathways. These rates indicate that only 75 patients (30.7%) out of 
the 244 originally identified with dysphagia at the time of admission suffered from 
this condition and stayed in the intervention wards for long enough as to be 
considered an eligible patient for the study. 
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Another explanation for the low recruitment rate is the need to obtain consent from 
the patient or a representative by a clinician in the ward before being approached 
by the researcher (CTA).  Despite the value of this safeguarding policy, the 39 
opportunities in which eligible patients were approached and asked for CTA after 
showing interest in receiving more information about the study (Table 15) were 
reduced to 23 opportunities to ask for consent to participate. When considering that 
17 patients were recruited out of the 23 that were offered to take part in the study, 
this requirement could mean that another 12 patients from the 16 missed after 
receiving CTA could have also become potential participants. The presence of this 
policy should, therefore, be considered when estimating the recruitment of future 
studies as it could potentially reduce the amount of participants by 40%. 
The unstable health of the recruited patients may represent another barrier when 
trying to maintain the number of participants. Over 50% of the patients recruited 
were not able to complete the survey due to death or to having lost capacity to 
respond to the questionnaires. Many of the patients are at the end of their lives and 
a period of six months of follow-up may become too ambitious when considering 
their life expectancy.  
One of the main methodological elements affecting the recruitment was the fact 
that patients were being recruited at the time of discharge instead of at the time of 
the admission or when dysphagia was first identified which stopped the researchers 
from recruiting patients that recovered from dysphagia. However, this still would 
not have eliminated the problems with transfers to other wards or access to the 
patients during viral outbreaks on the wards and higher drop out rates would have 
been reported instead of low recruitment rates. This is, therefore, suggesting that in 
order to increase recruitment while keeping drop out rates low in a future larger 
study, it would be necessary to either involve in the research study, all the hospital 
wards where patients are likely to be transferred or to develop a multi-site study 
that would also overcome the problems with viral outbreaks. Additionally, the 
recruitment rate should be based on calculations of not only prevalence of 
dysphagia in the stroke units and care-for-older-person wards, but also on the 
estimations of periods of lower risk of outbreaks, number of patients with the 
mental capacity to take part in the research and mortality rates of patients admitted 
to wards where the study is developed.  
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3.5.8. Outcomes of the follow-up of recruited patients 
The small number of patients completing the survey did not allow a statistical 
analysis that could justify the variance around the difference in the primary 
outcome measures between the control and the intervention groups after the 
implementation of the I-MAGs and recruitment.  
However, the questionnaires were returned completed in the majority of cases 
which should allow for a robust quantitative analysis of the data obtained from the 
outcome measures selected and it is possibly highlighting the appropriateness of 
the questionnaires chosen. Equally to recruitment, it would have been of interest to 
obtain baseline data at the time that dysphagia was diagnosed, as well as at the time 
of discharge as it would allow us to explore the changes in the patients’ health that 
are due to  the effect of the I-MAGs when comparing it to patients on the control 
wards. 
It should also be contemplated that all the patients recruited and those that just 
received I-MAGs had their medication reviewed by the pharmacist. Medication 
review has shown reductions in the hospital admission in older patients. A RCT 
carried by Krska and colleagues(348) on 332 older patients with chronic disease 
studied the effect of medication review led by pharmacists using medicine costs, 
use of health and social services and health‐related quality of life as outcome 
measures. The large sample size allowed them to observe a small non-significant 
increase in contacts with healthcare professionals and fewer hospital admissions 
among the intervention group than the control group. However, 70% of the care 
issues that had been resolved in the intervention group (vs. the 14% that had been 
resolved in the control group) did not lead to changes in health‐related quality of 
life in either group. Although the patients were not identified as dysphagic, it could 
be assumed that the large scale implementation of our service could show similar 
outcomes based on the similarities between the outcome measures in our study and 
those  presented by Krska and colleagues.(348) Conversely, it needs to be considered 
that a systematic review and meta-analysis carried out by Holland et al(350) 
concluded that pharmacist-led medication review does not reduce hospital 
admission in older people and puts in question its potential clinical benefit as the 
only studies that suggested positive effects on the quality of life were not 
statistically significant. 
The majority of the healthcare professionals involved in the administration of 
medication to PWD in the settings where the I-MAGs were present felt that 
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patients’ safety and care were improved by the implementation of the guides which 
represents a clear benefit. These outcomes were not contemplated in the patients’ 
health indicators, but if similar intervention is carried out in future research, the 
outcome measures should specifically focus on observing changes in factors such 
as patients’ safety and clinical confidence of the nurses. 
In order to determine the effect of the service on patients’ health, pharmacy 
practice researchers should continue incorporating quality of life outcome 
measures, complemented by clinical, economic, and other humanistic outcome 
indicators.  
3.6. Limitations and strengths of the research presented 
One of the main limitations of the pilot study was the low availability of eligible 
patients for recruitment at the time of discharge, as discussed before. During the 23 
weeks when the I-MAGs were implemented, the hospital experienced an outbreak 
of Norovirus which peaked in the months of our study (Figure 13). The Norovirus 
outbreak prevented full access to the wards for recruitment for seven weeks and 
partial access for another nine weeks, significantly affecting the production and 
updating of I-MAGs in the intervention wards and decreasing the chance of asking 
for consent to participate from the patients.  
 
Figure 13: The number of confirmed cases of Norovirus from January to July 2011 
 
When considering safer alternatives to the administration of the prescribed drugs in 
the intervention wards, the DP was limited to the list of drugs in the hospital 
formulary. This list didn’t contain many liquid formulations, and the request of a 
non-formulary item (like the amisulpride case described in section 3.4.3.) required 
the completion of several authorisation forms and the waiting time for obtaining 
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the product from the supplier. As a consequence, there was a delay in the 
generation of I-MAGs and, what it was more important, a delay in the patient 
getting the suitable formulation. 
The importance of having local policies adapted to the needs of the hospital should 
not be ignored. However, in some cases like the use of lisinopril and digoxin 
sublingually, these policies have no evidence and are decisions based solely on 
directly incurred costs and not costs which may derive from this policy. 
The fact that this evaluation was only carried out on one ward, and the length of 
time which elapsed between the training sessions and the evaluation, may have 
limited the results of this study. Transfers of members of staff to other wards or 
hospitals made them no longer approachable and the views of members of staff on 
non-rotational night shifts were not sought as in the same way they were not able to 
attend the training sessions. The nurses on night shifts were exposed to the use of I-
MAGs in the ward but they could not rely on the immediate support from the DP 
during their shifts and, therefore, the answers in questionnaires completed by these 
nurses could have highlighted different issues that the daytime members of staff 
did not necessarily identify. 
Despite many of the issues identified in the study being able to likely enhance the 
implementation of a similar service on a larger scale through a strong analytical 
point of view,  the limitations presented are seen as weaknesses of the research 
even if they were part of a pilot study. 
3.7. Conclusions 
This study has shown how a pharmacist-led service for PWD is potentially 
acceptable to healthcare professionals. There are, however, significant costs 
associated with the delivery of the service both in terms of training and ongoing 
provision and these would require justification before NHS resources could be 
allocated to this role. 
During the delivery of the service, patients receiving I-MAGs benefited from an 
optimised practice in the administration of medication and were able to use those 
recommendations in their own home or in the care home where they were 
discharged to. This created awareness in the patient of the importance of the correct 
administration of medication that could potentially change behaviours towards 
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medications. These potential changes and the acceptance of the guides may form 
the base of a future study.  
The need to explore any changes in the health of PWD that received I-MAGs was 
not identified while the I-MAGs were implemented. However, this may have a 
large impact in the post-hospitalisation care of patients and could potentially lead 
to changes in factors like readmission to hospital or prevalence of respiratory 
conditions. These factors could impact on NHS costs and research should be 
carried out to explore this.  
This study failed to identify significant changes in the patient’s health due to the 
small number of participants. It is, however, important to highlight the cases 
identified above where the intervention of the DP: 
- avoided substantial administration errors,  
- encouraged a safer practice for the nurses and the patient, 
- provided evidence based guidelines for the prescribers. 
This study identified several cases in which prescribing could be optimised in order 
to minimise the risk of errors during the administration of medication to PWD. The 
lack of knowledge in formulations available, the use of medication in unlicensed 
ways and the lack of evidence in some recommendations could be identifying a 
potential need of training for the prescribers and administrators. Further research is, 
therefore, needed to identify the suitable educational support for prescribers and 
administrators. 
Nurse participants identified a gap in knowledge in the administration of 
medication to PWD. Although in the hospital environment this issue can be 
partially resolved by the presence of other professionals on the ward, it stills places 
significant pressure on the time and workload of nurses who may be forced to 
crush tablets or open capsules and consequently act inappropriately. A specific 
training in the administration of medication to PWD that is followed with measures 
and records of competency should be included as part of nurses’ continuous 
professional development. However, further research may be required in 
identifying appropriate outcome measures and competency framework.  
The role of the DP was strongly guided by the presence of a dysphagia competency 
framework. This framework could be extrapolated to primary care but the approach 
to the competencies in primary care may be different to secondary care. The 
training needs of the pharmacist in primary care may require further development 
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than in secondary care due to the different interactions between professionals and 
the different environments.(347a) The limited level of interventions on the patient’s 
treatment for these professionals also needs to be considered and extended research 
on pharmacist training required for this intervention should also be contemplated. 
The delivery of I-MAGs provided an organised service that required a small use of 
the resources available. Had the recruitment provided a significant sample size 
capable of proving differences on patient’s health, the DP would be providing a 
specialised service throughout a hospital for the small addition of a Band 7/8 
pharmacist to the pharmacy team. The role of the DP as a link between HCPs was 
also essential for the delivery of this service and hence this study suggests that 
further research is required on identifying the impact in the patient treatment of this 
liaison between professionals and the DP’s input.  
The approach of recruiting patients at discharge to determine the long-term benefits 
of I-MAGs demonstrated that the size of the population suitable for such a study is 
too small, i.e. too many hospitals would need to be involved to provide the study 
with a sufficient sample size and the results may not warrant the cost of such a 
research project. It may be preferable to test the I-MAG in an environment where 
there is sufficient numbers of PWD from the outset, such as care homes. The 
recruitment of patients at the point of admission rather than at discharge could 
significantly increase the sample size, but it would only allow to implement the 
intervention to a large number of patients for a very short period of time, which 
could limit the observation of any likely impact on health outcomes. It could also 
be beneficial to incorporate research nurses to help with the recruitment of patients 
at the different stages of admission. 
The success of the I-MAG is based on its ability to enable implementation of the 
most appropriate formulation for the patient. In an environment where the 
opportunity to provide an alternative formulation is not present and the primary 
recommendation is formulation tampering, then the impact is also likely to be 
limited. The I-MAG may, therefore, be more effective in care homes where 
patients are likely to experience their effect for sustained periods of time and where 
practitioners may have more autonomy in the selection of the best formulation for 
residents. Therefore, the acceptance of the guides by the patients, relatives of the 
patient and/or the nurses in the care home, and the impact of the awareness 
generated by the pharmacist of the patient after being discharged from hospital 
needs to be explored.  
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The following points summarise the learning points from this section: 
- a pharmacist-led service for PWD is feasible, but it may require the 
identification of adequate outcome measures that recognise changes related to 
the intervention in the patient’s health, 
- a future randomised controlled trial should contain a very precise recruitment 
strategy with specific and defined inclusion criteria over a long period of time 
or in multiple locations, 
- all the clinicians in the intervention wards should be made fully aware of the 
research and consent to be approached should be sought at the time of 
admission, 
- the recruitment of participants should be carried out from the time of 
implementation of the I-MAGs by researchers with thorough knowledge in the 
field and the ability to communicate to the patient the importance of taking part 
in the research, 
- the consideration of barriers, such as Norovirus outbreaks and the transfer of 
patients from intervention wards to other wards of the hospital, can be crucial 
to maximise the recruitment, 
- the implementation of I-MAGs increased the nurses’ confidence in their 
practice and contributed to acceptance on the intervention wards. 
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4. Exploring the current model of administration of 
medication to PWD and the acceptability of changes 
Before testing an intervention, it must be developed to the point where it can 
reasonably be expected to have a worthwhile effect. As researchers, we need to 
identify what is already known about similar interventions. These comments 
extracted from the MRC guidelines describe optimally the next steps required for 
the development of our intervention: 
“The rationale for a complex intervention, the changes that are expected, and how 
change is to be achieved may not be clear at the outset. A key early task is to 
develop a theoretical understanding of the likely process of change by drawing on 
existing evidence and theory, supplemented if necessary by new primary research.” 
Page 981, Craig et al (2008)(1) 
The study presented in this section will describe components related to the 
development of interventions such as identification of theory and the development 
of new theories in order to explore the impact of our likely intervention as 
highlighted in Figure 14. 
 
  
Figure 14: Developmental components of an intervention  (Craig et al 2008, page 980)(1) 
Feasibility and piloting 
• Testing procedures 
• Estimating recruitment and 
retention  
• Determining sample size 
 
Development 
• Identifying the evidence base 
• Identifying or developing theory 
• Modelling process and outcomes 
 
Evaluation 
• Assessing effectiveness 
• Understanding change process 
• Assessing cost-effectiveness 
 
Implementation 
• Dissemination 
• Surveillance and monitoring 
• Long-term follow-up 
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4.1. Introduction 
To address the difficulties associated with administering medicines to residents 
who cannot swallow on the ward and to standardise care, I-MAGs were introduced 
on COO wards in the Norwich and Norfolk University Hospital as part of a 
previous research project and a proportion of patients with I-MAG were discharged 
to care homes where the I-MAG might have been equally useful. 
Whilst I-MAGs were well-received in the hospital environment, where there are a 
wide range of healthcare professionals to provide support, they may not be 
appropriate within the care home environment. The communication between 
healthcare professionals in the hospital tends to be seen as more frequent than in 
the care homes where the visits from these professionals are scheduled less often 
than in secondary care.(326, 351) Additionally, the increase in the time that drug 
rounds take may make the I-MAGs unacceptable and to successfully introduce 
them, they may require more specific training in the administration of drugs for the 
care home staff. 
The views of members of the nursing team in the care home on the relevance and 
acceptability of the concept of individualised medication administration guides for 
PWD had not been ascertained and, therefore, needed to be explored. Patients 
being discharged from hospital with an I-MAG to the care home facilities provided 
an opportunity to interview carers and explore their views in the use of the guides 
in the care home and identify issues surrounding the implementation of these 
guides previous to or after receiving the I-MAGs. The data obtained from the 
nurses could obtain information of sufficient quality to enable the production and 
implementation of I-MAGs more suitable for use within the care home 
environment.   
 
4.2. Aims and objectives 
The aims of this study were to explore: 
- the current model of administration of medication to PWD from the 
perspective of nurses in care homes, 
- how I-MAGs might be received and, where applicable used, in care homes for 
administering medication to PWD. 
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The objectives of this study were to: 
- identify elements that affect the administration of drugs to PWD in the normal 
practice of care home staff, 
- identify whether care home staff require any specific training in the 
administration of drugs to dysphagic residents, 
- introduce the concept of I-MAGs to care home staff, 
- obtain the views of care staff on the perceived usefulness of the I-MAG 
compared with normal practice, 
- explore the opinions of the members of the nursing team about whether, and 
what, professional support could help care staff use these guides in the care 
home, 
- identify any likely education support needed for the use of I-MAGs or for the 
general administration of medication to PWD. 
 
4.3. Methods 
This study collected data on the views of the members of the nursing teams in care 
homes about using the I-MAGs for administering medication to PWD. A 
qualitative interview design was chosen as it is often the most adequate and 
efficient way to obtain  information related to the insights, experiences and 
opinions  of the carers  required  to contend with the difficulties of an empirical 
situation.(352) Exploring the understanding of the nurses on the I-MAGs will help 
identify the type of educational support needed and the improvements needed in 
these guides in order to enhance its usability.  
Semi-structured interviews allowed the respondent to reply in his or her own words 
where the range of responses was unknown and could not be readily categorised 
and also helped the researcher to clarify any ambiguities in the perceptions and 
experiences in the use of I-MAGs.(336) Many issues important to the interviewee 
were probably hard to anticipate, therefore, a semi-structured interview was used. 
This comprised core interview topics provided in a question guide and also allowed 
flexibility in the order they were asked in pursuing topics of importance to 
interviewees. The main guide included research questions to explore knowledge, 
insights, experiences and opinions of the carers about the use of I-MAGs in the 
care home environment. Optional sub-questions were used to help adapt the 
interview to the specific situations and points of view of the interviewee, while 
ensuring the interview focused on the purpose of the study. The interviews were 
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carried out by the main researcher, drawing on his previous experience as a 
dysphagia pharmacist.  
The main researcher (also the author of this thesis) had been trained in general 
research methods at the University of East Anglia during September 2010 and 
February 2011. To enhance his qualitative research skills, the main researcher 
attended the following courses: 
- further qualitative research methods at the University of East Anglia (Master’s 
level) during March and June 2011. This course was aimed to gain further 
knowledge on qualitative study design, practical skills needed in the planning 
and design, the data collection, analysis, and interpretation, 
- introduction to qualitative interviewing, University of Surrey, in June 2011 
(postgraduate level). This one-day intensive course included sessions exploring 
the characteristics of qualitative research, interview preparation and advice on 
how to conduct interviews effectively and developing interview discussion 
guides, 
- introduction to qualitative data analysis, University of Surrey, in September 
2011 (postgraduate level). This one-day course covered different approaches to 
analysing qualitative data, ‘grounded theory’ principles, the process of coding 
data, the development of more conceptual ideas through analysis and issues 
such as validity and generalisability. 
The University of East Anglia’s Faculty of Health Ethics Committee granted 
ethical approval on 30th September, 2011 (Appendix 17). Only 63 (0.5%) of the 
12,955 care homes with nursing in England(353) belong to the NHS, these were very 
likely to have completely different systems and management processes, as well as 
residents. Consequently, it was more appropriate to focus on private care homes. 
The exclusion of these care homes meant NHS ethical approval was not needed. 
Only healthcare professionals (and not patients) were involved in this part of the 
study, but they were discussing their experiences when administering medication to 
patients in their care. One of the major ethical issues for the qualitative interviews 
research was maintaining confidentiality of the issues discussed. The need for 
confidentiality was identified in the documents sent to the potential participants 
and was also identified as one of the ground rules before the interview. As both the 
interviewer and the interviewee were healthcare professionals and maintenance of 
confidence was part of their ethical code, maintaining confidentiality would not be 
seen as likely to become a problem. However, if the interviewee had revealed 
activities that could have caused or were likely to lead to harm to an individual in 
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the care home, the main researcher had a duty of care and would have  needed to 
report it to the relevant authorities. The ethics committee’s extensive comments on 
revising this study contributed to the coherence of this study and reinforced good 
clinical practice during its conduct. 
4.3.1. Participant recruitment 
It was required to find participants with the particular characteristic of 
administering medication to PWD in care homes in order to identify the 
perceptions of the nurses. Purposive sampling was, therefore, used to select these 
possible participants. We aimed to construct a sample or study group which was 
meaningful theoretically to build certain characteristics to develop this suggested 
theory. The processes of sampling, data generation and data analysis are viewed 
dynamically and interactively as suggested by Mason (2002)(338) in relation to the 
need to seek setting-relevant dimensions of participant experience of administering 
medications in care homes. Some details of sample decision-making emerged 
during the process and deciding sample size depended on the adequate generation 
of a theory so that not all volunteers went on to be interviewed. Volunteers were 
made aware in a participant information sheet that they might not be selected. After 
consenting, the participants were given a questionnaire to gather preliminary 
information about different categories (including their qualifications, age group and 
location of the home) to assure that the purposively selected sample was as diverse 
as possible. As suggested by Marshall (1996),(325) the researcher actively selected 
what he considered the most conceptually-productive sample frame to answer the 
research question. This involved developing a framework of the variables that 
might influence an individual's contribution. These were the professional 
experience of the participant, cultural and educational background, location of the 
workplace and role. Their identification and selection was based on the researcher's 
practical knowledge of the research area, the available literature and evidence from 
the study itself. These variables were utilised during the analysis in order to “build” 
a grounded theory. 
The participants were nurses or carers in charge of administering medication in 
care homes where one or more residents had dysphagia or used enteral feeding 
tubes (EFT) for the administration of drugs. The sample was purposefully drawn 
from male and female participants, with and without English as first language, with 
and without degrees in nursing, with education from a UK university/organisation 
and from abroad. All the categories that helped building the sample were reflected 
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in the preliminary questionnaire (Appendix 18) handed out to the participants to 
complete after giving consent. 
During October 2011, 72 care homes in Norfolk and neighbouring counties were 
sent a letter addressed to the registered manager containing: 
- a covering letter to explain the nature, aims and implications of the study 
(Appendix 19), 
-  an information sheet explaining the topic and organisation of study, its aims 
and the implications of the study for those potential participants wishing to 
take part (Appendix 20), 
- an example of the consent form that the potential participants were offered 
before the interview (Appendix 21), 
- an initial contact acceptance letter addressed to the main researcher (Appendix 
22). 
The covering letter asked the registered managers to let care home staff know that 
there was the opportunity to be interviewed and to participate in the study. This 
would avoid coercion as the registered managers would only be informing 
participants of this opportunity while explaining that they were free to decide 
whether to take part. After receipt of the initial contact acceptance letter from the 
care home manager, the main researcher then provided further information on the 
study to the potential participants, and arranged the consent and the time for the 
interview with those interested in participating. A pre-stamped envelope was 
enclosed to help maximise the response rate.(335) 
When no reply was received within two weeks after sending the invitation, a copy 
reminder letter was again sent to the home. If there was still no response, no further 
letters were sent. The flow of the recruitment, purposive sampling and study 
analysis are represented in Figure 15. 
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When the care home manager had identified interested carers or nurses in their care 
home and sent their acceptance letter, the main researcher contacted him/her to 
agree a convenient time to provide further information to the potential participants 
and to proceed with consenting and interviews. When consent was not provided 
immediately before the interview, participants were still asked to confirm that 
he/she still wanted to take part. A £10 voucher was offered to participants 
completing the interview. 
Considering the narrow scope of the study, the obvious nature of the topic and that 
the design of the study only required one interview per participant, it was 
anticipated that a small number of interviews (n=10) would be needed to reach 
saturation.(354) However, taking into account that the quality of data may be poor in 
some interviews, and to allow for emergent issues to be taken into account as the 
data was analysed, the maximum number was increased to 15 interviews to allow 
scope to provide enough relevant information to achieve the aim of the research. 
Inclusion criteria:  
Members of the nursing team were considered eligible if they were: 
- any nurse or carer in charge of administering medication to:  
 
Figure 15: Study flow chart 
 
 First round of invitations to care homes 
 
Second round of invitations to care homes 
 
Purposive selection of participants 
 
Interviews are arranged and carried out 
 
Interviews are transcribed 
 
Thematic analysis of transcriptions 
 
Theory building 
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o residents with dysphagia, 
o residents that require the use of  EFT, 
- in a nursing home or care home with nursing in Norfolk and surrounding areas 
of neighbouring counties. 
 
Exclusion criteria:  
Potential participants were excluded when: 
- the premises of the care home were located outside the coverage area of the 
NNUH (Norfolk and adjacent areas of neighbouring counties), 
- the registered manager(355) of the eligible care home was unwilling to take part, 
- participants identified did not provide informed consent. 
Individuals who consented to participate were then selectively invited to take part 
in the research depending on whether their characteristics met the range of pre-
defined purposive sampling criteria. The purposive selection was shaped by the 
analysis of the interviews to follow the principles of a grounded theory approach.  
4.3.2. The interview process 
4.3.2.1. Rationale 
In this study, we tried to explore the social reality of the care homes’ environment 
through carers’ knowledge, views, opinions, perceptions and reactions about 
administering medication to PWD. These properties are commonly recognised as 
meaningful information provided in qualitative interviews.(338) Semi-structured 
interviews can yield highly accurate data about the perceptions on the use of the 
guides and this method is more appropriate for complex and unknown issues.(336)  
The setting of a face-to-face interview allowed the researcher to probe more 
complex issues and to clarify answers, especially when the questions referred to 
issues in the practice of the interviewees and when the information could be more 
sensitive (asking about the care home setting when the interview is carried out 
within these premises, conditions of employment, social conditions of the 
interviewee, etc.).(336) 
The design of the interview questions was presented and discussed with two 
academic supervisors in order to assess the appropriateness of the design to the aim 
and objectives of this study. These discussions provided additional points of view 
to that of the main researchers and helped in the generation of more refined 
questions and sub-questions. Following those discussions, a first draft was piloted 
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with a hospital nurse who had previous experience in care homes. This nurse was a 
staff member in the hospital where I-MAGs had been implemented (previous study) 
and she volunteered to be interviewed simulating the care home environment as 
remembered by her experience. The purpose of this pilot was to identify any 
challenges faced by the researcher and the interviewee related to the technique and 
the design of the interview questions. This pilot interview was “audio-recorded” 
with a similar recorder to the one planned for the research and a small part of the 
interview was transcribed and analysed by the main researcher and one of his 
academic supervisors. The transcription was utilised by the main researcher to 
practice the analysis technique and the code generation, but the dataset obtained 
from those codes was not used for the analysis of the study. As a learning outcome 
of the piloting, the terminology used in the interview highlighted the need to 
explain the concept of “administration of medication” to the interviewees within 
the context of the “physical provision of drugs to patients” rather than the 
administrative organisation of documents related to medication. This explanation 
was included in the introduction received by the actual participants previous to the 
research interviews which were carried out during the months of November and 
December 2012. 
4.3.2.2. Structure 
The interview normally took place in a private room in the care home at a time 
when it was least likely to be interrupted. It consisted of a meeting of no longer 
than one hour that covered a list of semi-structured questions to identify the 
opinions of participants based on their professional views and experience in 
relation to whether, and how far, they thought that they might find the I-MAG 
useful and what reasons they gave for their reply.  
Introduction 
The interview began by offering information about who the interviewer was and 
about the project. The interviewer checked whether participants had any further 
questions about the study, whether they were still happy to take part, and for the 
interview to be recorded.  
Preparation for interview 
The interviewer explained the structure of the interview and emphasised the 
importance and value of the interviewee’s own views in their own words, stated 
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that there were no right answers and the interviewer would encourage them to 
express their views in their own way. 
Questions 
The core of the interview consisted of five topics developed from the different 
objectives which reflected the aim of the study. The participant was given a card 
with the question to help remain focused on the topics of the interview. However, 
the researcher had other sub-questions that may or may not be asked depending on 
the flow of the interview and to help to raise relevant issues during the 
conversation. 
The questions and sub-questions (Appendix 23) were developed to explore any 
factors already known to the research team that can affect administering 
medication to PWD (like the care home environment, the workload, responsibilities 
within the care home, qualifications, etc.). However, more factors that may not 
have been so obvious to the researcher, but may have been relevant to the 
participant were expected to come up during the interview so that some sub-
questions in the guide were not asked and other improvised questions were.  
All these indicative questions were refined as the interviews proceeded based on 
the principles of the grounded theory approach. The schedule of the interviews can 
be seen in Appendix 23. 
The first main question, “What is it like working in this care home?”, and sub-
question topics were used to gain an idea of the interviewee’s view of the care 
home, what issues were relevant to them, and how far they saw themselves as 
interacting with the residents. This was needed because the research approach 
sought to understand the personal perception of the participant’s role in the care 
home and, therefore, the main question and sub-questions sought to explore the 
experience of what the carer/nurse in that particular nursing home was to provide 
contextual information for their other responses. The interviewer also supported 
interviewees to provide more specific details by asking them to discuss specific 
examples. 
The second main question, “What is your role within the care home?”, and sub-
question topics were used to gain an idea of the interviewee’s background and how 
she/he saw her/himself in the environment of the care home. This was needed 
because when administering medication in nursing homes, carers and nurses are 
often asked to practice jobs or to take on roles that are not part of the role of a carer 
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or nurse. It was important to identify the lived routines and expectations of the 
nursing home and its team to determine how the IMAGs could be designed to fit 
better within that routine. It was also needed because in developing the 
implications of findings, this information could also help to identify any further 
education that the interviewee would like to receive in relation to administration of 
medications in this setting.  
The third main question “When you give medication to residents with dysphagia 
here what does this usually mean you need to do?”, aimed at finding their level of 
knowledge about administering drugs to PWD, how resources might be used and 
their access to resources, their view on the implications of using drugs, and their 
awareness of their own liability. In developing the implications of findings this 
information also helped identify ways to improve this administration, who or where 
they might have wanted to get help from and what kind of help or support they 
would have liked. 
The fourth main question was “What would you expect if you were asked to use an 
individualised medication administration guide to help your work with people you 
look after?” At this stage the interviewee had not yet seen an I-MAG so they could 
give their view on what that might mean before them actually knowing what an I-
MAG looked like. This research was seeking the participant’s view of a general 
concept of a guide with individualised information about medication, based on 
their existing experience of often trying to administer medications without 
individualised information and perhaps having heard about I-MAGs rather than 
using them in practice. At this stage we needed to explore what preconceptions and 
expectations a nurse or carer had about individualised information on medication. 
However, some interviewees had been exposed to I-MAGs via a resident having 
been admitted to the hospital and the sub-question aimed to clarify these cases. 
The fifth main question was asked after showing the I-MAG to the interviewee. 
“Now you have looked at this example of an I-MAG, how do you think I-MAGs 
could be used in this care home?” This question sought to explore what ways they 
thought this could be used in administering medication, what kind of support they 
saw themselves as needing, and whether they could identify any ways of amending 
the I-MAG to make it more suitable for their care home environment, whether they 
had at this stage ideas about training in administering medication which were 
relevant for their work, and what kind of support they would have liked and from 
whom in using I-MAGs. This topic also provided insights into interviewee views 
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on the impact that a change in the way of administering drugs could have on the 
resident. 
Queries and acknowledgements 
The final part of the interview provided an opportunity to thank the interviewee for 
their time and to provide another chance for them to ask questions or to make 
further comments. The participant was also informed of what would happen next 
with the outcomes of the information, and then, the interview ended. 
 
4.3.3. Data 
4.3.3.1. Data Collection 
The interviews were audio-recorded and lasted up to one hour. A MP3-type 
recorder was used for all the interviews and the recordings were transferred to a 
digital storage device (pen drive) which was password protected. In cases where 
the researcher considered that extending the time of the interview was especially 
useful, consent from the participant would be obtained before carrying on. 
4.3.3.2. Data storage 
The interview recordings were kept in a locked filing cabinet in the University of 
East Anglia under restricted access to the researcher. These recordings were 
listened to by a research assistant and the supervisor of the study so that they could 
be transcribed. The verbatim transcription was then anonymised and stored as hard 
copy in the researcher’s filing cabinet and as an electronic file on a password-
protected pen drive. The recordings will be destroyed three years after the 
completion of the study. 
4.3.3.3. Data analysis  
The strategy for the analysis drew on grounded theory principles. Grounded theory 
can be seen as the creative activity of theory building founded on observational 
work.(356) We needed to generate theory based on the previously unexplored 
perceptions of individuals involved in administering medications that could 
provide means of identifying relevant issues, including problematic issues (and 
reasons for them and in relation to a variety of contexts) involved in the 
administration of medication to PWD. The theory generated was then applied to 
improve content and procedures relating to I-MAGs. 
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This involved generating categories from the data as presented, positioning them 
within a  theoretical model and then explicating a story from the interconnection of 
these categories.(357) These categories derived data from the interviews in an 
interpretive manner(338) to help to understand what those interpretations were in this 
particular context. The main researcher indexed these categories cross-sectionally 
in order to delineate the scope and coverage of the data systematically and 
consistently.(338) Another member of the research team (FP) reviewed the 
transcripts and the index to confirm range and type of categories identified. Data-
gathering continued until the research team considered that no new themes 
emerged, that was until theme saturation was reached. When the participant did not  
have the specific information required, secondary selection for sampling was 
used.(354) Secondary selection is a method that involves carrying out the interview 
then, instead of immediately analysing or transcribing it, the interview is set to be 
drawn on only if further analytic development of the study identifies the interview 
as specifically “pertinent to the research goals” as Morse and Field mentioned in 
1995.(354) 
The qualities of the interviewee and the interview were only fully assessed once the 
interview had been carried out following the inclusion criteria. As the main 
researcher was not formally defining the qualities of a good interviewee, the 
usefulness of the interview was ultimately defined by those points which emerged 
as relevant to the study.  
Any information which enabled identification of individuals was anonymised and 
no quotes were used in a way which can link them so as to identify any of the 
participants in any of the reports or publications related to the study. 
4.3.4. Quality assurance in the study 
The rigorous methods of gathering good quality data, including the involvement of 
other experienced researchers in the supervisory team during the analysis and 
interpretation of data and the purposive selection of the sample(358) increased 
credibility in the study, making it a source of reliable information. A thorough 
description of the environment of the nursing home, time and participant and 
detailed transcription of the interview was used to maximise transparency as a way 
of showing  the process by which the data were collected and analysed.(359) 
The audio recordings and the researcher triangulation were used to confirm the 
accuracy of transcriptions and appropriate interpretation of the information, 
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respectively. Internal validity was increased by individual participant validation. 
When considering the aims of the study, we needed to reflect our research 
approach, which meant that only the participants could confirm the truthfulness of 
the types of data we collected from them. It was, therefore, needed to check this 
with the respondents. The normal practice of nurses/carers, their ideas on the 
usability of the IMAGs, the effect of the IMAGs on the practice of the nursing 
home, and so on, are concepts that can only be understood by the nurses or carers 
and, therefore, it is the participants who had epistemological privilege by their 
standpoint.(338) The validation process enabled the participant to validate the 
interpretations and themes emerging just from his/her own interview but they were 
not asked to validate the theory grounded on the whole group of interviews. Theory 
was developed from a synthesis of the perspectives of a number of participants, and, 
therefore, it was inappropriate to expect that individual participants would have the 
ability to ‘validate’ the findings of the research study as a whole.(360) 
The confidentiality of the interview transcriptions and the results of the validation 
of the participants were continuously reassured during the process. 
4.4. Results 
4.4.1. Recruitment of participants 
During the first round of communications, 30 homes were invited to take part in 
the study. Five of them responded and agreed to receive more information leading 
to nine interviews being arranged. After two weeks, a second round of invitations 
was sent to 67 homes, including the non-respondent from previous round. Nine 
care homes responded, four of them rejected the invitation and another five 
accepted it, and six more interviews were arranged. Figure 16 shows the flow and 
results of the recruitment of participants.  
When contacting the participants, one of them pointed out that an I-MAG had been 
in place in the care home as part of the hospital study explained in this thesis. It 
was expected that care homes previously exposed to I-MAGs in the past would be 
more willing to participate in this study. However, identifying these homes for the 
purpose of this study would require identifying the details of the hospital patients 
linked to them. This could raise ethical concerns around confidentiality and data 
use without actually contributing significantly to the aims of this study and it was, 
therefore, left to the participants to identify whether they had been in contact with 
the previous IMAG study or not. 
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Participants were given a preliminary demographic questionnaire and were 
assigned a participants code. Table 22 shows the data collected from the 
questionnaires. 
 
  
 
Figure 16: Participants recruitment chart 
 
 
 First round of invitations 
(Beginning of October 2011) 
Second round of invitations 
(End of October 2011) 
30 Homes invited 
5 Homes 
responded 
 
25 Homes 
did not 
respond  
 
67 Homes invited (25 + 42) 
 
5 Homes 
accepted 
invitations 
 
9 Homes 
responded 
 
58 Homes 
did not 
respond  
 
4 Homes 
rejected 
invitations 
 
5 Homes 
accepted 
invitations 
 
9 Interviews 
arranged 
 
6 Interviews 
arranged 
 
15 interviews carried out and analysed 
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Participant 
code Role 
Age 
group Gender 
Location 
of care 
home 
Nursing 
qualification Employment 
Nursing 
experience Nationality 
N1 
Care 
home 
manager/ 
nurse 
36-50 Male Rural UK qualified Full time 23 years UK National 
N2 Senior nurse 51-65 Female Rural UK qualified Full time 34 years 
UK 
National 
N3 Nurse 20-35 Female Suburban Non-UK qualified Full time 6 years 
Non-UK 
National 
N4 Nursing student 20-35 Female Rural UK student Part time 3 years 
UK 
National 
N5 Carer 20-35 Male Rural None Full time 2 years UK National 
N6 Nurse 36-50 Female Suburban UK qualified Full time 25 years UK National 
N7 Nurse 20-35 Female Suburban UK qualified Full time 18 years UK National 
N8 Nurse 51-65 Male Rural UK qualified Full time 30 years UK National 
N9 Nurse 51-65 Female Rural UK qualified Full time 33 years UK National 
N10 
Care 
home 
manager/ 
nurse 
51-65 Female Rural UK qualified Full time 35 years UK National 
N11 Nurse 36-50 Female Rural UK qualified Full time 3 years UK National 
N12 Nurse 36-50 Female Town centre 
Non-UK 
qualified Full time 28 years 
Non-UK 
National 
N13  Senior nurse 36-50 Female Suburban 
Non-UK 
qualified Full time 4 years 
Non-UK 
National 
N14 Nurse 51-65 Female Suburban UK qualified Full time 30 years UK National 
N15 Nurse 20-35 Female Suburban Non-UK qualified Full time 8 years 
Non-UK 
National 
Table 22: Participants' demographics (N=15) 
 
4.4.2. Analysis of the interviews 
All the interviews were transcribed and analysed one by one. The transcriptions 
were then coded as represented in Appendix 24. All the codes generated were then 
manually grouped in categories (see images in Appendix 25) as they were 
emerging. A basic thematic diagram was built after the analysis of the first 
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interview. The codes and themes obtained from the next interviews were 
reorganised within the original diagram and new themes and sub-themes were 
represented in different colours that were assigned to the interview where those 
sub-themes emerged from. Drafts of these diagrams can be found in Appendix 26.   
While this explains the techniques used for coding and grouping the codes into 
sub-themes and themes, the next section (4.4.2.1.) will explain the approach taken 
for the thematic analysis drawing on grounded theory principles. The themes 
obtained were reorganised into detailed diagrams that represented and related the 
main themes identified. These diagrams are presented in Appendix 27. 
4.4.2.1. Identifying components and themes 
This section presents the components that enabled the suggested theory to be 
constructed by exploring the perceptions and experiences of our participants from 
perspectives that emerged as a thematic analysis was developed. 
The first four interviews (N1, N2, N4 and N5) were carried out in the same care 
home. The different roles of the participants in the home helped to identify the role 
in the care home as a variable in the construction of any emergent theory as well as 
the rural location of the care home as another variable. Therefore, the analysis of 
following interviews looked at the variability in these views depending on the 
location of the care home as the interviewees indicated. The next step was to focus 
on care homes located closer to bigger towns or a city or inside a residential area of 
them. 
The analysis carried on with the exploration of another three interviews (N3, N6 
and N7) from participants that worked in care homes located in suburban areas. 
These interviews revealed the importance of contemplating the use of temporary 
members of staff (commonly denominated “agency nurses”) and the impact of 
receiving new residents in the care home. Therefore, it was worth exploring the 
reality of homes where there are constant new members of staff and new residents.  
This phenomenon was not very frequent in care homes but it was very common in 
respite homes where residents spent only hours or a few days and new members of 
staff were required with short notice to look after these temporary residents. This 
location was not expected to resemble the reality of a care home but the effect and 
the concerns of the interactions between new members of staff and new residents 
with regards to administration of medication. 
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The main limitation on the attempt to observe the effect of frequent changes on 
staff and residents was that only one respite home consented to take part and 
interviewed (N8). So as to examine a home with a high turnover of residents and 
members of staff, a large care home was visited to interview participants (N9, N10 
and N11). The observation of larger care homes revealed many more categories 
than those with fewer residents and a smaller turnover.  
Looking back to the interviews already analysed, numerous new categories 
emerged during an interview with a non-UK trained nurse. The experience of 
having worked in different countries and seeing different practices could give the 
participants different points of view about the administration of medication which 
should also be considered. 
The interviews with N12 and N15 identified a relatively low number of new 
categories but none of the previous participants had experienced implementation of 
administration guides in their care homes, therefore, the following interviews (N13 
and N14) were carried out with participants that had experiences in the 
implementation of services that provided guidance in the administration of 
medication. Although saturation was unlikely to be reached, the interviews did not 
reveal new emerging themes.  
The thematic analysis carried out revealed that within the framework of the 
administration of medication to PWD in care homes and within the components 
explored (location of the care home, role of the participant, employment status and 
experience of the nurses), the following themes were identified: 
- the issues that affect the administration of medication to PWD. Five main 
themes were identified in the interviews. These are: 
• the care home environment, 
• interaction between healthcare professionals, 
• nurses’ heavy workload, 
• professional development of the nurses, 
• residents’ health conditions, 
- the issues that affect the implementation of a new service providing I-MAGs in 
care homes with nursing. The thematic analysis identified the following themes: 
• preparation in the care home, 
• generation of I-MAGs, 
• the content of I-MAGs, 
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• the location of I-MAGs, 
• the usability of I-MAGs, 
• the impact of I-MAGs. 
 
4.4.2.2. Factors that affect the administration of medication to PWD 
4.4.2.2.1. Care home environment 
The care home was for many nurses the only environment of work and their 
experience of work may have been limited to such settings. What it looks like, 
where it is, what I do and how I do it, were important perceptions in the daily 
routines of the nurses of the home and in the way that residents received care. 
Some of these different aspects about the care home were identified by the 
researcher as relevant in the way that they affected the care of the residents and the 
way that residents received medication.  
Roles in the care home 
As participants highlighted, the ultimate role of the nurses and carers was the 
provision of care. Participants’ understanding of care greatly diverged across 
different roles in the care home. Managers and senior nurses considered care to be 
a more organisational concern that involves much time away from direct contact 
with the residents, completing reports and making sure that the staff and premises 
complied with regulations. Care home structure, training, reputation and paperwork 
were some of the concepts that were repeated by participants in senior or 
managerial roles while their clinical roles were a secondary priority for them. For 
example, this is how participant N2 described her role in the home:  
 
“My role is care. […] putting the structure, putting training into place, building up 
a good reputation and things like that putting a lot of hard work into it, putting the 
paperwork in place and making carers understand about accountability that at the 
end of the day this is a client’s home.” (N2) 
In contrast, nurses in non-managerial roles focused their caring role on the direct 
contact with the residents. For these participants, their role in caring involved 
personal care of the residents, such as dressing and hygiene, the general well-being 
of the residents and the physical administration and organisation of their 
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medication. Most of our participants in general nursing roles highlighted the 
importance of their regular tasks in their routines: 
“I’ll be in charge of the units, so that would involve having a handover from the 
last shift, handing over to the care staff that are coming on, giving medication, um, 
doing dressings, taking bloods...”(N6) 
These members of staff were in close contact with residents that suffered from 
dysphagia and were able to identify health concerns as the resident’s conditions 
evolved. Participants often commented on the frustration experienced when facing 
difficult administrations during the drug rounds, as commonly they had to accept 
that the resident was not taking the medication the way that the nurses considered 
optimal and, therefore, they were not confident on the effect of the drug. In 
response to the question “When you give medication to residents with dysphagia 
here what does this usually mean you need to do?” participant N5 responded: 
 “You just have to sit with them really to be honest (resident’s name] will suck it 
which is not great but what can you do.” (N5) 
Participant N5 pointed out in this comment how the closeness to the resident is 
important. However, his comment clearly identified a lack of knowledge from the 
participant in the pharmacological effect of sucking a tablet and the lack of 
participant’s clinical skills to identify action that could improve that issue. In 
summary, these comments highlighted that the care received by the PWD may 
depend on the understanding of the condition by the care providers and the role of 
those professionals in the care home. Even when all these healthcare professionals 
had a nursing background, they had different perspectives which were reflected in 
the care they gave to residents. 
Location and appearance of the care home 
Some participants identified how the appearance and location of the home could 
raise concerns that could affect the residents’ care and well-being. It seems to be 
hard for care homes remotely located to fulfil the staffing needs in the home. Two 
issues were often highlighted by the participants. One was that new staff in the 
nursing team were harder to recruit when their access to the rurally-located home 
was not as convenient for them as in urban areas. The second issue was the greater 
likelihood of losing their members of staff to other homes that offered both further 
professional opportunities and a location in more largely populated areas with 
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easier access. When one of the participants was asked whether she thought that she 
counted on enough staff to look after the residents in the care home, she answered: 
“Not at the moment, We have had four staff leave in the last few months for various 
reasons one girl went home, two girls left because the travelling was too much and 
this is a problem you know we are very tucked away in a little village and a lot of 
the staff have to come in on the train so it’s quite expensive for them […] so 
sometimes it takes a little while to get good new staff.” (N2) 
This comment highlighted how the difficulty of recruiting trained members of staff 
had an impact on the way that medication is administered as not only the same 
tasks were shared by less people but also the training standards may not have been 
as high.  
Some care homes visited were located in old buildings which some participants 
described as “tatty”. Others described it as “homely”, as some of the participants 
considered that the residents were often used to living in similar looking properties 
in their own homes. Although many of the participants pointed out the appearance 
and the structure of the care home as a negative highlight, for some of the 
interviewees, it was not considered a reason to compromise the quality of care 
offered or the potential of the home, but an opportunity to adapt to a more 
particular type of residents and care. For example:  
“We cannot change building but we can change standard of care um and I thought 
that because of no big huge space for people to have really open space to walk 
around I thought this home couldn’t really meet clients’ needs but can give really 
good really high standards for clients with end of the life care palliative care so we 
um started to change the type of the client we care for.”(N12) 
It was worth highlighting the perception of some participants on the appearance of 
the home. Some pointed out how the old-fashioned look of the building could 
reflect the presence of very traditional approaches to care and the lack of evolution 
to reflect new recommendations: 
“The home that I came from was very clinical, it’s purpose built, it was very 
structured this is it’s a nice home. My biggest concern with this home is 
(manager’s name) and I have often discussed is some people have been here a very 
long time and there is a touch of the set in stone mentality (referring to and quoting 
the nursing team) this is the way we’ve always done it.” (N2) 
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Although the location of the home seemed to be a clear factor in success in 
recruiting healthcare professionals, the appearance of the home provided different 
points of view. It seemed that in some cases not enough consideration was taken by 
the interviewees on how the appearance of the building could compromise the care 
received by the residents and also how the residents perceived their care. On the 
contrary, other participants able to identify these issues, were capable of optimising 
the care by targeting a group of residents for which the care home would not be a 
limiting factor in the care provided. This was highly relevant to the care received 
by the residents with dysphagia as it highlighted how the care team needed to adapt 
and prepare for the needs of the residents rather than them expecting the residents 
to adapt to the nursing team. In summary, the comments from the participants 
showed that the administration of medication to dysphagic residents may require 
specialised care and knowledge and it was important that the resources were made 
available to the nursing and caring team regardless of the location of the care home. 
Care home policies 
Internal policies in the care home affected the way that residents received their 
medication according to the comments of the participants. Nurses and carers 
identified having policies as something positive for their practice that gave them 
confidence in what they do. When guidance was implemented in the care home, 
some of the participants highlighted a positive sense of confidence inspired by the 
support provided by specific instructions on how to practice at the time of making 
clinical decisions about the care of the residents. For example: 
“Well, we’re lucky with the fact that (care home’s name) has a policy to follow. […] 
It’s written on the risk assessment what medication you’re giving and in what form 
it is and why you’re giving it and so everybody is happy.” (N6) 
Having to implement excessive guidance also carried risks. None of our 
participants commented on the quality or purpose of the policies, and instead, they 
followed them without question. This often resulted in very passive practices where 
the nurses did what they were told which, according to the comments of one 
participant, could de-skill their professional clinical practice. As mentioned before, 
nurses felt frustrated when difficult medication administrations challenged 
recommended practices: 
“I’ve never thought about it. I was just doing what I was told to do.” (N7) 
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More importantly, having these policies in place did not always mean that they 
reflected usual nursing practice when administering medication, showing a lack of 
standardised practice in the care home. Despite participants’ awareness of the 
differences in practice between nurses in the administration of medication to 
residents, they generally seemed to accept this issue without any concerns for their 
potential consequences for the residents and for their profession. Several 
participants highlighted how different ways of practising may cause confusion 
during the training of staff members.  
“I’ve seen staff doing it in different ways in terms of whether they mix the 
medication all together with water and give it all at once or flush out the tube first 
and then give the medication and then some more water…[…] it seems to be done 
differently by different people, so ah, I’m not sure.” (N4) 
The comment by this participant showed that current practice was being transferred 
to newly-trained members of staff. Due to this lack of standardised practice, the 
criteria when handling the formulation for medicines prescribed for residents also 
varied greatly. The nurses and carers resorted to manipulating original formulations 
without doctors’ consent for different reasons such as thinking that it was better for 
the resident, not challenging the information received or just because the 
formulation was easier for them to administer without considering the 
consequences for the resident: 
“[...] and I have seen when working in other care homes how we were told to crush 
the tablets if the patients couldn’t take them and then we would sort it out with the 
doctor, but that could take days and sometimes the GP came and told us that he 
had not authorised that.” (N2) 
When talking about a resident with dysphagia recently discharged to the care home, 
one of the participants commented with frustration: 
“We recently had somebody who did have a swallowing difficulty came from 
hospital with virtually all of their tablets being crushed um we weren’t happy with 
some of them particularly being crushed. […]doesn’t nobody seems to identify 
those before people get here and people like (name of other nurse) and myself are 
saying I’m sure we shouldn’t be crushing this we need to check it out.“(N10) 
This quote recognised shared confusion and uneasiness with this practice for 
members of staff that were capable of identifying issues with the administration of 
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medication. When talking about it, as here, some participants sometimes identified 
the alteration of drug formulations as an issue of potential concern but they did not 
usually follow these up. For example: 
“We have a lady at the moment who is epileptic very, very difficult because of her 
dementia to get her sodium valproate into her. She’s a spitter and bless her she 
actually had two very nasty fits yesterday and I feel it as a result of the sodium 
valproate not being swallowed. […] I think in a situation like this there is an issue.” 
(N2) 
In summary, the interviewees revealed that there was, in general, a lack of initiative 
to challenge current instructions given to the care home by other external 
healthcare professionals which was leading to a practice in which nurses were not 
always applying their clinical knowledge in their routines when administering 
medication to residents with dysphagia. 
4.4.2.2.2. Interaction between healthcare professionals 
There were numerous HCPs from different disciplines involved in the care of PWD 
and residents in the care homes often received treatment from other clinicians in 
secondary care and acute care in hospital, as well as a large input from the GPs and 
other healthcare professionals in primary care due to the complexity of the 
conditions that residents of care homes may suffer from. Communication between 
HCPs and the level of involvement in the care of residents with dysphagia played 
an important role in the way that the residents received their medication. The 
analysis of these interviews helped in identifying the nature of that interaction with 
HCPs within and outside of the care home.  
Secondary care environment 
Care home residents often need treatment for a short period of time for a brief but 
serious illness, injury or other health condition in a hospital or by secondary care 
providers that did not work in hospitals, such as occupational therapists or 
physiotherapists. The majority of participants commented that the hospital 
environment was often very different to the care home and the information 
received from secondary care was not always suitable within the care home 
environment. This was widely recognised by the participants, which also described 
the care home as a place where much more general care was provided, with higher 
involvement from the family and where more time was dedicated to the resident in 
comparison to the hospital where, from the points of view of the participants, often 
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set practices in primary care that were not suitable for the care home. The 
following quotes are an example of the differences identified by the participants in 
relation to the administration of medication: 
“Oh quite busy um obviously different from hospital because here you probably 
have more general needs to take care of as well as the drugs and dressing and 
things like that and family involvement is quite a lot as well.”(N8) 
On the contrary, one of the main differences that the participants highlighted is the 
access to other healthcare professionals such as doctors and pharmacists. There was 
a feeling of isolation in the care home where the interaction with other 
professionals - the majority of times - only occurs by phone, compared to hospital 
where consultants, SALTs, pharmacists, nurses, etc. are working much more 
closely. One of the participants commented on this: 
“I guess in hospital it’s different because you have more professionals in one area 
to get together whereas when we call a doctor in or we can phone the pharmacist 
or a SALT or the dietician, they visit when they visit whereas in hospital you have 
more there don’t you.” (N9) 
Many participants explained the difficulties that they needed to overcome when 
contacting professionals in secondary care. In consequence, the interviewees often 
referred to the hospital as some kind of unreachable source of information from 
which they just accepted the instructions received as they arrived. A feeling of 
frustration for the lack of recognition from the hospital for the work done in the 
care home was identified. This relationship with secondary care professionals 
could often bring friction between clinicians within primary care too, especially 
when changes had to follow approval from both the GP and the consultants in the 
hospital and sometimes no agreement was achieved between all parties. It was 
observed during the interviews how this affected the confidence of other 
professionals’ expertise. An example of one of the several cases indicated is the 
experience of participant N11 when one of the residents received instructions from 
the hospital on crushing a film- coated tablet. Our participant complained about the 
fact that the GP would not question the hospital instructions and, therefore, the 
nurses in the care home were not confident on whether they were doing something 
appropriate or not:  
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“It would be nice to have a guideline to refer back to and got the correct answers 
so when we’re referred back to the doctors and they say it’s how it happened in the 
hospital and they don’t like to interfere.” (N11) 
The members of the nursing team in the care home tended to liaise primarily with 
the GP even when the information about the resident’s condition came directly 
from the hospital. The participants identified this as a consequence of the lack of 
quality in the communication (for instance, access and approachability) between 
the nursing team in the care home and the professionals in secondary care. The GP 
was seen as the main key contact for the care home when the nurses needed to 
know or queried any information about the resident’s medication: 
“Sometimes they come (from hospital) with tablet forms. In that case we liaise with 
the GP with regard to whether we can crush medication and then swallow or 
prescribe a liquid form or form which will be more suitable for someone with 
dysphagia to swallow their medication and we tend to do like to liaise with GP.” 
(N13) 
Interactions within the primary care environment 
Primary care includes the healthcare services which play a role in the local 
community involving HCPs who act as a first point of consultation for all residents 
within the healthcare system or, in our subject, residents in care homes. The main 
source of interaction in the care homes with healthcare professionals derives from 
primary care and includes mainly the GP, the pharmacist and the SALTs when 
considering PWD. The geographical and organisational closeness of these 
professionals was not seen by the participants as a factor that improved a fluid 
communication and interaction between them and the care home: 
“One of the GPs that look after our patients is only around the corner, but 
sometimes it is just easier to speak to the emergency doctors to organise a visit and 
then they ask why we didn’t call the GP instead!” (N2) 
The nurses expected to receive some specific consent from the GP to enable them 
to alter original formulations consequently rendering the administration unlicensed. 
It was frequently the nurse’s role in the care home to request this consent or to 
request liquid medication. This situation was one of the main sources of conflict 
with the doctor as mentioned by the interviewees. The following quote identified 
legal liability as one of the main concerns for all the professionals involved in the 
care of residents from the point of view of a nurse in managerial role and another 
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one with clinical roles. Sometimes the nurses perceived this interaction as a lack of 
commitment from the GP afraid of accepting liability as indicated by participant 
N1, originating friction between the care home and the GP: 
“If you have a GP and I have seen them, who say right, just give these, but crush 
them, can you put that on the prescription please? No. Because they know that they 
will then be liable. In which case, we’re not administering it. […] My nurses I 
know will come to me if they have an issue and I will go fight that battle for them.” 
(N1) 
The comments from this participant highlighted uneasiness when trying to discuss 
issues with the GP at the same time as an imposing attitude from the manager of 
the care home to obtain the outcome that he expected from the GP without 
considering the views of the doctor. In the second instance, nurses felt coerced to 
administer medication without the resident being aware. Following the 
recommendations from the GP was not always an easy task for the nurses who feel 
that the whole liability of the administration falls on them after crushing a tablet: 
“We had a gentleman here who has sadly died and the doctor was not prepared to 
write this gentleman up for liquids. We did ask repeatedly but we were told we had 
to crush them and it wasn’t actually written on the MAR chart. We were not 
prepared to crush and again both (care home manager’s name) and I am very 
stringent on that I don’t give covert medication. If a client refuses medication we 
don’t give it.” (N2) 
The participant N2 showed an impression of the doctor as someone whose 
principals were not based on caring for the resident, or not with the same strong 
drive as the participant.  
The same challenges could also occur when the HCPs involved were temporary 
clinicians such as locums or emergency doctors. Participant N3 explained that 
often they needed to contact the doctors in an emergency and when the prescriber 
was a locum doctor who did not know the resident and her/his needs, the locum 
doctor tended not to sign their consent and, therefore, the nurse had to contact who 
she called “the proper registered GP” and get the medication changed or the 
consent signed.  
It is important to mention that the participants focused their attention mainly on 
negative experiences when obtaining consent. Although this reality can be a very 
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regular experience for many nurses, some other participants mentioned that often 
they would contact the regular GP and consents would be received without the 
need of much discussion.  
Another common concern for most participants was the communication with 
occasional nursing staff referred to as “agency nurses” by the regular nurses in the 
care home. Having to update occasional members of staff with a lot of information 
was considered “difficult” (N14) and “time consuming” (N13): 
“We have to give them (agency nurses) lots of details and usually write a list of 
everybody and what their diagnoses are and if they got any special medication like 
if they’re say like on antibiotics twice a day the timings of that we’d highlight 
anything like that or insulin’s yes that would be highlighted on hand-over and 
written so that they could refer to it as opposed to just giving them the keys and 
letting them get on with it.” (N9) 
When this communication did not provide the right information, it could often 
result in serious incidents in the administration of medication. However, the 
participants were not made aware by the care home managers of the outcome of the 
action taken about the incident. One participant explained their experiences in 
relation to an incident involving the administration of crushed medication without 
consent from the doctor: 
“One agency nurse crushed the tablets before having consulted and we informed 
the manager and the manager contacted another particular person who came for 
shift and they informed the agency as well that did the mistake and I don’t know 
actually what they did but we just follow the rule here.”(N3) 
The interviewee was able to identify good practice by knowing what to do on the 
administration of medication and what action to take when an error has been 
identified.  
The relation with the pharmacist was perceived as very positive in the majority of 
cases. It was often explained by the participants that when they had any queries 
about whether they could crush tablets or open capsules, the GP would be 
contacted as a first source of information and then sometimes, and as a second 
choice, they would contact the pharmacist: 
“We tend to rely on the doctors to know what can and can’t be crushed but if we’re 
in any doubt we would ask the pharmacist as well.”(N6) 
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To the contrary, other participants recognised the role and expertise of the 
pharmacist. However, it was highlighted by the participants’ comments how the 
lack of agreement between the advice given by the pharmacist and by the GP could 
present a challenge to the relationship between the nursing team and the GPs. The 
following comment from one of the participants highlighted how the concerns of 
the interaction between primary and secondary care could also be reflected in the 
general practitioners and the impact that it might have on the interaction between 
the care providers in primary care settings:  
“It’s quite difficult um… we recently had somebody who did have a swallowing 
difficulty came from hospital with virtually all of their tablets being crushed um… 
we weren’t happy with some of them particularly being crushed and checked that 
out with the pharmacist who said no you shouldn’t be crushing those tablets. The 
GP was then very reluctant to give us alternative preparations because he said the 
hospital weren’t doing it so why should he, which to some extent you have to agree 
with and when the person was assessed by the SALT in the hospital they had 
recommended that they had all liquid medicines but that hadn’t happened so it 
does make things difficult sometimes.” (N10) 
The interaction between the GP, the pharmacist and the SALT in the example 
described by participant N10, occurred only with the care home staff as a mediator. 
There was no discussion between the pharmacist and the GP or the SALT directly, 
and the nurses found themselves dealing with issues related to prescribing or the 
assessment of dysphagia which was in this case beyond their expertise and 
responsibility. Participant N3 indicated how these conflicts were avoided by 
making better use of the professional’s expertise and liaison between GP and 
pharmacist. The participants’ comments identified that a good network of 
healthcare professionals eased the flow of problem solving in the care home. When 
the professionals making recommendations or suggestions on the administration of 
medication (GP, pharmacist and SALT) communicated between them, it was 
described as much smoother process than the ones described previously: 
“The best person if you work here is like the pharmacist yes even if you call the GP 
sometimes they don’t tend to give the answers so we’ll go through pharmacist and 
they’ll speak to GP and finally they’ll come to the conclusion and let us know what 
exactly so it’s more like you know the pharmacy people pharmacist is the one you 
know telling all the information.”(N3) 
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The SALTs were valued very positively by the majority of the nurse participants as 
“very supportive and accessible” (N1). Their expertise in speech impediments and 
their availability were their most appreciated qualities. These characteristics seem 
to have an enormous positive impact on the relationship with the care home as it 
was described in this example: 
“She (referring to SALT) will give you an off-the-record opinion as to well I should 
think you should get a swallowing assessment done or you know she’s useful we 
can always get her advice even if it isn’t her in her official capacity.” (N14) 
In summary, the comments presented identified that the relationship between 
healthcare professionals in primary care was affected by the inadequate use of the 
resources and expertise available as well as by the legal concerns about liability 
that the complexity of some drugs administrations may bring. 
Within the care home 
It was important to explore the professional relationship between members of staff 
within the care home. It was, in general, observed that the members of the team 
were working in a very structured pattern where the roles of the managers, senior 
nurses, nurses and carers where clearly defined, but they counted on support from 
each other when this was needed. The majority of the participants acknowledged 
strong support from the carers, managers and senior nurses within the care home 
that could be perceived as effective team work. Often managers had to leave their 
managerial role to help with the clinical role of the nurses. Also, nurses and carers 
would support each other when possible. Availability and expertise were again 
important qualities that were highlighted by most of the team members at any level:  
“You know there’s always one (nurse) on this side if you need help but you know 
and I’m quite lucky because you can just pop over and ask them.” (N5) 
4.4.2.2.3. Nurses' heavy workload 
Despite having certain routines in place, the members of staff in the care home 
needed to be prepared for unexpected health episodes with the residents that can 
increase the nurses' heavy workload. Most participants described their regular days 
as “stressful” (N3) or “running back and forward” (N7). Participant N1 described 
his work as “new challenges every day and a lot of the clinical care issues” (N1). 
In this section, the perceptions of the nurses on workload elements that could relate 
to the care received by the residents with dysphagia were identified.  
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Physical workload 
The work of the nurses involved drug rounds, monitoring of some conditions and 
behaviours of residents, stock control and completion of reports as the main daily 
tasks. As part of their current role, the nurses were in charge of the hand-over from 
the last shift, giving medication, dressings, taking bloods, but also sorting out 
operational organisation like covering off-duties, rotas, appraisals and supervision 
for the staff.  
Most of these tasks had to be completed on a daily basis within each shift. 
However, the time involved in achieving them often seemed to be underestimated 
as unexpected events regularly interrupted the planned schedules causing the 
nurses to work extra time in order not to compromise the care of residents. This 
often meant that administrative jobs were sacrificed in the care home for other 
tasks of higher priority: 
“Normally I can work up to 60 hours a week nursing especially for sickness. It’s 
not very often I’ve actually got an office day. This is quite rare. I was actually 
promised an office day when I came but we’ve had all sorts of issues with nurses 
coming and going and things so that never really materialised.” (N2) 
While this comment highlighted that the direct care of the residents was prioritised 
above other jobs, it also pointed out that the care was being provided under 
pressured circumstances for the nurses and by over-worked members of staff that 
had to fulfil other tasks within a care home lacking in professional resources. 
Nurses tended to identify the amount of paperwork to be completed as one of the 
most excessive chores of the day. They saw this task as something a bit detached 
from their clinical role and it seems to drastically increase their workload and keep 
them apart from the direct contact with the residents: 
“Sometimes in the morning it take us at least an hour to attend one client with 
personal care and then we have the medication and the form filling and 
appointments and all those and I do find sometimes like this is we go from thinking 
have I sent that, have I done that,  which of the six clients?” (N15) 
Participant N15 made obvious once again that the nurses in care homes often had 
to work under high-pressure conditions. Participants, however, did not consider the 
administrative tasks as part of the care of the residents and those tasks were often 
not prioritised. 
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Emotional workload 
The daily tasks of the nurses and carers were undoubtedly laborious and may have 
represented a heavy physical workload for them. However, some of the interviews 
also highlighted the importance of the emotional workload that care in nursing 
carried and differentiated the view of residents as subjects from the view of them as 
human beings. The participants felt responsible for the care provided at the last 
stage of the life of the residents. There was a sense of humane responsibility in the 
comments from the participants, but also a sense of frustration for not being able to 
achieve what they wanted for the resident due to the excessive workload.  
Participant N4 comments on this emotional pressure:  
“When you’re working with people who are extremely vulnerable and obviously, I 
suppose for a lot of these people, um, sort of this is their last point at which they’ll 
be cared for, so there’s a real, I personally feel and I’ve spoken to others about this 
and they feel that um, you know, you really have a responsibility to get it right, 
because you are that last point of care.” (N4) 
Emotional pressure was, however, not reflected in any regulation or policy 
mentioned by the participants but just mentioned as a personal concern. One of the 
nurses in a managerial role highlighted this issue for how he tried to encourage that 
closer view of residents, not only as human beings but as relatives: 
“All I ask of my staff is that they treat everybody as they like to be treated 
themselves and the simple rule is if this is your mum or your dad, what would you 
like? Very simple.” (N1) 
4.4.2.2.4. Professional development of the nurses 
It has been mentioned, on page 168, how the care provided by the nurses can vary 
in its qualities depending on the standpoint of the person offering it. The analysis 
of these interviews helped the researcher categorising several components that are 
involved in the quality of care provided by the nurses. These components are 
presented in this section.  
Professional experience 
The participants’ understanding of experience differed greatly between their 
descriptions in the interview. Some participants would say that it is defined as the 
number of years practising the same job, but others identified professional 
experience as the number of places where a nurse had practiced, the number of 
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roles, the type of residents who they offered care to, the countries where a nurse 
had practiced or even a combination of all of these. 
Some interviewees could not explain their ways of providing care without looking 
back at their personal experience, but it was also these experiences that allowed 
them to see the threshold of care that they could currently provide. Participant N1 
explained how his experience in dysphagia had influenced his current practice and 
how certain roles had been more de-limited in order to specialise the care of PWD: 
“Certainly on the acute medical wards we were taught and certificated in actually 
doing simple dysphagia assessment. Now I would not use it as an assessment tool. 
A) Because the license for it is long expired and B) I am not certain on the 
suitability of it, C) if I had those kinds of doubts there are healthcare professionals 
that are far more capable than I am. I can make a simple decision, is this person 
capable of swallowing? That’s enough. Then after that it has to go to another 
remit.” (N1) 
This comment also highlighted the acceptance of change in practice and the way 
that nursing roles have evolved throughout time partly due to the specialised 
practice of other HCPs. Based on previous experience in other care homes and in 
past years, some of the participants considered that there was a greater involvement 
of the nurses in the residents’ care that had led to a much more personalised care 
which was often seen by the participants as an improvement compared to practice 
in the past: 
“There’s a big difference and they’re more involved. There’s more one-to-ones 
going on here, There’s people that need it more than what there was in other 
places[…] It’s better.”(N7) 
But in most cases, practice experience in different roles was what helped 
participants to improve the care provided to residents. Participant N12 explained 
how her experience was being reflected in the well-being of residents. In her case, 
her experiences came from being in a variety of roles, in different countries. 
Observing mistakes made in the past and working on many different roles provided, 
according to some participants, could help to identify how to improve current 
practice and relationships with the team members. These improvements based on 
experience would be likely to be reflected in better care for the residents. As 
participant N12 explained, communication and understanding of the impact of 
decisions on the team and the residents were key for the good functioning of a team: 
Exploring the current model of administration of medication to PWD and the 
acceptability of changes 
 
Page 183 of 380 
 
“When I was a position of carer or even cleaner I realised, actually because 
everybody does mistakes, how many mistakes management have done.[…] I never 
made any decision without talking with my staff and I know how much any decision 
which is made by head office by manager can affect staff. […]” (N12) 
The participants emphasised how their experience was what made a difference in 
the quality of care provided to the residents, but it was also important to transmit 
that feeling of care to the residents: 
“I think we come to that point when we reach really high standards you know with 
care and improved quality of life for our clients and that is the most important 
thing even if they are very poor condition physical medical conditions they still 
have that sense of well-being.” (N12) 
The professional experience of the nurses was one of the most valued elements that 
affected the care of PWD. Any intervention that could enhance their experience 
was perceived by the participants as a positive approach towards the well-being of 
the residents: 
“I always think that when I have learnt new ways of doing things, like small things, 
you know, like wounds or stitches, different to when I went to the nursing school, I 
feel better in what I do, more confident, you know, and my clients are receiving 
better care.” (N8) 
Training and qualifications 
There was not substantial inconsistency between the participants on their 
qualifications and previous training. However, their approach towards the need for 
training and qualifications, and the routes to implement change, varied greatly 
between participants. Often, negative approaches towards new ways of practicing 
were observed in the interviews. This was more common within teams that have 
not been up-to-date with newer recommendations, triggering conflicts in the 
delivery and implementation of new guidelines between the members of the team.  
The subjective evaluation of new policies by members of staff, and the addition of 
workload as a consequence, could bring challenging situations that could create 
differences in the quality of care provided. The implementation of changes in the 
care home was challenged by these approaches from the members of staff and 
traditional practices. The managers often had the role of talking their staff through 
the rationale for changes and sometimes followed the new processes closely to 
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ensure the implementation of new practices by the members of staff.  Participant 
N2 explains the difficulty of implementing changes in practices in her care home: 
“They don’t understand why they have to do that. […] Sometimes it’s very difficult 
you’ve got some staff that will accept change very well, very readily and as I say 
some staff who prove difficult and then we need to start off and go down the 
supervision route and things like that, but most of them you know once you explain 
to them why we have to do things and sometimes you might have to explain it two 
or three times but they usually get the general idea. […] Then they think well yes 
ok don’t always like it, but yes, they can see the thinking behind it the principle 
behind it.” (N2) 
This comment, once again, describes how the practices seen in care homes could 
vary greatly between different members of the nursing team and how this could be 
related to different approaches to practice.  
In some cases the perception of changing practice was identified as a correction of 
“wrong practice” rather than as an enhancement of a current one. Some participants 
tended to see the appropriateness of their practice on a ‘black or white’ scale rather 
than a scale with small improvements to enhance the care of the residents.  
Participant N14, when asked about including additional guidance to help with the 
administration of medication to residents with dysphagia, responded: 
“If we were doing them wrong but I’d like to think that we weren’t so you know if 
we’re doing them correctly anyway, it’s not going to make any difference, is it? so 
and I’d like to think we are doing what the guidelines would be but not that 
something like this would be to  change our practice completely because that 
would mean we’d be doing it horribly wrong wouldn’t it?” (N14) 
Participant N14 clearly highlighted the confrontation between what personally was 
correct and what was correct according to professional guidelines. There were 
certainly negative approaches towards the implementation of change, but the 
majority of the participants admitted that they would happily accept changes to 
their normal practice especially if those changes improved the well-being of the 
residents. In her role of nurse, N2 commented: 
“I’ve never believed in being stale in old practice and I would be prepared to try 
anything that certainly improves practice and keeps clients safe and keeps nurses 
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safe, my seniors safe, yes particularly for the seniors. I think nurses are always 
aware of their pain. They’re aware of their responsibility, their duty of care.“(N2) 
Participant N2 was clearly highlighting the importance of a strong rationale in the 
implementation of change and a description of how it could benefit the resident. In 
summary, the comments from the participants highlighted that the implementation 
of training for nurses was a challenging task for the managers in the care homes 
where very traditional approaches towards change remain embedded and it may 
require strong supervision and follow-up of the new practice to ensure the 
compliance of the members of the nursing team. 
Decision making process  
Previous knowledge and experience were characteristics that may have affected the 
administration of medication by the nurses. However, nurses had to face 
unexpected situations and challenges during drug rounds and they cannot always 
count on enough guidance on how to act on challenging administrations of 
medication. This section identified some of the elements that affected their process 
of clinical decision-making in these situations. 
The rapid development of a resident’s conditions and problems with swallowing 
could force nurses to question what Participant N1 refers to as “deciding if this 
drug is appropriate at this time” (N1). There was recognition that altering the 
original formulation of a drug carries liability issues which are sometimes the basis 
of the decision made. Participant N1 commented:  
“The doctor is not responsible for my registration as a nurse. I am. Part of my 
code of conduct, if something I think is wrong, I cannot do it. If I do do it, I have 
broken my code of conduct. I have knowingly put somebody at risk. It is also my 
duty and duty of care and bearing in mind the recent changes within safeguarding 
legislation, by not challenging it, I could be guilty of neglect by omission if I have 
not challenged it which I believe now carries a five year jail term.” (N1) 
The comments made by participant N1 showed how nurses were under pressure not 
only as a team in the care home, but also as individuals, and they had to 
individually assess the correctness of every administration of medication. Again, 
the fear of the consequences of misconduct was one of the reasons for a constant 
self-assessment in their practice. 
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It was often mentioned by the participants that the nurses knew the residents well 
enough to believe that they could make decisions on what is the preference of the 
resident. Based on that, participants often tried to ‘direct’ other professionals in 
getting what the nurses thought to be best for the resident. Participant N3 
commented: 
“We change the dose you know like if they start some medication even though they 
want to do it during that shift and we come next morning and we know what the 
resident likes and we will approach the GP, you know, the proper registered GP 
and we will try and change the dose of different antibiotic different form of 
antibiotic.” (N3) 
Participant N12 talked through the changes and decisions they made regularly 
based on what they thought was best for the residents at the time and using their 
internal assessment tools and clinical knowledge: 
“We sometimes have to, after two hours, we have to change advice for the staff 
who care for that client because condition you know change and that is the best 
way […] Also we have self-management review techniques for our clients so 
actually we use that tool to assess the client before if we are start to be concerned 
for them.” (N12) 
In other cases the decisions were made based on instructions and nothing was 
questioned. Participant N9 responded with the following when talking about 
following instruction at the time of administration: 
“I don’t know why but that’s what they tell us we must do so it would be interesting 
to know why but I don’t know why but that’s what they say we must do so that’s 
what we must do.” (N9) 
These findings highlighted that liability, closeness to the resident, current practice 
in the care home and the guidance implemented in the care home were some of the 
elements likely to influence the clinical decisions made by the nurses when facing 
challenging administrations of medicines to residents with dysphagia. 
Clinical confidence of the nurses 
Clinical confidence was an essential part of the practice of any healthcare 
professional as often clinical decisions had to be made to adapt to the individual 
needs of the residents or in this case the residents of the care home. During the 
study, this subject was often highlighted by participants implicitly when talking 
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about the causes and results of a lack of confidence. It was, therefore, relevant to 
explore the elements that affected their clinical confidence from their own 
perspectives. 
The lack of confidence can add to the pressure that nurses face in the 
administration of medication. Previous elements, like the knowledge, experience or 
their main focus at the time of making a decision, can affect their confidence. For 
example, one participant stated the following when talking about altering 
formulations:  
“No I don’t really like doing that. I don’t know what’s in them if you know what I 
mean what’s in the capsule so I don’t know you know I might end up doing more 
harm than good […] If I’m worried, I won’t do it.” (N5) 
Some participants highlighted the importance of getting the right sources of 
information in order to help with their confidence in their practice. External 
professional guidance could provide enough evidence to back-up their queries in 
the communication with healthcare professionals in different settings and it would 
avoid the use of unreliable sources of information, as indicated in some of the 
comments from one of the participants: 
“It (guidance on administration) would certainly help us to be more confident 
about what we give and how we are giving it because sometimes it is a bit awkward. 
You get something and it might have to be given in a particular way but we’re 
relying sometimes on residents for that information.” (N8) 
The lack of input from other professionals and the lack of complete understanding 
of the prescribing rationale had a significant impact on the nurses’ confidence as 
indicated by participant N10. Specific instructions and expert guidance seemed to 
be essential during the administration of residents with dysphagia: 
“We’re crushing this. Should we be crushing this? Has anybody checked it? What 
are we going to do about it? Why won’t the doctor prescribe something else? So I 
think that helps from that point of view that we’re working from more specialist 
advice than just from ourselves.” (N10) 
Participant N10’s comment highlighted that nurses may require individual 
confirmation of how to administer every drug for them to feel confident in their 
practice. However, being able to identify weaknesses in confidence may be an 
advantageous standpoint. Being over-confident can lead to bad habits of practice 
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by over-riding concerns that can be significant in the care of residents as explained 
by some of the participants. The comments of some participants suggested that the 
provision of any changes in practice should never over-ride the professional 
decision-making process of the subjects in order to avoid the habit of stopping 
questioning everyday practice. Participant N2 also highlighted how very structured 
routines, regardless of being based on good or bad recommendations, could lead to 
bad practice: 
“You can get into bad practice and very easily and sometimes you’re not 
questioning and sometimes I think they (the nurses) are not checking because 
they’ve always done it like that and they (the residents) have always been on this 
medication and they’re not actually looking.” (N2) 
However, views on confidence varied throughout our group. Participant N3 
mentioned how training helped them with their confidence and they are able to 
identify who to refer to when needed: 
“Definitely we’re confident because we do know what we are doing and we have a 
proper training to do that and if anything, something wrong with the machine but 
still we have the numbers to ask them what is wrong with them, but still we all fine.” 
(N3) 
4.4.2.2.5. Residents’ health conditions 
Participants identified how different conditions triggered different views from the 
carers as well as from the residents. As one participant said about this interaction: 
“[…] just by a different approach you have to whichever way you’re going to 
connect with that person with dementia and obviously different people are going to 
connect with that person maybe differently as well.” (N9) 
This comment highlighted that the individual ideas of each resident, nurse and 
carer could condition the kind of interaction between them and this could be 
reflected in the care received in relation to the administration of medications. 
Perceptions of the residents’ choice and approach to medication 
Many residents in the care home had none or almost no capacity to express their 
choices or approaches towards medication. In certain cases, residents were seen to 
take a very passive approach towards their medicines and consider the management 
of their drugs, including the administration, to be somebody else’s responsibility as 
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they classified that as part of the care they paid for. Participant N1 explains this as 
adopting ‘the sick role’:  
“[…] also there are some people who take on the sick role. I have come to a care 
home, why should I worry about my tablets, I want them to come and give me them.” 
(N1) 
It was frequently observed by the interviewed nurses that numerous residents 
“don’t like” (N5) their tablets. Our participants generally assumed that flavour was 
the main cause of dislike and often alternative formulations were attempted in 
order to over-ride that rejection. However, this approach ignores other elements 
conditioning the approach when liking or disliking a drug, such as the texture of 
the medication and the difficulty swallowing it. An experience described by 
participant N13 demonstrates this difficulty:  
“We tend to liaise with GP and ask for to prescribe liquid medication and 
sometimes they (the residents) don’t like it so we go back to the tablet. We have a 
lady; she doesn’t like the soluble paracetamol. She doesn’t like the baby 
paracetamol (liquid formulation for babies) um all that’s it, isn’t it?  And we went 
back to tablets but they seem to be more difficult and she struggles with them.” 
(N13) 
Participant N13 was also highlighting how every resident had individual needs and 
how that could affect the adherence to the medication prescribed and the 
management of dysphagia. The approaches of residents towards medication may 
vary drastically depending on the residents’ conditions. The nurses in the care 
home were in a good position to identify the preferences of the residents but this 
identification required an open-minded approach from the nurses in order to 
adequately observe those variables: 
“I have heard how some nurses just say that the patient is funny about swallowing 
and carry on, but we are the ones that should take notice those problems because 
we spend our days with them, is that right?” (N11) 
Dysphagia awareness 
Dysphagia assessment in the UK is currently a role beyond general nurses, tending 
to be allocated to SALTs. As dysphagia appears or worsens, the nurses are the first 
professionals identifying signs of dysphagia. Whilst several participants reported 
referrals to SALTs or GP when the signs appeared, none of the nurse participants 
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were able to comment on the level of difficulties or to carry out any small 
assessment on the resident’s condition and instead they would limit their practice to 
following instructions from the resident’s care plan. When asked about undertaking 
dysphagia assessment, one participant responded: 
“I can make a simple decision, is this person capable of swallowing? That’s 
enough. Then after that it has to go to another remit.” (N1) 
Information in the resident’s care plan 
On occasions when dysphagia appeared before or during a hospital admission, the 
information in the care plan was not suitably adapted to the needs of the care home 
and created confusion in the practice of the nurses. It had already been identified 
how the communication with secondary care and other health care professionals 
was not always optimal, and this was reflected further in the information contained 
in the care plan: 
“I think for people coming out of hospital the SALT advice needs to be followed 
and if they should be having liquid preparations then that’s what they should come 
out of hospital with and I think if they came out of hospital with them then the GP 
would happily continue to prescribe them. I think it’s they’re coming out of 
hospital with tablets saying they’re all fine to be crushed and then us saying 
something different.”(N10) 
Participant N10 was commenting on the challenges found when her regular 
practice contradicted new guidance from other professionals. Contradictory or 
incomplete information in care plans affected nurses’ trust on the grounds of their 
own clinical practice. When the instructions given to the nurses did not match the 
information in the care plans, it created a sense of frustration as the rationale for 
this practice was not explained: 
“So what do I do when the doctor says something about the medication but he 
doesn’t’ write it anywhere? I can’t just go and wait another day for him to come 
and add it to the care plan, but I can’t do different to what the plan says either. Yes, 
sometimes it is very frustrating.” (N14) 
This highlighted that any guidance containing the rationale of any discrepancies 
with the information contained in the care plan could help the nurses to understand 
the reasons behind those recommendations and hence feel more confident about 
applying their clinical judgement during the administration of medication.  
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Access to care plans 
As the administration of medication was very conditioned by the information 
contained in the care plans, the access to them also affected the level of dysphagia 
awareness within the nursing team.  It was mentioned how the care plans are 
accessible to carers and nurses for them to read and to input any significant events 
about a resident’s health.  
When some of our participants were asked about how often the nursing team refers 
to the care plan to find out information about a resident’s health, there seemed to be 
no regularity in the access of the care plans and recent or significant changes in a 
resident’s health were not always known by the members of staff looking after a 
resident. There was a general assumption within the nursing teams in the different 
care homes about the lack of need to read the care plans as they “know” the 
resident. Participant N1, in a senior role, commented the following about the 
frequency of access to the care plans by the nursing team: 
“They should do and they should read it. Whether or not they do, well a lot of the 
things because we have our residents for quite a long of the time we know them 
very well. It is documented, but we might not know it’s documented, it’s just that’s 
what we do. We know it. But it certainly is ah... Whenever a new resident comes 
here we take time getting to know them and make sure that we get things right for 
them. [...] so we don’t always have the time to check the plans everyday but we 
know the patients well anyway.” (N1) 
Participant N1 was justifying not accessing the care plans on every drug 
administration as it may become too time consuming. 
4.4.2.3. Factors affecting the implementation of I-MAGs in care homes   
The interviews with members of the nursing team in care homes offered an 
opportunity to investigate the acceptability of a new service provided by a 
community pharmacist providing individualised guidance in the administration of 
medication to residents with dysphagia. These section presents the themes which 
emerged as previously outlined. 
4.4.2.3.1. Preparation required for I-MAGs in the care home 
The majority of the participants were interested in the concept of the I-MAGs but 
also explained that they would expect a certain level of training on how to 
implement the changes and how to use the guides. According to them, the 
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pharmacist would be the most suitable professional to provide this kind of training 
as the participant acknowledged the expertise of the pharmacist on the 
administration of medication: 
“I think possible if we could have a pharmacist when we start this one just to talk a 
little bit, I mean it is very clear there and there but sometimes you know, yes I don’t 
think a doctor, probably a pharmacist.” (N15) 
In the minority of cases, the participants mentioned nurses in senior roles, maybe 
due to traditional practice where senior specialist nurses from secondary care often 
offer training session in care homes. However, the participants would expect that 
the person offering the training would also be someone who had experience in how 
to use the guides and that can provide the rationale for the implementation of this 
service and answers any questions that could potentially emerge during the training 
and implementation of the guides: 
“I guess it would help to have a chat with somebody and understand why it’s 
implemented I think sometime if they’ve got a rationale or any recommendation it 
helps I’d just be happy using it.” (N11) 
The preference for training by the care home should consist of short sessions where 
all the members could be made aware of the implementation of the new service and 
how to use it, as well as who to refer to for potential enquiries: 
“I think the only thing that we’d need, would be somebody who’s used to the tool 
and actually having maybe an hour or two question and answer session with my 
trained and senior carers and just to thrash out things and then tell people this is 
what we are going to do and this is how we are going to do it and sort out the 
logistics as in to stay with the MAR charts, medication administration record or 
would it stay with the care plan or would it stay with the client.” (N1) 
Participant N1 was suggesting that a short intervention by someone experienced 
would be enough support. The participant’s approach to this intervention was 
rather imposed on the members of staff and did not contemplate the nursing team’s 
opinion on the individual suitability of the service in the care home or any 
explanation on the rationale of the service. 
The consensus view seemed to be that the implementation of I-MAGs could be 
enhanced by preparing brief training sessions that are supported by a professional 
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that provides experience and expertise and that liaises with the members of staff in 
the home to adapt the implementation of those changes. 
4.4.2.3.2. Generation of I-MAGs 
Participants identified two particular areas of concern when exploring the provision 
of I-MAGs by a community pharmacist after training provided within the care 
home. These were: 
- the communication between healthcare professionals which would 
include the pharmacist, GP, SALTs and the nurses in the care 
home and in the health centres, 
- how regular updates of the guides would be managed. 
Issues with communication between professionals were identified by the researcher 
earlier in the analysis (page 173). However, our participants highlighted how 
essential the involvement of certain healthcare professionals over others in the 
implementation of I-MAGs was. Often, they expected the expertise of more than 
one healthcare professional to be combined, but in most cases the pharmacist was 
expected to be present: 
“I think it would need to be a combination of SALT and pharmacist and the nurses 
really. I don’t expect the GP would want too much input but I would think it would 
be very helpful to have the pharmacy input and the SALT information you might 
have separately anyway which we could then input into it, but I think the 
pharmacist input would be quite significant and would make a difference to what 
we were actually doing.” (N10) 
The collaboration between a SALT, as a dysphagia specialist, and the pharmacist’s 
expertise in medications were considered the main components to integrate into the 
nursing team according to this participant. Concerns about the regularity of the 
updates for I-MAGs arose from the infrequent visits of the community pharmacist 
to the care home. Many of the participants highlighted how they thought that the 
care home could benefit a lot from more pharmacy advice and more regular visits 
and support from their community pharmacist: 
“We would need to have good two-way relationship with them (the members of 
staff in the pharmacy) to keep those as up-to-date as possible.”(N6) 
The nurse participants would expect I-MAGs to be updated regularly, at least once 
a month, and as medications change. In contrast to this, the interviewees pointed 
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out on several occasions how the pharmacist’s visits to the care home were limited 
to only once a year in several cases. Participant N8 commented about this: 
“A monthly update would be the most valuable and contact with the pharmacist 
would generally would be very useful if we had that, so they understood how we 
work I think sometimes, it’s just people having an idea of you in their heads sort of 
thing.”(N8) 
It was hence identified how the collaboration between the SALT and the 
pharmacist is essential for the implementation of the guides. This collaboration 
would be enhanced by a close relationship with the members of staff in the care 
home, and regular follow-ups from the pharmacist. 
4.4.2.3.3. Content of I-MAGs 
The majority of the participants commented on the need for certain sections 
contained in I-MAGs. While essential parts such as resident’s details and a core 
section containing clinical information about the drugs and their administration 
were anticipated by the research team, the interviewees highlighted the importance 
of the following sections. 
Signatures of the healthcare team members producing and/or utilising I-
MAGs 
This would provide an opportunity for the nurses to sign the I-MAG as proof that 
they have read it and also it would be an opportunity for the pharmacist, GP and 
SALT to sign the recommendations offering reassurance and consent on the 
instructions given: 
“I think that it’s something that everybody certainly understands. I think that 
maybe there should be something in the back where staff could all sign to say that 
they agreed that they at least read it and agreed with what was on it and that they 
then sign to indicate that they would then carry it out you know and to adhere to it 
yes I like it you know it’s safe practice.”(N2) 
Comments box 
Although regular updates would be made to I-MAGs, a comments box would offer 
the chance to add any events or suggestions about the medication or about the 
resident that may emerge on the daily practice. These comments could then be 
reflected in the following updated version and it would help with the 
communication between the healthcare team: 
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“Here it’s really clear advice and actually, if doctor come and review during the 
month or during the week, we can put some comments. Each nurse can put some 
comments and when GP come to review client it’s clear information because it can 
be about preference also monitoring.” (N12) 
Information about times for the medication 
This would not refer to all the times to give the medication, only those medicines 
that require special attention about when to administer them. This would help in 
identifying which drugs are more or less flexible to be administered within a time 
threshold. Participant N9 commented on this when she was given a chance to 
suggest any further additions to the I-MAG: 
“Timing, as if there was any problem with timings, you know. Some drugs have to 
be given at special times whatever for Parkinson’s drugs, etc. um maybe then if the 
timings were wrong…”  (N9) 
Information about compatibility with food and other drugs 
This would consist of additional information about how the tablets would interact 
with food or with certain foods and whether drugs needs to be taken with or 
without food. The lack of comments would offer reassurance to the nurses that 
there is no compatibility issues with the drug as only significant interactions would 
be highlighted: 
“Maybe things like the best thing to give it with obviously we do have things like 
with food without food but that’s not always but if somebody’s got 10 tablets to 
take I can’t go back 10 times (…) some things are more basic side-effects basic 
problems to look for not mixing that sort of thing yes.” (N2) 
Detailed information about the devices required for the administration 
A few participants highlighted how they were not sure about the accuracy of the 
measuring devices that should be used when administering medication and the 
effects of inaccurate measurements. It seemed that the nurses could benefit from 
having this information reflected in the I-MAG: 
“The carers were saying to me do we use a syringe or do we use a spoon and I 
couldn’t tell them and I said whichever you use just use one all the time if you’re 
going to use a spoon use it all the time if you use a syringe use it all the time don’t 
deviate but I didn’t really know just how accurate a 5ml spoon is.” (N2) 
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4.4.2.3.4. Location of I-MAGs 
It seemed relevant to our research topic to identify the best location of I-MAGs 
based on previous experience in the hospital. If I-MAGs were placed in an 
accessible location, the users could easily refer to the guides without being 
distracted from their duties and facilitating the identification of any necessary 
information as well as easing entries of new significant events. Participants all 
identified that the I-MAG should be attached to the MAR chart of the resident: 
“Um, I think this should be with their MAR chart because as we give the 
medication, we sign up that it’s given and if that is there or we have any doubts 
how to give it, so we can always refer back to the information there. I think that 
should be with the MAR chart.” (N13) 
4.4.2.3.5. Usability of I-MAGs 
I-MAGs were originally designed to be used by the permanent nurses in the care 
homes. The interviews revealed that, from the nurses’ point of view, the 
implementation of I-MAGs would be beneficial especially when new residents 
were admitted in the care home and the regular members of staff were not familiar 
with the behaviour and conditions of the resident. It seemed, based on the 
comments from participant N9, that I-MAGs could enhance the resident’s records 
with enough information to improve the administration of medication to new 
residents: 
“If it’s a new resident who’s come in and we need to (administer medication) and 
it’s not clearly stated in their records, then maybe that could be an 
improvement.”(N9) 
Participants expressed a very positive attitude towards the use of I-MAGs in the 
care home while also highlighting the specific benefit of implementing I-MAGs for 
times when the care home has to use “agency nurses”. The agency nurses were not 
always familiar with the care home or with the resident and the administration of 
medication was a bigger challenge for them as they did not often know all the 
details about the resident. Participant N3 commented the following when asked 
about this subject:  
“So even this will help when new staff come and does the medication first time isn’t 
it, because if it’s from agency or bank staff still it’s really helpful how to give 
medication for them you know, to have a brief idea. This is a brilliant idea really, 
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yes I think, more than this because it covers everything here what diet you know 
how to mix the liquid and everything yes (N3) 
According to participant N3’s comments, I-MAGs are a useful tool to 
communicate the information required about the administration of medication in 
hand-overs of shifts to nurses not familiar with the home or its residents. 
4.4.2.3.6. Impact of I-MAGs 
In order to explore the likely impact of an I-MAG service on the nurses’ practice, it 
was also necessary to recognise the effect of I-MAGs on care homes’ routines. The 
interviews revealed five areas of concern for the implementations of I-MAGs: 
- time of the administration during drug rounds, 
- standardisation of practice, 
- nurse’s clinical confidence, 
- skills of nurses, 
- residents’ health. 
 
Time of the administration during drug rounds 
In the care home environment, nurses did not count on immediate support of other 
professionals. It was highlighted by the interviewees that the guides could actually 
help reducing the time of administration as I-MAGs would provide a quick 
reference on how to administer medication correctly to each particular resident. 
When asked about the impact on the drug rounds time, participant N10 commented: 
“I think it might actually make that easier because you would know from the start 
what your plan was for that person and everyone else would know and so you 
wouldn’t be thinking each time how am I crushing this? What am I dispersing in it? 
How thick am I making the liquid to give them?  So I don’t think it would make a 
medicines round take any longer and hopefully it would help a little bit not make 
the problem shorter but run more smoothly maybe.” (N10) 
The comments of participant N10 indicated that, on some occasions, the decrease 
in time in the drug rounds maybe due to the absence of need to double-check the 
way of administering medication with other colleagues in the care home. In this 
way, the nurse or carer giving medication can concentrate in administering 
medication without distractions: 
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“Probably save time because if it’s written down on here I wouldn’t need to pop 
over and double-check with them (nurses in other wings of the care home).” (N5) 
It was also believed that I-MAGs could save time when the nurses have to do the 
hand-over from different shifts as the guides would contain any information needed 
for the administration and new comments about recent events in the resident’s 
health. Participant N13 commented on how laborious the handover was and how 
having I-MAGs in place would provide accurate and accessible information for the 
nurses on duty: 
“It takes longer to explain everything and even then you cannot explain everything. 
[…] It probably will be very useful for them to um, at least it (the I-MAG) will give 
them information at the time they need it say in the middle of the night, I don’t 
know they have to deal with certain medication or resident so if they don’t know if 
it’s there they always can refer to that and continue so I think it will help them.” 
(N13) 
In other cases, time was not always a concern for our participants, but the efficacy 
of the drug round. This however, would be reflected in a reduction of the time 
involved in completing reports and possibly in a more effective and accurate 
administration of medication as mentioned by one of the participants: 
 
“It’s not about reducing time, it’s about increasing efficacy and accuracy like I say 
sometimes when you’ve got complex regimes or complex ways of dispersing 
medication or whatever then to have accurate information about how to do that 
would reduce the likelihood of errors from a nursing point of view so it should 
reduce our incident reporting which is time consuming so yes it would definitely 
support our practice I think.” (N8) 
In summary, the participants’ comments in this section highlighted that I-MAGs 
had the potential to optimise the time involved in drug rounds while also enhancing 
that practice. The efficacy and accuracy of the information provided are factors that 
may determine the usability of the guides. 
Standardisation of practice 
It had already been noted that the lack of standardised guidance affected the 
administration of medication depending on the different practices of the nurses 
giving the medicines to the resident. Participants suggested that I-MAGs could set 
standards of practice within the care home so everyone would be administering 
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medication the same way. Our participants identified this as beneficial when 
challenging administrations appear as the guide would ensure that all members of 
staff carry out the same processes in the administration of medication to residents 
with particular needs as mentioned by participant N4: 
 
“It would be useful to know, to what extent they struggle and what works best for 
them because I find myself, you know, having to ask again and again and ah, if I 
could have that information to hand for individuals, that would be helpful.” (N4) 
Nurses’ clinical confidence 
Many interviewees identified ways in which the presence of I-MAGs could 
enhance their practice and increase their clinical confidence when administering 
medication to PWD.  Participant N8 commented: 
“If it comes direct from the pharmacist then you know, if it were signed, it would 
certainly help us to be more confident about what we give and how we are giving it 
because sometimes it is a bit awkward, you get something and it might have to be 
given in a particular way, but we’re relying sometimes on relatives for that 
information.” (N8) 
This comment also identified the importance of obtaining confirmation from the 
HCPs involved on the guidance provided in order to support the good practice of 
the nurses. 
Skills of Nurses 
There could be a point where excessive support could be detrimental for the 
nursing team by causing the alienation of individual capacity to make clinical 
decisions about their practice. Participant N4 commented:  
“I think it’s definitely useful. The only thing I can think of, the only downside is 
perhaps it, if this were used, sort of as standard perhaps it might, I don’t know, de-
skill nursing staff if they became reliant on a system like this. And, you know, 
reading the instructions, reading the instructions and not, hmm. That would be my 
only concern, but I think the benefits far outweigh that.” (N4) 
This comment is indicating that any guidance or support should always be 
implemented allowing certain flexibility to apply the clinical knowledge of the 
nurse if necessary, transforming that support on an educational tool rather than 
dictation.  
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Residents’ health 
When exploring the views of the participants on how I-MAGs could have any 
likely effect on residents’ health, several participants mentioned the difficulty in 
identifying any changes on residents’ health. Some participants suggested 
considering the medication administration error rates as a possible indication of 
improvement in care: 
“I think obviously it would maximise our efficiency or help to maximise our 
efficiency which it’s more from our point of view of reducing the likelihood of 
incidents and accidents of not giving people exactly the correct dose or not doing it 
in the correct way so obviously there would be a knock on effect and improvement 
in health.” (N8) 
In this quote, participant N8 is pointing out how current practice not only may not 
be very efficient, but also how that lack of efficiency may have affected the care 
received by the residents. This was identified as a direct link between efficiency 
and residents’ safety by our participant. 
Other participants considered that I-MAGs could have an impact on residents’ 
health related to medication adherence. According to participant N6, if adherence 
to the treatment was increased and aspiration of drugs was avoided, the chances of 
chest infections would be reduced. Participant N6 mentioned the following when 
asked about her opinions on the likely effect of I-MAGs on residents’ health:  
“Definitely. They’re getting medication they should be and properly, so yeah. And 
also, obviously, it’s telling you to use (brand of dietary thickener) and so, that’s 
also going to help um, preventing chest infections and things like that.” (N6) 
This comment still highlighted that the nursing team may not be necessarily able to 
identify the challenges of the administration of medication without guidance. When 
trying to explore ways of measuring the impact of our intervention on the residents’ 
health. 
4.4.3. Building the theory: DIAMMOND 
It was essential after obtaining the main codes, categories and themes, to identify a 
way to relate them in order to build our theory. The categories and themes that 
emerged during the previous part of the analysis took on different roles when 
constructing a model that could represent the reality of the administration of 
medication to PWD within the framework of our study. While many of the codes 
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were identified as substantive codes in indicating the substance of the experience in 
this research, it was the theoretical codes that integrated the way that the substantial 
codes may relate to each other and formed the framework for an emergent theory: 
“Theoretical coding, in establishing new connections that make ideas relevant is so 
often the new and original about theory.”   
Page 145, Glaser B.G.(361) 
 
Theoretical codes gave integrative scope, broad pictures and a new perspective that 
helped the researcher - as the analyst - to maintain the conceptual level in writing 
about concepts and their inter-relations. 
While the approach originally adopted navigated along the different components in 
a lineal structure to identify the emerging themes (Figure 17), the principles of 
grounded theory also informed a component approach that explores the relations 
between themes and sub-themes. For instance, one of the sub-themes linked to the 
professional development of the nurses was “confidence”. However, “confidence” 
could also be linked to “workload” and appeared to relate to and affect other 
themes like “interaction with healthcare professionals”. It was, therefore, more 
authentic and useful to change from a lineal thematic structure to an inter-related 
structure which can be visually represented by a Venn diagram in Figure 18.  
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Figure 17: Representation of the first analysis approach 
.  
 
Figure 18: Representation of the second analysis approach 
 
Further examination of these relationships between themes and sub-themes in the 
interviews helped the main researcher to identify four categories which the 
participants had recognised to have a direct impact on the administration of 
medicines to PWD. These were:  
- dysphagia awareness, 
- the formulation choices, 
- patients’ choice, 
- time spent with the patient. 
The reorganisation of the themes identified and the focus on categories with direct 
and indirect impact on the administration of medicines to PWD, provided an 
opportunity to represent a theory based model that had potential to explain the 
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interactions between all the themes that emerged from the analysis. This model is 
explained in the next part of this section (DIAMMOND). 
DIAMMOND: Designing and Improved Administration of Medication MOdel 
iN Dysphagia 
The analogy of our theory with a diamond follows the principle of a very complex 
structure in which our theoretical themes are highly dependent on each other. As in 
any crystalline diamond, not all vertices outlining the theory may be visible but this 
study tried to relate those that can shape the structure. 
The model is not a theory of direct cause-consequence, but a network of direct and 
indirect theoretical components that can shape the way that PWD receive their 
medication. DIAMMOND (Figure 19) aims to reflect how those components inter-
relate and which of them would be likely to be positively and/or negatively 
affected when changes in the current model of administration are implemented.  
The vertices of the DIAMMOND model are represented in Figure 19, in three 
“traffic light” code colours: 
- red vertices: to be avoided or decreased, 
- yellow vertices: likely to have both positive and negative implications for the 
relationship with other codes, not indicating changes without caution, 
- green vertices: generally found to have a positive effect on the administration 
of medication to PWD and, therefore, related changes in practice likely to 
enhance these vertices, could be encouraged. 
The arrowed links between the vertices indicate whether the interaction occurs in 
one direction (single arrow) or in both directions (double arrow). Dysphagia 
awareness, formulation choices, residents’ choices and time spent by the nursing 
team with PWD represent the four main components that compose the 
administration of medication to PWD. 
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Figure 19: DIAMMOND Model 1 2 
  
                                                   
 
1 The DIAMMOND model contains the four categories identified as directly related to the 
medicines administration to PWD (dysphagia awareness, formulation choices, patient’s 
choice and time spent with PWD). All the direct and indirect categories are colour coded: 
green represents positive outcomes; yellow represents caution when affecting that category 
and red when changes affecting that category should be avoided.  
2  The model suggests practice-based direct and indirect conceptual links between 
theoretical components that can shape the way that PWD receive their medication but it 
does not imply a theory of direct cause-consequence.  
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The following examples are presented to gain some understanding about the 
practicality of this model. In continuation with the previous chapter of this thesis: 
- example 1 illustrates the effect of one of the main differences from the 
hospital which is the isolated location of the care home, 
- example 2 will illustrate how the implementation of an intervention similar 
to the one introduced in the hospital in chapter 3, could fit within the care 
home. 
Example 1: The scope of the role of the nurse in the care home may be affected by 
the location of the care home. That role will required specific training that will 
enhance the professional experience of the nurse, their knowledge and their 
confidence in practice. However, the implementation of that training may increase 
the workload of the nurse. This is in addition to the heavy workload that may be 
conditioned by the location of the home. Heavier workload may divert the attention 
of the nurse from accessing care plans and identifying dysphagia, as well as 
affecting the time spent with the residents. These interactions can ultimately be 
reflected in the administration of medication to PWD. 
Example 2: If we wanted to implement an intervention to improve the 
communication between primary care and secondary care through more accurate 
information in care plans for PWD, it is likely that it would increase the awareness 
of dysphagia in the care home and would enhance the formulation choices for the 
residents and their administration. However, it would also be likely that such 
intervention had an impact on the nurses’ workload (i.e. challenging formulations, 
more frequent access to care plans required, etc.). That impact (positive or negative) 
on the nurses’ workload and other interactions could be identified prior to 
implementing the intervention when following the DIAMMOND model. 
 
4.5. Discussion 
4.5.1. Making professional resources more accessible to nurses 
From the interviews with the participants, it seems that the care home environment 
may lack  professional resources (workforce) and that this could be compromising 
the care to PWD by not including enough nurses in the team, causing the important 
responsibility of administering medication to often fall on a single person in the 
unit or even on the care home. Additionally, the reliance on temporary and locum 
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staff and high turnover means that institutional memory and good practices are 
quickly lost. 
The results of this study point out that recruitment and retention of staff, and 
education and training were priority issues believed by nurses to influence the 
quality of care they could deliver. These results bear out previous literature that 
also identified financial constraint as the main cause for the lack of resources.(362) 
Besides the financial constraints, the interviews outlined other limiting elements 
not previously identified by the literature, such as the location of the premises and 
the professional isolation of the care home environment that make the provision of 
enough qualified members of staff in the home less accessible. 
This study also identified that the lack of training for staff adds to the extreme 
pressure on the workforce often leading to poor staff morale. This has also been 
recognised by a recent report published by the Royal College of Nursing that 
outlined how nurses working in care homes are facing huge challenges in providing 
care for people(363) as there are not enough full time registered nurses employed and 
they did not have adequate training, equipment and medical supplies to meet 
residents’ needs. 
While the main role of nurses clearly remained the care for residents, the study 
participants highlighted how this role had evolved into a role where reports and 
feedback about the residents’ care are drastically increasing nurses’ workload and 
could potentially affect the quality of care provided by reducing their time with the 
residents. In particular, PWD need more specialised care. They often require 
compensatory strategies such as dietary modification, postural manoeuvres and 
postural adjustments therapy(17, 104, 105) and this can add extra pressure to the 
administration of medication on the nurses in charge. The care of PWD requires 
much individualised guidance based on a standardised practice from the nursing 
team, but multiple elements such as background, training and approach towards 
changes challenge the implementation of standardisation of care.  
This research suggests that the care of PWD could be enhanced by: 
- implementing methods that improve and encourage  the access of nurses to 
care homes remotely located, 
- incorporating changes that standardised practice in the administration of 
medicines, 
Exploring the current model of administration of medication to PWD and the 
acceptability of changes 
 
Page 207 of 380 
 
- optimising the time spent on completion of reports and the time involved in 
direct care of the resident. 
4.5.2. Communication between healthcare professionals 
Many efforts are being made to improve the transfer of residents between 
secondary care and primary care as well as to assess the care received in the care 
homes.(363,364) The NHS provides general guidelines on the design of a care plan at 
the time of discharge and also provides advice for the carers.(365) However, these 
instructions are only informative and its execution, according to our participants, is 
not always standardised or what is more important, adapted to be received by the 
care home. 
The involvement of multiple professionals in the care of PWD tends to reveal 
communication problems in the care home environment due to the lack of 
synchronised interaction between these healthcare professionals. This is as well as 
the challenges faced on the communication between primary and secondary care 
when residents are transferred from hospital or acute units to the care home and 
vice versa. The participants identified issues such as not questioning current 
practice or over-riding practices implemented by other professionals, as described 
by participant N5 in section 4.4.2.2.1. These issues (as mentioned by the 
interviewees) revealed frictions between primary and secondary care that were 
eventually reflected in a lack of standardisation of the care of PWD between 
primary and secondary care settings. In addition, it is important to explore 
decisions made in secondary care as GPs tend to follow these without question. 
These challenges were already highlighted in studies by Kelly & Wright(317) and 
Cornish,(165) mentioned in chapter 2, and suggesting that systems for close 
communication between doctors, SALTs, nurses, and pharmacists need to be 
developed in order to minimise adverse events related to inappropriate 
administration of medicines to PWD. The implementation of a pharmacy service 
providing guidance - like the one presented in I-MAGs - was identified by the 
participants as a beneficial tool to improve the communication between HCPs. This 
matches the suggestions by Kelly & Wright(317) for the need to employ a HCP with 
an interest in dysphagia to liaise with all the professional groups involved. This 
HCP could develop and evaluate policies and procedures, before cascading them 
throughout the hospital and local community Trusts so as to improve care for this 
client group. 
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It could be added to the argument, however, that some of the communication 
problems are due to wrong expectations of the communication between HCPs as a 
result of the lack of awareness of who is the best person to refer to when challenges 
arise. A study carried out by Dean et al(366) where prescribers were interviewed 
after making a prescribing error, revealed that many doctors considered the task of 
prescribing was unimportant, and they expected that pharmacists would check and 
correct the doctors’ prescriptions. This is in contrast with what our participants 
highlighted about how often they needed to contact the GP in order to get 
permission to tamper with medication. When we consider that the pharmacist is the 
professional with the highest level of expertise in drugs and their administration, 
the pharmacist should be the first line of advice to be sought. On the contrary, the 
participants revealed that the pharmacist is often excluded from the nurses’ 
enquiries about medication and the doctors’ recommendations on their 
administration. 
The fact that medicine management in PWD lies on the inter-professional 
boundaries means that it risks being marginalised.(367) When responsibilities are not 
clearly designated or seen as central to one’s role and professional identity(367) they 
may be missed as each professional assumes the other is taking responsibility. In 
consequence, the workload of the healthcare professionals is sub-optimally 
increased, their expected roles are not developed and what is more important, the 
resident is not receiving the most appropriate care. Some comments indicated a 
total transfer of the liability of recommendations on the care of patients from the 
SALT to doctors or other HCPs. The SALT was sometimes perceived by the nurses 
as someone perhaps with less authority in their recommendations, but bringing a 
much more personal (rather than professional) approach with ‘off-record’ opinions. 
The results of the study, therefore, suggest that, while standardised systems in the 
transfers between primary and secondary care could be beneficial for enhancing a 
continuous high quality of care of PWD, it is also very important to delineate the 
basic end roles of all the professionals involved in the care of residents in order to 
optimise the interaction between these professionals. 
4.5.3. Setting standards of practice 
Nurses in care homes are the professionals who spend more time in direct contact 
with the residents and they play an important and continuous role in observing any 
changes in the health of the residents. With such an important task as the direct 
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care of residents, it is important that the nurses count on the appropriate training, 
knowledge and experience to deliver the expected level of care in the home. 
Some participants identified as a problem the lack of standardised practices in the 
care home. This problem was further compounded by the fact that in order to give 
many PWD any medications at all, unlicensed medicines need to be used, without 
full knowledge of the effects of their actions. This issue was also identified by the 
literature.(189) 
The Care Quality Commission (CQC)(126) set national standards of care that are 
classified as essential when receiving care services. When referring to safety, the 
CQC requires that residents receive the medicines they need, when they need them 
and in a safe way and it will be performed by members of staff that have the 
knowledge, skills and experience needed to meet the residents’ health and welfare 
needs. However, it could be argued that the provision of care always complies with 
these standards based on comments from our participants who did not always have 
the knowledge, the skills or the confidence to carry out a complex task like the 
administration of medication to PWD. This lack of confidence could also be a 
reason for the participants not being able to challenge other professionals that they 
may consider ‘above’ them such as doctors, pharmacists or even nurses in 
secondary care at the time of making basic clinical decisions on the administration 
of medication. Enhancing the clinical confidence of nurses is a hard task that may 
require achieving a balance between receiving expert guidance and applying their 
own clinical judgements. Conversely, there is a tendency from the nurses to assume 
that they know better because they are in closer contact with the resident.  
The participants also identified that the drive for good practice was not always the 
clinical knowledge, but the fear of legal action when a clinical error is made. In this 
case, the fear could result in under-reporting of errors and the subsequent loss of 
the ability to learn from it. 
In connection with previous discussion, it has been highlighted by the interview 
participants how the lack of standardised practice between nurses due to different 
training, experience or approaches can inefficiently increase the workload of the 
nurses and have negative consequences for the quality of care received during the 
administration of medication to PWD.  
The participants also commented about the view that regulatory bodies recommend 
high standards of care, but these standards do not necessarily articulate values like 
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sympathy, patience or closeness to the resident. Those regulations may be over-
riding an area of personal conflict for the nursing team where these values are 
essential to the care of the residents. Introducing these human values as stated 
policy, then to be enacted in practice may however lead to an increase in the 
workload of the nurses and their professional pressures. Conversely, these 
perceptions of human values open another component of caring and it calls into 
question whether nursing as a profession may be becoming detached from the 
human side of care (from which it originated) and moving into a more technical job 
focused on complying with regulations and policies. 
This piece of research highlights the importance of setting standards of practice in 
the administration of medication to residents with dysphagia, but beyond that it 
identifies that the implementation of changes, training or other processes that are 
designed to enhanced the skills of the nurses or the clinical confidence in their 
practice, could potentially have a negative effect on their workload that would also 
be reflected in the care received by the residents. It is, therefore, important to 
analyse the effects that new services have on nurses’ workload in order to ensure 
that the likely benefit for the residents outweighs the negative impact on nurse 
practice.  
4.5.4. Individualised resident care 
The care of PWD requires a highly individualised approach in the various aspects 
of their care such as the administration of medication.(155) Our participants 
identified the importance of recognising the residents’ conditions and their personal 
choices and approaches towards medication in order to communicate it to other 
members of the nursing team and other healthcare professionals. This 
individualised care was anticipated in chapter 1 where studies identified the 
perception of nurses on having to closely monitor medications(226) and the 
relevance of providing individualised resident care by the nurses.(224, 228) 
Participants recognised that not all residents will necessarily fit into clear models of 
care and considered that it is essential to obtain a detailed history of the presenting 
problem and how it is managed to ensure that the most appropriate course of action 
is taken. This information should come from family members, professional care-
givers from residential or care homes with nursing, and ward or community health 
teams.(367) A structured approach to information gathering, assessment and 
management was outlined in the literature review with practical application in 
recently published guidelines and research evidence, which ensures appropriate 
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individualised care.(215, 313) As described by our participants and the literature 
reviewed in chapter 1, an approach which considers ethical, legal and cultural 
issues surrounding the individual, and not solely the diagnosis, is needed.(367) The 
interviews revealed concerns about establishing the preferences of the residents 
with regards to medication (section 4.4.2.2.5.), and, therefore, as part of the 
individualised care of PWD, it should be established whether the resident has 
capacity to make advanced decisions on the management of the medication or has 
appointed someone to make healthcare decisions on their behalf, should they lose 
capacity. 
It was believed by the interviewees that this increase in the awareness of dysphagia 
has a likely beneficial effect for the resident but it is important to highlight that this 
information should be reflected upon and made accessible to all of the 
professionals involved in the care of the resident with dysphagia. When 
considering the workload of nurses and the other members of the healthcare team, 
the participants identified that information about the residents’ medical conditions 
should be held in a very accessible location. The suitability of the care plans to ease 
the access to the information about the resident could be argued as these plans are 
not reviewed by the nurses daily. When taking into account that the medication 
chart is accessed at least once a day, this location could be optimal for identifying 
significant events related to the administration of medication that need to be 
communicated to the rest of the team. 
4.5.5. Awareness of the available formulation 
As described in chapter 2, the formulation of the medicine is as important for PWD 
as the active ingredients(155) and, therefore, it is vital to ensure that each resident 
has an individualised medication regimen. 
Participants recurrently described how obtaining alternative formulations 
prescribed for the residents was a challenging task and how, most of the time, this 
also excluded the pharmacist from that interaction. In agreement with the research 
presented in chapter 1 that identified that prescribers are not always aware of the 
availability and cost of the prescribed formulations,(228) the participants also 
identified that, in their opinion, the pharmacist was the HCP that would hold the 
most expert knowledge regarding the availability of different formulations. 
Although the interviews revealed that the pharmacist was frequently not the first 
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line of help, they agreed that it should be the pharmacists’ role to introduce the 
available formulations to the prescriber when dysphagia is identified. 
The participants also showed a preference for the administration of liquid 
medication for PWD based on the easiness of administering such formulation. 
Although liquid medicines have their advantages and are often recommended as 
the solution to putting drugs through feeding tubes,(321, 370) their viscosity can also 
be a problem and dispersible and orodispersible tablets may be more suitable. 
These issues were not considered by the nurses possibly due to the lack of 
pharmaceutical knowledge. 
4.5.6. Expanding the role of HCPs 
The provision of care to PWD is complex in its own nature. It requires the input of 
different healthcare professionals in order to provide adequate individualised care. 
While in the hospital environment, the communication and interaction between all 
these professionals is close and immediate, the participants highlighted during the 
interviews that the care of residents in care homes is a very different situation. In 
the community, these professionals come from the private and the public sector; 
they are conditioned by different budgets and guidelines and often from locations 
of difficult access to the care home. Synchronising the work of these professionals 
is seen as a very hard task.  
Several participants explained that some residents spat or chewed their medication. 
While this could be indicating that dysphagia is not being identified, healthcare 
professionals need to find out if residents have problems swallowing their 
medication and, if so, exactly what they are.(370-373) The pharmacist has the potential 
to play an important role in the identification of dysphagia recognising those issues, 
especially as residents are not always forthcoming about their problems. Wilkins et 
al(374) found that 46% of PWD do not tell their doctor about the problem and 
hypothesised that the data reflects the continuous process of problem definition that 
occurs as residents translate symptoms to problems in need of medical help. 
Therefore, the challenge for professionals is to identify resident problems in 
partnership with them and then fit the service to their needs.(375) 
As models of dysphagia assessment and management are often derived from the 
stroke population,(101, 302-304) the participants identified how they gradually have 
become more detached from the basic assessment role of dysphagia. An early 
pharmaceutical assessment of the medication taken by the resident as part of the 
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guidance provided to care homes was seen by the some of the nurses interviewed 
as a beneficial intervention that could improve the understanding of the properties 
of the various preparations. The literature has previously identified that this 
intervention could reduce the risk of adverse drug events.(165) 
The comments from some participants indicated their lack of understanding of 
dysphagia and suggested that PWD were less likely to receive an assessment from 
a SALT when suffering from mild difficulties with swallowing. This finding may 
point to the need of implementing basic assessment tools for nurses to enable them 
to accurately identify when to refer, which professional to refer to and what actions 
to take whilst awaiting support and guidance. 
The preference for liquids and the concerns discussed previously in this section 
may be highlighting that the pharmacist could develop a role in training nurses and 
other HCPs in the best use of medication, expanding not only the role of 
pharmacists and their expertise, but also developing specialised nursing roles 
within the care homes based on frameworks like the IDF mentioned in chapter 1. 
Also, it offers an opportunity to encourage the advising role to the prescriber as 
identified in the literature review. 
4.5.7. Relating the DIAMMOND model to literature 
The saturation represented by the numerous instances in the data and the selective 
coding provided the empirical evidence to identify theoretical codes and 
relationships to ground this more comprehensive theory. However, in order to 
indicate how this theory contradicts, confirms or extends existing theories, any 
emerging theory needs to be integrated with the existing ones in the field. 
The scope of our theory is difficult to specify as no literature has been found which 
identifies a nurse’s view of the factors affecting the administration of medication to 
PWD. Nevertheless, it is important to consider that the description and 
interpretation of our theoretical codes and relationships contain a substantive focus 
that may be enhanced by reviewing other theories on the same substantive level.   
Several studies and theories identified various concepts of this suggested theory in 
the literature, some indicated in Table 23. The high level of specificity to the topic 
of the model did not allow the main researcher to identify or compare current 
theories and concepts integrated in DIAMMOND such as how the administration 
of medication to PWD is affected by the emotional workload of the nurses, or how 
the location of the care home can indirectly affect the care provided to its residents.   
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Relationship Examples of Relevant Literature 
Communication 
between yrimary and 
secondary care 
Kripalani et al(351) highlights the need of standardised 
summaries and how the deficits in communication and 
information transfer at hospital discharge are common and may 
adversely affect resident care. 
Paterson(45) indicated the importance of how primary care 
physicians must be aware of  the role of non-specific treatments 
offered by other health professionals to improve residents’ care. 
Dysphagia awareness Young & Durant-Jones(131) identified how the improved 
communication between professionals in primary care increases 
the awareness of dysphagia and enhances residents’ care. 
Time spent with PWD 
and resident care 
Bates-Jensen et al(376) observed how the time spent with 
residents in care homes was mainly conditioned by the 
workload of the members of staff and conditioned the quality of 
care of the residents. 
Nurses’ training and 
workload 
Werner(377) identified the benefits of specialised training for 
nurses. However, there are no remarks about the impact of the 
training in the workload of the nurses. 
Formulation choices 
and residents’ choices 
Kelly et al(155) highlighted how PWD required better 
communication with healthcare professionals and how PWD 
could benefit from being aware of other formulation choices. 
Table 23: Relating the new theory to literature 
 
4.5.8. DIAMMOND and I-MAG: implications for our research 
question 
It was implied in our research questions that the implementation of any changes in 
current methods of practice requires the prior identification of the theory on the 
administration of medication to PWD, before implementing any changes aimed to 
enhance its delivery. 
The development of the DIAMMOND model in the administration of medication 
to PWD in care homes provided an opportunity to highlight elements that had not 
been identified before, as well as to theoretically predict the potential impact of the 
implementation of services and changes to the current model of practice before the 
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actual empirical implementation. Therefore, it seems appropriate to discuss how 
implementing I-MAGs could theoretically affect current practice within the 
framework of our model. 
The comments from the participants revealed that the design of the guides should 
be optimised in order to be an accessible document, not only to the nurses, but to 
other healthcare professionals whose input could be reflected in I-MAGs. When 
located within the MAR charts of the resident, it should contain significant 
information that may already be reflected in the care plan regarding the dysphagia 
directly or indirectly related to medication, but it will also be an opportunity to add 
any additional events related to the swallowing function of the resident. The nurse 
participants identified themselves as first-line professionals when recognising any 
changes in the residents’ ability to swallow and, therefore, the reflection of those 
changes in the I-MAG could increase the awareness of other healthcare 
professionals on the presence and development of dysphagia. 
The guides would also serve as a tool to identify appropriate formulation at all 
times. When any changes in the resident’s condition are reflected in the I-MAG, 
the nurses, pharmacist, SALT or GP could apply changes to the formulation or 
refer the case to another professional for immediate action. 
Residents’ approach towards medication, and how nurses perceive it, are some of 
the main limiting elements affecting the administration of medication to PWD as 
mentioned by the participants. The lack of capacity from the resident, reluctances 
to change and the impact of the residents’ behaviour on the emotional and physical 
workload of the nurses should be considered in the decisions of the prescriber at 
the time of choosing a particular formulation. However, the presence of I-MAGs 
could potentially reduce the effect of this limiting element by providing a clear set 
of information relevant to the resident which could potentially increase the 
awareness of the level of the current swallowing problem.  
This research identified serious concerns from the nurses about the liability of 
manipulating medication. The difficulty of coordinating information and policies 
about altering medications(199) had already been recognised in the literature, but our 
participants  also remarked that those concerns were reflected in lower confidence 
in their practice. The clinical and legal liability of drugs administration may have 
become a concern for practice when nurses were not confident on what was the 
best way of administering medication, according to their comments. Nurses might 
often have to query this and some participants even resorted to obtaining 
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information from the residents’ relatives. I-MAGs would not only contain precise 
and individualised instructions on the administration but also would include 
signatures of other healthcare professionals agreeing with that practice to provide 
reassurance to the nurse administering the medicines.  
Although it was highlighted by our participants how the presence of I-MAGs could 
reduce the time of the drug rounds by not having to contact other members of the 
team, searching information on how to administer medication, etc., this is not the 
primary aim of the guides. The nurse participants highlighted how important it is to 
get to know the resident and hence I-MAGs would provide enough information to 
help them understand their residents’ preferences and how to safely and efficiently 
administer medication so they could focus on spending more time actually with the 
resident. 
The implementation of any changes in current practice may require some training 
sessions for the nurses and, possibly, to other professionals involved. In the case of 
I-MAGs, nurses would expect short sessions explaining the rationale behind the 
use of I-MAGs and the implications of the use of the guides. Although some 
clinical or administrative issues may have to be covered by the training, the 
participants found I-MAGs very understandable in concept, as the guides are in 
their nature a training tool and an intervention simultaneously.  
The implementation of I-MAGs was perceived by our interviewees as a learning 
and practical tool that could increase the clinical confidence when administering 
medication and could also help coordinating the care of residents when they are 
moved between services. Although at this stage the value of the implementation of 
I-MAGs in care homes is virtually theoretical, it is, in essence, an intervention very 
closely related and focused on meeting the essential national standards set by the 
CQC and by requests of recent reports from the RCN(363) that recommended: 
- re-evaluation of how funding is allocated to cover the needs of residents in care 
homes, 
- national guidance on staffing levels and ratios for care homes, 
- a government review of care home workforce planning and to ensure that this 
workforce is appropriately supported, trained, qualified and valued. 
This discussion is, therefore, suggesting that the implementation of I-MAGs could 
be positively received within the care home as, theoretically, the components of 
such an intervention take into consideration similar interactions to the ones in the 
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design of DIAMMOND where the ultimate aim is the care of PWD.  However, the 
model only represents theoretical interactions and, therefore, a practical 
observation of the problems that challenge the medication management of PWD in 
care homes should be considered as a method of triangulation. 
4.6. Limitations and strengths of the research 
The volume of data obtained, and the structured methodological process followed 
in analysing it, are strengths of this work. Credibility was enhanced by the 
interview techniques which encouraged the participants’ openness and provided 
sufficient information to identify the current model of practice in the administration 
of medication to PWD from the perceptions of nurses in care homes. The structural 
coherence of the grounded theory method (generation of codes, construction of 
categories, statements of relationships and scoping of the theory) helped to identify 
the true values. Data triangulation with current theories and the density of the 
sampling also increased the credibility of the research and the valid interpretation 
of the data.  
The sample was selected purposively to represent relevant characteristics of the 
general group such as experience, background, nationality and location. The 
description of the settings, approaches and contextualised findings increase the 
transferability of this suggested theory. While the generalisability of this suggested 
theory could be strong within the UK, and possibly countries with similar health 
systems, it is questionable whether it could be generalised to locations where the 
variables of the sample reach different components or new variables need to be 
included. 
It would be difficult with these study data and findings to further extrapolate the 
relationships between our theoretical codes to apply these categories to different 
fields or populations, i.e. nurses working in hospitals have a very different 
interaction with the other HCPs than those in our sample, or older residents in their 
own homes where they are usually also cared for by a relative instead of by only a 
nurse. 
The generation of codes and categories was carried out manually without the aid of 
any computer software. While the strength of this laborious process enhanced the 
immersion of the main researcher in the data, it could be argued how this affected 
the level of abstraction from the data at the time of generating the theory. For 
example, “formulation choices” is a theoretical code closely related to our research 
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question and present in the model despite other codes that appeared more often 
could not necessarily be represented in this suggested theory. The (manual) process 
of analysis is long and slow which may also trigger omission of significant 
information during the generation of codes.(336) To minimise these limitations and 
secure the rigour of the analysis, blind generation of codes by one academic 
supervisor was carried out and compared with a small number of interviews 
analysed by the main researcher. 
4.7. Conclusions 
The administration of medication to PWD is a complex process defined by 
numerous elements such as the care home environment, the interaction between 
healthcare professionals, the nurses’ heavy workload, the professional development 
of the nurses and the residents’ health conditions. 
The interaction between these components may have an impact on the awareness of 
dysphagia, the formulations chosen for the administration, the choices made by the 
resident regarding their medication and the time spent by the nurses with the 
resident during the administration.  
The current health system could benefit from extending the role of the 
professionals involved in the care of PWD in order to maximise the use of the 
expertise of multidisciplinary teams through novel interventions like I-MAGs. A 
greater involvement of the pharmacist in the care of PWD may improve the 
knowledge of nurses in care homes and enhance the interaction with other HCPs 
like GPs and SALTs. 
I-MAGs are identified as a tool that is likely to reduce the workload of nurses in  
care homes by optimising the time spent in communicating with other healthcare 
professionals and increasing the clinical confidence of nurses in the administration 
of medicines to PWD. These guides can be used as a tool to enhance the clinical 
confidence and experience of the nurses and to increase the awareness of dysphagia. 
I-MAGs have not yet been proven to have an effect on resident’s health, but they 
could offer a step toward providing standardised practice and individualised care. 
The guides may also improve prescribers’ awareness of available formulations in 
the residents’ medication which enhances the assessment of personal needs 
suggested by the CQC(126) as essential for the promotion of good resident care. 
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While reducing the heavy workload of nurses and its impact on PWD remain a 
challenge in care homes, the DIAMMOND model may help to identify the 
theoretical effect of implementing interventions that can improve the 
administration of medication to PWD. 
The theory highlighted by the DIAMMOND model identified several implications 
for PWD that had not been explored in the current model of practice. Despite the 
fact that the communication between different settings and professionals had 
historically been identified as a concern with potential consequences in the resident 
care, other elements more indirectly related like the location of the care homes and 
the enforcement of updated policies, can also have implications to the services and 
the care received by the residents.  
The DIAMMOND model could be enhanced by the observation of drug rounds to 
residents with dysphagia in care homes in order to test the applicability of the 
model as well as to identify other elements that may affect the administration of 
medication to PWD that a qualitative approach may not have recognised. 
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5. Observation of drug administrations in care homes 
While exploring the perceptions of HCPs can provide a strong theoretical 
component for the development of a complex intervention, researchers should be 
aware of their limitations and interpret and present the findings with due caution 
when non-experimental methods are used.(1) As identified by Rutter (2007)(378) 
wherever possible, evidence should be combined from different sources that do not 
share the same weaknesses. 
The relevancy of combining quantitative and qualitative methods during the 
development and evaluation of a complex intervention has been strongly 
recognised in the last few years.(1, 2, 7, 9, 14) Campbell et al(2) described the strengths 
of this approach: 
“Although these trials pose substantial challenges to investigators, the use of an 
iterative phased approach that harnesses qualitative and quantitative methods 
should lead to improved study design, execution, and generalisability of results.” 
Page 696, Campbell, Fitzpatrick et al. 2000(2) 
The following study will contribute to the development of a pharmacist-led 
intervention, by identifying a range of measures that may be needed for our 
intervention and specifying a required degree of adaptation to local settings, see 
Figure 20. 
  
Figure 20: Developmental components of an intervention (Craig et al. 2008, page 980)(1) 
Feasibility and piloting 
• Testing procedures 
• Estimating recruitment and 
retention  
• Determining sample size 
 
Evaluation 
• Assessing effectiveness 
• Understanding change process 
• Assessing cost-effectiveness 
 
Implementation 
• Dissemination 
• Surveillance and monitoring 
• Long term follow-up 
 
Development 
• Identifying the evidence base 
• Identifying or developing theory 
• Modelling process and outcomes 
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5.1. Introduction 
The problems identified in hospital wards when administering medicines to PWD 
were related to errors such as giving medicines unlicensed when licensed 
alternatives were available. Other errors involved processes associated with the 
preparation of medicines which could be optimised. A qualitative analysis of the 
perceptions and experience of nurses in care homes outlined common challenges to 
those found in hospital as well as other elements more specific to the care home 
environment. However, the empirical identification of the difficulties experienced 
on the administration of medication to PWD by nurses in care homes and the extent 
of such problems has not been explored. It would also be helpful for the researcher 
to identify if there are situations in which administering medication becomes more 
challenging and results in medication administration errors as a consequence of 
sub-optimal prescribing. Identifying these issues and the nature of the errors could 
help to enhance the administration process, to estimate the effect of nurses’ 
decision- making and poor formulation choices, and to recognise any other 
constraints of the environment. Such information could contribute to the 
development of training packages for HCPs. 
The approaches to these human errors applied in healthcare organisations have 
been thoroughly discussed in the literature. Reason (2000)(263) described how the 
human error problem could be viewed in two ways: the person approach and the 
system approach. Each has its model of error causation and each model gives rise 
to quite different philosophies of error management.(263) While it would appear that 
nurses are more susceptible to blame than other professional groups, especially 
from their colleagues,(379, 380) several approaches to error theory recognise that the 
contribution from those involved at the sharp end in a given error is likely to be just 
one component of causation.(381) Reason (2000)(263) addressed some of the key 
principles in a summary overview and concluded that the differences between two 
approaches have important practical implications for coping with the risk of 
mishaps in clinical practice. This theory was followed by other more 
comprehensive papers from medical practitioners such as Pani et al (2004)(382) and 
psychologists such as Parker & Lawton (2003)(383) which supported the system 
approach by recognising that errors are a consequence of the systems in which 
humans work. Other authors focused on the theories in identifying mechanisms that 
avoid errors. Leape et al (1994)(384) identified five specific mechanisms that should 
be used to avoid errors: reduced reliance on memory, improved information access, 
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error proofing, standardisation, and training. A more recent publication by 
Amalberti et al(384) described five systemic barriers that can lead to a safer 
healthcare system: 
- acceptance of limitations on maximum performance, 
- abandonment of professional autonomy, 
- shift from a hierarchical mind-set to professional equivalence, 
- system leadership, 
- simplification of professional rules and regulations. 
Human error theories have traditionally been associated to a cause analysis of 
errors. However, as outlined by Armitage et al,(381) error theory can also have 
applications in the management of errors in the nursing profession. This paper 
explained how error theory can: 
- provide a framework for incident analysis and even feedback that considers the 
individual’s behaviours in conjunction with the other factors discussed above, 
- systematise the resultant action taken, 
- review any changes to reduce the likelihood of similar errors recurring , 
- identifying priorities in education and training or, if more appropriate, personal 
supervision. 
These applications of error theory are related to the development of interventions in 
health organisations and, therefore, the following study presented will focus on 
describing the type of errors observed and will discuss the applicability of error 
theory to the development of pharmacy interventions for PWD. 
5.2. Aims and objectives 
The aim of this study is to describe the quality, type of errors and frequency of 
errors in the administration of medication to elderly residents with dysphagia in 
care homes. 
The objectives of this study are to identify: 
- the methods used by nurses and carers in the administration of medication to 
residents in care homes that suffer from dysphagia or receive medication via 
enteral feeding tubes (EFTs), 
- the medicines administration error rate in PWD and without dysphagia, 
- the approaches when prescribing to PWD where medication choices could 
potentially be improved to enhance the administration process. 
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5.3. Methods 
5.3.1. Declaration of funding and liaison with collaborators 
The study presented was designed by the author of this dissertation with the 
intention of exploring the practice of administering medication in care homes. Due 
to the cost of this research, external financial support was sought. A pharmaceutical 
company (Rosemont Pharmaceuticals), who had previously expressed interest to 
UEA for research in swallowing difficulties, was approached. The main supervisor 
connected the main researcher with GPs in North Yorkshire who had contacted him 
through a joint meeting arranged by Rosemont Pharmaceuticals. As a result, a 
meeting was arranged in North Yorkshire in November 2011 where the main 
researcher, the two GPs and a representative from Rosemont Pharmaceuticals 
attended and agreed to support the processes required to carry out the research. The 
study was fully funded by Rosemont Pharmaceuticals as agreed in December 2011 
(see page one of agreement of funding in Appendix 28). The grant was an 
unrestricted education grant and, therefore, the company had no input in the design 
of the project or in the data analysis. 
5.3.2. Collaboration of care homes and recruitment of participating 
nurses 
Registered managers of care homes within the North Yorkshire Primary Care 
Research Network and receiving services from two medical centres in York (UK) 
interested in research on PWD, were contacted to describe the nature of the study. 
The project was also communicated to other GPs via the local Primary Care 
Research Network (PCRN) in PCRN meetings to give them the opportunity of 
engaging with this research in their practices and the care homes that they provide 
care to. Medical practices that demonstrated an interest in the study contacted the 
registered managers from care homes that received care from any of those medical 
practices.  Any other GP practices that were willing to collaborate in this study 
were also invited to participate in the research to allow the main researcher to 
follow the nurses or carers while administering medication to PWD in drug rounds. 
Figure 21 shows the study development and recruitment flow. 
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The GP practices sent to the registered managers of the care home: 
- a letter to explain the nature, aims and implications of the study, 
- an information sheet, 
- an example of the consent form for the potential participants, 
- an initial contact acceptance letter addressed to the main researcher, 
- a pre-paid envelope to help maximise the rate of response addressed to the 
main researcher.  
In the letter describing the study (Appendix 29), the registered manager was asked 
to inform the nurses and carers in the care homes that there was the opportunity to 
participate in the study. Coercion from the researcher to the participants was 
avoided this way as the registered managers were only informing the participants 
about this opportunity and making it clear that they were free to decide whether to 
take part or not. 
The information sheet explained the topic and organisation of the study, its aims 
and the implications of the study for the potential participants who wished to take 
part (Appendix 30). The registered managers also received an example of the 
Liaison with collaborators 
Expression of interest 
from GPs and care 
homes within PCRN 
Ethical                
approval 
November 
2011 to June 
2012 
 
Data analysis 
Observational drug rounds 
Recruitment of participants 
Provision of information by the researcher to  
interested care homes  
July 2012 to   
beginning of 
August 2012 
August 2012 
September 
2012 
Figure 21: Study development and recruitment flow chart 
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consent form that the potential participant was also offered previous to the drug 
round (Appendix 31). 
The initial contact acceptance letter was sent back to the main researcher from the 
registered manager as a confirmation that the registered manager agreed to be 
contacted by the main researcher. The main researcher then provided further 
information on the study to the registered manager and potential nurse participants 
and arranged the consent and the time for the drug rounds with the nurses and/or 
carers if the care home had shown interest in participating. 
If no reply from the registered manager was received within two weeks after 
sending the invitation, a reminder letter with the same content was again sent to the 
home. If again no response was received, no further letters were sent. 
At the time agreed with the registered manager and before the observational drug 
round and after the registered manager of the homes had accepted to participate, 
the nurse or carer was given: 
- an invitation letter (Appendix 32), 
- an information sheet about the study (Appendix 30), 
- a consent form for being observed whilst administering drugs (Appendix 31) 
that would only be collected at the time of the observation. 
The researcher allowed one week between sending the participant information 
sheet to the nurses and the time of the observation. It was planned that two 
observational drug rounds would take place in each care home on different days 
and where possible, with different members of staff.  
The care homes were then selected based on the following inclusion and exclusion 
criteria: 
Inclusion criteria:  
Care homes were eligible if they received services from any GP practice within the 
North Yorkshire Primary Care Trust and: 
- the responsible nurses or carers were in charge of administering medication to:  
• PWD, 
• residents that required the use of enteral feeding tubes, 
- the care home was located in the area of coverage of the North Yorkshire 
Primary Care Research Network, 
- private care home. 
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Equally to the previous study in care homes mentioned in this thesis (Section 4.3), 
NHS care homes were excluded as only 63 (0.5%) out of the 12,955 care homes 
with nursing in England(352) are NHS homes and these were very likely to have 
completely different systems and management processes as well as residents. 
Consequently, it was more appropriate to focus on private care homes.  
Nurses in the participating care homes were eligible when they administered 
medication to PWD or residents with enteral feeding tubes. 
Exclusion criteria:  
Potential participants were excluded when the care homes or all the staff nurses in 
the home did not wish to participate in this research or if it was a NHS care home. 
5.3.3. Sample size 
In a study carried out on residents in care homes,(299) it was found  that 22.3% (95% 
CI 17.3 to 27.9%) were exposed to at least one situation where administration of 
medication could be enhanced. A more recent study in four hospitals of East 
Anglia identified that 32.6% (95% CI 26.2-39.8%) of residents with dysphagia 
suffered from at least one medication error.(272) Based on these proportions, it was 
estimated that a sample size of 150 residents would provide 95% CI of ±6% and 
100 residents would provide 95% CI of ±8% around an identified proportion of 
30%. 
The hospital study by Kelly(272) identified MAE rates of 13.8% (95% CI = 10.5–
17.2%) for residents without dysphagia in comparison to the 32.6% (95% CI= 
26.2–38.9%) of PWD. The frequency of MAEs, excluding time errors, was 5.9% 
(95% CI = 4.7–7.1%) for those without compared with PWD which was 21.1% (95% 
CI = 18.0–24.1%). 
Adjusting for time errors, Kelly et al(272) reported an approximate error rate 
difference between the two groups of 15% and an error rate of 5.9% in the control 
group (residents without dysphagia). At 80% power of study, at least 76 
administrations in each group (total sample size of 152) would be appropriate to be 
observed in order to detect a significant difference on a level < 0.05. 
As the average size of a care home has been recently increased to 32 residents,(386) 
and considering that dysphagia affecting medicines are present in up to 30% of 
residents in care homes,(188) it was estimated that eight care homes would provide 
our required sample size.  
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5.3.4. Outcomes 
The primary outcome is the type of medication administrations that could be 
improved. The classification of the observed administrations allowed us to 
highlight the main points where future interventions should focus to improve 
current practice in the administration of medication to PWD. Examples of these 
administrations are: 
- medicines mixed inappropriately,  
- crushing tablets or opening capsules when authorisation would be appropriate, 
- use of unlicensed medication when licensed formulations are available. 
Where the selection of formulation could minimise the risk for errors and simplify 
the administration process, comparison was made with national guidelines(215) as 
nurses were not deviating from the instructions from the prescriber. Where practice 
was not following national guidance,(215) the researcher identified whether this was 
due to formulation selection of the drug or to the practice in the care home. The 
observer was the main researcher of this thesis and had extensive background in 
applying national guidelines(215) in administration of medication to PWD and able 
to independently compare observations with recommended practice. The observer 
was also able to classify the type of errors (244, 262, 270-272, 274) according to the 
literature presented in chapter 2 (page 71). 
The researcher also aimed to identify, as a secondary outcome measure, available 
alternative formulations of medicines which could make the administration easier. 
This required describing the prescribing practice to PWD in order to explore the 
likely reasons for the selection of those formulations by the prescriber. When 
considering that inappropriate food or medication texture is the main risk factor for 
aspiration pneumonia,(387) it seemed appropriate to explore any possible association 
between the formulation choices at the time of prescribing and aspiration in PWD.  
In order to identify when a formulation was not suitable due to the elevated risk of 
aspiration, the researcher recorded those cases in which aspiration had already been 
acknowledged by other HCPs or when two or more signs of aspiration were 
observed at the time of the drug rounds. As recognised in the literature,(79-83) these 
signs included: 
- absent swallow,  
- coughing when lying flat or sitting up quickly from a reclined position, 
-  choking,  
- hoarsened voice during or after taking medication, eating or drinking,  
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- difficulty handling secretions,  
-  reflexive cough after water bolus. 
 
5.3.5. Data collection  
5.3.5.1. Observations of drugs administrations 
A week previous to the day of the observational drug round, the main researcher in 
liaison with the nurses, handed out a letter of information to the residents observed 
(or to their relatives when the resident didn’t have capacity to respond) explaining 
to them the nature of the study and giving them the opportunity to choose not to be 
observed (Appendix 33). The methodology for this part of the study had already 
been used and tested in a hospital environment as part of a larger study observing 
nurses administering medicines at four hospitals in East Anglia. The methodology 
and documentation received scientific peer review and research management 
approval from East Norfolk and Waveney Research Governance Committee 
(Administration of medicines to older persons with dysphagia – is it optimal? Ref 
No. 2007MFE03S (93-06-07)) and ethical approval from West Kent Research 
Ethics Committee (REC Ref No. 07/H1101/65). The methodology followed that 
within another study (“Will an individualised service improve medicine 
administration to adults with dysphagia – a pilot study? REC 08/H0302/153) 
approved by NRES Committee East of England – Essex. 
The researcher had previously obtained experience observing the administration of 
drugs by nurses in the hospital study. He observed nurses’ drug rounds at the same 
time as the chief researcher of the hospital study mentioned in this thesis (J. Kelly). 
They both used the same data collection form and the results were compared between 
them to assure that similar data had been collected.  
Before the drug round, the nurse requested verbal consent from the resident on 
behalf of the researcher on the day of the observation,  before the researcher joined 
the nurse and the resident to observe the administration. During each drug round, 
the researcher observed the nurse participants administering medication to 
residents with and without dysphagia as diagnosed by the SALT. At the time of the 
observation, the researcher collected data reflected in the patients’ notes about 
identification and diagnosis of dysphagia (i.e. the HCP that made the diagnosis, 
any symptoms identified, any signs of aspiration reflected in the notes, etc.) as well 
as information about food intake (time, allergies, texture) Notes were taken during 
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the observation on standardised data collection forms (Appendix 34 and Appendix 
35) for the administration of medication. These forms collected information 
regarding the time of the administration, medication, dose, time of administration, 
route, etc. and allowed the researcher to record details of the observation using the 
same codes from the previous study where the forms were obtained. These codes 
described the preparation, texture, time, missed dose, etc. The forms only contained 
encrypted data of the participants to preserve confidentiality. 
5.3.5.2. Care home environment notes  
The observation of the administrations and the visit to the care homes provided an 
opportunity to explore the interaction between the nurse participants and the 
residents, as well as what care values might be highlighted in the care home 
environment. 
Although field notes are traditionally associated to qualitative ethnographic studies, 
Emerson(388) highlighted the power of field notes when : 
- transforming direct observations into vivid descriptive results,  
- identifying and following processes in witnessed events, 
- conveying participants’ explanations for when, why or how particular 
things happen, 
- identifying the practical concerns, conditions and constrains that people 
confront and deal with in their routines. 
It was recognised by the main researcher that collecting field notes during the 
observations as originally planned, could be a challenge as they would have 
required ongoing recording to provide very thorough descriptions which could 
compromise the data collection at the time of observing the administration of drug 
rounds. However, a description of the environment based on the principles of field 
notes could potentially help understand the nature of suboptimal practice in the 
administration of medication and therefore notes describing the care home were 
annotated during the observations (referred to henceforward as environment notes 
in the remainder of this document). 
5.3.6. Data storage 
Both the care homes and the nurses recruited were coded and encrypted with 
numbers when the data was recorded. The coding sheets listing the care 
homes/nurse names and their corresponding study numbers, together with the 
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completed consent forms were kept separately in a locked filing cabinet in the 
School of Pharmacy at the University of East Anglia, Norwich. No information 
recorded about the administration of medication identified any resident or 
participant. Only the encrypted data was analysed by the main researcher and this 
was stored on a password-protected laptop computer, used solely for the purpose of 
research, and kept at the main researcher’s office. The access to any confidential 
data and the use of it complied with the NHS code of practice(389) and the guidance 
provided by the Research Council of the United Kingdom.(390) All confidential 
documentation will be destroyed in five years’ time. During this time, the data will 
be stored in the University of East Anglia in designated areas for that purpose and 
only accessible to the main researcher and his academic supervisors. 
5.3.7. Data analysis 
The number of medicines administrations to PWD was recorded along with the 
number of times that the administration process could be improved to better meet 
national guidelines. As for the purpose of this study, these deviations were 
classified as medication administration error (MAE). 
The main aim of this study was to describe the type of administration that could be 
optimised. Therefore, the analysis of the administrations observed identified the 
focus points of future training packages that will aim to improve current practice in 
the administration of medication to PWD. This analysis will also test the 
theoretical model of administration of medication to PWD in care homes identified 
in a previous chapter (DIAMMOND).  
The analysis of the data obtained from the observations aimed to test the following 
null hypotheses: 
- there is no difference in the MAE rate between residents with and without 
dysphagia, 
- there is no difference in the number of drugs prescribed for PWD compared to 
those without, 
- there is no difference in the appropriateness of prescribing to PWD compared 
to those without. 
Data analysis focussed on the MAE rate which was calculated from the number of 
administrations with one or more errors divided by the sum of the number of 
observed drug administrations plus the number of omitted drug administrations 
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(opportunities for error), calculated as a percentage. This MAE rate formula was 
also used in the study by Kelly (2011):(288)  
𝑀𝑀𝑀𝑜 = 𝑂𝑂𝑂𝑂𝑜𝑂𝑂𝑂 𝑂𝑜𝑜𝑜𝑜𝑂
𝑇𝑜𝑇𝑇𝑇 𝑛𝑛𝑛𝑂𝑂𝑜 𝑜𝑜 𝑜𝑜𝑜𝑜𝑜𝑇𝑛𝑛𝑜𝑇𝑜𝑂𝑂 𝑜𝑜𝑜 𝑂𝑜𝑜𝑜𝑜 𝑥 100 
Equation 1: MAE rate formula as per Kelly (2011)(288) 
 
The general MAE rate should be calculated considering that each administration 
may carry more than one error (i.e. a drug can be administered late and also 
prepared differently to what was prescribed). However, that carries the risk of 
obtaining a figure not representative of the reality due to the variation that could be 
when, for example, one administration carries four different errors and others carry 
one. For that reason, for the purposes of this study, the MAE rate was calculated 
based on administrations that carry at least one error. This way, our MAE rate 
represents the probability of having at least one medication error per administration. 
With regards to the analysis of the type of errors, it could be argued that a late 
administration could count as an omission, so in order to avoid duplication of 
errors, time-related omissions were classified only as time errors. Those cases 
where the resident refused to take medication were not included under omissions 
and, therefore, for the purposes of this study, only omissions related to the practice 
of the nurses were explored. 
The analysis of the 25 medications most prescribed helped the researcher to 
estimate how often the formulations which may be more suitable for PWD were 
chosen, what the estimated cost of current administrations was and the likely 
impact of improving the formulation choices on  the financial cost of the  
prescribing. 
5.3.8. Ethical approval 
Ethical approval was sought and obtained from the Faculty of Medicine and Health 
Sciences Research Ethics Committee on 28th June 2012 (Appendix 36). 
The main ethical concern was that the researcher was witnessing potential errors 
and had to face deciding whether to intervene or not. The researcher also had to 
consider that those administrations would occur in his absence and that by 
interfering, the researcher might have affected the MAE rate reported. This could 
have had an educational effect and, therefore, could affect the subsequent similar 
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administrations during the research. Besides, the participants might have felt under 
pressure by being observed and corrected and that could also have affected the real 
MAE rate. However, the researcher was a registered pharmacist with the General 
Pharmaceutical Council and must abide by the Standards of Conduct, Ethics and 
Performance, especially the first one in which, as a pharmacist, he must make the 
residents’ health his main concern.(306) With these issues in mind, the researcher 
therefore only intervened when the error represented a significant risk to the 
resident (e.g. wrong dose or wrong drug given, medication given to the wrong 
resident) that could result in a sudden negative change in the health of the resident 
(extreme drop or raise of blood pressure, sedation, undesired effects, etc.). 
However, the majority of errors were thought to have minimal propensity for 
harm.(274, 391, 392) 
The other ethical concern was that the researcher was aware of the medicines being 
prescribed to a resident which is information that they would not normally have 
access to.  
The focus of the research was on the practice of the nurses and, therefore, by 
default, the researcher observed residents’ medication details. However, residents’ 
personal details were not recorded as part of the process. Information on medicines 
was recorded but completely anonymously. Residents and relatives were informed 
of the study and were given the opportunity to opt out. However, there was no risk 
associated with the study, which was designed to ultimately enhance nursing and 
prescribing practices and, therefore, it was not deemed necessary to obtain 
individual resident consent to participate. 
5.4. Results 
5.4.1. Recruitment of participants 
A total of five health centres showed interest in taking part in the research. The 
GPs from those health centres invited the managers of care homes to which they 
provide services to participate in the research. Eight care homes received 
information from the researcher but only six of them accepted the invitation. The 
six participating care homes received services from only three of the medical 
practices.  
These homes provided an opportunity to observe a total of 13 drug rounds with 11 
different nurses during morning, lunchtime, teatime and bedtime drug rounds. A 
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total of 166 residents, with and without dysphagia, were observed while receiving 
medication totalling of 738 administrations. Table 24 reflects how the observations 
were divided. 
Medical 
practice 
Care 
home 
code 
Nurse 
code 
No. 
residents 
No. of administrations 
Morning 
(7-9am) 
Lunchtime 
(12-2pm) 
Teatime 
(6-8pm) 
Bedtime 
(10-
11pm) 
Total 
1 
1 7 20 88 0 9 0 97 
2 1 6 33 0 0 0 33 
3 2 28 136 1 0 0 137 
2 
4 
3 19 88 0 0 0 88 
4 18 0 0 0 36 36 
9 15 67 0 0 0 67 
6 
10 12 44 0 0 0 44 
11 12 46 1 0 0 47 
3 5 
5 16 79 0 0 0 79 
6 14 74 0 0 0 74 
8 6 36 0 0 0 36 
Total 166 691 2 9 36 738 
Table 24: Sequence of observations 
 
5.4.2. Environment of the observations 
Recording data on observations of the administration of drugs rounds provided an 
opportunity to collect a modest amount of environment notes. The star ranking that 
the CQC used to rate the observed care homes was identified from online reports 
(www.cqc.org.uk) in September 2012 following these observations so as to avoid 
environment notes being biased by any researcher’s preconceptions about the home. 
The CQC rates the care homes based on the care provided being: 
- safe, 
- effective, 
- caring, 
- responsive to people’s needs, 
- well-led. 
Care home 1 (CQC rated 5*) 
The care home is in a rural location, looks clean, tidy and well organised. During 
the first visit, one nurse was unable to attend work due to sickness so the other 
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nurse had to do the drug rounds for all the residential and nursing residents in the 
home which made the drug round very slow and often residents had for their 
medication beyond the regular time recommended (after 11am). Measuring cups 
and disposable spoons were normally washed and reused, but as in the previous 
drug round, the nurse misplaced them, the participant nurse had to spend 30 
minutes looking for them and started the drug round later than expected. Two 
residents refused to be observed. In a second visit, only three residents that were 
not observed in the morning were seen.  
Care home 2 (CQC rated 5*) 
The care home has a homely feeling and plenty of memorabilia. The bedrooms are 
big with classic decoration and have numerous family pictures. Most of the 
residents are still in bed at 9am and they get served breakfast in their own room. 
The members of the nursing team were very laid-back (as described by themselves) 
and the drug round started late as the hand-over took longer than expected. The 
drug round was done with the sister who was not distracted by carers, phones or 
other tasks. The nurse assured that residents take the medications most times due to 
their friendly and familiar approach to residents. 
Care home 3 (CQC rated 3*) 
All rooms are spacious, modern and comfortable and residents have en-suite 
bathrooms. The care home was described by the nurse as a building that retains the 
clinical look of a hotel from the 1990s. Despite its large size and the 32 residents 
accommodated there, there is only one nurse to do the entire drug round which in 
consequence requires an early start and late end.  
The nurse remarked that due to the visit of the researcher, she warned the rest of 
the carers not to interrupt her whilst doing the drug round which actually meant 
that she finished earlier than usual. The participant highlighted that residents’ 
attitude toward swallowing in most residents with capacity seemed different due to 
being observed. By the end of the morning drug round, the nurse participant had a 
short break and then carried on with the lunchtime drug round and so on with the 
evening drug round. According to the participant, the medication rounds often 
takes all or most of her 12- hours shift at work. The nurse participant would not 
leave the resident’s room until making sure that the residents had taken their 
medication (except when the resident explicitly refused to take it). 
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Care home 4 (CQC rated 5*) 
The morning drug round started after 9am. The participant nurse seemed quite 
indifferent about residents taking the medication. She left the pot of tablets next to 
the residents and asked the resident to take them. Some residents seemed a bit 
surprised when she actually tried to help them take the medication by putting it 
their mouths. She seemed rushed and concerned mainly about getting the drug 
round done and showed a very indifferent attitude towards the residents. The round 
took two hours and ten minutes with 18 residents and 88 observations. 
During the evening drug round (8:30pm) in dementia units, it was common during 
the observations to find residents in the wrong rooms. Members of staff did not 
take any remedial action. The participant nurse was very relaxed about the 
residents’ behaviour and relied constantly on carers to come and move residents 
around. The drug round was perceived as time inefficient by unnecessarily taking 
too much time for the organisation of medicines causing residents to receive 
medication such as sleeping tablets far later than recommended. For every single 
resident, the nurses’ office would be opened, dispensing trolley unlocked, blister 
packs taken out, pop out tablets, put blisters away, lock the trolley, lock the office 
and walk to the resident’s room or wherever the resident was located. Hardly any 
resident has more than one or two tablets to take at this time of day, and it took two 
hours to administer medication to 14 residents and 35 observations.  
In a third visit that occurred in the morning, most of residents were still in bed at 
9am and waiting for breakfast. The participant nurse had to prepare breakfast for 
the residents as well as administer the medication as part of her daily routine. The 
nurse seemed very confident but often forgot to give some medication. 
Care home 5 (CQC rated 2*) 
During the first drug round, the nurse seemed to know well most of the residents’ 
relatives. The nurse participant ensured that residents were aware that they were 
being observed and that they took their medication. Time seemed to be a big 
concern for the nurse. Although the drug round started late due to problems locking 
the dispensing trolley, most residents received their medications in an appropriate 
time. The members of staff were very friendly to the residents. 
In a second visit, the nurse participant seemed very friendly with the residents and 
knew most of them. However she was asked to cover the drug round on that floor 
because of the researcher’s visit. She was confident on the needs of the residents 
but she almost constantly forgot to ask residents about pain and constipation relief. 
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Hardly any residents required pain relief, but most of them required laxatives when 
offered. The drug round ended late and the nurse blamed it on not being familiar 
with that floor. Two residents refused to be observed. 
A third visit revealed a nurse participant with a very indifferent approach to the 
residents; she forgot their names and on several occasions she approached the 
residents referring to medications as “I bring you that disgusting stuff”. The nurse 
often did not offer constipation and pain relief expecting residents to ask for it if 
they need it. 
Care home 6 (CQC rated 5*) 
The care home looked very new, clean, tidy and homely. Not much memorabilia 
was present. Only two nurses agreed to be observed and the other two refused on 
the grounds that they were new and had concerns about being observed. The first 
visit was a dementia unit with 13 residents. The nurse was a bank nurse. She was 
very confident in her decisions; however, she was not very constant in her practice 
and often did not administer pain relief or constipation relief if she did not consider 
it necessary. 
In the second visit, the nurse was the manager of the dementia unit. She went 
through all 16 residents very quickly as most of the time they didn’t demonstrate 
any problems taking medication. Only one resident had dysphagia but he was fine 
taking liquid medication. Not having to face challenging administration of 
medication allowed the nurse to finish the round in 45 minutes and proceed with 
other jobs. 
5.4.3. Prevalence of dysphagia 
From the total of 166 residents observed, 38 (22.9%) had been diagnosed with 
dysphagia. The diagnosis was made by the GP, SALT, or in some cases by HCPs 
in the hospital and this diagnosis was identified in the patient’s care plan or in the 
patient’s notes. These residents were accountable for 143 observations (19.4%) out 
of the total 738. PWD received a mean (SD) of 3.76 (1.8) different drugs compared 
to those without who received 4.65 (2.4), which is 23.67% lower for PWD when 
compared to those without. Table 25 shows how the observation of dysphagia 
varied across the different care homes and medical practices. 
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Medical 
practice 
Care 
home 
code 
No. residents Administrations 
Total PWD % Total PWD % 
1 
1 20 12 60.0% 97 46 47.4% 
2 6 1 16.7% 33 6 18.2% 
3 28 3 10.7% 137 11 8.0% 
2 
4 52 8 15.4% 191 30 15.7% 
6 24 6 25.0% 91 20 22.0% 
3 5 36 8 22.2% 189 30 15.9% 
Total  166 38 22.9% 738 143 19.4% 
Table 25: Prevalence of dysphagia 
5.4.4. Frequency of administration errors 
A total of 300 administration errors were identified during the drug rounds across 
100 residents. Thirty (78.95%) PWD and 70 (54.7%) of the residents without 
dysphagia suffered at least one administration error. Table 26 shows the frequency 
of errors in residents with and without dysphagia from the total amount of 
administrations observed, i.e. the combination of dysphagia and time errors was 
present in 5.4 % (9) of the total 166 residents. 
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Table 26: Frequency of errors from the total number of administrations 
 
5.4.5. Description of errors and analysis 
5.4.5.1. Wrong Time Administrations 
Table 27 shows how PWD were commonly less exposed to late administrations 
compared to those without.  
  No. residents (N=166) 
 
Administrations (N=738) 
  
Type of 
error 
  PWD N=38 
No dysphagia 
 N=128 
 
 
PWD 
N=143 
No dysphagia 
N=595 
Total N % N % 
 
Total N % N % 
Wrong time 30 9 5.4% 21 12.7%  126 21 2.8% 105 14.2% 
Omission 19 5 3.0% 14 8.4%  31 14 1.9% 17 2.3% 
Wrong drug 2 0 0.0% 2 1.2%  2 0 0.0% 2 0.3% 
Extra dose 0 0 0.0% 0 0.0%  0 0 0.0% 0 0.0% 
Wrong dose 5 4 2.4% 1 0.6%  8 5 0.7% 3 0.4% 
Wrong   
technique 9 4 2.4% 5 3.0%  22 9 1.2% 13 1.8% 
Unordered 
drug 0 0 0.0% 0 0.0%  0 0 0.0% 0 0.0% 
Wrong adm. 
prep 5 4 2.4% 1 0.6%  7 6 0.8% 1 0.1% 
Wrong route 0 0 0.0% 0 0.0%  0 0 0.0% 0 0.0% 
Deteriorated 
medicine 3 1 0.6% 2 1.2%  3 1 0.1% 2 0.3% 
Drug 
compatibility 5 2 1.2% 3 1.8%  7 3 0.4% 4 0.5% 
Allergy 0 0 0.0% 0 0.0%  0 0 0.0% 0 0.0% 
Inappropriate 
prescribing 19 14 8.4% 5 3.0%  44 35 4.7% 9 1.2% 
Others 45 5 3.0% 40 24.1%  50 5 0.7% 45 6.1% 
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 Administrations 
 
To PWD 
N=99 
To residents without dysphagia 
N=201 
Type of error N (%) N (%) 
Inappropriate 
prescribing 
35 (35.4%) 9 (4.5%) 
Wrong time 21 (21.2%) 105 (52.2%) 
Omission 14 (14.1%) 17 (8.5%) 
Wrong technique 9 (9.1%) 13 (6.5%) 
Wrong adm. prep 6 (6.1%) 1 (0.5%) 
Wrong dose 5 (5.1%) 3 (1.5%) 
Others 5 (5.1%) 45 (22.4%) 
Drug compatibility 3 (3.0%) 4 (2.0%) 
Deteriorated medicine 1 (1.0%) 2 (1.0%) 
Wrong drug 0 (0.0%) 2 (1.0%) 
Extra dose 0 (0.0%) 0 (0.0%) 
Unordered drug 0 (0.0%) 0 (0.0%) 
Wrong route 0 (0.0%) 0 (0.0%) 
Allergy 0 (0.0%) 0 (0.0%) 
Table 27: Comparison of frequencies of errors by type between the two groups of 
residents 
 
On a total of 126 (17.1%) occasions the residents’ drugs were administered at least 
one hour late affecting 30 (18.1%) of the residents. Table 28 shows the drug groups 
most commonly administered at the wrong time.  
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   PWD No dysphagia 
Drug group Total % N % N % 
Antiplatelet 16 12.7% 1 6% 15 94% 
Supplements 14 11.1% 2 14% 12 86% 
Gastrointestinal 
disorders 11 8.7% 2 18% 9 82% 
Laxatives 11 8.7% 2 18% 9 82% 
Antidepressant 10 7.9% 3 30% 7 70% 
Pain killers 9 7.1% 1 11% 8 89% 
Antidiabetic drugs 6 4.8% 0 0% 6 100% 
Cardiac glycosides 6 4.8% 1 17% 5 83% 
Diuretics 6 4.8% 0 0% 6 100% 
Thyroid regulators 6 4.8% 1 17% 5 83% 
Antiepileptic 5 4.0% 2 40% 3 60% 
Anti-hypertensives 5 4.0% 0 0% 5 100% 
Anti-parkinsonism 3 2.4% 2 67% 1 33% 
Anti-angina 2 1.6% 0 0% 2 100% 
Lipid-regulating 2 1.6% 0 0% 2 100% 
Calcium salts 2 1.6% 2 100% 0 0% 
Dementia 2 1.6% 1 50% 1 50% 
Steroids 2 1.6% 0 0% 2 100% 
Gout control 2 1.6% 0 0% 2 100% 
Antibiotics 1 0.8% 0 0% 1 100% 
Antihistamines 1 0.8% 0 0% 1 100% 
Antineoplastic 1 0.8% 0 0% 1 100% 
Antipsychotic 1 0.8% 0 0% 1 100% 
Anxiolytics 1 0.8% 1 100% 0 0% 
Nausea and vertigo 1 0.8% 0 0% 1 100% 
 126 100%     
Table 28: Frequency of wrong time errors by drug group 
5.4.5.2. Omission 
One of the most common errors observed was the omission of medication by the 
nurse and in consequence residents failed to receive medications by the time of the 
next scheduled dose. Omissions were found to be the third most frequent type of 
error in PWD and higher in this group than in the group of residents without 
dysphagia (Table 27).  
While the majority of omission cases (18) were due to the nurses not considering it 
necessary or suitable to give that medication for various reasons (having to wake 
Observation of drug administrations in care homes 
 
Page 241 of 380 
 
up the resident, resident often refused the medication, etc.), in seven cases nurses 
forgot to administer that medication to the resident. The remaining six incidents 
were due to not having organised the provision of the right medication. On the 
seven occasions when the nurse forgot to administer the medication, and in one 
case when the omitted drugs could affect the resident’s well-being (vertigo 
medication), the researcher, in his duty of care, felt the need to intervene and 
discretely reminded  the nurse of the missing administration. Table 29 compares 
the drugs that were omitted and the reason between PWD and those without.  
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Reason PWD No dysphagia 
Resident had refused 
medication previously                                            
Alendronic acid 70mg  tablets 
Amlodipine 10mg  tablets   
Folic acid 5mg tablets        
Isosorbide mono. 20mg   tablets,  
Levothyroxine 100mcg    tablets  
Levothyroxine 25mcg tablets 
(x2),   
Paracetamol 250mg/5ml  liquid   
Sotalol 40mg tablets         
Prednisolone 5mg  tablets                                                       
Macrogol   sachets     
Paracetamol 500mg  
tablets                              
Resident asleep                                                                                                                                                                                                                                      N/A 
Calcium salts tablets 
Clopidogrel 75mg tablets      
Lactulose solution                   
Nurse identified the 
need to check with 
pharmacy as dose was 
confusing                                                                                             
Erythromycin 250mg    tablets         
Calcium salts tablets 
Macrogol   sachets 
Nitrofurantoin 50mg   
tablets       
Tablets have not been 
reordered with the 
monthly prescription 
Furosemide 40mg   tablets             N/A 
Capsules dispensed 
instead of 
orodispersible tablets 
so not administered                                                                                                                                                                            
Lansoprazole 30mg  OD tablets        N/A 
Nurse didn't consider 
that the drug was 
needed                                                                             
N/A 
Macrogol sachets 
Paracetamol 250mg/5ml  
liquid (x2)     
Nurse run out of 
tablets                                                                                                                                                                                                                      
N/A 
Paracetamol 500mg   
tablets      
Nurse forgot to 
administer it 
Cetirizine 10mg/1ml  liquid          
Calcium salts tablets (x2) 
Macrogol  sachets  (x2) 
Alendronic acid 70mg  
tablets     
Table 29: Drugs omitted and nurse's reason for omission 
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5.4.5.3. Wrong drug 
On one occasion, the medication for two of the residents (lorazepam and 
simvastatin) was prepared remotely during an evening drug round and each 
resident’s tablet was put in a pot. At the time of administering to the resident, the 
nurse could not differentiate which tablet was which and the wrong medication 
ended up being given to the wrong resident. The researcher identified the case and 
intervened before residents actually took the tablet. No other cases were identified.  
5.4.5.4. Wrong dose (under dose) 
In eight cases, a reduced dose than the one prescribed was administered to the 
resident. These erroneous doses were as a consequence of using extra utensils that 
retain residues of the medication and are not rinsed after use, or as a result of 
mixing medication with food that was only partly taken by the resident. While the 
preparation for the administration was correct, the resident did not received the 
whole dose. The researcher highlighted this issue to the participant at the end of the 
administration. 
The tampering of medication resulting in smaller doses being administered was 
more likely to occur in PWD. This was observed in PWD three times more often 
than in those without (Table 27). 
5.4.5.5. Wrong technique recommended 
This type of error applied to 22 administrations that had been prescribed correctly 
for the resident but they were given to the resident for her/him to chew them 
despite the inappropriateness of the formulation for being chewed. Although this 
classification of error had not been originally described as a type of its own, the 
high frequency observed of this type of error, made the researcher consider it as a 
type in its own right based on the description by Barker in 2002.(393) This error was 
defined as an incorrect performance in the administration of each dose of 
medication.(270)  
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Drugs administered  
PWD No dysphagia 
Aspirin 75 mg tablets (x2) 
Bisoprolol 10mg tablets 
Digoxin 250mcg  tablets 
Lansoprazole 30mg  capsules (x2) 
Lisinopril 5mg  tablets 
Paracetamol 500mg  tablets  (x2) 
Aspirin 75 mg tablets  (x2) 
Codeine 30mg  tablets 
Ferrous fumarate 210mg  tablets 
Lansoprazole 30mg  capsules 
Levothyroxine 100mcg  tablets 
Paracetamol 500mg  tablets 
Mebeverine 135mg  tablets 
Quetiapine 25mg  tablets 
Simvastatin 20mg  tablets 
Trazodone 50mg tablets 
Table 30: Drugs administered for chewing as per nurse advice 
 
Four PWD counted for nine of those administrations while the remaining 13 
administrations belonged to five residents not diagnosed with dysphagia, making 
PWD more commonly exposed to medications wrongly administered for chewing 
(Table 27). 
5.4.5.6. Wrong dose preparation and administration 
These administrations refer to cases where wrong preparation had led to unsuitable 
administration. Seven cases were identified where the method of preparation by the 
nurse compromised the administration. These are some examples: 
- orodispersible tablets were dispersed following instructions for capsule 
formulation of the same drug, 
- nurse didn’t thicken the solution containing the dispersed drugs despite clear 
instructions from the SALT recommending only thickened fluids, 
- part of the content of the sachet was left behind accidentally.  
Four PWD accounted for six of these administrations and the single resident 
without dysphagia accounted for one.  
Observation of drug administrations in care homes 
 
Page 245 of 380 
 
5.4.5.7. Wrong route 
The observations of these drug rounds did not identify any cases where the 
administration of drugs could have been compromised by having used the wrong 
route for the administration of drugs to the residents. 
5.4.5.8. Deteriorated medicine 
Only three cases occurred where a deteriorated medicine was administered. These 
were: 
- a sachet prepared with water is not administered until 3.5 hours later against 
manufacturer instructions, 
- tablets were dispersed in water without doctor’s consent and against 
manufacturer instructions, 
- drug was administered with food despite recommendations explicitly requiring 
the opposite. 
No significant difference was found between groups in the frequency of this error 
(Table 27). 
5.4.5.9. Drug compatibility 
Ten drug incompatibilities were found during the observations of a total of seven 
residents that were exposed to these erroneous administrations. The main reasons 
for these incompatibilities were: 
- calcium salts and proton pump inhibitors were administered together 
compromising the absorption of calcium, 
- alendronic acid was going to be administered with the rest of the morning 
medication to a PWD despite the risk of oesophageal damage caused by reflux. 
The researcher intervened but the resident refused to take the medication. 
5.4.5.10. Unordered drug, extra dose and allergy related error 
No cases of extra dose or allergy-related errors were identified during the 
observations in any resident with or without dysphagia. Nor did the observations of 
these drug rounds identify any cases where the administration of drugs could have 
been compromised by not having ordered any particular drug for the residents. 
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5.4.5.11. Inappropriate prescribing 
Several cases were observed where the risk of an adverse drug event outweighed 
the clinical benefit, particularly when safer or more effective alternatives were 
available(164) and, therefore, classified as inappropriate prescribing (IP). Based on 
that definition, IP was identified in the administrations where:  
- doses were prescribed incorrectly (i.e. antibiotics like nitrofurantoin 
prescribed as required), 
- there was incompatibility between the drugs prescribed (i.e. lansoprazole and 
calcium salts prescribed to be taken together), 
- inappropriate formulation choice by the prescriber (i.e. prednisolone EC 
tablets prescribed for PWD when soluble tablets are available and were 
suitable for that patient). 
This classification took into consideration specific instructions made by the 
prescriber. For example, when lansoprazole and calcium were both recommended 
to be taken daily with breakfast, it was classified as IP. It was not considered IP in 
those cases where incompatible drugs were not specifically prescribed to be taken 
together.  
Table 31 shows the percentages of administrations affected by inappropriate 
prescribing comparing the group of PWD and the one without. 
 
 Total 
Inappropriate 
prescribing 
administrations to 
PWD 
N (%) 
Inappropriate 
prescribing no 
dysphagia 
N (%) 
Fisher's exact test 
P 
Medical 
practice 1 
267 20 (7.5%) 2 (0.7%) p<0.01 (0.000)* 
Medical 
practice 2 
282 9 (3.2%) 6 (2.1%) p<0.01 (0.000)* 
Medical 
practice 3 
189 6 (3.2%) 1 (0.5%) p<0.01 (0.000)* 
Total 738 35 (4.7%) 9 (1.2%) 
 
*As represented by SPSS 
Table 31: Comparison of inappropriate prescribing between medical practices 
 
Observation of drug administrations in care homes 
 
Page 247 of 380 
 
The analysis of the data revealed that signs of aspiration were present in 20.3% of 
the administrations of medication to PWD and this was significantly higher in 
PWD than in those without (Fisher’s Exact, p<0.01).  Inappropriate formulation 
choices increased the rates of aspiration in both groups but these rates were higher 
in the group of PWD (Table 32). 
 
 PWD No dysphagia 
 
 
Signs of 
aspiration 
N (%) 
Number 
of 
admins. 
Signs of 
aspiration 
N (%) 
Number 
of 
admins. 
Fisher's 
exact test 
p 
Appropriate 
formulation 
choices 
2 (1.9%) 108 1 (0.2%) 586 
p<0.01 
(0.000)* 
Inappropriate 
formulation 
choices 
27 (77.1%) 35 3 (33.3%) 9 
p<0.01 
(0.000)* 
Total 29 (20.3%) 143 4 (0.7%) 595 p<0.01 (0.000)* 
*As represented by SPSS 
Table 32: Association between aspiration and formulation choices in PWD 
5.4.5.12. Others 
On 50 occasions the administration of medication was considered erroneous for 
reasons not specifically contemplated in the classification of errors used. These 
errors consisted in administrations that differed from the instructions recommended 
by the prescriber or the pharmacist and were always associated with the 
administration of the drug with or without food or on empty stomach: 
- in 11 cases, aspirin was administered on an empty stomach contrary to 
prescriber’s instructions, 
- iron salts were given on an empty stomach against the recommendations 
from the doctor to avoid gastrointestinal disturbances in 15 administration, 
- proton pump inhibitors and oral antibiotics accounted for another 24 cases. 
5.4.6. Medication administration error rates 
A total of 99 administration errors were observed across the 38 PWD in 
comparison to the 201 errors observed in the group of 128 residents without 
dysphagia. 
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The classification of medication errors per individual type showed significant 
variability within types and groups. Table 33 indicates MAE rates of each type of 
error when considering the opportunities of error as 143 and 595 in the group of 
residents with and without dysphagia, respectively.  
 
 
Administrations  
  
PWD No dysphagia  
Type of MAE Total N (MAE rate %) N (MAE rate %) 
P value 
(Fisher’s 
Exact) 
Time 126 21 (14.7%) 105 (17.6%) 0.458 
Omission 31 14 (9.8%) 17 (2.9%) 0.001 
Wrong drug 2 0 (0.0%) 2 (0.3%) 1 
Wrong dose 8 5 (3.5%) 3 (0.5%) 0.009 
Wrong technique 22 9 (6.3%) 13 (2.2%) 0.023 
Wrong adm. prep 7 6 (4.2%) 1 (0.2%) <0.001 
Deteriorated 
medicine 
3 1 (0.7%) 2 (0.3%) 0.476 
Drug compatibility 7 3 (2.1%) 4 (0.7%) 0.137 
Inappropriate 
prescribing 
44 35 (24.5%) 9 (1.5%) <0.001 
Others 50 5 (3.5%) 45 (7.6%) 0.095 
Table 33: MAE rates per type of error 
 
As represented in Table 34, a total of 82 administrations to PWD contained at least 
one error, compared to the 183 in the group of residents without dysphagia.  
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Dysphagia 
Yes 
(N=143) 
No  
(N=595) 
P value 
(Fisher’s Exact Test) 
Administrations 
with at least one 
error 
(MAE rate) 
82 (57.3%) 183 (30.8%) <0.001 
Table 34: Comparison of MAE rates for residents with and without dysphagia 
 
Table 34 shows a MAE rate in PWD almost double (1.86 times higher) than in 
those without. However, time errors appeared far more common in the group 
without dysphagia (Table 33) due to the fact that the other errors occur less 
frequently in that group. Besides, the wrong time administrations are probably due 
to the large amount of drugs involved on each drug round and the complexity of its 
administration. 
While the rest of the administration errors could potentially be avoided by 
improving practice, time errors are virtually inevitable and, therefore, a second 
analysis of MAE rates was carried out for this study based on the same 
mathematical principles, but not including time errors.  
In consequence, the amount of administrations that carry at least one error not 
including time was reduced to 65 for PWD and 89 for those without as reflected in 
Table 35. The statistical analysis showed association between PWD and MAE rates 
(excluding time errors), making PWD three times more likely to be exposed to an 
administration error not related to time compared to those without dysphagia.   
 
 
Dysphagia 
Yes 
(N=143) 
No  
(N=595) 
P value 
(Fisher’s Exact Test) 
Administrations 
with at least one 
error 
(MAE rate) 
65 (45.5%) 89 (15.0%) <0.001 
Table 35: MAE rates excluding time errors 
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5.4.7. Medication most frequently prescribed to PWD 
A total of 54 different drugs were prescribed in the 143 administrations to PWD in 
comparison to the 125 drugs observed in the 595 administrations to residents 
without dysphagia. From those 54, 25 drugs represent the most prescribed (twice or 
more) of the sample. The 25 medications most commonly prescribed to PWD 
accounted for a total of 114 (79.7%) of the administrations. 
The majority of alternatives suggested an increase in the price of the administration 
(Table 36). However, the consideration of this percentage increase in cost per 
formulation would assume that all the administrations are sub-optimal. It is, 
therefore, important to reflect the percentage increase of replacing sub-optimal 
formulations but also considering that some of those formulations are already 
appropriate. For example, the percentage increase of optimising the administration 
of paracetamol considers optimising nine administrations of tablets and 
effervescent tablets plus the cost of six administrations of liquid formulations. 
Hence, the percentage increase of optimising paracetamol in our sample is 74% 
rather than the percentage increase from 2.9p to 13p (348.3%). Table 36 
summarises the individual cost of the top 25 drugs prescribed to PWD and the 
potential price increments when optimal formulation choices are available and 
prescribed. 
It was estimated that the cost of a hypothetical drug round containing these drugs in 
the same frequencies would be £15.48 but only 53% of those formulations would 
be considered alternative which removes the need for formulation tampering for 
PWD. If alternative licensed formulations were prescribed, the cost would be 
affected by a 77.4% increase going up to £27.47 and by 361% when special 
unlicensed formulations were recommended with a total cost of £71.34.  
Further comparison of the 25 medications most frequently prescribed in PWD and 
residents without dysphagia highlighted the main differences between these groups. 
In the group of residents without dysphagia, the top 25 medications accounted for 
419 administrations (70.4%).  
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 Drug Formulation used 
Times 
prescribed 
(N) 
Cost 
per 
dose 
(dose)* 
Liquid 
formulation or 
dispersible tablet 
available 
Cost of 
alternative 
formulation 
per dose* 
Percentage 
increase of 
alternative 
administration 
Paracetamol 
Tablets 8 2.9p (500mg) 
Paracetamol 
250mg/5ml 
suspension 
13p 
74% Effervescent 
tablet 1 
11p 
(500mg) 
Paracetamol 
250mg/5ml 
suspension 
13p 
Suspension 6 13p   
Macrogol Oral Powder 12 22p    
Aspirin 
Gastro- 
resistant 
tablets 
2 3.2p (75mg) Dispersible tablets 3p  -1% 
Dispersible 
tablets 8 
3p 
(75mg)   
Citalopram 
Tablets 5 3.4p (20mg) 
Citalopram 
40mg/ml drops 28.5p 79% 
Liquid 5 28.5p (20mg)   
Calcium 
salts 
Effervescent 
tablet 1 
15.5p 
(1.5g) 
Chewable tablets 
1.5g 8.25p -10% 
Chewable 
tablets 7 
8.2p 
(1.5g)   
Lansoprazole 
Orodispersible 
tablets 2 
10.6p 
(15mg)   
61% 
Capsules 4 4.6p (15mg) 
Lansoprazole 
15mg 
orodispersible 
tablets 
10.6p 
Sodium 
valproate 
Solution 5 9.4p (200mg)   
-3% 
Crushable 
tablets 1 
11.2p 
(200mg) 
Sodium valproate 
200mg/5ml oral 
solution sugar free 
9.43 
Levothyroxine Tablets 5 9.9p (25mg) 
Levothyroxine 
50mg/5ml solution 137p 
1,284% 
Co-beneldopa 
Capsules 2 11.8p (25/100mg) 
Dispersible tablets 
(25mg/100mg) 10.45p 
-6% 
Modified 
release 
tablets 
1 12.77p (25/100mg)   
Dispersible 
tablets 1 
10.45p 
(25/100mg)   
Co-codamol 
Effervescent 
tablet 3 
8.2p 
(8/500mg)   16% 
Tablets 1 3.7p (8/500mg) 
Effervescent tablet  
8mg/500mg 8.2p 
Folic acid Tablets 3 4p  (5mg) 
Folic acid  
2.5mg/5ml oral 
solution sugar free 
61.1p 1428% 
Omeprazole 
Dispersible 
tablets 2 
41.4p 
(20mg)   42% 
Capsules 1 4.78p (20mg) 
Dispersible tablets 
20mg 41.4p 
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 Drug Formulation used 
Times 
prescribed 
(N) 
Cost 
per 
dose 
(dose)* 
Liquid 
formulation or 
dispersible tablet 
available 
Cost of 
alternative 
formulation 
per dose* 
Percentage 
increase of 
alternative 
administration 
Sertraline Tablets 3 27.53 (100mg) 
Unlicensed 
Sertraline 
50mg/5ml oral 
suspension 
657.5p 2,288% 
Co-careldopa Tablets 3 6.9p (12.5/50mg) 
Unlicensed co-
careldopa                        
25mg/100mg/5ml 
oral suspension 
371.3p 5,281% 
Atenolol Liquid 2 9.31p (25mg)   
 
Bisoprolol Tablets 2 4.1p (5mg) 
Unlicensed 
bisoprolol 
2.5mg/5ml 
solution 
441.7p 10,673% 
Cetirizine 
Tablets 1 3.7p (10mg) 
Cetirizine 1mg/ml 
oral solution sugar 
free 
9.6p 
44% 
Liquid 1 9.6 (10mg)   
Digoxin Tablets 2 3.8p (125mcg) 
Digoxin 50mcg/ml 
elixir 22.3p 
487% 
Fludrocortisone Tablets 2 5.1p (100mg)   
0% 
Fluoxetine Capsules 2 3.5p (20mg) 
Fluoxetine 
20mg/5ml oral 
solution 
30.5p 771% 
Furosemide Tablets 2 3.1p (20mg) 
Unlicensed 
furosemide 
50mg/5ml oral 
solution sugar free 
267.1p 8,516% 
Lactulose Solution 2 6.64p (10ml)   
 
Memantine Liquid 2 123.2p (10mg)   
 
Co-careldopa 
 with entecapone Tablets 2 
72.4p 
(50/12.5/ 
200mg) 
   
Trimethoprim Tablets 2 4.3p (100mg) 
Trimethoprim 
50mg/5ml oral 
suspension sugar 
free 
21.3p 395% 
*Price obtained from Drug Tariff 2013(322) 
Table 36: Comparison of the cost of medicines when optimising formulation choices 
 
The table in Appendix 37 shows how 16 of the drugs were repeated in both groups 
and how the main differences fell on the higher proportion of antiepileptic, anti-
Alzheimer’s disease and anti-parkinsonism drugs prescribed to PWD. These 
medications accounted for 12.9% of the total administrations to PWD and 14.9% of 
the top 25 drugs. Table 37 reflects a comparison of the prescribing rates for those 
drugs in both groups. 
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Drug Prescribing rate  to PWD Prescribing rate to other 
residents 
Sodium Valproate 4.2%* 0.3% 
Co-Beneldopa 2.8%* 0.3% 
Co-Careldopa 2.1%* 0.2% 
Memantine 1.4%* 0.7% 
Co-Careldopa with 
Entecapone 
1.4%* 0.2% 
* Drug is part of the top 25 drugs prescribed 
Table 37: Comparison of the use of antidementia and antiepileptic drugs 
 
5.5. Discussion 
5.5.1. Time of the drug rounds 
One of the objectives of this study was to identify the factors that affect the 
administration of medicines to PWD. The comments from the participating nurses 
made it obvious to the researcher before and during the drug rounds that time was 
one of the factors with a large impact on the nurses’ practice. This is in agreement 
with studies highlighted in the literature review, where time constraints remained 
one of the main concerns for nurses.(224, 225) 
Some of the environment notes taken during the observations revealed how very 
often drug rounds not only did not start on time but they took over most of the 
nursing time in care homes. It was possibly the time constraints that triggered the 
different approaches of the nurses observed when administering medication. While 
some nurses achieved drug rounds within the scheduled time, this was often 
achieved at a certain level of indifference towards the residents, rushing them to 
take their medication or just leaving the medication for them to take.  
Time constraints and, as a consequence, wrong time administrations were not only 
a problem of PWD but a problem for residents in care homes in general, as one late 
administration was often just the cause and the consequence of another late 
administration regardless of the nature of the conditions suffered by the resident. 
While the severity of taking certain medication at a later time than prescribed could 
be argued to be small, some of the late administrations consisted of antiepileptic 
drugs like phenytoin, which is recommended to be taken at the same time every 
Observation of drug administrations in care homes 
 
Page 254 of 380 
 
day, with breakfast, to avoid gastrointestinal side-effects such as nausea, vomiting, 
diarrhoea and constipation.  
Although it could be said that time errors are hard to avoid due to lengthy drug 
rounds and the complexity of administrations, this study suggests that further 
research should explore interventions that enhance the time-efficiency of the drug 
rounds without compromising the direct care of nurses for their residents.  
5.5.2. Errors not related to time 
The omission of medication was a common error observed during the drug rounds 
but the nature of those omissions varied greatly. Following the error classification 
by Ferner & Aronson (2006),(262) the causes for most of the omissions observed 
were the lack of pharmaceutical knowledge about the importance of administering 
medication and the inappropriate assessment of the need for medication. These are 
called genuine mistakes. Often these mistakes were the result of the nurses’ 
assumptions of the resident’s willingness to take the medication. On other 
occasions the nurse decided to prioritise the immediate comfort of the resident 
without considering the potential health consequence of omitting medication. In 
addition to these genuine mistakes, lapses in memory and slips in the processes 
(action-based errors) were the cause of the other omissions. However, these errors 
bring up the argument that the genuine reason for the omissions could be the time 
pressure of having to administer medication to residents that often reject their 
medicines. The time pressure could also be the cause of the omissions related to the 
forgetfulness of the participant that could find it hard to focus on appropriately 
administering medication. This may be suggesting that not only can time 
constraints be the trigger of other types of errors, but also that the nurses could 
benefit from simple interventions that enhance their knowledge and act as a 
reminder of good practice during the drug rounds. 
The lack of knowledge on the legal liability issues and the pharmacokinetics of the 
medicines could be the cause for practices that trigger deterioration of drugs and 
tampered administrations without formal consent from the doctor. These were 
therefore described as knowledge-based errors.(262) 
For those cases where residents received the wrong medication, action-based slips 
were the most likely reason. The identification of tablets is not a task that is related 
to the knowledge of nurses; however, the processes involved in the prevention of 
errors in the administration of drugs, as well as the storage and the delivery of the 
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medicines to the residents rely completely on the skills of the nurses. In these cases 
the nurse did not see the need for taking the medicines trolley out of its storage 
room and, instead, the tablets were placed in pots and delivered to the residents on 
the other side of the building without any notes accompanying the medication. At 
the time of administering it to the residents, the nurse wrongly guessed which drug 
was which and had it not been for the intervention of the researcher, two residents 
would have received the wrong medication (lorazepam instead of simvastatin and 
vice versa). This error could have easily been prevented by keeping the residents’ 
medication and any information about how to administer it in the residents’ rooms. 
In certain homes, this is not always possible as the medication is stored in lockable 
rooms where the care plans for the residents are also kept. However, keeping just 
the relevant information about the administration of medication would promote a 
safer practice and would highlight any issues relevant to the way that the resident 
has his/her medication administered, like in the case of PWD. 
Skills-based issues were also the cause of the wrong dose administrations as nurses 
failed to identify the use of food and utensils as potential factors that affect the 
amount of drug that the resident received. During the observations, the same 
measuring devices (which are designed for single use) were used for several 
residents in one of the care homes and certain medications were mixed with food. 
Although it was not always necessarily incorrect to do this, nurses should only 
carry out this practice with certainty that the full dose will be taken and otherwise it 
should be avoided. Time constraints might have encouraged nurses to rely on 
mixing medication with food in the hope that the carers would administer the mix 
of food and medication, allowing the nurse to carry on with other tasks. The joint 
administration of incompatible drugs was also considered a skills-based error due 
to the fact that nurses are provided with information regarding the compatibility of 
the medicine with food from the pharmacy and that information is labelled on the 
medicine container. 
This study identified the lack of skills on the administration of medication, 
inappropriate assessment (rule-based) and lack of knowledge as primary causes for 
administration errors to happen in care homes. These results are in accordance with 
those identified by numerous qualitative studies where the nurses expressed their 
concerns about their skills,(199, 223) knowledge(225) and the influence of their 
environment on those elements.(199, 223, 225) However, time pressure when carrying 
out drug rounds remains a concern for the nurses and it is reflected in their practice.  
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One of the main concerns was the numerous times that the researcher had to 
intervene. While in several cases, the interventions were due to human errors like 
forgetting the administrations of drugs, in many others, the researcher intervened 
according to his judgement on the severity of the errors. This judgement, however, 
was undertaken from a pharmacist’s point of view and it may indicate that 
optimising the administration of medicines is highly dependent on different 
professional views and, therefore, could be benefited from a multidisciplinary 
approach.  
This study brings to the discussion the two approaches of errors theory identified 
by Reason(394) as, while it could be said that the nurses are to blame as the ultimate 
cause for the error, the context of the administrations observed exposed a system in 
which time pressure and lack of professional development (skills and knowledge) 
are very often part of the nurses’ practice. Therefore, the implementation of 
interventions to improve the care received by PWD should consider both a general 
and an individual approach, i.e. this study suggests that pharmacist-led 
interventions in the care home could enhance the knowledge and the skills of the 
nurses when administering medication to PWD while reducing the prevalence of 
knowledge-based and rule-based errors.  
5.5.3. MAE rates in hospital compared to care homes 
Although other studies have contemplated the rates of medication errors in PWD, 
our study used the same methodology of data collection and analysis as used by 
Kelly,(288) carried out in hospital wards. The same issues were described by Kelly 
with regards to the time of the administrations, leading to calculation of the MAE 
rates based on the exclusion of time errors. Kelly concluded in her study that the 
proportion of MAE rate was over three times (3.6) greater in PWD compared with 
those without. These results are in agreement to those in our study where PWD 
were also three times (3.03) higher than those without.  
MAE related to IP were the most frequent in our study. Although in Kelly’s study 
those classified as ‘others’ were the most frequent errors, her classification didn’t 
consider IP. This may explain the high rates of ‘others’ in our study. Nevertheless, 
after excluding time errors and IP as part of others, the frequency of errors by type 
are similar in both studies.  
It is concerning, however, that the MAE rates for PWD and those without are more 
than double (45.5% vs. 21.1% and 15.0% vs. 5.9%, respectively) in the care home 
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compared to hospital. It is hard to identify the actual reasons for this increase in the 
MAE rate but one of the reasons that was identified by the nurses in qualitative 
studies is the isolation of the care home environment described as an information 
vacuum by Barnes.(199) 
Despite the current efforts of the CQC on improving the safety of the residents in 
care homes, the reports generated by this commission may not be specific enough 
to identify the raised risks that PWD are exposed to. Care homes highly rated as 
five stars by the CQC were identified in this study to have some of the highest 
MAE rates where 70% to 100% of PWD observed were exposed to at least one 
administration error not related to time. While more effective changes should be 
encouraged to reduce the amount of MAEs in care homes, PWD should be a 
priority target when implementing interventions to improve the practice of HCPs. 
5.5.4. Inappropriate prescribing in PWD 
It was the inappropriate formulation choices made by the doctor at the time of 
prescribing to PWD which revealed the highest MAE rates. Despite the fact that 
the signs of aspiration in PWD were strongly associated to the formulations 
prescribed and administered, it could be argued that the nurses carried out an 
appropriate assessment at the time of the administration in the cases where the 
residents diagnosed with dysphagia received solid medication. The observation of 
signs of aspiration requires certain skills that are not attributed to general nurses 
and it is recognised that the liability of administering solid medication to PWD is 
shared between the doctor and the nurse.  
This study was designed to identify potential improvements in the medication 
choices but the nature of the results obtained may help us in estimating some of the 
likely reasons for those choices.  
The cost of prescribing suitable alternative formulations to PWD in our sample was 
estimated to be 4.6 times the cost of current practice. However, it should be 
considered that this would improve up to 47% of the administrations of drugs and 
that could theoretically reduce the aspiration rates from 77.1% to 1.9%. When 
considering that aspiration related to wrong food or medication texture is the most 
significant risk factor for pneumonia,(89, 90) it could be expected that optimising the 
formulation choices for PWD would be likely to reduce the rate of expensive 
hospital admissions related to respiratory diseases in older people. This link has not 
been established before and it could be the aim of future research. 
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Another factor that could be affecting the formulation choices was the lack of 
awareness of the condition. When the formulation errors were observed, only nine 
of the 22 administrations belonged to residents that had been diagnosed with 
dysphagia. Chewing tablets and food (excessively) is one of the main signs of the 
presence of a swallowing disorder and these cases should be referred to the doctors 
or the SALT for further investigation. There is a possibility that a large group of 
PWD are not being diagnosed. 
In summary, despite the pharmacist being recognised as the expert in medication, 
the doctor still remains as the prescriber and the professional selecting the 
formulation of the drug. The pharmacist has expert knowledge on the 
pharmacokinetic and the effects of tampering with drugs’ formulations as well as 
on the alternative formulations available on the market. The doctors’ lack of 
knowledge on these alternatives could be affecting the prescribing of medication to 
PWD but it offers an opportunity for the pharmacist to get more involved in the 
care of PWD. 
This study placed the cost of the optimisation of prescribing to PWD, the lack of 
awareness of the condition and the lack of knowledge of alternative formulations as 
the most likely factors that affected the formulation choices made by the doctor. 
However, further research is needed to validate this hypothesis and to identify 
other potential factors that influence the prescribing of medication to PWD. 
5.5.5. Restriction of medicines at the time of prescribing 
The observation of administrations to PWD identified 54 different drugs in 
comparison to the 125 different ones observed in the non-dysphagic group (section 
5.4.7.). These figures indicated the wider variety of conditions that dysphagia is 
associated to, i.e. Parkinson’s and Alzheimer’s disease and other forms of dementia. 
However, PWD received on average a number of drugs 23.67% lower than those 
residents without dysphagia (section 5.4.3.). These figures indicated that despite 
more complicated conditions being present in the group of PWD, the residents in 
our sample were prescribed a more limited number of drugs per patient than those 
without dysphagia. Nevertheless, this study was not able to identify whether these 
differences in the figures could be indicating under-prescribing or what the causes 
for this difference were. In general multi-morbidity, polypharmacy, ageism, lack of 
scientific evidence, fear of adverse events and economic problems may contribute 
to under-prescribing of indicated drugs.(395) Conversely, in some residents, a 
limited life expectancy, the lack of a favourable risk-to-benefit ratio or a resident’s 
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refusal might represent appropriate reasons not to prescribe a drug.(395) Under-
prescribing in PWD has not been explored broadly in the literature but these results 
agree with studies that identified the need of more creative prescribing methods in 
dysphagia(167) and, as a consequence, PWD might be being prescribed less 
medication than needed.(168) This study also brings to the discussion other factors 
such as doctors not being aware of more suitable formulation and the increased 
cost of prescribing to this group of patients. 
5.5.6. Lack of standardised practice 
The environmental notes revealed different approaches between the practices of the 
nurse participants and how the nurse-resident interaction could be compromising 
the administration of medication. For example, while some nurses relied on the 
residents to take the medication in the absence of the nurse, other nurses would not 
abandon the resident’s room until confident that the residents had received the 
medication. Despite the available recommendations for the administration of 
medication to PWD(215, 292, 312, 313) and the internal policies and guidance inside the 
care home, the differences in practice fell on the nurses as individuals and a strong 
initiative is needed to over-ride those individual factors that make practice differ 
between professionals. 
The comments from the participants also revealed concerns about the clinical 
confidence of the nurses on the administration of medication. While some of the 
nurses felt they needed to prepare for the visit of the researcher in his observer role, 
other nurses did not feel confident to take part. 
The lack of standardised practice had already been identified by the literature (195, 
228) in observational studies in other settings. However, this modest collection of 
field notes also added contextual factors to the causes of such practice. While this 
study suggests that interventions that focus on setting up standards of practice 
could be beneficial for the nurses’ practice, those interventions should, therefore/ 
consider qualitative and quantitative outcomes. 
5.6. Limitations and strengths 
One of the strengths of this study is that each administration of medicines was 
recorded in all the different categories of errors, allowing us to determine the 
frequencies of the most common errors as well as to identify the total MAE rates 
for PWD and without dysphagia when including and excluding time errors. 
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Conversely, the severity of the errors was not considered in the design of this study 
but it could be beneficial to include it as part of a larger study, where HCPs from 
different backgrounds (GPs, pharmacists, nurses, SALTs, etc.) could rate the 
severity of the errors identified. 
The researcher observed drug rounds in the hospital in preparation for this study 
and compared the data collected with the nurse chief investigator of the hospital 
study. While this could be seen as a limitation of the study as the dataset was 
collected by a researcher with a pharmacist point of view, those observations in the 
hospital matched also the data from the research nurse and, therefore, this is also a 
strength of the study. However, the researcher was not observed in the care homes 
and, therefore, competency was not confirmed and the validity of the observations 
could be questionable. 
Despite the small percentage of NHS care homes in England, the results of this 
study are not only limited to observations in private homes but also to those in the 
North Yorkshire area. A larger scale study could benefit from including NHS care 
homes as well as those from the private sector across England or the whole UK. 
Additionally, local guidelines, processes and systems may be different to other 
parts of the country, e.g. dysphagia guidelines, local support from pharmacist 
teams, greater or lesser SALT input, etc. 
The care homes visited belonged to groups of multiples (several homes that belong 
to the same company) and therefore these results may not represent the practices 
observed in independently-owned homes. Similarly, the participating care homes 
were care homes with nursing and not residential homes which also limits the 
scope of the findings.  
While the support of the medical practices was essential and effective for the 
recruitment of participants, the participation rates were likely affected in a negative 
way by the concern from the participants about being observed and this should also 
be considered. It is undeniable that the presence of a researcher observing the drug 
rounds of the nurses may condition the behaviour and practices of the 
participants(274, 396, 397) so this potential example of the Hawthorn effect(398) needs to 
be considered as one of the limitations of the scope of the results. Several of the 
nurses approached refused to participate in the research and, therefore, the 
observed sample is likely to be biased with those who are possibly more confident 
of their practice or wanting feedback on their practice more likely to consent. 
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If the study was repeated, we would need to undertake observations in a large 
number of homes which represented the general distribution of care homes with 
respect to ownership, size and resident type. Also, increasing the amount of 
observations during the research could make observations usual practice, and 
reduce the Hawthorn effect of the initial observations and enable practice to revert 
to normal.(399) 
5.7. Conclusions 
This study has identified numerous factors that can affect the way that PWD are 
receiving their medication in care homes. At a nurse level, the lack of basic 
pharmaceutical knowledge, inappropriate assessment and poor skills-based practice 
are the main concerns. However, as part of the care home, time pressure remains as 
the factor with highest impact on the administration of medication. External factors 
like the appropriateness of the formulation choices made by the prescriber are 
exposing PWD to a higher risk of aspiration that can potentially evolve into 
respiratory complications. This is in addition to the complexity of the conditions 
suffered by PWD, where Parkinson’s and Alzheimer’s disease, as well as other 
forms of dementia, are often present. 
The weight of improving administration of drugs to PWD falls directly and almost 
completely on the nurses in the care homes and on the appropriate prescribing 
choices of the doctors. The support and expertise of other professionals like the 
community pharmacists is required to enhance the pharmaceutical knowledge of 
nurses and to provide advice to prescribers in the selection of suitable formulations.  
With 22.9% of the residents observed suffering from dysphagia, this study 
concludes that more specific reports and inspections are required to enhance the 
safety of such a large group of residents. Also, the high prevalence of MAE in care 
homes should make the care of residents in care homes, and especially those with 
dysphagia, one of the main targets of the CQC to achieve safer practice. 
This piece of research has identified some likely causes and consequences of the 
poor practice carried out in care homes and it has highlighted those concerns to 
some of the professionals involved. Increasing the awareness of dysphagia in 
healthcare professionals at the time of making clinical decisions could be the first 
step towards a better care of PWD in care homes.  
Observation of drug administrations in care homes 
 
Page 262 of 380 
 
The design of interventions that improve nurses’ practice and its impact on the 
residents’ health need to be evaluated with the correct outcome measures. The 
association between aspiration and inappropriate prescribing highlights the 
importance of considering aspiration rates as a suitable outcome measure for future 
studies. Nevertheless, environment notes helped to identify other factors like the 
clinical confidence of nurses and the workload in the care homes. In summary, 
further research in improving the administration of medicines to PWD should 
include both quantitative and qualitative outcome measures. 
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6. General discussion 
Research on the administration of medication to PWD started over a decade ago 
when the problems of medicine administration to PWD in care homes with nursing 
were explored.(158) Since then, numerous publications have contributed to the 
awareness of these problems shared by nurses, carers and patients and to optimise 
the medicine administration to PWD in hospital wards and care homes.(23, 195, 228, 292, 
320, 400, 401) Those publications have set a milestone for national research on 
medicines management to PWD, demonstrating how the combination of qualitative 
and quantitative methods of research can provide a wider picture of the problem 
explored.  
While most of the previous research was carried out and focused on hospital 
wards,(246, 270, 281, 282, 284-286) the increasing numbers of the older population in care 
homes,(386) the high rates of medication errors in this environment,(196, 240, 275) and 
higher awareness of dysphagia in primary care,(73, 76, 97, 159, 323, 402) provided an 
opportunity to explore the problems experienced by nurses in care homes with 
regards to the administration of medication to PWD.  Following similar approaches 
to those of  Kelly et al(272) in hospital wards, this dissertation identified the need for 
improving the administration of medication to PWD in care homes and focused on 
establishing the elements needed to develop, evaluate and implement a pharmacist-
led intervention in older PWD in care homes that improves the medicines 
management of dysphagia.  
This final chapter will discuss: 
- the barriers identified by this research in the medicines management of PWD, 
- how this study provides good evidence for the need to improve administration 
of medication to PWD in care homes, 
- the relevance of the findings of this study to the development of a complex 
intervention within the MRC guidelines framework. 
 
6.1. Medicines management of PWD: barriers identified in this 
research 
This section discusses the evidence provided by this thesis to current literature in 
identifying the problems faced by PWD in the management of medication. 
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The literature review, in chapter 2, indicated the complexity of the administration 
of medication to PWD. While probably other research fields rely on established 
research to which new papers can only contribute with updates and reviews, the 
process explored in this thesis is a combination of numerous elements such as 
flaws in knowledge, challenging multidisciplinary interactions and pharmaceutical 
technology. This confirms the complexity of any interventions identified as 
potentially suitable to enhance the care provided to PWD by nurses in care homes.  
The results from the provision of a pharmacy-led service in the hospital wards, as 
described in chapter 3, found that, often, the administration of medication to PWD 
could be simplified by choosing more suitable formulations for the patients 
according to recommendations of current guidelines mentioned in chapter 1.(215, 292, 
312, 313) Nevertheless, it was also estimated that the cost of optimising those 
administrations by selecting more suitable formulations could be more than double 
(2.4) when using licensed medication and up to almost 10 times (9.9) when 
including ‘specials’ as part of the administration.  
The obvious differences between the type of setting and population between 
primary and secondary care would not allow a statistical comparison in the cost of 
medication. However, the increase in the costs when recommending appropriate 
formulations for PWD in the care home environment were also noticeable (based 
on Drug Tariff 2013(322) cost calculations). This is indicating that the cost involved 
in providing suitable licenced medication and special formulations is a likely 
common barrier to the administration of medicines to PWD both in primary and 
secondary care. Conversely, the limitations of the hospital study and the 
differences between populations, as previously mentioned, would only allow this 
discussion to suggest further research on whether the cost may impact the 
practitioners’ decisions when prescribing to PWD and whether the current practices 
observed in primary and secondary care are related.    
When we consider the results from the observational drug rounds in chapter 5, the 
MAE rates due to inappropriate formulation choices in care homes were not only 
higher in PWD than in those without but also higher than the ones identified by the 
literature.(272) Additionally, the PWD observed during the drug rounds were 
prescribed on average 3.8 drugs, which is not only 23.7% less than the observed 
patients without dysphagia (as discussed in section 5.5.5.) but it is also 
significantly lower than the average of eight medicines reported in the study by 
Barber in 2009.(299) PWD in care homes may not be receiving all the required 
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medication possibly due to the reasons identified by other authors such as a limited 
life expectancy, the lack of a favourable risk-to-benefit ratio or a patient’s 
refusal.(395) Conversely, some of the participants of the interviews in the care homes 
(chapter 4) identified clearly a concern by the prescriber about prescribing liquid 
medicines: 
“The doctor was not prepared to write this gentleman up for liquids.” (N2) 
Other elements alongside the cost could be influencing the prescribers’ decisions. 
Awareness of dysphagia has been a problem reflected in the literature (131, 228) and 
throughout the research presented in this thesis. Not only the results of the 
interviews highlighted a lack of awareness of the condition, but also the 
observational drug rounds identified five patients who had not been diagnosed with 
dysphagia and chewed their tablets in 13 instances. Chewing medication is a sign 
of dysphagia and a natural mechanism often found in PWD, but these patients had 
not been assessed for any swallowing disorders.(48) Additionally, when signs of 
dysphagia were identified, the nurses did not feel competent to carry out 
swallowing assessments as they considered it someone else’s ‘remit’(section 
4.4.2.2.4.). These facts show how the lack of awareness of dysphagia may also be 
accompanied by problems in the assessment of the swallowing function. If no 
assessment is possible, the presence or the severity of dysphagia cannot be 
determined. 
As the literature suggests,(159, 228) HCPs are not asking often enough about 
dysphagia. When considering the impact of this disorder in the treatment received 
by the patients, it would be sensible to suggest that routine checks of the 
swallowing function could be incorporated to the visits of the HCPs to the residents 
of care homes and reflected in the care plan or in the medication chart in order to 
communicate it to others care providers such as the pharmacist or SALTs.  
After identifying PWD, other barriers have been outlined in this research. In 
accordance to Elliott & Liu (2012),(174) the ‘nine Rs’ should be followed by 
practitioners when prescribing and administering medication to patients. The 
interviews with nurses identified challenges between the doctors and the care home 
when requesting liquid formulations. For example, one of the participants 
commented: 
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“If you have a GP and I have seen them, who say right, just give these, but crush 
them, can you put that on the prescription please? No. Because they know that they 
will then be liable.” (N1) 
This interaction already outlines the following concerns:  
- is the patient getting the right medicine as other more suitable medications may 
need to be considered for that patient? (right medicine)  
- is the patient going to receive this medication on time when considering that 
the administration is already presenting challenges to the nurses’ practice? 
(right time) 
- is there an alternative formulation that avoids tampering? (right form) 
- is the patient going to get the right dose after crushing tablet? 
- if getting the right dose, is the medication going to deliver the right responses 
after being tampered with? 
- can this advice be documented and appropriately authorised by the prescriber? 
- is there a more suitable alternative route for this medication that obtains the 
same action? 
With all of the nine Rs being questioned in one single interaction about medication 
with the doctor, the input of other HCPs like the pharmacist who is the only expert 
in formulation science, could be considered beneficial. This input was able to ease 
the interaction between prescribers and the nursing team, which indicates that the 
doctors are not always aware of the alternative formulations, doses, actions and 
responses of the medication prescribed in addition to the concerns on the cost of 
them. Conversely, it could possibly mean that the prescribers are aware of these 
concerns, but they expect the pharmacist to co-ordinate those changes as suggested 
by Dean in 2002(365) in which case, the pharmacist should take a pro-active role in 
identifying these kind of interventions and producing the appropriate advice to the 
prescriber and the administrator. Beyond those suggestions, these interactions 
between HCPs also highlight the numerous and individualised elements that should 
be present when prescribing and administering medication to PWD. The 
implementation of interventions like the I-MAG is perceived by the nurses as a tool 
with the potential of providing recommendations that assure the right medication, 
dose, response, form, effect, documentation and action. Although I-MAGs were 
considered to maximise the time spent with the patient so the administration of 
medication could be done timely and efficiently in the hospital, further research is 
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required to identify whether the guides would have the same effect in the practice 
of the nurses in a different environment like the care home.   
The next step on the management of dysphagia leads to the person administering 
medication. The services provided in the hospital wards offered an opportunity to 
explore the acceptability and the perceptions of the nurses on the implementation 
of a pharmacy intervention for nurses administering medication to PWD. The 
findings in the questionnaire completed by the nurses highlighted how they felt 
more confident in their practice when I-MAGs were in place, as quoted from one 
of the participant’s comments, they “knew the right way of administering each 
drug”. This lack of confidence in the administration of medication has been 
reflected in a lack of standardised practice throughout the studies reflected in this 
thesis and previous studies by Kelly and Wright.(195, 228) 
The interviews with nurses in care homes identified different practices between 
participants who revealed being hesitant on the most appropriate methods of 
administering medication as mentioned by one of the participants:  
“It seems to be done differently by different people, so ah, I’m not sure.” (N4) 
The observational drug rounds in the care homes also demonstrated a lack of 
standardised practice which became obvious when interpreting the differences in 
the practices between nurses (reflected in the environment notes), but also when 
carrying out the rounds with nurses that had been selected by their work colleagues 
as being more ‘confident’ in their practice. The non-standardised practice may 
derive from variations in pharmaceutical knowledge and administration skills 
which was highlighted by the analysis of MAEs in the observational drug rounds 
and had also been identified in chapter 2.(199, 223, 225) Time constraints, as identified 
by the literature, (224, 225) were also one of the main concerns for nurses in the wards 
and in the care homes and it was an element to blame for the heavy workload of the 
nurses who often were the only qualified member of staff administering medication 
in the whole care home. The qualitative interviews also outlined other elements 
that, according to the participants, could affect the administration of medication to 
PWD such as the care home environment and the patient’s health conditions. This 
was not only supported by literature,(199, 223, 225) but also from the practices observed 
in the drug rounds, as described in the environment notes. 
If all of the previously identified barriers to optimal medicines administration 
practices could be overcome, adherence to the treatment by the patient needs to be 
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explored as the complexity of dosing in the administration of medication to PWD 
and lack of understanding can provide barriers to adherence.(232)   
 
6.2. Implications of this research in current practice 
The barriers faced by HCPs in the administration of medication identified in the 
previous section provided an opportunity to explore the implementation of a 
pharmacy intervention for PWD. Whilst the I-MAG was implemented as a tool to 
improve the administration of medication by nurses to PWD, this research has 
shown how these guides have the potential of overcoming those challenges.  
The presence of I-MAGs in the hospital wards increased the awareness of 
dysphagia within the nursing team and highlighted concepts of safety for the 
patients and the professionals on the hospital wards. The generation of I-MAGs by 
a pharmacist triggered a closer interaction between the pharmacist and other 
professionals on the wards such as the SALT, the consultants, the ward pharmacist 
and the nursing team. As a result, not only standardised practice was set in the 
service wards, but also a reflection of a holistic approach towards the care of PWD 
was reflected in the guides. The lack of pharmaceutical knowledge of the nurses 
was solved by the individualised recommendations reflected in I-MAGs, reducing 
the time constraints of the drug rounds, the risk of inappropriate tampering of 
medication and the workload of the nurses.  
It is recognised that the practice seen in care homes derives from training within 
secondary care(195) and, therefore, similar problems in the nurses’ practice were 
identified. However, the environment of the care homes uncovered additional 
challenges to those seen in hospital. The design of a model like the DIAMMOND 
allowed us to identify these additional challenges faced in the administration of 
medication to PWD in care homes and to estimate the impact of implementing a 
pharmacy intervention like I-MAGs in the care home. The theoretical acceptability 
of I-MAGs during the interviews in the care homes relied on the support of most of 
the participants but was faced by negative approaches towards change by some of 
the interviewees, which was not identified in the hospital. This contrast between 
hospital and care homes may be due to the isolated environment of the care homes 
as recognised by the literature(199) and by the interviews’ participants. The isolation 
of the care home may be limiting the access to professional resources and it is seen 
as a disadvantage in the recruitment of skilled nurses for specialised care within the 
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care home. This difference between the hospital and care home environments may 
also reflect a limitation to the applicability of the model in secondary care. 
Whilst the DIAMMOND model is untested and not-validated in practice yet, the 
observation of drug rounds provided an opportunity to test this model. Dysphagia 
awareness was placed as one of the four pillars in the DIAMMOND model 
obtained from the thematic analysis of the interviews, as the identification of PWD 
is essential to improve the way that residents receive their medication. The 
observations highlighted how the lack of awareness of dysphagia was also present 
in the practices seen in the care homes. Prescribers and nurses in primary care were 
not always aware of the presence of dysphagia and when identified, the 
communication between them was not optimal. Although the communication 
issues could be a reason for the identified inappropriate formulations being 
prescribed for PWD, further research is required to establish that association. 
Additionally, doctors possibly are not always aware of alternative formulations but 
pharmacists have an important role on suggesting suitable formulations for the 
patients as suggested in the interviews with the nurses. This is highlighting the 
need to explore the likelihood of a link between the communication of HCPs and 
the formulation choices made at the time of prescribing in primary care. 
The time constraints and the lack of pharmaceutical knowledge identified during 
the drug rounds had an impact on the workload of the nurses observed in the care 
home and, therefore, the heavy workload of nurses was identified as one of the 
barriers in the administration of medication to PWD. The identification of this 
barrier was in agreement with the workload identified in the hospital and also with 
one of the elements that form part of the DIAMMOND model. 
The observational drug rounds represented a strong step towards the validation of 
the DIAMMOND model. The time constraints during the drug rounds were 
reflected in high MAE rates related to time in both of our groups in agreement to 
the DIAMMOND. However, the likely lack of awareness of dysphagia from the 
prescriber and the administrators, and the inappropriate formulation choices made 
at the time of prescribing, were the most common cause of errors affecting the 
administration of medication to PWD in accordance to the same elements 
identified in the model. 
The fourth main element of our model was the patient’s health, which it may not 
have an identified impact on wrong administrations, but it may have affected the 
number of omissions made by the nurses when the residents were asleep, or when 
General discussion 
 
Page 270 of 380 
 
the patients refused the medication prescribed. Indirectly influenced by the 
pharmaceutical knowledge of the nurses and other factors like the lack of highly 
qualified nursing staff available in the care homes, the workload of nurses in the 
care homes observed challenged the administration of medication to the residents 
and especially to those with dysphagia, leading to late, omitted and wrong dose 
administrations. 
The research strongly suggests that while IMAGs may require further small 
amendments for the implementation in care homes (i.e. the incorporation of 
signatures of the members of the team to accept the recommendations, comments 
box and layout of the guide), they will be beneficial in this environment. I-MAGs 
will provide continuous professional development for the knowledge and skills of 
the nurses, and a holistic care of PWD due to the enhanced involvement of HCPs. 
This may reduce the isolating elements observed in the care home and, therefore, 
improve the care received by PWD. 
6.3. Implications for the implementation of a pharmacy 
intervention for PWD in care homes 
As from the beginning of this dissertation, the MRC guidelines for complex 
interventions have set the standpoint for all the studies presented. While the aim of 
this thesis is still to improve the care of PWD, the focus of this thesis is to develop 
a pharmacist-led intervention in care homes where community pharmacists can 
provide individualised administration guidance for nurses administering 
medication to PWD. The literature in chapter 1 already outlined the complexity of 
this process due to the numerous components affecting the figurate delivery of such 
an intervention and the qualitative and quantitative nature of them.  
The implementation of a framework to develop our intervention is essential in 
order to evaluate the scope of the process.(1) As indicated  in chapter 1, the 
framework presented by Saunders and colleagues(16) offers a systematic approach 
to assess the implementation of a targeted health promotion intervention to aid in 
understanding the relationship between specific programme elements and 
programme outcomes (Table 1).  
It seems, therefore, sensible to commence this section with a discussion of how the 
research presented has contributed to the development of such intervention, as well 
as to outline the elements that may have been identified but not explored and that 
will be the subject of future research. 
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Theoretical development 
An in-depth review of the literature available was presented in chapter 2. While the 
literature related to the medicine management of PWD is limited, this review 
aimed to identify most of the components that may influence our likely 
intervention. The perceptions of nurses and carers, explored though semi-structured 
interviews, as presented in chapter 4, were used to develop a theoretical model that 
may reflect which elements are affected by implementing changes in the routines 
of care homes as a consequence of the intervention. This model was supported not 
only by a thorough and strict thematic analysis but also by previous literature on 
the interaction of some of the components that form the DIAMMOND model. 
Testing the I-MAG service in the hospital setting using traditional randomised 
controlled methodology was found to be unfeasible due to the majority of patients 
only requiring the intervention for a small number of days and the resultant number 
of patients suitable for randomisation being too small to justify the cost of the 
research. The completion of the questionnaires by the patients highlighted the 
strengths of this choice of outcomes, probably due to the fact that the 
questionnaires were exploring issues in the medicines management that were very 
specific to PWD,  as complex interventions may work best if they are tailored to 
local contexts rather than completely standardised.(6)  However, these outcome 
measures (adherence, patient’s satisfaction, health services use and quality of life) 
may need to be adjusted to the care home environment where patients do not 
always have mental capacity to provide this information. 
While the literature review identified criteria to determine the appropriateness of 
prescribing, and this is suitable tool for the UK, the results of the observation of 
drug rounds described in chapter 5 highlighted the association between aspiration 
(or signs of aspiration) and inappropriate prescribing and, therefore, this could be 
used in future research as an outcome measure of the changes in the prescribing 
due to our intervention. Differences in the MAE rate, as identified in chapter 5, 
could also be utilised as an outcome measure to assess the impact of training nurses 
in the administration of medication to PWD. 
Feasibility and piloting 
The DIAMMOND model offers a theoretical framing of the elements affected by 
an intervention. However, the validity of this model had not been tested before and 
a practical validation before the implementation of the intervention was more 
suitable for further development of the model prior to the intervention. The 
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observational drug rounds served as an assessment of the feasibility of our model 
in practice, as previously described.  
The pilot study of I-MAGs estimated the recruitment of patients at the time of 
discharge without considering other elements such as the consent to be approached 
by a researcher, the limited access to the wards experienced by the researchers or 
the extensive impact of the lack of mental capacity on many of the patients at the 
time of being approached for recruitment. Although the design of the intervention 
should include an estimation of the sample size, it could be beneficial to re-
estimate the recruitment rate once the sites for the intervention have been selected 
as part of the cycle between development and feasibility prior to, or as part of, a 
piloting phase.  
The studies in this dissertation also explored the recruitment of nurse participants. 
While the recruitment rates of nurses in care homes was considerably lower when 
approached to participate in the interviews described in chapter 4, face-to-face 
recruitment between the researcher and the nurses in the ward for the evaluation of 
the I-MAG service found drastically higher rates. Equally, the direct involvement 
of a doctor in the recruitment of care homes for the observational drug rounds, 
mentioned in chapter 5, increased the participation of the care homes despite this 
then being compromised by a lower participation of the nurses as individuals. It 
could be argued that other factors such as the close environment in the hospital 
ward between HCPs, or that the care home managers personally knew the doctors, 
are the reasons for the increased recruitment rates. In summary, when recruiting 
patients or HCPs, the standpoint of the researcher and the participants is of crucial 
relevance to the recruitment rates.   
Evaluation of the intervention 
The questionnaire designed for the evaluation of the I-MAG service was an 
example of alternative outcome measures to those expected by the completion of 
the patients’ questionnaires. While patients’ outcomes are important, the pilot study 
had the potential to study other outcomes such as the changes in the nurses’ 
practice, or the improvement in their knowledge or increase in confidence like that 
highlighted by the evaluation of the service. The findings from the responses of 
quantitative and qualitative questions in the evaluation provided a wider view of 
the concerns of the nurses and the value of the components assessed in the 
questionnaire. 
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6.4. Limitations and strengths 
One of the strengths of this thesis is the combination of qualitative and quantitative 
methods used throughout the studies presented. Where quantitative data were 
explored, such as in the questionnaire or the drug rounds, the addition of qualitative 
components to the I-MAG service questionnaire and environment notes during the 
observational drug rounds added a contextual element to the analysis of the data 
that helped understand the environment of the practice of the nurses and carers in 
charge of the administration of medication to PWD. Another strength is that each 
study presented was analysed and evaluated before moving onto the next study in 
order to assure the exploration of more components that defined the design of our 
complex intervention. 
Recruitment of participants has often been a limitation seen in the research 
presented in this thesis. During the I-MAG service study, the recruitment of 
patients was extremely low due to the improvement of dysphagia while in the ward 
and the difficulties experienced when trying to approach the patients. Conversely, 
the recruitment of participants (HCPs) for the evaluation of the I-MAG service was 
relatively high, but still excluded the 35% of the nurses involved during the 
delivery of the process. During the recruitment of care homes for the semi-
structured interviews, the response rate of the care homes approached was 
unexpectedly low and although the sample size obtained was appropriate for our 
study, the results may not necessarily represent the insights of others within the 
same region. In addition to this, the interviews were only based in Norfolk and it is 
possible that the results could have benefited from exploring the insights of nurses 
and carers in other areas of the country. Although, demographically, North 
Yorkshire and Norfolk could be comparable, the results of the observational drug 
rounds may not necessarily be extrapolated to practice of the nurses interviewed in 
care homes in Norfolk. However, the methodology and the results identified in 
these entire studies offer strong grounds for larger-scale studies where the limiting 
factors discussed can be avoided and, therefore, these studies represent a 
contribution to the feasibility and piloting phase of the development of a complex 
intervention.  
Time and funding have also been close-limiting factors, for further development of 
the intervention outlined in this thesis. Complex interventions require the 
exploration of numerous components and often the costs and the time involved on 
the development of those processes were not feasible within the framework of a 
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PhD term. However, these can also be seen as a strength of this research due to the 
fact that the studies presented have shown the importance of identifying barriers in 
the cost, time, interaction between HCPs and recruitment of participants that will 
be reflected in the design of future research to develop a pharmacy-led intervention 
for PWD in care homes. 
 
7. Conclusions and further research 
The research carried out in this thesis has made several contributions to the current 
evidence on the medicines management of PWD and to the development of a 
pharmacist intervention for PWD in care homes.  
The pilot study demonstrated that I-MAGs were acceptable to nurses in hospitals 
who were positive regarding their introduction and use with the majority asking for 
the service to be continued. Stated benefits associated with I-MAGs were increased 
confidence when administering medicines, enhancing standardisation of care and 
improving the safety of administrations.   
It was also identified that it is not possible in the hospital setting to test the 
hypothesis that individualised medication administration guides are a cost-effective 
intervention to improve the care of patients with dysphagia.  Due to the limited 
available population, the significant attrition rate and the fact that, for many 
patients, I-MAGs would only be in place for a few days, it was hypothesised that 
care homes may be a more suitable location to test such a hypothesis. 
The proposed outcome measures for the hospital-based pilot study included patient 
self-reported adherence, quality of life and patient satisfaction. Due to the loss of 
patient autonomy in care homes and the reduction in mental capacity frequently 
seen in residents, self-reported outcomes based on perception and ability to manage 
one’s own medicines may not be appropriate in this setting. Literature(39, 90) 
suggests that incidence of chest infection, hospitalisation and mortality may be 
more appropriate outcome measures in the care home environment and this may 
apply to our intervention when considering the impact of I-MAGs. 
The hospital I-MAG service was delivered by a pharmacist trained in swallowing 
difficulties(149) with practice experience in primary and secondary care. The 
community pharmacist was identified as the most suitable professional alternative 
for providing an I-MAG service to care homes, but further research is required to 
establish the appropriate training necessary for them to provide a similar service. 
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The research has demonstrated that there is a significant population with 
medicines- related dysphagia in the care home setting, and this may be an 
underestimate due to the lack of routine assessment for the condition. The 
recruitment rate in this population may be affected by different elements to those 
identified in the hospital and, therefore, would need to be determined prior to any 
future definitive study. 
The practice seen in the administration of medication by nurses to PWD in care 
homes is often more challenging than the one observed in hospital and it could 
benefit from interventions that standardise practice, enhance the clinical knowledge 
and skills of the nurses, and improves the communication of the HCPs involved in 
the care of PWD. 
Factors which were found to affect medicines administration in the care home 
environment were time constraints, lack of dysphagia awareness, the formulation 
choices made at the time of prescribing, and the patients’ health conditions. 
The DIAMMOND model outlines other elements involved in the administration of 
medication to PWD and provides an overview of the likely interaction between 
those elements when implementing changes in the practice of the nurses in care 
homes. The model offers a strong theoretical background that may be useful in the 
design of research studies on the medicines management of dysphagia in the care 
home environment. 
The observation of the MAE in care homes provided information about the cause 
of those errors and an opportunity to validate the DIAMMOND model. The 
provision of I-MAGs is an example of an intervention that can affect the practice of 
the nurses with a potential effect on the MAE rate. Therefore, changes in the MAE 
rates can be recommended as an outcome measure for future research in PWD, but 
the impact of the observer in those rates needs to be considered. 
The medicines management of dysphagia requires a multidisciplinary approach and 
often, the practices of the HCPs involved in the care of PWD are challenged by the 
cost, awareness and availability of suitable formulations of medicines. The 
pharmacist as the HCP with highest expertise in medication can play a crucial role 
in the training of nurses and carers, by providing advice to the prescribers and, 
when possible, advising PWD on the importance of their treatment. The care home 
environment offers an opportunity to extend the role of the pharmacist improving 
the practice of HCPs and the care received by PWD. 
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This research also suggests that in order to improve the administration of 
medication to PWD, local policies and HCPs will need to focus on: 
- re-assessing  the methods  of identifying and diagnosing  dysphagia in the care 
home, 
- estimating the individual needs of each patient when administering medication, 
- enhancing the pharmaceutical knowledge and skills of nurses administering 
medication, 
- increasing the involvement of the community pharmacist in the care home, 
- providing advice to the prescriber on suitable formulation choices. 
The key conclusions of this thesis, in addition to those mentioned in previous 
chapters, are that: 
- the provision of I-MAGs by a specialised pharmacist in the hospital wards 
increases the nurses’ confidence in their practice and the safety of the 
administrations of medication to PWD, 
- the medicine management for PWD requires a multidisciplinary approach 
between nurses, pharmacists, doctors, SALTs and dieticians and, consequently, 
PWD could benefit from interventions that overcome the barriers between 
HCPs observed in current practice, 
- the lack of awareness of dysphagia, the interaction between HCPs, the lack of 
standardised practice and pharmaceutical knowledge in the nurses’ practice, 
and the time constraints experienced by nurses are the main barriers 
challenging the medicines management of PWD as perceived by nurses, 
- the DIAMMOND provides a theoretical model to explore the effects of 
implementing a medicines management intervention for PWD in care homes, 
- appropriate formulations are often not being prescribed for PWD, but the likely 
association with cost, lack of awareness of dysphagia or lack of knowledge on 
available formulations by the prescriber has not yet been established, 
- the gaps in the pharmaceutical knowledge and skills of the nurses in care 
homes are some of the causes for the increased MAE rates in PWD in care 
homes when compared to those without, 
- the implementation of I-MAGs in care homes could potentially increase the 
awareness of dysphagia, enhance the interaction between HCPs and promote 
standardised practice. This may increase the nurses’ confidence in their clinical 
practice, reduce the time pressure in the care home and reduce errors. 
Conclusions and further research 
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As suggested by Campbell,(4) developing complex interventions is not a linear 
process and it requires evaluation of new elements identified during the process. 
This thesis outlines several suggestions for future research that would contribute to 
enhance the care received by PWD and to develop additional components for the 
implementation of I-MAGs in care homes. Therefore, further research is needed on: 
- exploring the feasibility of the provision of I-MAGs in care homes by 
community pharmacists , 
- exploring the perceptions of other HCPs on the implementation of I-MAGs in 
care homes, 
- identifying the applicability of the DIAMMOND model and the impact on the 
practices of the HCPs of the implementation of novel interventions in the care 
home setting, 
- exploring if any improvements in patients’ health can be achieved and justified 
at the cost of the service in primary and secondary care, 
- exploring the practicality of a training package designed by a pharmacist on the 
administration of medication to PWD for its use in care homes and its impact 
on the MAE rates, 
- determining qualitative and quantitative outcome measures that may reflect 
significant changes in residents’ health, 
- the measures and records of competency for nurses on the administration of 
medication to PWD in primary and secondary care, 
- identifying additional reasons that affect prescribers’ decisions when choosing 
a formulation for PWD in primary and secondary care, 
- identifying the link between formulation tampering and appropriate 
formulation selection and its impact on hospital admission rates. 
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Appendix 2: Introductory sessions’ flyer 
 
Introduction Session to 
“Will an individualised service improve medicine 
administration to adults with dysphagia?” 
A pilot Study 
We would like to invite the Healthcare team to a quick introduction to our clinical study on 
dysphagia that will be carried out in (Participating wards’ names). 
The 20 minutes introduction will be on room 22 near Guist Ward on the following dates: 
- 27th of July at 13:00 
- 27th of July at 15:00 
- 3rd of August at 13:30 
- 3rd of August at 14:30 
Lunch will be provided  
If you are not able to attend but you are interested in knowing more about this study 
we can arrange further sessions. 
Please, fill in an invitation response and leave it in this envelope or contact Manuel at 
jmanserrano@hotmail.com or 07838198822. 
Thank you 
Jenny Kelly (Chief Investigator) J.Kelly@uea.ac.uk 
Manuel Serrano (Dysphagia Pharmacist) jmanserrano@hotmail.com 
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Appendix 3: Feedback forms from introductory sessions 
 
 
Will an individualised service improve medicine 
administration to adults with dysphagia? 
Introduction session 
We would like some feedback from you: 
Being 1 the most negative score and 10 the most positive  
How would you score…? 
- The flyers displayed   ………………………………. 
- The time of the introduction……………………. 
- The facilitator/s………………………………………. 
- The presentation……………………………………. 
- The subject of the study………………………….. 
- The location of the room…………………………. 
- The snacks provided……………………………….. 
Please add any comments: 
…………………………………………………………………………………….. 
…………………………………………………………………………………….. 
…………………………………………………………………………………….. 
 
 Appendix 4: Training sessions’ flyer  
 
“Will an individualized service improve medicine 
administration to adults with dysphagia - a pilot 
study?” 
 
Important changes are going to happen in the way medication is administered to patients 
with Swallowing Difficulties. 
Please attend to one of the following training sessions on any of these locations: 
- 21st of September: (participating ward) Staff room 
o 12pm 
o 1pm 
o 2pm 
o 3pm 
- 30th of September : (participating ward)  Staff room 
o 12pm 
o 1pm 
o 2pm 
o 3pm 
-  
It is essential that all and only the Staff Nurses from (participating ward)  and 
(participating ward) attend to this training. If you are not able to attend or need more 
information, please contact the sister of your ward or Manuel Serrano ( m.serrano-
santos@uea.ac.uk ) ,  
tel: 07838198822 for further arrangements. 
Food will be provided in all the sessions.  
 
UEA and (participating hospital), 14th September, 2010 
 
 Appendix 5: Feedback forms from training sessions 
 
Will an individualised service improve 
medicine administration to adults with 
dysphagia? 
Training session 
We would like some feedback from you: 
Being 1 the most negative score and 10 the most positive  
How would you score…? 
- The flyers displayed   …………………………… 
- The time of the introduction……………………. 
- The facilitator/s……………………………….…. 
- The presentation…………………………………. 
- The materials provided………………………….. 
- The location of the room…………………………. 
- The snacks provided……………………………… 
Please add any comments: 
………………………………………………………………………………… 
………………………………………………………………………………… 
………………………………………………………………………………… 
 Appendix 6: Consent To Approach (CTA) form 
 
                                                    
 
 
The patient  
Or next of kin 
has given verbal/written consent / assent to a 
clinician in the ward (please initial the patient’s 
label ) to be approached by a Research Assistant 
of the study  “Will an individualised service 
improve medicine administration to adults with 
dysphagia?” 
Please put this sheet upside down in the 
Dysphagia Pharmacist’s tray on the ward 
reception desk  
“Will an individualised service improve medicine administration to adults with dysphagia? 
– a pilot study “ 
 
If you have any queries  call the Dysphagia Pharmacist: 
Manuel Serrano ( Switchboard / 01603 286286) 
Pager 07623606508 (outside call) 
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Appendix 7: Patient Information Sheet (Hospital Study) 
 
 
 
  
Project Title: Will an individualised service improve 
 medicine administration to adults with dysphagia? 
 
Name of Researcher: Jenny Kelly (j.kelly@uea.ac.uk) 
 
 
 
INSTITUTE OF HEALTH 
Teaching Centre 
Queen Elizabeth Hospital 
King’s Lynn 
Norfolk 
PE30 4ET 
 
Telephone 
01553 613751 
Fax 
01553 613723 
 
Invitation 
You are invited to take part in a research study. Before you decide to do so it is important that you 
understand why the research is being done and what it will involve. Please take time to read the following 
information carefully. 
What is the purpose of the study? 
Patients with swallowing difficulties (dysphagia) and / or being fed through a tube sometimes 
experience problems taking their medicines. This study is designed to try and find ways of 
reducing these problems. It aims to evaluate the effectiveness of giving nurses written 
information on how best to give medicines to patients with swallowing difficulties. These guides 
will be introduced on two wards in the hospital by a pharmacist trained in improving how 
medicines are given to patients with swallowing difficulties. 
Why have I been chosen? 
You have been chosen to take part in this study because you have swallowing difficulties and take oral 
medication.  
Do I have to take part? 
No. It is up to you to decide whether or not to take part. If you do, you are asked to read, complete and 
return the two copies of the enclosed Consent form to the research assistant. The research assistant will 
also sign them, and will return one to you to keep. You are still free to withdraw at any time and without 
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giving a reason. A decision to withdraw at any time will not affect the standard of care you receive in 
anyway.  
If you wish to obtain independent information or advice about your rights regarding being involved in this 
research study you can do so by contacting your local NHS Patient Advisory Liaison Service situated at 
this hospital.  
What will my participation involve? 
If you are happy to take part in this study, you will be asked to complete four brief questionnaires before 
you leave hospital. The research assistant will help you to complete them if you wish. Six weeks and six 
months after you have been discharged from hospital the research assistant will contact you again and ask 
you to complete the same four questionnaires that you completed in hospital. If you need help with 
completing them she will help you. Together with the research assistant I would like to have permission 
to look at your medical notes to identify if you have had any emergency admissions to hospital during the 
study period. 
What are the possible benefits of taking part in this research? 
There are unlikely to be any immediate benefits for you in taking part. However, your participation will 
help to evaluate the use of a new document which could improve medicine administration to patients with 
swallowing difficulties in the future.   
What if there is a problem? 
Any complaint about the way you have been dealt with during the study or any possible harm that you 
might suffer will be addressed. If you have any concerns please telephone Dr David Wright, who is a 
senior member of staff within the School of Pharmacy at the University of East Anglia on 01603 592042.   
What happens after I have returned the questionnaires? 
Your answers to the questionnaires, and those of other patients, will be analysed by the researcher.  
Will my taking part in the study be kept confidential? 
Yes. All information about your participation will be kept confidential in accordance with the Data 
Protection Act 1998. Thus all the information about you will be coded so that you cannot be identified 
from it. All personal information and your consent form will be stored by the researcher in a locked filing 
cabinet in an office in the School of Pharmacy at the University of East Anglia, Norwich. These will only 
be viewed by the Chief Instigator and the research assistant. Only the encrypted data will be analysed by 
the research team and this will be stored on a password-protected personal laptop computer, used solely 
for the purpose of research, and kept at the Chief Investigator’s home.  All confidential documentation 
will be destroyed in five years’ time.  
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What will happen to the results of the research? 
The results of the study will be written up as part of a doctoral thesis, a copy of which will be kept in the 
library of the University of East Anglia. They will also be published in a nursing or pharmaceutical 
journal to make other professionals aware of the value of the special guides to administering medicines to 
patients with swallowing difficulties that this project is developing and testing out. 
Who is organising and funding the research? 
The research is being organisd through the School of Pharmacy at the University of East Anglia. The 
project is funded by the National Institute for Health Research for Patient Benefit Scheme. 
Who has reviewed the study? 
This study has been reviewed and agreed by the East Norfolk and Waveney Research Governance 
Committee and the Essex 2 Research Ethics Committee.    
Contact details: 
If you would like further information about this study you can contact Jenny Kelly on 01553 613613, or 
at j.kelly@uea.ac.uk, or UEA School of Nursing and Midwifery, Queen Elizabeth Hospital, King’s Lynn, 
Norfolk, PE30 4ET 
 
 
 
Thank you for taking the time to consider 
becoming involved in this project 
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Appendix 8: Consultee Information Sheet (Hospital Study) 
 
 
 
  
Project Title: Will an individualised service improve 
 medicine administration to adults with dysphagia? 
 
Name of Researcher: Jenny Kelly (j.kelly@uea.ac.uk) 
 
 
 
INSTITUTE OF HEALTH 
Teaching Centre 
Queen Elizabeth Hospital 
King’s Lynn 
Norfolk 
PE30 4ET 
 
Telephone 
01553 613751 
Fax 
01553 613723 
 
Invitation 
We would like to invite (name) to take part in a research study. However, the clinical team do not feel 
that s/he is able to give informed consent to take part in this study because of his / her current mental state. 
The Mental Capacity Act 2005 allows a ‘personal consultee’ to be identified who is willing to be 
consulted about whether a person would want to participate in a study. We would like you to consider 
being the consultee for (name). Before you decide that you would like to act as consultee it is important 
for you to understand why the research is being done, what it will involve, and what your role as 
consultee will be. Please take time to read the following information carefully. 
What is the purpose of the study? 
Patients with swallowing difficulties (dysphagia) and / or being fed through a tube sometimes experience 
problems taking their medicines. This study is designed to try and find ways of reducing these problems. 
It aims to evaluate the effectiveness of giving nurses written information on how best to give medicines to 
patients with swallowing difficulties. These guides will be introduced on two wards in the hospital by a 
pharmacist trained in improving how medicines are given to patients with swallowing difficulties. 
Why have I been approached? 
We want to recruit patients with swallowing difficulties who take oral medication. You care for such a 
person or are interested in his or her welfare other than in a professional capacity or because you are paid 
to do so. You are therefore by law able to act as a personal consultee and we would like you to take on 
this role for (name).  
What does the role of consultee involve? 
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If you decide that the participant should take part in the research you will be asked to complete the four 
brief questionnaires that the participant would have been asked to complete prior to leaving hospital. The 
research assistant will help you to complete them if you wish. You will be offered a diary to record health 
events for the participant and six weeks and six months after the participant has been discharged from 
hospital the research assistant will contact you and ask you to complete the same four questionnaires 
again. If you need help with completing them he / she will help you. Together with the research assistant I 
would like to have permission to look at the participant’s medical notes to identify if they have had any 
emergency admissions to hospital during the study period. 
If you wish to obtain independent information or advice about your rights in acting as a personal 
consultee and being involved in this research study you can do so by contacting your local NHS Patient 
Advisory Liaison Service, situated at this hospital. The research assistant will offer you a copy of the 
Department of Health’s booklet ‘Making decisions: A guide for family, friends and other unpaid carers, 
which includes a section on research. There is also a statutory Independent Mental Capacity Advocate 
(IMCA) service which offers assistance to people lacking mental capacity. The research assistant will 
discuss this service with you and can provide you with a copy of the booklet ‘Making decisions: the 
Independent Mental Capacity Advocate (IMCA) Service’ if you wish. 
Do I have to be a personal consultee? 
No the role is totally voluntary and you are under no obligation to take it on. If you do agree to act as 
personal consultee and then change your mind you can withdraw from the role at any time and this will 
not be detrimental to you in any way, or to the person you care for. 
What are the possible benefits of taking part in this research? 
There are unlikely to be any immediate benefits in taking part. However, your involvement and that of the 
participant’s will help to evaluate the use of a new document which could improve medicine 
administration to patients with swallowing difficulties in the future. 
What if there is a problem? 
Any complaint about the way you have been dealt with during the study or any possible harm that you or 
the participant might suffer will be addressed. If you have any concerns please telephone Dr David 
Wright, who is a senior member of staff within the School of Pharmacy at the University of East Anglia, 
on 01603 592042. 
What happens after we have returned the questionnaires? 
The information from the questionnaires that you completed and those of other patients will be analysed 
by the researcher.  
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Will my involvement in the study and that of the person I care for be kept confidential? 
Yes. All information about your involvement and that of the person you care for will be kept confidential 
in accordance with the Data Protection Act 1998. Thus all the information about the participant will be 
coded so that they cannot be identified from it. All personal information and the form you will be asked to 
sign acknowledge the information you have received will be stored by the researcher in a locked filing 
cabinet in an office in the School of Pharmacy at the University of East Anglia, Norwich. These will only 
be viewed by the Chief Instigator and the research assistant. Only the encrypted data will be analysed by 
the research team and this will be stored on a password-protected personal laptop computer, used solely 
for the purpose of research, and kept at the Chief Investigator’s home.  All confidential documentation 
will be destroyed in five years’ time. 
What will happen to the results of the research? 
The results of the study will be written up as part of a doctoral thesis, a copy of which will be kept in the 
library of the University of East Anglia. They will also be published in a nursing or pharmaceutical 
journal to make other professionals aware of the value of the special guides to administering medicines to 
patients with swallowing difficulties that this project is developing and testing out. 
Who is organising and funding the research? 
The research is being organised through the School of Pharmacy at the University of East Anglia. The 
project is funded by the National Institute for Health Research for Patient Benefit Scheme. 
Who has reviewed the study? 
This study has been reviewed and agreed by the East Norfolk and Waveney Research Governance 
Committee and the Essex 2 Research Ethics Committee.    
Contact details: 
If you would like further information about this study you can contact Jenny Kelly on 01553 613613, or 
at j.kelly@uea.ac.uk, or UEA School of Nursing and Midwifery, Queen Elizabeth Hospital, King’s Lynn, 
Norfolk, PE30 4ET 
Thank you for taking the time to consider 
Becoming involved in this project  
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Appendix 9: Patient consent form (Hospital Study) 
 
Name of Researcher:   Jenny Kelly (j.kelly@uea.ac.uk) 
I confirm that I have read and understand the information sheet   
I have had the opportunity to consider the information, ask questions and have these 
answered satisfactorily. 
 
 
I understand that my participation is voluntary and that I am free to withdraw at any 
time, without giving any reason, without my medical or legal rights being affected.  
I agree to take part in the above study.  
I agree to allow access to my medical records for the purpose of the study.   
I would like to be sent a copy of the research findings.  
 
 
 
 
  
Name of personal consultee Date Signature 
 
 
  
Name of research assistant Date Signature 
When completed, 1 copy for patient; 1 copy for researcher file 
 
Patient Identification Number:    
 
 
Project Title:  Will an individualised service improve medicine administration to 
adults with dysphagia? 
 
Patient Consent Form 
 
 
 
 
INSTITUTE OF 
HEALTH 
Teaching Centre 
Queen Elizabeth Hospital 
King’s Lynn 
Norfolk 
PE30 4ET 
 
Telephone 
01553 613751 
Fax 
01553 613723 
Appendices 
 
    Page 329 of 380 
  
Appendix 10: Consultee consent form (Hospital Study) 
 
 
 
Patient Identification Number:    
 
 
Project Title:  Will an individualised service improve medicine administration 
to adults with dysphagia? 
 
 
Personal Consultee’s Checklist 
 
 
INSTITUTE OF 
HEALTH 
Teaching Centre 
QueenElizabethHospital 
King’s Lynn 
Norfolk 
PE30 4ET 
 
Telephone 
01553 613751 
Fax 
01553 613723 
 
Name of Researcher:   Jenny Kelly (j.kelly@uea.ac.uk) 
Please tick box when completed    
Explanation of why they have been approached. 
  
Discussion of the role of personal consultee, that acting as a consultee is completely 
voluntary, and that they are free to withdraw at any time, without giving any reason, 
without their medical or legal rights being affected. 
 
 
Discussion of what the study involves and what their involvement in it would entail.  
Discussion on whether the participant should take part in the study and if in their opinion 
the participant would have wanted to be involved if they had mental capacity to give 
informed consent.  
 
Offered a copy of Department of Health’s booklet ‘Making decisions: A guide for family, 
friends and other unpaid carers’ and ‘Making decisions: the Independent Mental Capacity 
Advocate (IMCA) Service’. 
 
 
Decision that patient SHOULD / SHOULD NOT (please circle) take part in the study.  
Whether a copy of the research findings is required.  YES / NO (please circle)  
 
 
 
  
Name of personal consultee Date Signature 
 
 
  
Name of research assistant Date Signature 
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Appendix 11: Health Service Use Questionnaire  
 
Project Title: Will an individualised service improve medicine 
                      administration to adults with dysphagia? 
 
Patient Code:          
 
Health Services Use Questionnaire 
 
We would like to monitor your use of the health and social 
care services, and how this changes over the period of this 
study. We would therefore be grateful if you could complete 
the following questions. 
 
 
INSTITUTE OF 
HEALTH 
Teaching Centre 
Queen Elizabeth Hospital 
King’s Lynn 
Norfolk 
PE30 4ET 
 
Telephone 
01553 613751 
Fax 
01553 613723 
 
 
1.  During the 4 weeks prior to this admission have you seen, or been visited by, a health professional? 
Yes    No   
  
 If Yes, please complete the table below.  If No, please go to question 2. 
 
  Number of visits 
in the previous 4 
weeks 
Number of visits 
related  to your 
swallowing 
problems  
Where were you most 
commonly seen? 
(1= GP clinic,  
2 = Home; 3= Hospital) 
Physiotherapist    
Occupational therapist     
Social worker    
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Speech and language 
therapist 
   
Nurse    
GP    
Pharmacist …………………………
…… 
   
 
Q2  Have you been admitted to a residential / nursing home in the 4 weeks prior to this 
admission?   [If ‘NO’, please put ‘00’ in the boxes] 
 
  How many times?  
 
  Name of home ………………………………………………………………………………. 
Q3  Have you attended a day centre in the  4 weeks prior to this admission?  [If ‘NO’,  
  answer ‘00’] 
 
  How many times per week?      
 
Q5  Have you had a home help or community care assistant in the 4 weeks prior to this 
admission?  [If ‘NO’, answer ‘00’] 
 
  How many times per week?  
 
  How long approximately in minutes do they stay?  
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Q6   In a typical week over the 4 weeks prior to this admission, has anyone who lives with 
you had to help you with everyday activities (For example, personal care tasks, housework, 
shopping, trips to see your GP)? [if ‘NO’, answer ‘00’] 
 
  How many times per week?  
 
  How long approximately in minutes do they help you for?               
 
 Did they have to take time off work to help you?  Yes   No   
 
 
Q7  Has a relative or friend who has looked after you in the in the 4 weeks prior to this 
admission had to give up  work completely to in order to do so?    Yes  
 No   
 
Q8  In a typical week over the 4 weeks prior to this admission, has a friend or relative who 
does not live with you had to come and help you with everyday activities (For example, 
personal care tasks, housework, shopping , trips to see your GP)? [If ‘NO’, answer ‘00’] 
 
  How many times per week?  
 
  How long approximately in minutes do they help you for?               
 
  Did they have to take time off work to help you?  Yes   No   
Thank you for taking the time to complete this questionnaire.  
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Appendix 12: Screenshot of database with individualised recommendations 
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Service Evaluation: 
the use of  
Individualised  
Medication  
Administration 
Guides  
 (I-MAGs) 
 
 
 
 
 
• This questionnaire is designed 
to take less than 10 minutes to 
complete. 
 
• Please tick only one box per 
answer 
 
• Complete all the sections unless 
otherwise indicated. 
 
• Return in the stamped 
addresses envelope provided 
 
Appendix 13: Nurse questionnaire (service evaluation) 
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1. Did you attend to the training sessions prior to the commencement of the study? 
    If you answered NO or UNSURE, please go to question 6. 
2. “ The training session adequately prepared me for using the I-MAGs on the ward”  
Strongly 
agree 
 Agree  Undecided  Disagree  Strongly 
disagree 
 
3. “The time allocated for the training sessions was appropriate” 
Strongly 
agree 
 Agree  Undecided  Disagree  Strongly 
disagree 
 
4.  “I found the handout of the session helpful”  
Strongly 
agree 
 Agree  Undecided  Disagree  Strongly 
disagree 
 
5. How do you think the session could improve? 
 
 
 
 
 
 
 
6.  Have you ever seen I-MAGs in the ward?   
                            If your answer is NO, please go to question 23 
7. Do you think that the Medication Chart is the right location   for the I-MAG?  
If your answer was NO, please indicate where you would think it should be 
situated:  
 
8. What layout do you think it is more suitable?        
 
 
 
9. Was the font in the text of the I-MAG easy to 
read? 
 
 
10. What would you suggest changing to improve the presentation of the I-MAGs? 
 
 
  
Yes  No  Unsure  
Yes  No  
Yes  No  
Portrait
 
 Landscape
 
 
Very easy  Easy  Undecided  Hard  Very hard  
Preparation 
Presentation 
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11. How often did you find an I-MAG attached to the medication chart of patients with dysphagia? 
 
 
12. How often did you see the warning that was located in the medication chart indicating how to use 
of the I-MAG? 
 
 
13. Did you ever use the I-MAGs when administering medication?    
If your answer is NO, please explain why and go to question 15 
 
 
 
 
14. How often did you follow the recommendations on the I-MAG?  
 
I
f you didn’t follow them EVERYTIME, what could have encouraged you to use them more often? 
 
 
 
 
15. “The use of the I-MAG increase the amount of time that I spent administering medication” 
 
 
16. ”I am more confident in my practice when the I-MAGs  are  in place” : 
Strongly 
agree 
 Agree  Undecided  Disagree  Strongly 
disagree 
 
 
17. How often were the I-MAGs up-to-date with the information in the Medication chart?  
 
 
18. What do you think that would make the I-MAG more practical? 
 
 
 
 
 
 
 
 
19.  “The Dysphagia Pharmacist was available whenever I needed him” 
Strongly 
agree 
 Agree  Undecided  Disagree  Strongly 
disagree 
 
  
Every time  Very often  Sometimes  Rarely   Never  
Every time  Very often  Sometimes  Rarely   Never  
Yes  No  
Every time  Very often  Sometimes  Rarely   Never  
Every time  Very often  Sometimes  Rarely   Never  
Every time  Very often  Sometimes  Rarely   Never  
Practicality  
Dysphagia Pharmacist 
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20. “The instructions in the I-MAG were easy to understand” 
Strongly 
agree 
 Agree  Undecided  Disagree  Strongly 
disagree 
 
 
21. How often were the instructions in the I-MAG different to what you would have normally 
done/recommended? 
 
 
22. What other information would you like to see in the I-MAG? 
 
 
 
 
 
 
23. Would you like the I-MAGs to continue being produced for patients with 
dysphagia? 
24. Could you mention three main advantages of this service? 
 
 
 
 
25. And what were in your opinion the main three disadvantages? 
 
 
 
 
26. Please add any more comments that you would like to make about this service? 
 
 
 
 
 
 
 
Thank you for taking the time to answer this questionnaire. Please return it to the Dysphagia 
Pharmacist in the stamped envelope.
Every time  Very often  Sometimes  Rarely   Never  
Yes  No  
Content 
 
 
Your Opinion 
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Service Evaluation: 
the use of  
Individualised  
Medication  
Administration 
Guides  
 (I-MAGs) 
 
 
 
 
 
• This questionnaire is designed 
to take less than 10 minutes to 
complete. 
 
• Please tick only one box per 
answer 
 
• Complete all the sections unless 
otherwise indicated. 
 
• Return in the stamped 
addresses envelope provided 
 
Appendix 14: Pharmacist and SALT questionnaire (service evaluation) 
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1. Did you attend to the Informative sessions prior to the commencement of the study? 
    If you answered NO or UNSURE, please go to question 5. 
2. “ The training session adequately informed me about the implementation of the I-MAGs on 
the ward”  
Strongly 
agree 
 Agree  Undecided  Disagree  Strongly 
disagree 
 
3. “The time allocated for the training sessions was appropriate” 
Strongly 
agree 
 Agree  Undecided  Disagree  Strongly 
disagree 
 
4. How do you think the session could improve? 
 
 
 
 
 
 
 
5.  Have you ever seen I-MAGs in the ward?   
                            If your answer is NO, please go to question 21 
6. Do you think that the Medication Chart is the right location   for the I-MAG?  
If your answer was NO, please indicate where you would think it should be 
situated:  
 
7. What layout do you think it is more suitable?        
 
 
 
8. Was the font in the text of the I-MAG easy to read? 
 
 
9. What would you suggest changing to improve the presentation of the I-MAGs? 
 
 
  
I am : Speech and 
Language 
Therapist  
 Pharmacist  Dietician  
Yes  No  Unsure  
Yes  No  
Yes  No  
Portrait
 
 Landscape
 
 
Very easy  Easy  Undecided  Hard  Very hard  
Preparation 
Presentation 
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10. How often did you find an I-MAG attached to the medication chart of patients with dysphagia? 
 
 
11. How often did you see the warning that was located in the medication chart indicating how to 
use of the I-MAG? 
 
 
12. Did you consider the I-MAGs when giving recommendations in the administration of 
medication?    
 
13. “Having I-MAGs in the ward increased the amount of time that I spent in my recommendations 
about how to administer medication” 
 
 
14. ”I am more confident in my practice when the I-MAGs  are  in place” : 
Strongly 
agree 
 Agree  Undecided  Disagree  Strongly 
disagree 
 
 
15. How often were the I-MAGs up-to-date with the information in the Medication chart?  
 
 
16. What do you think that would make the I-MAG more practical? 
 
 
 
 
 
 
 
17. “The instructions in the I-MAG were easy to understand” 
Strongly 
agree 
 Agree  Undecided  Disagree  Strongly 
disagree 
 
 
18. How often were the instructions in the I-MAG different to what you would have normally 
recommended? 
 
 
19. What other information would you like to see in the I-MAG? 
 
 
 
 
 
 
 
 
 
 
Every time  Very often  Sometimes  Rarely   Never  
Every time  Very often  Sometimes  Rarely   Never  
Yes  No  
Every time  Very often  Sometimes  Rarely   Never  
Every time  Very often  Sometimes  Rarely   Never  
Every time  Very often  Sometimes  Rarely   Never  
Practicality  
Content 
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20.   “The Dysphagia Pharmacist was available whenever I needed him” 
Strongly 
agree 
 Agree  Undecided  Disagree  Strongly 
disagree 
 
          
 
 
21. Would you like the I-MAGs to continue being produced for patients with dysphagia? 
22. Could you mention three main advantages of this service? 
 
 
 
 
 
23. And what were in your opinion the main three disadvantages? 
 
 
 
 
 
24. Please add any more comments that you would like to make about this service. 
 
 
 
 
 
 
 
 
 
Thank you for taking the time to answer this questionnaire. Please return it to the 
Dysphagia Pharmacist in the stamped envelope. 
Yes  No  
Dysphagia Pharmacist 
Your Opinion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     Page 342 of 380 
 
  
Appendix 15: Cover letter for service evaluation 
 
 
 
Manuel Serrano 
School of Pharmacy,  
University of East Anglia 
Norwich  NR4 7TJ  
m.serrano-santos@uea.ac.uk 
Tel: 01603 591996 
 
 
 
Individualised Medication Administration Guides (I-MAGs): 
Service Evaluation 
Dear Colleague: 
My name is Manuel Serrano and I am studying for a PhD at the University of East Anglia under the 
main supervision of Professor David Wright. Since the last 10 of January, I have been working as the 
Dysphagia pharmacist in some of the wards of the Norwich and Norfolk University Hospital. As part 
of my role, I have been issuing Individualised Medication Administration Guides (IMAGs) for all in-
patients with dysphagia or Enteral Feeding Tubes (EFT). 
This part of the study is now finished and I would like to ask for your collaboration in evaluating the 
service offered during this period by completing a short questionnaire covering all the facts 
surrounding the delivery of this service. As there are different Health Care professionals involved in 
this project, some of the questions may not be relevant to you as part of your role, which is why I 
would like to start the questionnaire asking you what your role in the wards is. Your feedback is 
extremely valuable so please take some time to fill in these boxes. All information about your 
answers will be kept confidential. Thus all the information about you will be anonymised so that you 
cannot be individually identified from it.  
It is important that your questionnaire reaches us before the 31st of October so, when you have 
finished completing the questionnaire; please return it to the Dysphagia Pharmacist or to one of the 
ward Clerks in the Stroke unit.  
Thank you for taking the time to fill in this questionnaire. Your feedback is important. 
Yours sincerely 
Manuel Serrano 
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Appendix 16: Results from the closed questions (service evaluation) 
 
  Nurses (n)  Pharmacists and SALTs (n) 
Preparation         
  Yes No Unsure  Yes No Unsure 
Did you attend to the Informative sessions prior to the 
commencement of the study? 
 6 5 2  5 1 0 
  SA/A U D/SD  SA/A U D/SD 
“ The training session adequately informed me about the 
implementation of the I-MAGs on the ward” 
 5 1 0  5 0 0 
“The time allocated for the training sessions was 
appropriate” 
 5 0 1  5 0 0 
“I found the handout of the session helpful"  5 1 0     
Presentation         
  Yes No Unsure  Yes No Unsure 
Have you ever seen I-MAGs in the ward  13 0 0  5 1 0 
Do you think that the Medication Chart is the right location   
for the I-MAG? 
 
13 0 0  5 0 0 
  Portrait Landscape  Portrait Landscape 
What layout do you think it is more suitable?  9 4   2 3  
  VE/E U H/VH  VE/E U H/VH 
Was the font in the text of the I-MAG easy to read?  11 2 0  4 1 0 
Practicality         
  Yes No Unsure  Yes No Unsure 
Did you ever use the I-MAGs when administering 
medication? 
 
13 0 0  4 1 0 
  ET/VO S R/N  ET/VO S R/N 
How often did you find an I-MAG attached to the 
medication chart of patients with dysphagia? 
 10 3 0  3 1 1 
How often did you see the warning that was located in the 
medication chart indicating how to use of the I-MAG? 
 10 3 0  4 0 1 
How often did you follow the recommendations on the I-
MAG? 
 12 1 0     
“The use of the I-MAG increase the amount of time that I 
spent administering medication” 
 6 4 3  1 1 3 
How often were the I-MAGs up-to-date with the 
information in the Medication chart? 
 11 2   3 1 0 
  SA/A U D/SD  SA/A U D/SD 
”I am more confident in my practice when the I-MAGs  are  
in place” 
 8 4 1  2 3 0 
Dysphagia Pharmacist         
  ET/VO S R/N  ET/VO S R/N 
“The Dysphagia Pharmacist was available whenever I 
needed him” 
 9 1 3  4 1 0 
Content         
  SA/A U D/SD  SA/A U D/SD 
“The instructions in the I-MAG were easy to understand”  13 0 0  4 1 0 
  ET/VO S R/N  ET/VO S R/N 
How often were the I-MAGs up-to-date with the 
information in the Medication chart? 
 11 2 0  3 1 0 
Your Opinion         
  Yes No Unsure  Yes No Unsure 
Would you like the I-MAGs to continue being produced for 
patients with dysphagia? 
 12 1 0  6 0 0 
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Dear Manuel 
 
Re: Individualised Medication Administration Guidance: Interviews in Nursing homes Ref: 2010/11-47 
 
The resubmission of your above proposal has been considered by the Faculty Research Ethics Committee at 
their meeting on 29th September and we can confirm that your proposal has been approved.  
 
Please could you ensure that any amendments to either the protocol or documents submitted are notified to 
us in advance and also that any adverse events which occur during your project are reported to the 
committee. Please could you also arrange to send us a report once your project is completed 
 
The Committee would like to wish you good luck with your project 
 
Yours sincerely 
 
 
 
 
 
Yvonne Kirkham 
Project Officer 
 
 
 
 
 
 
 
  
Appendix 17: Ethical approval (care home interviews) 
 
 
Manuel Serrano 
School of Pharmacy, room 0.04 
University of East Anglia 
Norwich 
NR4 7TJ 
  
 
 
 
 
 
 
 
 
 
Research & Enterprise Services 
 West Office (Science Building) 
 
University of East Anglia 
Norwich Research Park 
Norwich  
NR4 7TJ 
 
Email: fmh.ethics@uea.ac.uk   
Direct Dial: +44 (0) 1603 59 1566 
Web: http://www.uea.ac.uk 
 
 
30th September 2011 
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Appendix 18: Preliminary information (care home interviews) 
 
 
 
 
Name: _____________________________ 
Preferred contact number: _____________ 
Email address: _______________________ 
 
        Please tick the relevant boxes: 
Age group 20-35  
 36-50  
 51-65  
 66+  
   
Gender 
 
Male 
 
 
 Female 
 
 
   
Location of the Nursing 
home where you  usually 
work  
 
Town centre   
Rural  
Suburban/residential  
Close to Medical centre   
 Other(please state) ____________________________ 
   
Nursing Qualification UK Qualified  
 Non-UK qualified  
 No Nursing qualification  
 Other(please state) ____________________________ 
   
Employment Full time  
 Part Time: ___hours per week  
   
Time spent working as a 
Nurse or Carer in the UK 
  
(to the nearest year)___________________________ 
    
Nationality ____________________________________________ 
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Dear Sir or Madam 
 
My name is Manuel Serrano and I am studying for a PhD at the University of East Anglia under the 
main supervision of Professor David Wright. As part of my role, I am preparing and studying the 
usefulness of Individualised Medication Administration Guides (I-MAGs) for patients with dysphagia.  
These are designed to help the nurse on the ward to give medicines to this group of patients in a 
standardised and safe manner.  They do this by stating clearly when medicines can be safely crushed 
or dispersed, when alternative forms of medication should be used and how to put medicines down 
enteral feeding tubes.   
 
When patients who have agreed to take part in the study are discharged from the Hospital, we are 
giving them I-MAGs to help them to take their medicines appropriately in their homes.  I am 
contacting you to ask whether I could arrange to come and discuss the I-MAG and how useful it is in 
practice with either you yourself, or a member of your staff who may be more directly involved in 
administering medicines. 
 
I would like to carry out an interview of up to one hour.  I would ask about whether the information 
provided in the guide is useful, advantages and disadvantages of using it, and possible ways to 
improve it. Participants will be asked if these interviews can be recorded so that they can be 
accurately typed up to help me accurately identify and analyse the issues discussed and find out how 
to improve the usefulness of I-MAG guides.  However, no individual interviewed or care home will be 
identifiable in any reports.  The study’s findings about carers’ opinions of will help us decide whether 
it would be feasible and useful to develop further research to test the impact of using I-MAGs within 
care homes. 
 
Appendix 19: Cover letter for care home (care home interviews) 
 
 
 
 
 
 
 
 
 
 
Manuel Serrano 
 
School of Pharmacy,  
University of East Anglia 
Norwich  NR4 7TJ  
Email: m.serrano-santos@uea.ac.uk 
Tel: 01603 591996 
 
The Registered Manager 
Care Home address 
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Please provide this information to the nurses or carers in your nursing home to tell them about the 
general nature of this study.  If any of the nurses or carers in your home, including you, may be 
interested in participating, please send back the Initial Contact Acceptance letter.  I will then contact 
you to agree a suitable time to provide more information to potential participants and to seek 
consent for interview. If convenient and after consent has been confirmed, we could then carry out 
the interview or arrange a different, more convenient time. I would appreciate if we could use a 
room or office in your nursing home for the interview. This interview will usually be carried out 
during the working hours of the carer or nurse, but when that may affect the routine of the home, 
alternative times can be arranged by using a room available at the University of East Anglia and the 
travel expenses involved will be covered by the researcher.  Please contact me if you have any 
queries about any aspect of the study at: 
Manuel Serrano 
Medicines Management Research Group 
School of Pharmacy, 
University of East Anglia, 
Norwich Research Park 
Norwich, NR4 7TJ 
Norfolk 
 
Tel 01603591996 
Mob 07838198822 
m.serrano-santos@uea.ac.uk 
 
 
Thank you for taking your time to consider this request. 
 
Yours sincerely 
 
 
 
Manuel Serrano 
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Appendix 20: Participant information sheet (care home interviews) 
 
Manuel Serrano 
School of Pharmacy,  
University of East Anglia 
Norwich NR4 7TJ  
Email: m.serrano-santos@uea.ac.uk 
Tel: 01603 591996 
The effect of Individualised Medication Administration Guidance in 
patients with Dysphagia in Nursing Home 
 
Invitation 
You are invited to take part in a research study. Before you decide to do so it is important that you 
understand why the research is being done and what it will involve for you if you take part. Please 
take time to read the following information carefully. 
 
What is the purpose of the study? 
The aim of this study is to explore your view about using a new type of guide called Individualised 
Medication Administration Guides (I-MAGs) which have been designed for patients who have 
swallowing difficulties and who live in care homes.  These guides are designed to help the nurses and 
carers to give medicines to patients with swallowing difficulties in a standardised and safe way.  This 
means they say clearly when medicines can be safely crushed or dispersed in drinks, and when other 
ways of giving them need be used and how to give medicines through enteral tubes. We also want 
to see how I-MAG guides may be changed to improve their usability in the care home. 
 
What will the study involve? 
If you take part you will have a short interview of up to  an hour with the researcher ((Manuel 
Serrano, a dysphagia pharmacist)  to talk about your views on possible usefulness of Individualised 
Medication  Administration Guides. 
Where will the interview take place? 
The interview will take place in a private room in the Nursing home during your work hours unless it 
is differently agreed to fit the routine in the home or if you prefer to be interviewed somewhere 
else. The travel expenses involved will be covered by the researcher. 
 
Why have I been chosen? 
You have shown interest on this study after being informed by the registered manager of the care 
home where you work for being the nurse or carer in charge of giving medication to patients with 
swallowing difficulties. Your experience is very relevant for this study. However, there is a possibility 
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that you may not be selected if many people have volunteered to be interviewed, even after having 
consented to be interviewed. 
 
Do I have to take part? 
No. It is up to you whether or not you take part. If you choose to take part in the study, you will be 
asked to sign a consent form before you are interviewed. Even after you have signed a consent form, 
you are still free to withdraw from the study at any time and without giving a reason. If you choose 
not to take part, this will not affect your employment or other rights in any way. If you wish to 
obtain independent information or advice about your rights regarding being involved in this research 
study you can do so by contacting Prof David Wright, School of Pharmacy at the University of East 
Anglia, and who is a supervisor for this study, on 01603 592042 or email D.J.Wright@uea.ac.uk, 
University of East Anglia, Norwich  NR4 7TJ. 
 
What will taking part in this study involve for me? 
The researcher (Manuel Serrano) will ask you some questions about what it is like to work in a care 
home and about your views on using I-MAGs guides in your usual practice in giving medications in 
the care home where you work. The interview questions will aim to find out your views about what 
it would be like using the I-MAG guide, how it fits into the daily routines of the care home and what 
you think could be changed to improve how useable it is. We also wish to record the interview if you 
are willing, to help review and analyse the conversation.  
 
What are the possible benefits of taking part? 
There are no direct benefits for you in taking part.  However, you will be helping share and highlight 
the experiences of nurses administer medication to patients with swallowing difficulties, so as to 
help reduce levels of risk of medication errors and improving patients’ health chances. 
 
What are the possible disadvantages of taking part? 
There are no expected disadvantages for you in taking part; however, if you feel uncomfortable 
about discussing any of the questions, you can ask the researcher to discuss them in a way that you 
are more comfortable with or not to discuss the topic at all. 
What if there is a problem? 
If you have any complaint about how you have been dealt with during the study or any concerns or 
possible harm that you might suffer, this will be addressed. If you have any concerns please contact 
Prof David Wright, who is a senior member of staff within the School of Pharmacy at the University 
of East Anglia, and who is a supervisor for this study, on 01603 592042 or email 
D.J.Wright@uea.ac.uk. 
 
What happens after the project comes to an end? 
The data will be analysed by the researcher and his supervisory team and the care home will be sent 
a copy of the overall findings. 
 
Will my taking part in the study be kept confidential? 
Yes. All information about your participation will be kept confidential. Thus all the information about 
you will be anonymised so that you cannot be individually identified from it. All personal information 
and your consent form will be stored by the researcher in a locked filing cabinet in an office in the 
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School of Pharmacy at the University of East Anglia, Norwich. These will only be viewed by the 
Dysphagia Pharmacist and the research assistant. The data will only be analysed by the research 
team (Manuel Serrano and academic supervisors) and this will be stored on a password-protected 
laptop, used solely for the purpose of research, and kept at the researcher’s home. All confidential 
documentation will be destroyed five years after the interview (2016).However the Dysphagia 
Pharmacist as main researcher has the Duty of Care if the interviewee reveals activities that have 
caused or are likely to lead to harm to an individual in the nursing home, the Dysphagia Pharmacist 
as main researcher has a Duty of Care and may need to share this information the relevant 
authorities (Duty of Care Disclosure) 
 
What will happen to the results of the research? 
The results of the study will be written up as part of a doctoral thesis, a copy of which will be kept in 
the library of the University of East Anglia. The results may also be published in an academic or 
professional journal.  These will be used to add to scientific knowledge of this topic and to share with 
other professionals any findings about individualised medicine administration guides from this 
project. 
Who is organising and funding the research? 
The research is being organised and funded through the School of Pharmacy at the University of East 
Anglia.  The information is being used for the researcher’s postgraduate research degree, supervised 
by a multidisciplinary team of experienced researchers.  
Contact details: 
If you would like further information about this study you can contact Manuel Serrano on 
01603591996, at m.serrano-santos@uea.ac.uk, or by writing to Medicines Management Research 
Group, School of Pharmacy, University of East Anglia,   and Norwich, NR4 7TJ. 
 
 
Thank you for taking the time to consider 
becoming involved in this project 
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Appendix 21: Consent form for carer/nurse (care home interviews) 
 
 
 
 
Manuel Serrano 
 
School of Pharmacy,  
University of East Anglia 
Norwich  NR4 7TJ  
Email: m.serrano-santos@uea.ac.uk 
Tel: 01603 591996 
 
«Nursing_home_Name» 
«Address» 
«Postcode»  
 
The effect of Individualised Medication Administration Guidance in 
patients with Dysphagia in Nursing Homes 
 
Please initial the box for each statement with which you agree 
1. I have had the opportunity to consider the information, ask 
questions and to have these answered 
 
2 I understand that if I tell the researcher about something likely to 
lead to harm to an individual in the nursing home, they may need 
to report it to the relevant authorities. 
 
3. I understand that my participation is voluntary and that I am free 
to withdraw at any time, without giving any reason and without it 
affecting my work conditions. 
 
4. I agree for the interview to be audio taped  
5. I agree to take part in the above study.  
 
Name of Participant Signature  Date 
.............................                               .......................                                     ..................... 
Name of the Researcher                       Signature                                                  Date 
...........................                                  ......................                                     ......................
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Appendix 22: Initial contact acceptance letter (care home interviews) 
 
 
 
 
Registered Manager’ Name: ___________________________ 
                                                                     Care Home address: ___________________________              
___________________________ 
 
 
Date: ....../......../........... 
 
 
F.A.O. Manuel Serrano 
Medicines Management Research Group 
School of Pharmacy, 
University of East Anglia, 
Norwich, NR4 7TJ 
Norfolk 
 
Re: The effect of Individualised Medication Administration Guidance in patients with 
Dysphagia in Nursing Home 
 
Dear Manuel: 
Further to the invitation letter to the study mentioned above, and after having informed the 
members of my team about this, I would like to be contacted to agree a time when you can 
give my team members more information about the study. 
Yours sincerely 
 
 
Name:  
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Appendix 23: Set of questions and sub-questions and interviews schedule 
 What is it like working in this care home? 
How busy is the Care home? 
How many residents? 
How many staff? 
How easy do you find the work here? 
What kind of residents lives in this care home? 
What do you think is done differently in this care homes compared to others? 
 
What is your role within the care home?  
How long have you worked here? 
What is your job title? 
Have you worked in other care homes before and if so what kind of work did you do? 
What are your responsibilities in relation to medication here? 
What training have you received or would like to receive?  
What about training for medication? 
 
When you give medication to residents with swallowing difficulties here what does this usually mean 
you need to do? 
Do you ever have to crush tablets, open capsules or change the original formulation of the 
medicines? 
How do you find the administration of medication by EFT? 
What kind of support do you get or would like to get on that practice? 
Do you know what the risks of manipulating medication are? 
How would you improve that? 
 
What would you expect if you were asked to use an individualised medication administration guide to 
help your work with people you look after? 
Is it something you have heard before? 
How do you interpret that concept? 
How would you describe this idea? 
How would it benefit your daily practice? 
What would you like to see in such a guide? 
Now you have looked at this (I-MAG presented), how do you think I-MAGs could be used in the care 
home? 
How would you find having to use and I-MAG on the administration of medication? 
What else would like to see on it and wouldn’t? 
What support do you think you would need to make the best use of this guides? 
Who do you think that could support you on its use? 
Do you think the I-MAG could have an impact the patient’s health? In what ways? 
 
 
  Date of 
interview Participant code Date of interview Participant code 
7/11/2011 N1 23/11/2011 N9 
7/11/2011 N2 24/11/2011 N10 
7/11/2011 N3 25/11/2011 N11 
8/11/2011 N4 25/11/2011 N12 
7/11/2011 N5 30/11/2011 N13 
13/11/2011 N6 29/11/2011 N14 
13/11/2011 N7 2/12/2011 N15 
14/11/2011 N8 
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Appendix 24: Fragment of coded transcription 
  
 Transcription Codes 
MS So, could you please explain what is like working in this care home 
for you? 
 
001 I am actually the manager of the nursing home and also a registered 
nurse.  for me this is possibly nursing at its purist essence in terms 
of we are looking of the whole person , I find  that really rewarding 
and even as a manager  I go home at the end of each day knowing 
that I have made a difference to people‘s lives and that is  why I am 
here and that is what I do 
Qualifications 
 
Essence of nursing 
 
Reward in care 
 
Ms How busy is your home?  
001 At the moment we are actually quite quiet. I have a few empty beds 
and I would say that we tick along quite nicely because I 
fortunately I have some very good staff in senior roles which 
means that without regimentation we work to set standards and 
protocols on times so I wouldn’t say that we are madly busy but is 
due to good time management rather than anything else. Things get 
done appropriately 
 
Workload 
 
Staff in senior roles 
 
time management 
Ms Ok, How many staff would you say you have to help you?  
001 On a normal shift in my nursing until I would normally have 4 
carer in the morning plus a trained nurse, 3 carer in the afternoon 
plus a trained nurse and at night I would have I carer and a trained 
nurse 
And on my dementia unit I would have  3 carers in the morning , 3 
carers in the afternoon and two carers at night  
 
Workforce  
 
Nurse workload 
Ms Ok, so your dementia until r within different premises to here  
001 Yes , they are, within the same site but slightly different building  Swapping location 
Ms And is manager’ role as the same structure as...  
001 No, ...Normally my dementia unit I keep the same staff there partly 
because they have the skills to handle the residences they form 
relationships within a period of time  ..... other staff do work there 
and sometimes I bring my nurses around the dementia unit staff  
over to the general nursing side basically to have the insights and 
inputs on some of my nursing patients who also suffer from 
dementia 
 
Communication with the 
nursing team 
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Appendix 25: Images of the coding process 
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Appendix 26: Organisation of codes into themes 
 
Nurse Home 
environment 
geographical 
Location remote/rural 
Appearance: 
Building 
Appearance 
homely 
atmosphere 
Workload 
Emotional 
Personal  Roles In NH 
Nursing 
home 
Work in the 
NH 
Nurses inputs 
Location of 
staff 
Nurses and 
cares' shifts 
Daily 
Workload 
work in 
nursing 
NH 
Registration 
NH structure Turnover of Patients 
NH 
qualifications 
Teamwork monitoring 
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Professional 
Development of 
Nurses 
General 
approach 
Skills 
development 
Current training Student nurses on MEds.  
Standards of 
care 
Challenges Support from managers 
Personal 
approach 
Personal 
Qualifications 
Experience 
responsability in 
NH 
training 
current training  
past training 
moto 
view of nusing 
on others 
view of nursing 
on oneself 
Views Future training 
Changes in 
practice 
negative 
approach 
Positive 
approach 
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Medicines 
administration 
Dysphagia 
awareness 
Patient level 
Swallowing 
difficulties  
awareness 
Care Plan Level 
Information in 
Care Plans 
Access to Care 
plans 
Care plan format 
errors 
lack of 
standardised 
information 
General practice 
 Drug rounds 
Stock Control 
Medication 
practice 
lack of 
standaridised 
practice 
Covert 
medication 
lack of 
confiedence 
Policies 
GP Instructions 
reporting 
role of nurses 
Decision making 
process 
Pharmacist 
instructiuons 
Hospital 
instructions 
Consequences  
on Decisions in 
MA 
Health 
consequences 
Legal 
consequences 
Duty of Care Knowledge 
Concerns in care 
Time of 
administration 
Support from 
pharmacist 
Regular 
Pharmcist 
Local Pharmacist 
Occasional  
HCPs 
Locum GP 
Agency nurses 
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Patient's Care 
Personalised  
Care from 
Nurses 
Formulation 
choices 
Patients's mood 
Patient's 
Condition 
Other patient's 
conditions 
Selfcare of 
Patients 
Nurse's views of 
Patients 
Holistic Care 
traditional care  
vs innovative 
care 
Communication 
with nursing team 
GP 
Contacting GP 
proof of contact 
Consideration of 
nurses from GP 
Practices of  GP 
Dealing with 
problems reaction from GP  
role of nurses 
SALT Accesible Role of SALT 
Multidisciplinary 
teams 
Health Care 
professionals 
Roles 
Relatives Role of nurses 
Reputation 
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Practicalilty of I-
MAG 
trianing on use of 
I-MAGs 
trainig aims 
Provision of 
training 
Combinations of 
Pharmacist and 
SALT 
I-MAG layout 
Design Signatures from HCPs 
Content 
comments box 
compatibilit with 
food 
side effects 
compatibility 
with other 
products  
measuring 
devices 
times for 
medications 
Usability 
location 
Users 
new members of 
staff 
new patients 
Uses 
Impact of the 
IMAGs 
Practice 
First impression 
Interest 
Patient's care 
decrease in errors 
Improvements in 
heath 
Nurse's practice 
Deskill nurses' 
practice 
Time saving 
Increase of 
confidence decrease cost 
Difference to 
current Practice 
Generation of I-
MAGs 
Community 
pharmacist 
concerns about 
regular updates 
regular visits 
GP 
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Carers 
Qualifications 
Registration 
Knowledge 
use of 
knowledge 
lack of 
Knowledge 
defining the 
role of carer 
Replacing 
nurses 
Suppport 
from the 
nurses 
to the nurses 
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Appendix 27: Final diagrams of the thematic analysis (2) 
Medication administration to patients with dysphagia in nursing homes 
 
Nursing Home Structure 
Role in the 
nursing home 
Location of the 
Nursing Home 
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•lack of 
standardised 
practice 
•formulation 
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Registration 
Interaction between 
Health Care team 
Members 
Secondary Care 
•information from 
hospital 
Primary Care  
•Staff within the 
Nursing Home 
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Physical 
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•drug rounds 
•monitoring 
•reporting 
•stock control 
Emotional 
Workload 
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nurses 
Experience 
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•Positive and 
negative 
approach to 
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Implementation of I-MAGs for Patients with Dysphagia in Nursing Homes 
 
 
Preparation in the 
Nursing Home 
provisionof 
training by 
pharmacist 
Generation of I-
MAGs 
Comunication 
between GP, 
SALT, Nurses 
and Pharmacist 
regular updates 
Content 
Patient details 
signatures of 
HC team 
members 
Comments box 
Clinical 
information 
about drugs 
and their 
administration 
measuring 
devices 
information  
times for 
medication  
Compatibility 
with food and 
other drugs 
Location  
MAR charts 
Users 
 current 
members of 
staff 
new or 
temporary 
members of 
staff 
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standardisation 
of practice 
nurses' 
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nurses's skills 
Patient's health 
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Appendix 28: Agreement of funding 
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Appendix 29: Cover letter for care home (observational drug rounds) 
 
 [Practice’s 
name] 
 
[GP’s Name   
address] 
Telephone number 
 
The Registered Manager 
 
Dear Sir or Madam 
 
My name is [GP’s Name] and I am one of the General Practitioners in [Practice’s name].  
We are aware of the lack of support for patients with swallowing difficulties in our community, so 
[Practice’s name] in liaison with the University of East Anglia is trying to carry out a research study in 
Care Homes with the aim of designing a training programme to support nurses and carers in the best 
practice of administration of medication to patients with swallowing difficulties and/or Enteral 
Feeding Tubes (EFTs). This training will focus on improving the standards of care set by the Care 
Quality Commission (CQC). 
The study will be carried out by a research Pharmacist (main researcher) studying for a PhD at the 
University of East Anglia under the main supervision of Professor David Wright. As part of his role, he 
will observe the different methods used by the nurses and carers in the administration of medication 
to patients with swallowing difficulties and Enteral feeding Tubes (EFTs) in care homes. 
To achieve this, the main researcher would like to observe nurses in your care home during two 
early morning drug rounds. He may be taking notes on the methods used in the administration of 
drugs to patients with swallowing difficulties or EFTs.  Although the main objective is to describe 
what nurses do when administering oral medicines to patients with dysphagia, and to quantify the 
appropriateness of these interventions, he would like to observe the entire drug round and will 
record data when the nurse administers medicines to patients both with and without swallowing 
difficulties, noting the drug details and the administration process on a Data Collection Form. He will 
collect data on each medicine, noting the name, dose, route and formulation given to each patient 
together with the details on the prescription chart so that he can compare the two. He will also note 
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how the nurse prepares and administers each medicine. No personal data will be collected about 
you, the care home or the patient.   
The data from the observations will be used to identify if you are receiving the best formulations for 
your patient’s medication and to ease the design of a training programme focused on how to 
optimise the administration of medication for patients with swallowing difficulties in your care 
home. 
 
Please provide this information and the Participants Information Sheet to the nurses or carers in 
your nursing home to tell them about the general nature of this study.  If any of the nurses or carers 
in your home, including you, are willing to participate, please send back the Initial Contact 
Acceptance letter to me or to the research pharmacist.  He will then contact you to agree a suitable 
time to provide more information to potential participants and to seek consent for the drug round. If 
convenient and after consent has been confirmed, we could then carry out the drug round or 
arrange a different, more convenient time. 
 
Please contact us if you have any queries about any aspect of the study at: 
 
 
[GP’s Name  
and address] 
OR 
 
Manuel Serrano 
Medicines Management Research 
Group 
School of Pharmacy, 
University of East Anglia, 
Norwich Research Park 
Norwich, NR4 7TJ 
Norfolk 
Tel 01603591996 
Mob 07838198822 
m.serrano-santos@uea.ac.uk 
 
Thank you for taking your time to consider this request. 
 
Yours sincerely 
 
 
(GP’s name] 
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Appendix 30: Nurse information sheet (observational drug rounds) 
Observational drug rounds in Care Homes 
 
Invitation 
You are invited to take part in a research study. Before you decide to do so it is important that you 
understand why the research is being done and what it will involve for you if you take part. Please 
take time to read the following information carefully. 
 
What is the purpose of the study? 
The aim of this study is to design a training programme to support nurses and carer in the best 
practice of administration of medication to patients with swallowing difficulties and/or Enteral 
Feeding Tubes (EFTs).  
What will the study involve? 
A  researcher will be observing two early morning drug rounds in the care home where you work. 
The researcher may be taking notes on the methods used in the administration of drugs to patients 
with swallowing difficulties or EFTs. 
Why have I been chosen? 
You have been chosen because you work on one of the care homes involved in the study. 
Do I have to take part? 
No. It is up to you whether or not you take part. If you choose to take part in the study, you will be 
asked to sign a consent form before you are observed. Even after you have signed a consent form, 
you are still free to withdraw from the study at any time and without giving a reason. If you choose 
not to take part, this will not affect your employment or other rights in any way. If you wish to 
obtain independent information or advice about your rights regarding being involved in this research 
study you can do so by contacting Prof David Wright, School of Pharmacy at the University of East 
Anglia, and who is a supervisor for this study, on 01603 592042 or email D.J.Wright@uea.ac.uk, 
University of East Anglia, Norwich  NR4 7TJ. 
 
What will taking part in this study involve for me? 
You will be observed carrying out a drug round. Although the main objective is to describe what 
nurses do when administering oral medicines to patients with dysphagia and where nurses struggle 
on these administrations, the researcher will observe the entire drug round. He will record data 
when you administer medicines to patients both with and without swallowing difficulties, noting the 
drug details and the administration process on a Data Collection Form. He will collect data on each 
medicine, noting the name, dose, route and formulation you give to each patient together with the 
details on the prescription chart so that he can compare the two. He will also note how you prepare 
and administer each medicine. No personal data will be collected about you or the patient.   
His role whilst observing you is purely to collect data for this study and he will not be ‘checking’ the 
drugs with you. If however he observes that you are about to make a potentially serious mistake 
such as giving the wrong drug or dose, he will bring it to your attention in order to minimise patient 
harm. It will then be necessary to complete the home’s standards serious event/incident procedure.  
You will also have to request verbal consent on behalf of the observer to the patient on the day of 
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the observation and before the observer joins you. If you feel the patient suffers from serious 
dementia and is incapable of making a decision, please contact the patient’s relative to ensure they 
are aware that this observation is taking place. 
What are the possible benefits of taking part? 
There are no direct benefits for you in taking part.  However, you will be helping to share and 
highlight the experiences of nurses administering medication to patients with swallowing difficulties 
and will be helping us to identify how we can help you to optimise the administration of medication 
to your residents. 
What are the possible disadvantages of taking part? 
There are no expected disadvantages for you in taking part; however, if you feel uncomfortable 
about discussing any of the questions, you can ask the researcher to discuss them in a way that you 
are more comfortable with or not to discuss the topic at all. 
 
What if there is a problem? 
If you have any complaint about how you have been dealt with during the study or any concerns or 
possible harm that you might suffer, this will be addressed. If you have any concerns please contact 
Prof David Wright, who is a senior member of staff within the School of Pharmacy at the University 
of East Anglia, and who is a supervisor for this study, on 01603 592042 or email 
D.J.Wright@uea.ac.uk. 
 
What happens after the project comes to an end? 
The data will be analysed by the researcher and his supervisory team and the care home will be sent 
a copy of the overall findings. 
 
Will my taking part in the study be kept confidential? 
Yes. All information about your participation will be kept confidential. Thus all the information about 
you will be anonymised so that you cannot be individually identified from it. All personal information 
and your consent form will be stored by the researcher in a locked filing cabinet in an office in the 
School of Pharmacy at the University of East Anglia, Norwich. These will only be viewed by the main 
researcher. The data will only be analysed by the research team (Manuel Serrano and academic 
supervisors) and this will be stored on a password-protected laptop, used solely for the purpose of 
research, and kept at the researcher’s home. All confidential documentation will be destroyed five 
years after. However the main researcher has the Duty of Care if the rounds reveal activities that 
have caused or are likely to lead to harm to an individual in the nursing home, the main researcher 
has a Duty of Care and may need to share this information the relevant authorities (Duty of Care 
Disclosure) 
What will happen to the results of the research? 
The results of the study will be written up as part of a doctoral thesis, a copy of which will be kept in 
the library of the University of East Anglia. The results may also be published in an academic or 
professional journal.  These will be used to add to scientific knowledge of this topic and to share with 
other professionals any findings about individualised medicine administration guides from this 
project. 
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Who is organising and funding the research? 
The research is being organised and funded through the School of Pharmacy at the University of East 
Anglia and Rosemont Pharmaceuticals.  The information is being used for the researcher’s 
postgraduate research degree and supervised by a multidisciplinary team of experienced 
researchers.  
Contact details: 
If you would like further information about this study you can contact Manuel Serrano on 
01603591996, at m.serrano-santos@uea.ac.uk, or by writing to Medicines Management Research 
Group, School of Pharmacy, University of East Anglia,   and Norwich, NR4 7TJ. 
 
Thank you for taking the time to consider 
becoming involved in this project
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Please initial the box for each statement with which you agree 
1. I have had the opportunity to consider the information provided 
in the Information sheet ( Version 1, April 2012), ask questions 
and to have these answered 
 
2 I understand that if I do or I tell the researcher about something 
likely to lead to harm to an individual in the nursing home, he 
may need to report it to the relevant authorities. 
 
3. I understand that my participation is voluntary and that I am free 
to withdraw at any time, without giving any reason and without it 
affecting my work conditions. 
 
4. I agree to be observed during one or more drug rounds  
5. I agree to take part in the above study. 
 
 
If you feel the patient suffers from serious dementia and is incapable of making a decision, please 
contact the patient’s relative to ensure they are aware that this observation is taking place. 
Name of Participant Signature  Date 
.............................                     ......................                             ..................... 
Name of the Researcher                  Signature                                          Date 
...........................                                 ......................                                      ..................... 
 
Appendix 31: Nurse consent form (observational drug rounds) 
 
 
 
 
 
Manuel Serrano 
School of Pharmacy,  
University of East Anglia 
Norwich  NR4 7TJ  
Email: m.serrano-santos@uea.ac.uk 
Tel: 01603 591996 
 
{Care Home Name and address]  
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Appendix 32: Nurse invitation letter (observational drug rounds) 
 
 
 
 
 
 
 
 
 
 
Manuel Serrano 
School of Pharmacy,  
University of East Anglia 
Norwich  NR4 7TJ  
Email: m.serrano-santos@uea.ac.uk 
Tel: 01603 591996 
 
 
Dear Sir or Madam 
 
My name is Manuel Serrano and I am a Research Pharmacist studying for a PhD at the University of 
East Anglia under the main supervision of Professor David Wright. As part of my role, I am trying to 
observe the different methods used by the nurses and carers in the administration of medication to 
patients with swallowing difficulties and Enteral feeding Tubes (EFTs) in care homes with the aim of 
designing a training programme to support nurses and carers in the best practice of administering 
medication to patients with swallowing difficulties and/or Enteral Feeding Tubes (EFTs). 
 
I would like to observe you during two early morning drug rounds in the care home. I may be taking 
notes on the methods used in the administration of drugs to patients with swallowing difficulties or 
EFTs. Although the main objective is to describe what nurses do when administering oral medicines 
to patients with dysphagia and where nurses struggle on these administrations, I will observe the 
entire drug round and will record data when you administer medicines to patients both with and 
without swallowing difficulties, noting the drug details and the administration process on a Data 
Collection Form. I will collect data on each medicine, noting the name, dose, route and formulation 
you give to each patient together with the details on the prescription chart. I will also note how you 
prepare and administer each medicine. No personal data will be collected about you or the patient.   
 
Please take some time to read though the Information sheet attached to this letter and, if 
convenient and after consent has been confirmed, we could then carry out the drug round or 
arrange a different, more convenient time. This observational drug round will usually be carried out 
during the morning.  
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 Please contact me if you have any queries about any aspect of the study at: 
Manuel Serrano 
Medicines Management Research Group 
School of Pharmacy, 
University of East Anglia, 
Norwich Research Park 
Norwich, NR4 7TJ 
Norfolk 
 
Tel 01603591996 
Mob 07838198822 
m.serrano-santos@uea.ac.uk 
 
 
Thank you for taking your time to consider this request. 
 
Yours sincerely 
 
 
 
Manuel Serrano 
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Appendix 33: Patient information sheet (observational drug rounds) 
Patient Information Sheet 
Observational drug rounds in Care Homes 
 
Invitation 
A researcher will be visiting the care home tomorrow to observe one of the nurses giving out 
medicines to a group of patients, of which you (your relative) may be one.  
What is the purpose of the study? 
The aim of this study is to design a training programme to support nurses and carer in the best practice 
of administration of medication to patients with swallowing difficulties and/or Enteral Feeding Tubes 
(EFTs).  
Why will the nurse be observed giving drugs to me (my relative)? 
The researcher wants to observe the nurse giving medicines to patients with and without swallowing 
difficulties and feeding tubes so that a comparison can be made. 
What will my (relative’s) participation involve? 
You (your relative) will not need to do anything other than take your (their) medicines as normal.  
Do I (my relative) have to take part? 
No. It is up to you to decide whether or not to take part. If you do not wish to take part (do not want 
your relative to take part) please indicate this to the nurse either before or during the medicine round. 
If you choose not to take part (do not want your relative to take part) you do not need to give a reason 
and it will not affect the standard of care you (your relative) receive(s) in anyway.  
Please, feel free to discuss with your relatives 
Thank you for taking the time to consider becoming involved in this project 
 
 
 
 
 
 
 
 
 
 
Manuel Serrano 
School of Pharmacy,  
University of East Anglia 
Norwich  NR4 7TJ  
Email: m.serrano-santos@uea.ac.uk 
Tel: 01603 591996 
   
 
Preparation code 
NONE 1 
Tablet crushed with pestle and 
mort 2 
Tablet crushed with syringe 3 
Capsule opened 4 
Dispersed / dissolved in water 5 
Liquid diluted with water 6 
Squash added 7 
Prepared by Manufacturing Dept 8 
 
Missed dose code 
Medicine unavailable 1 
Prescription wrong 2 
Patient refused to take  3 
Patient unable to take med (give reason) 4 
NIL by mouth 5 
Omitted for medical reason 6 
+/- 60 min late 7 
 
Texture 
Nectar 1 
Honey 2 
Pudding 3 
 
 
Appendix 34: Data collection form (EFTs) 
 
 
 
Use shaded area if what given differs from that prescribed 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
  
    
    
          
 
 
 
 
  
Date            /              /  2008 
Care Home  
Day M   T   W   T   F   S   S 
7-9am 12-2pm Time 
   
Nurse code  Pt Code  
Room number  
Dysphagia Yes    No   
Insert codes or annotate using  or  
 
Drug Chart  
 
Preparation Code(s) 
+ 
Comments 
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Other Comments 
e.g. Tablet not allowed enough time 
to dissolve, etc. 
Medicine Dose Route Form. 
                
                
                
                
                
                
                
                
                
                
                
                
                
                
 
Administration code 
Flushed down tube 1 
Dissolved in mouth 2 
 
Help sought 
Doctor = D Pharmacist = P 
Sister  = S Medicines Info     = M 
Nurse  = N SALT Team         = T 
BNF    = B Dietician               = F 
 
   
 
Texture 
Nectar 1 
Honey 2 
Pudding 3 
 
Missed dose code 
Medicine unavailable 1 
Prescription wrong 2 
Patient refused to take  3 
Patient unable to take med (give reason) 4 
NIL by mouth 5 
Omitted for medical reason 6 
+/- 60 min late 7 
 
Preparation code 
NONE 1 
Tablet crushed with pestle and 
mort 2 
Tablet crushed with syringe 3 
Capsule opened 4 
Dispersed / dissolved in water 5 
Liquid diluted with water 6 
Squash added 7 
Prepared by Manufacturing Dept 8 
 
 
Appendix 35: Data collection form (oral medication) 
 
 
 
Use shaded area if what given differs from that prescribed 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
  
   
 
   
          
 
 
 
 
Date          /              /  2008 
Care home  
Day M   T   W   T   F   S   S 
Nurse Code  Pt Code  
Room  Number   
Dysphagia   Yes    No   
7-9am 12-2pm Time 
   
Administration code 
Sprinkled on food 1 
Swallowed with water 2 
Swallowed 3 
Dissolved in mouth 4 
Sucked/chewed 5 
 
Insert codes or annotate using  or  
 
Drug Chart  
 
Preparation Code(s) 
+ 
Comments 
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Other Comments 
e.g. Tablet not allowed enough time to 
dissolve, etc. 
Medicine Dose Route Form. 
               
               
               
               
               
               
               
               
               
               
               
               
               
               
 
Help sought 
Doctor = D Pharmacist = P 
Sister  = S Medicines Info     = M 
Nurse  = N SALT Team         = T 
BNF    = B Dietician               = F 
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Appendix 36: Ethical approval (observational drug rounds) 
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Appendix 37: 25 most frequently prescribed drugs  
 
25 most frequently prescribed drugs to residents 
without Dysphagia 
Times 
prescribed % 
Paracetamol          52 8.7% 
Aspirin                46 7.7% 
Macrogol  37 6.2% 
Furosemide         30 5.0% 
Lansoprazole             29 4.9% 
Levothyroxine         29 4.9% 
Calcium salts  21 3.5% 
Citalopram            21 3.5% 
Ferrous salts         21 3.5% 
Omeprazole             17 2.9% 
Digoxin               15 2.5% 
Lactulose solution              13 2.2% 
Bisoprolol            11 1.8% 
Metformin               9 1.5% 
Amlodipine       8 1.3% 
Folic acid        7 1.2% 
Gliclazide              7 1.2% 
Simvastatin               7 1.2% 
Atenolol                6 1.0% 
Clopidogrel               6 1.0% 
Co-Codamol           6 1.0% 
Sertraline              6 1.0% 
Codeine                5 0.8% 
Isosorbide mononitrate     5 0.8% 
Prednisolone     5 0.8% 
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25 most frequently prescribed drugs to PWD Times prescribed % 
Paracetamol    15 10.5% 
Macrogol      12 8.4% 
Aspirin                  10 7.0% 
Citalopram    10 7.0% 
Calcium salts            8 5.6% 
Lansoprazole    6 4.2% 
Sodium valproate    6 4.2% 
Levothyroxine    5 3.5% 
Co-Beneldopa    4 2.8% 
Co-Codamol    4 2.8% 
Folic acid   3 2.1% 
Omeprazole   3 2.1% 
Procal shot                      3 2.1% 
Sertraline    3 2.1% 
Co-Careldopa                         3 2.1% 
Atenolol               2 1.4% 
Bisoprolol       2 1.4% 
Cetirizine   2 1.4% 
Digoxin     2 1.4% 
Fludrocortisone    2 1.4% 
Fluoxetine    2 1.4% 
Furosemide    2 1.4% 
Lactulose solution               2 1.4% 
Memantine    2 1.4% 
Stalevo    2 1.4% 
 
